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i 
 
Abstract 
The methanolic atom transfer radical polymerisation (ATRP) of 2-hydroxypropyl 
methacrylate (HPMA) to controllably form the hydrophobic polymer p(HPMA) 
using a one-pot methodology at ambient temperature has been demonstrated, where 
polymerisations were shown to reach >99 % conversion.  By simple variation of 
initiator:monomer feed ratio, polymers of varying chain length were synthesised. 
Using identical polymerisation conditions, addition of a small amount of ethylene 
glycol dimethacrylate (EGDMA) divinyl brancher resulted in the generation of high 
molecular weight branched copolymers without any modification of reaction 
kinetics. This approach was extended to include the first synthesis of linear and 
branched amphiphilic A-B block copolymers using polyethylene oxide (PEG) 
macroinitiators without loss of the ATRP controlled polymerisation. A series of 
systematically varying copolymers, containing variation in PEG length and/or 
variation in p(HPMA) primary chain length, have been synthesised to allow direct 
comparison of the impact of architectural variation on polymer properties. 
  
Nanopreciptation approaches were investigated for the linear and branched 
copolymers and extremely stable hydrophobic nanoparticles were produced using 
copolymers with branched architecture. Moreover, it has been shown that 
nanoparticle z-average diameter can be controlled using extremely facile methods.  
The loading capacity of amphiphilic branched A-B block copolymer nanoparticles 
with various guest-molecules has been systematically investigated.  The world 
leading HIV/AIDS antiretroviral drug Lopinavir (LPV) was used in a preliminary 
loading screen and shown to produce candidate LPV/drug nanocarrier options for 
future studies and optimisation. 
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and copolymerisations of HPMA and HPMA/EGDMA by methanolic 
ambient ATRP.  p(HPMA50) (circles) and p((HPMA50)-co-
EGDMA0.95) (triangles). 
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Figure 3.21: GPC (THF eluent) chromatograms for the kinetics study of the 
copolymerisation of HPMA and EGDMA by methanolic ambient 
ATRP to form p((HPMA50)-co-EGDMA0.95). 
Figure 3.22  Overlaid GPC chromatograms of p(HPMA50) (solid line) and 
p((HPMA50)-co-EGDMA0.95) (dashed line). 
Figure 3.23:   Weight average molecular weight and dispersity vs. conversion (%) 
plots determined during the kinetics study of the copolymerisation of 
HPMA and EGDMA by methanolic ambient ATRP to form 
p((HPMA50)-co-EGDMA0.95). 
Figure 3.24:  Mn vs. conversion plot for the copolymerisation of HPMA and 
EGDMA by methanolic ambient ATRP polymerisation to form 
p((HPMA50)-co-EGDMA0.95). 
Figure 3.25:  GPC chromatograms at varying points during a branched chain 
extension using methanolic ATRP to form p((HPMA30)-b-
((HPMA50)-co-EGDMA0.95)). 
Figure 3.26:  Overlaid Refractive Index chromatograms from GPC analysis (THF 
eluent) of p((HPMA80)-co-EGDMA0.95) (solid line) and p(HPMA30)-
b-p(HPMA50)-co-EGDMA0.95) (dashed line). 
Figure 3.27:  Overlaid Refractive Index chromatograms from GPC analysis (THF 
eluent) of p((HPMA120)-co-EGDMA0.95) (solid line) and p(HPMA30)-
b-p((HPMA50)-co-EGDMA0.95) (dashed line). 
Figure 3.28:  Representation of the range of materials believed to be present within 
p((HPMAx)-co-EGDMA0.95) samples. 
Figure 4.1:  Z-average diameter analysis of nanoparticles comprising of 
p(HPMA80) at 1 mg mL
-1
 using two methods; dripping method (solid 
line) and dialysis (dashed line). 
Figure 4.2:  DLS characterisation of rapidly nanoprecipitated linear polymers 
from a starting concentration of 10 mg mL
-1
 in acetone giving a final 
aqueous concentration of 2 mg mL
-1
. p(HPMA50) (solid line), 
p(HPMA80) (large dashed line)and p(HPMA120) (small dashed line). 
Figure 4.3:  DLS characterisation of nanoprecipitated linear polymers from a 
starting concentration of 5 mg mL
-1
 in acetone giving a final aqueous 
concentration of 1 mg mL
-1
.   p(HPMA50) (solid line), p(HPMA80) 
(large dashed line)and p(HPMA120) (small dashed line). 
Figure 4.4: DLS measurements of nanoparticles (1 mg mL
-1
) formed from 
p((HPMA80)-co-EGDMA0.95) via three different preparation routes.  
Dialysis (sold line), Dropwise (medium dashed line), Rapid (small 
dashed line). 
Figure 4.5:  Comparison of nanoparticles formed from p((HPMA50)-co-
EGDMA0.95) using two different starting copolymer/acetone 
concentrations each achieving a five-fold dilution.  5 mg mL
-1
 
(dashed line), 10 mg mL
-1
 (solid line). 
Figure 4.6:  DLS measurements for the nanoparticles of p((HPMA50)-co-
EGDMA0.95) (solid line),  p((HPMA80)-co-EGDMA0.95) (large dashed 
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line) and p((HPMA120)-co-EGDMA0.95) (small dashed line) prepared 
using rapid nanoprecipitation (starting copolymer concentration = 5 
mg mL
-1
, final copolymer concentration = 1 mg mL
-1
). 
Figure 4.7:  DLS nanoparticle distributions with adjusted initial concentrations for 
primary chain lengths. p((HPMA50)-co-EGDMA0.95) (3.125 mg mL
-1 
starting concentration, 0.625 mg mL
-1
 final concentration) (short 
dashed line), p((HPMA80)-co-EGDMA0.95) (5 mg mL
-1 
starting 
concentration, 1 mg mL
-1
 final concentration) (medium dashed line) 
and p((HPMA120)-co-EGDMA0.95) (7.5 mg mL
-1 
starting 
concentration, 1.5 mg mL
-1
 final concentration) (solid line). 
Figure 4.8:  DLS measurements of rapidly precipitated nanoparticles comprising 
of p((HPMA80)-co-EGDMA0.95) (5 mg mL
-1
 starting concentration; 1 
mg mL
-1
 final concentration)  prepared on three separate occasions. 
Figure 4.9:  DLS characterisation of nanoprecipitated p((HPMA80)-co-
EGDMA0.95) using  5 mg mL
-1
 starting concentration; 1 mg mL
-1
 final 
concentration.  1 mL starting volume; 5 mL final volume (solid line), 
10 mL starting volume; 50 mL final volume (dashed line). 
Figure 4.10: Z-average diameters of nanoparticles prepared using rapid 
nanoprecipitation from acetone. (A)  Control of particle z-average 
diameter by varying initial copolymer concentration in acetone for 
p((HPMA50)-co-EGDMA0.95). (B)  DLS characterisation of 
nanoprecipitated p((HPMAx)-co-EGDMA0.95).  Demonstrating control 
of nanoparticle z-average diameter by varying primary chain length.  
DPn =50 (circles), 80 (triangles), 120 (squares). 
Figure 4.11:  Scanning electron microscopy images of nanoprecipitated 
p((HPMA80)-co-EGDMA0.95) and histogram distributions derived 
from the analysis of 250 individual nanoparticles.  Variation of 
dilution from an initial concentration of 5 mg mL
-1
 in acetone to give 
final concentrations of; 1 mg ml
-1
 (A and D) (mean 77 nm, sd 13.8 
nm), 2 mg mL
-1
 (B and E) (mean 75 nm, sd 26.2 nm) and 5 mg mL
-1
 
(C and F) ( mean 173 nm, sd 83.8 nm). 
Figure 4.12:  Further scanning electron microscopy images of nanosuspensions 
comprising of p(HPMA80)-co-EGDMA0.95) with variation of dilution 
from an initial concentration of 5 mg mL
-1
 in acetone to give final 
concentrations of; 1 mg ml
-1
 (A), 2 mg mL
-1
 (B) and 5 mg mL
-1
 (C). 
Figure 4.13:  DLS characterisation of branched copolymers in acetone at 10 mg 
mL
-1
. p((HPMA50)-co-EGDMA0.95) (solid line), p((HPMA80)-co-
EGDMA0.95) (medium dashed line), p((HPMA120)-co-EGDMA0.95) 
(small dashed line). 
Figure 4.13: Serial dilution data for the nanoparticles comprised of p((HPMA80)-
co-EGDMA0.95) with a starting and finishing concentration of 5 and 1 
mg mL
-1
 respectively.  A) Nanoparticle diameter and polydispersity 
vs. Concentration of suspension.  B)  Derived count rate and 
Attenuator vs. Concentration of suspension. 
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Figure 4.14:  Studies into the response of methanol addition to nanoprecipitated 
p((HPMA80)-co-EGDMA0.95) (5 mg mL
-1
 initial concentration; 1 mg 
mL
-1
 final aqueous concentration.  (A) Z-average diameters and 
polydispersity. (B) Derived count rate and Attenuator both measured 
using DLS. 
Figure 4.15:  Z-average diameter and polydispersity measurements of nanoparticles 
comprised of p((HPMA80)-co-EGDMA0.95) using a starting 
concentration of 5 mg mL
-1
 and varying the dilution ratio from 1 to 
0.05  Solid symbols indicate measurements after one day, open 
symbols indicate measurements after seven months. 
Figure 4.16:  Comparison of nanoprecipitated p(HPMA) from an initial 
concentration of 5 mg mL
—1
 in acetone to give varying final aqueous 
dispersions from 5 mg mL
-1
 (far left), 4 mg mL
-1
, 2 mg mL
-1
, 1 mg 
mL
-1
, 0.25 mg mL
-1
 (far right). (A) p(HPMA80-co-EGDMA0.95) 
branched copolymer seven months after nanoprecipitation; (B) 
p(HPMA80) linear polymer two weeks after nanoprecipitation. 
Figure 4.17:  Temperature studies on nanoprecipitated p((HPMA80)-co-
EGDMA0.95) prepared by rapid precipitation (5 mg mL starting 
concentration; 1 mg mL final concentration). z-average diameter 
(circles) and polydispersity (triangles). 
Figure 4.18: DLS characterisation of sonicated p((HPMA80)-co-EGDMA0.95) 
nanosuspension prepared by rapid precipitation (5 mg mL
-1
 starting 
concentration; 1 mg mL
-1
 final concentration) using 50 % intensity 
over 365 seconds. 
Figure 4.19: Sonication studies of nanoprecipitated p((HPMA80)-co-EGDMA0.95) 
aqueous suspension. (5 mg mL
-1
 initial concentration; 1 mg mL
-1
 final 
concentration). (A) Z-average diameter and polydispersity vs. 
sonication time. (B) DLS characterisation of particles at various 
sonication times.  Time = 0 seconds (solid line) 5 seconds (medium 
dashed line), 225 seconds (small dashed line). 
Figure 4.20: Sonication studies of nanoprecipitated p((HPMA80)-co-EGDMA0.95) 
aqueous suspension. (5 mg mL
-1
 initial concentration; 1 mg mL
-1
 final 
concentration).  Derived count rate against total sonication time. 
Figure 4.21: DLS characterisation of nanoprecipitated p((HPMA80)-co-
EGDMA0.95) 5 mg mL
-1
starting concentration; 1 mg mL
-1
 final 
concentration.  Response to electrolyte (0.5M NaCl) addition. (A) Z-
average diameter (solid circles), Polydispersity (open circles) (B) 
Attenuator (solid triangles), Derived count rate (open triangles). 
Figure 4.22:  Triple Detection GPC analysis of p(HPMA) oligomers.  THF eluent 
(A). Acetone eluent (B). 
Figure 4.23:  Aqueous solubility study of p(HPMA) with varying chain length (DP-
n). 
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Figure 4.24:  Study of the effect of temperature on an oligomer of p(HPMA) (DPn 
= 8 by 
1
H NMR).  Derived count rate and attenuator measure during 
heating within the DLS instrument. 
Figure 4.25:  GPC chromatograms (THF eluent) of p(HPMA) blocking 
experiments.  Linear-b-linear; block 1 (88% conversion) (blue line), 
final block copolymer (>99% conversion) (dark blue line).   Linear-b-
branched; block 1 (81% conversion) (red line), final branched block 
copolymer (>99% conversion) (dark red line). 
Figure 4.26:  DLS characterisation of p((HPMA30)-b-(HPMA50-co-EGDMA0.95)).  
A) p((HPMA80)-co-EGDMA0.95) (solid line) and p((HPMA30)-b-
(HPMA50-co-EGDMA0.95)) (dashed line). B) p((HPMA30)-b-
(HPMA50-co-EGDMA0.95)) nanoparticle analysis over time. (5 mg 
mL
-1
 starting concentration; 1 mg mL
-1
 final concentration). 
Figure 5.1:  
1
H NMR spectra in CDCl3 of PEGx-OH. (A) PEG17-OH. (B) PEG45-
OH. (C) PEG113-OH. 
Figure 5.2:  
1
H NMR spectra of (A) monomethoxy PEG-OH and (B) Esterified 
monomethoxy PEG-Br recorded in CDCl3. 
Figure 5.3:  
1
H NMR spectra in CDCl3 of PEGx-Br. A) PEG17-Br. B) PEG45-Br. 
C) PEG113-Br. 
Figure 5.4:  GPC chromatograms of two PEG macroinitiators. PEG45-OH (Mn = 
2100; Mn theory = 2000; dashed line) and PEG113-OH (Mn = 5600, Mn 
theory = 5000; solid line). 
Figure 5.5:  Representation of amphiphilic copolymers with varying both 
hydrophilic (PEG) (A) and hydrophobic (HPMA) (B) content 
Figure 5.6:  
1
H NMR spectrum of PEG17-b-p(HPMA50) in DMSO-d6. 
Figure 5.7:  GPC chromatograms of PEGx-Br initiated linear pHPMA 
copolymers.  (A) PEG17-p(HPMAx) (B) PEG45-p(HPMAx) (C) 
PEG113-p(HPMAx).  DPn = 50 (solid lines), DPn = 80 (medium dashed 
lines) DPn = 80 (small dashed lines) 
Figure 5.8: GPC chromatograms of PEG17-b-p(HPMA50) (red line), PEG45-b-
p(HPMA50) (green line), PEG113-b-p(HPMA50) (blue line). 
Figure 5.9:  Kinetic studies of p(HPMA80) using PEG-Br based macroinitiators.  
A) PEG17-b-p(HPMA80). B) PEG45-b-p(HPMA80). C)  PEG113-b-
p(HPMA80). 
Figure 5.10:  Kinetic studies of p(HPMA80) polymerisation using PEG-Br based 
macroinitiators.  A)  Conversion vs. time.  PEG17-Br (red), PEG45-Br 
(green), PEG113-Br (blue).  B) Semi-logarithmic plot.  PEG17-Br (red), 
PEG45-Br (green), PEG113-Br (blue). 
Figure 5.11:  Evolution of molecular weight with conversion.  PEG17-Br (red), 
PEG45-Br (green), PEG113-Br (blue).   
Figure 5.12:  Kinetic studies of p(HPMAx) using PEG17-Br initiator.  A) PEG17-b-
p(HPMA30). B) PEG17-b-p(HPMA50). C)  PEG17-b-p(HPMA100). 
Figure 5.13:  Kinetic studies of p(HPMAx) using PEG17-Br macroinitiator.  A)  
Conversion vs. time.  x = 30 (filled circles), x = 50 (filled triangles), x 
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= 100 (filled squares).  B) Semi-logarithmic plot.  x = 30 (open 
circles), x = 50 (open triangles), x = 100 (open squares). 
Figure 5.14:  GPC chromatograms (THF eluent) for PEG17-Br initiated p(HPMA) 
copolymers with target DPn ranging from 20 to 120 monomer units. 
Figure 5.15  Dispersity vs. target DPn for PEG17-Br initiated polymers. (Symbol 
colours are indicative of those used for individual GPC 
chromatograms in Figure 5.14). 
Figure 5.16:  Target vs. Actual Mn for PEG17-Br initiated copolymers with target 
DPn ranging from 20 to 120 monomer units. 
1
H NMR (squares) GPC 
(triangles). (Symbol colours are indicative of those used for 
individual GPC chromatograms in Figure 5.14 and Figure 5.15). 
Figure 5.17:  Triple detection GPC chromatograms for the chain extension of 
p(HPMAx) utilising PEG17-Br initiator.  (A) PEG17-b-(p(HPMA30)-b-
p(HPMA30)).  (B) PEG17-b-(p(HPMA50)-b-p(HPMA30)).  PEG17-b-
(p(HPMA100)-b-p(HPMA30)). 
Figure 5.18:  GPC chromatograms of PEG17-Br initiated chain extended HPMA 
polymers (dot-dot-dashed lines) and their linear non-extended 
counterparts (solid lines).  (A) Overall DPn = 60 monomer units. (B) 
Overall DPn = 80 monomer units. (C) Chain extended polymer - 
overall DPn = 130 monomer units and non-extended polymer - overall 
DPn = 120 monomer units. 
Figure 5.19:  Representation of the targeted branched p(HPMAx) copolymers 
utilising PEGx-Br based macroinitiators. 
Figure 5.20: GPC chromatograms of PEGx-Br initiated branched p(HPMA) 
copolymers.  (A) PEG17-b-(p(HPMAx)-co-EGDMA0.95)) (B) PEG45-b-
(p(HPMAx)-co-EGDMA0.95)) (C) PEG113-b-(p(HPMAx)-co-
EGDMA0.95)).  X = 50 (solid lines), X = 80 (medium dashed lines) X = 
120 (small dashed lines). 
Figure 5.21:  Repeat GPC Chromatograms (THF eluent) of PEG17-b-(p(HPMAx-
co-EGDMA0.95).  A) PEG17-b-(p(HPMA50-co-EGDMA0.95). B) 
PEG17-b-(p(HPMA80-co-EGDMA0.95). C) PEG17-b-(p(HPMA120-co-
EGDMA0.95). 
Figure 5.22:  Repeat GPC Chromatograms (THF eluent) of PEG45-b-(p(HPMAx-
co-EGDMA0.95).  A) PEG45-b-(p(HPMA50-co-EGDMA0.95). B) 
PEG45-b-(p(HPMA80-co-EGDMA0.95). C) PEG45-b-(p(HPMA120-co-
EGDMA0.95). 
Figure 5.23:  Repeat GPC Chromatograms (THF eluent) of PEG113-b-(p(HPMAx-
co-EGDMA0.95).  A) PEG113-b-(p(HPMA50-co-EGDMA0.95). B) 
PEG113-b-(p(HPMA80-co-EGDMA0.95). C) PEG113-b-(p(HPMA120-co-
EGDMA0.95). 
Figure 5.24:  GPC (THF eluent) chromatograms of linear and branched p(HPMA80) 
utilising PEGx based initiators.  A) PEG17-Br B) PEG45-Br C) PEG113-
Br. 
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Figure 5.25:  GPC chromatograms of PEGx-b-(p(HPMA80)-co-EGDMA0.95)).  
RALS (blue line), LALS (red line) and Intrinsic Viscosity (green 
line). A) PEG17 RI (dark red dashed line). B)  PEG45 RI (dark green 
dashed line). C) PEG113 RI (dark blue dashed line) 
Figure 5.26: Kinetic studies of branched p(HPMA80) using PEG based 
macroinitiators.  A)  Conversion vs. Time.  PEG17-Br (dark red), 
PEG45-Br (dark green), PEG113-Br (dark blue).  B) Semi-logarithmic 
plot.  PEG17-Br (dark red), PEG45-Br (dark green), PEG113-Br (dark 
blue). 
Figure 5.27:  Kinetics plots for linear (open symbols) and branched (full symbols) 
copolymerisations of p(HPMA80) using various PEG macroinitiators. 
A) PEG17-Br, B) PEG45-Br, C) PEG113-Br.    
Figure 5.28:  Evolution of Mw with conversion.  A) PEGx-b-(p(HPMA80)-co-
EGDMA0.95)) PEG17-Br (dark red), PEG45-Br (dark green), PEG113-Br 
(dark blue).  B) PEG17-b-p(HPMA80) (red) and PEG17-b-(p(HPMA80-
co-EGDMA0.95) (dark red). 
Figure 5.29:  Kinetics plots for p(HPMA80)-co-EGDMA0.95 (black symbols) and 
PEG17-b-(p(HPMA80)-co-EGDMA0.95)) (dark red symbols). 
Figure 5.30:  GPC chromatograms of kinetics studies for branched 
copolymerisations. A) p(HPMA80)-co-EGDMA0.95 B) PEG17-b-
(p(HPMA80)-co-EGDMA0.95)). 
Figure 5.31:  GPC chromatograms of branched copolymers at different stages of 
polymerisation.  p(HPMA80)-co-EGDMA0.95 (black traces), PEG17-b-
(p(HPMA80)-co-EGDMA0.95)) (red traces).  RI detector responses (A) 
and (B), RALS detector responses (C) and (D). 
Figure 5.32:  Evolution of Mn during p(HPMA80)-co-EGDMA0.95 (black) and 
PEG17-b-(p(HPMA80)-co-EGDMA0.95)) copolymerisations. 
Figure 6.1:  DLS measurements for linear PEGx copolymer nanoparticles using a 
rapid precipitation approach varying p(HPMAX) primary chain length. 
(10 mg mL
-1
 starting concentration, 2 mg mL
-1
 final concentration).  
A) PEG17 B) PEG45 C) PEG113. 
Figure 6.2:  DLS size determination of nanoparticles comprising of PEGx 
containing linear copolymers using dialysis.  10 mg mL
-1
 starting 
concentration, 2 mg mL
-1
 final concentration. 
Figure 6.3:  DLS size determination of nanoparticles comprising of PEGx 
containing linear copolymers using dialysis.  5 mg mL
-1
 starting 
concentration, 1 mg mL
-1
 final concentration. 
Figure 6.4:   DLS size determination of nanoparticles comprising of PEGx 
containing linear copolymers using a modified dialysis approach .  5 
mg mL
-1
 starting concentration, 1 mg mL 
-1
 final concentration. 
Figure 6.5:   DLS size determination of nanoparticles comprising of PEGx 
containing branched copolymers using dialysis.  10 mg mL
-1
 starting 
concentration, 2 mg mL
-1
 final concentration. 
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Figure 6.6:  DLS size determination of nanoparticles comprising of PEGx 
containing branched copolymers using dialysis.  5 mg mL
-1
 starting 
concentration, 1 mg mL 
-1
 final concentration. 
Figure 6.7:  DLS size determination of nanoparticles comprising of PEGx 
containing branched copolymers using a modified dialysis approach .  
5 mg mL
-1
 starting concentration, 1 mg mL 
-1
 final concentration. 
Figure  6.8:  DLS analysis of nanoparticles comprised of PEG17-b-p((HPMA50)-
co-EGDMA0.95) prepared by rapid precipitation at various 
starting/final concentrations. (A) 10 mg mL
-1
 starting concentration. 
(B) 5 mg mL
-1
 starting concentration. (C) 1 mg mL
-1
 starting 
concentration. 
Figure 6.9:  Z-average diameters of nanoparticles comprised of PEG17-b-
(p(HPMAx)-co-EGDMA0.95)) produced via rapid precipitation with 
varied dilution ratios.  Starting concentrations; 10 mg mL
-1
 (circles), 5 
mg mL
-1
 (triangles) and 1 mg mL
-1
 (squares). A) x = 50 B) x = 80 C) 
x = 120. 
Figure 6.10:  Z-average diameters of nanoparticles comprised of PEG45-b-
(p(HPMAx)-co-EGDMA0.95)) produced via rapid precipitation with 
varied dilution ratios.  Starting concentrations; 10 mg mL
-1
 (circles), 5 
mg mL
-1
 (triangles) and 1 mg mL
-1
 (squares). A) x = 50 B) x = 80 C) 
x = 120. 
Figure 6.11:  Z-average diameters of nanoparticles comprised of PEG113-b-
(p(HPMAx)-co-EGDMA0.95)) produced via rapid precipitation with 
varied dilution ratios.  Starting concentrations; 10 mg mL
-1
 (circles), 5 
mg mL
-1
 (triangles) and 1 mg mL
-1
 (squares). A) x = 80 B) x = 120. 
Figure 6.12:  Z-average diameters of nanoparticles comprised of PEGx-b-
(p(HPMA80)-co-EGDMA0.95)) produced via rapid precipitation with 
varied dilution ratios.  A) Starting concentration = 10 mg mL
-1
 B) 
Starting concentration = 5 mg mL
-1 
C) Starting concentration = 1 mg 
mL
-1
. 
Figure 6.13:  Polydispersity of nanoparticles comprised of PEGx-b-(p(HPMA80)-co-
EGDMA0.95)) produced via rapid precipitation with varied dilution 
ratios.  A) Starting concentration = 10 mg mL
-1
 B) Starting 
concentration = 5 mg mL
-1 
C) Starting concentration = 1 mg mL
-1
. 
Figure 6.14:  Serial dilution data of nanoparticles comprised of PEG17-b-
(p(HPMA80)-co-EGDMA0.95)) with a starting and finishing 
concentration of 5 mg mL
-1
 and 1 mg mL
-1
 respectively.  A) 
Nanoparticle diameter and polydispersity vs. concentration of 
suspension.  B)  Derived count rate and Attenuator vs. concentration 
of suspension. 
Figure 6.15:  Zeta potential measurements of nanoparticles comprised of PEGx-b-
p(HPMA80) and PEGx-b-(p(HPMA80)-co-EGDMA0.95)), produced by 
rapid precipitation.  5 mg mL
-1
 starting concentration; 1 mg mL
-1
 final 
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concentration. (x = 17, 45, 113). Linear Polymers (black), Branched 
Polymers (grey).       
Figure 6.16:  Zeta potential measurements of nanoparticles comprised of PEG113-b-
p(HPMAx) and PEG113-b-(p(HPMAx)-co-EGDMA0.95)), produced by 
rapid precipitation.  5 mg mL
-1
 starting concentration; 1 mg mL
-1
 final 
concentration. (x = 50, 80, 120). Linear Polymers (black), Branched 
Polymers (grey). 
Figure 6.17:  DLS size determination of (A) linear and (B) branched copolymers in 
water at 10 mg mL
-1
.  PEG45-b-p(HPMA50) and PEG45-b-
(p(HPMA50)-co-EGDMA0.95)) (blue).  PEG113-b-p(HPMAx) (x = 50, 
80, 120) and PEG45-b-(p(HPMA50)-co-EGDMA0.95)) (x = 50, 80, 
120) (green) 
Figure 6.18: DLS size determination of linear (A) and branched (B) copolymers in 
acetone at 10 mg mL
-1
. 
Figure 6.19: Loaded nanoparticle analysis using PEG17-b-(p(HPMA80)-co-
EGDMA0.95)) using rapid nanoprecipitation (5 mg mL
-1
 starting 
concentration; 1 mg mL
-1
 final concentration), with varied loading 
material concentration, A) Z-average particle diameter vs. loading. B) 
Polydispersity vs. loading. Blank nanoparticle (black), Oil Red O 
(red), Pyrene (green), Ibuprofen (blue). 
Figure 6.20:  Loaded nanoparticle analysis of PEG17-b-(p(HPMA80)-co-
EGDMA0.95)) using rapid nanoprecipitation (5 mg mL
-1
 starting 
concentration; 1 mg mL
-1
 final concentration), with varied loading 
material concentration, A) Oil Red. B) Pyrene. C) Ibuprofen. 
Figure 6.21:  Loaded nanoparticle analysis using PEG45-b-(p(HPMA80)-co-
EGDMA0.95)) using rapid nanoprecipitation (5 mg mL
-1
 starting 
concentration; 1 mg mL
-1
 final concentration), with varied loading 
material concentration, A) Z-average particle diameter vs. loading. B) 
Polydispersity vs. loading. Blank nanoparticle (black), Oil Red (red), 
Pyrene (green), Ibuprofen (blue). 
Figure 6.22:  Loaded nanoparticle analysis of PEG45-b-(p(HPMA80)-co-
EGDMA0.95)) using rapid nanoprecipitation (5 mg mL
-1
 starting 
concentration; 1 mg mL
-1
 final concentration), with varied loading 
material concentration, A) Oil Red. B) Pyrene. C) Ibuprofen. 
Figure 6.23:  Loaded nanoparticle analysis using PEG113-b-(p(HPMA80)-co-
EGDMA0.95)) using rapid nanoprecipitation (5 mg mL
-1
 starting 
concentration; 1 mg mL
-1
 final concentration), with varied loading 
material concentration, A) Z-average particle diameter vs. loading. B) 
Polydispersity vs. loading. Blank nanoparticle (black), Oil Red (red), 
Pyrene (green), Ibuprofen (blue). 
Figure 6.24:  Loaded nanoparticle analysis of PEG113-b-(p(HPMA80)-co-
EGDMA0.95)) using rapid nanoprecipitation (5 mg mL
-1
 starting 
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concentration; 1 mg mL
-1
 final concentration), with varied loading 
material concentration, A) Oil Red. B) Pyrene. C) Ibuprofen. 
Figure 6.25:  Chemical structures of hydrophobic guest-molecules. A) Oil Red O.
   B) Ibuprofen. C) Pyrene. D) Lopinavir. 
Figure 6.26:  Nanoparticle analysis of PEGx-b-(p(HPMA)-co-EGDMA0.95)) using 
rapid nanoprecipitation (five-fold dilution). Concentrations adjusted 
for p(HPMA) content (see Table 6.14). (Approximately 5 mg mL
-1
 
starting concentration, 1 mg mL
-1
 final concentration). (A) PEG17, (B) 
PEG45, (C) PEG113. 
Figure 6.27:  Analysis of LPV loaded PEGx-b-(p(HPMA)-co-EGDMA0.95)) and 
blank nanoparticles prepared using rapid nanoprecipitation (five-fold 
dilution). Copolymer concentrations adjusted for p(HPMA) content 
(see Table 6.16). (Approximately 5 mg mL
-1
 starting concentration, 1 
mg mL
-1
 final concentration). (A) PEG17, (B) PEG45, (C) PEG113. 
Figure 7.1:  Cytotoxic assay of methacrylate monomers using a Caco-2 cell line. 
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List of Schemes 
Scheme 1.1:  Synthesis of monomethyl PEG by nucleophilic attack of an epoxide 
ring. 
Scheme 1.2:  Representation of hyperbranched polymer and dendrimers synthesis. 
A) Polycondensation of an AB2 monomer to give a hyperbranched 
polymer B) 1) Divergent growth and 2) convergent growth giving a 
third generation dendrimer. 
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1.  Introduction 
“The ultimate success of a biomaterial is determined by the ability to tailor its 
properties”.  This short quote encapsulates the essence of this thesis.1   
Due to their versatility, polymers (and structures comprised thereof) are a class of 
material extensively used in a wide range of biomedical applications such as contact 
lenses,
2
  tissue engineering,
3
 artificial organs,
4
 and orthopaedic devices
5 
to name a 
few.   
This introduction aims to highlight some routes to the production of successful 
biomaterials and therefore lead to the rationale of the research carried out in 
subsequent chapters.  The field of materials science for biomedical applications is 
extremely vast and here it is limited to those comprised of polymers with the aim of 
drug delivery.  Creating carriers is of extremely high importance as a large fraction 
of new drugs have poor water solubility and if dosed orally, achieving an adequate 
therapeutic dose is extremely difficult.   Alongside this, drugs can have adverse side 
effects and are often toxic (leading to poor patient compliance); by effectively 
“hiding” the drug within a polymeric vector these unwanted effects can be reduced.6  
1.1  Human Immunodeficiency Virus (HIV) 
1.1.1  Statistics 
The huge surge in research in this area is because HIV/AIDS constitutes one of the 
most serious infectious diseases we face today. Shockingly, over 60 million people 
have been infected globally
7
 and it was estimated that approximately 34 million 
people are presently living with the disease.
8
 The infection has claimed over 25 
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million lives worldwide
9
 since its discovery in the 1980’s.  The first published 
research about Acquired Immunodeficiency Syndrome (AIDS) was in 1981 written 
by Gottlieb et al.
10
 However, the discovery of the HIV virus is attributed to 
Montagnier.
11
 The effects of HIV/AIDS are most prevalent in sub-Saharan Africa, 
where around two thirds of HIV sufferers reside and is responsible for the death of 2 
million Africans in 2005 alone.
12
  
Anti-retroviral drugs and their subsequent delivery systems have been shown to 
convert the once fatal infection to a more manageable chronic infection. Although 
this is a huge achievement; according to the World Health Organisation (WHO) 
guidelines in 2011 only 56 % of HIV sufferers were able to receive treatment in sub-
Saharan Africa and globally only 54 % of people with HIV received treatment;
 13
 
clearly much more research still needs to be done to help combat this epidemic. 
1.1.2  Infection 
A brief overview of the replication cycle of the HIV virus is given here and can be 
seen in Figure 1.1.  Human HIV infection is mainly achieved through fusion with 
CD4+ cells and through self–replication via integration of the viral genome into a 
host cell in the human body (mainly immune system cells) after which the virus can 
quickly spread through the body. Once entered, mucosal surface CD4+ antigens and 
either the CCR5 or CXCR4 chemokine receptors on the virus are recognised by T 
lymphocytes and are subsequently bound by interactions mediated by the 
transmembrane gp120 glycoprotein, leading to opening of the host cell membrane 
(Figure 1.1 (1)).  Once successfully fused and transported across the cell membrane 
reverse transcriptase and transfer ribonucleic acid (tRNA) can produce proviral 
deoxyribonucleic acid (DNA) (Figure 1.1 (2)), which is then integrated into the 
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genome using integrase (Figure 1.1 (3)).  The cell will now convert the HIV genes 
into messenger ribonucleic acid (mRNA) and leave the nucleus ready to be used for 
producing more HIV proteins and enzymes.  New viral particles are also formed and 
these contain the entire HIV genome which, together with HIV proteins and enzymes 
will migrate to the cell surface and leave in a process known as “budding”.  These 
are now free to infect other immune system cells and start the replication cycle 
again.   The virus replication cycle requires energy and resources (e.g. enzymes) 
from the host cell in order for each process to take place and produce new mature 
particles. Eventually the T lymphocytes’ energy sources will be depleted and the cell 
will die in a form of apoptosis.  As the virus can rapidly spread throughout the body, 
plasma viral load increases and the number of T lymphocytes and other cells drops 
significantly, this leaves the patient unable to fight off infection effectively. Weight 
loss and acquiring opportunistic infections (namely pneumonia and tuberculosis) 
along with other illnesses such as cancer (e.g. lymphoma and Kaposi’s sarcoma) and 
dementia are the main contributors to death in HIV/AIDS sufferers.  Once infected 
by either a mucosal or parenteral route, a person may suffer symptoms such as fever, 
diarrhoea and lymphadenopathy due to the initial high level of virus, however, 
generally these symptoms are not synonymous to HIV and therefore the disease can 
remains undetected for many years and those infected may pass on the virus through 
bodily fluids.
14,15,16,17
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Figure 1.1: HIV replication cycle. 
 
1.1.3  Treatment 
Treatment for HIV/AIDS comes in the form of a class of drugs known as anti-
retrovirals, which target specific stages in the replication cycle and inhibit viral 
replication.  Currently there are 24 drugs approved by the Food and Drug 
Association (FDA) on the market for the treatment of the HIV-1 virus
18
 (a complete 
list can be found in Appendix 1.  There are 5 subgroups of antiretroviral drugs: 
nucleoside reverse transcriptase inhibitors (NRTIs), non- nucleoside- reverse 
transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), integrase inhibitors and 
fusion inhibitors (FIs). 
The first antiretroviral drug for the treatment of HIV-1 was an NRTI (Zidovudine) 
and there are currently eight within this drug class currently available.  These inhibit 
viral reverse transcriptase by DNA chain termination, shown in Figure 1.1 (2).  The 
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drugs have similar structures to natural deoxynucleoside without the 3’- hydroxyl 
group which elongates DNA and these drugs compete for binding sites.
19 
Three 
different NNRTIs exist, which act non-competitively and bind to pockets within 
reverse transcriptase which changes conformations of subunits close to the active site 
of the polymerase enzyme and the active site becomes inactive
20
 (see Figure 1.1 (2)). 
A PI selectively inhibits enzyme activity impeding the production of new virus by 
inhibition of precursor polyprotein cleavage (which produce immature infectious 
virus).
21, 22 
There are now seven different PIs available for administration to patients.  
There is only one integrase inhibitor on the market currently (Raltegravir) and this 
catalyses integration of viral DNA into host DNA (see Figure 1.1 (3)); the diketo 
acids (integrase inhibitor) selectively bind to the enzyme and inhibits the transfer of 
viral and host DNA.
23, 24
 
As the virus can readily mutate and become resistant to single drugs
25, 26 
it became 
common to administer two or more drugs simultaneously, known as Highly Active 
Anti-Retroviral Therapy (HAART).  Developed in 1996, it is thought that this 
approach has altered HIV/AIDS from being a certain death sentence, to a chronic 
condition and shown a huge decrease in mortality among AIDS patients.    
Prior to 1996 people aged 15-24 were expected to survive for 12.5 years after 
infection and those aged 45-54 had an average life expectancy of 7.9 years.
27
 Post 
1996 a decrease in the risk and death due to AIDS has been reported and is more 
than likely attributed to HAART.
28, 29, 30
 The correct time for initiating antiretroviral 
drugs is debated,
31
 however, US guidelines recommend treatment when CD4+ cell 
count reaches below 500 per mm
3 
or a viral load greater than 10 000 – 20 000 copies 
per mL.
32
 Although this has been debated, and it is argued that it is more beneficial 
to start patients on HAART at a much earlier stage, irrespective of the CD4+ cell 
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count.
33
 The drugs themselves exert toxicities which will be unfavourable to what 
are considered “healthy” patients.   
1.1.4  Treatment Failures 
There are many advantages of HAART with research suggesting suppression of viral 
replication for decades therefore increasing life expectancies of sufferers, provided 
patients comply with recommended regimens.
18
 The increased viral suppression 
makes the attainment of resistance much more difficult as the virus must mutate in 
such a way to overcome the effects of a cocktail of drugs rather than just one.
34
   
Despite these positives, there exist many downfalls to the current administration of 
antiretroviral drugs including extensive first pass metabolism where little drug 
reaches the blood stream.  This occurs when certain drugs are dosed orally and are 
metabolised by the liver after absorption from the gastrointestinal tract via the 
hepatic portal vain, leading to poor bioavailability.
35
  The drugs tend to have short 
half-lives which increased the frequency of administration and this in turn decreases 
patient compliance (also known as ‘pill burden’).36   
Poor bioavailability is primarily linked to ‘reservoir’ or ‘sanctuary’ sites in the body; 
this is where the virus can reside and replicate where dissolved drugs struggle to 
enter.
37
  Cellular sites include CD+ T lymphocytes and monocytes/macrophages 
where as anatomical sites include the Central Nervous System (CNS), liver, lungs, 
lymphatic system and genitals.
38
  It is thought that alongside poor 
bioavailability/targeting, limited access to sanctuary sites is linked to the 
development of multi-drug resistance.
39
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The administration of these toxic antiretroviral drugs (in some patients) can induce 
undesirable side effects.  PI’s can cause nephrotoxicity,40 lypodystrophy, 
hyperlipidaemia and insulin resistance.
41
 Administration of NRT’s can result in liver 
steatosis, myopathy, lactic acidosis,
42
 and lipoatrophy
43
 where as NNRTIs can cause 
hypersensitivity
44
 and hepatotoxicity.
45
  
Literature suggests that there are no significant side effects associated with 
Raltegravir
46
 (Integrase inhibitor) and the same is true for FIs, although 96 % of 
patients receiving enfuvirtide experienced hypersensitivity at injection site.
47,48,49 
In 
order to increase life expectancies, HIV sufferers must take combinations of these 
drugs (based on individual requirements) and unfortunately encounter some of the 
aforementioned side effects. 
Perhaps most shocking of all is the cost of production and distribution of 
antiretroviral drugs; particularly to Africa which is resource limited.
50
 The global 
budget required just to treat (research not included) HIV patients from 2009 to 2031 
is predicted to be approximately US$ 397-727 billion.
51
 Clearly, much more research 
is desperately needed in this field in developing new drug delivery vehicles for 
HIV/AIDS drugs.   
 
1.2  Polymers for Drug Delivery 
The field of polymer synthesis is ever expanding, where synthetic techniques are 
becoming highly sophisticated generating new and structurally complex materials 
which have the ability to encapsulate and deliver drugs.  The necessity for this is due 
to the often hydrophobic nature of drugs which limits their interaction within the 
body and therefore limits therapeutic effect.  The scope of materials from which 
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scientists can choose in this area is enormous and reviewing all polymers (considered 
and currently approved) is almost impossible.  However, it is the intent here to give 
an overview of perhaps the most commonly reported and used polymers, strategies 
and drug delivery systems. 
1.2.1  Naturally occurring polymers 
As naturally occurring polymers are high in abundance and usually biodegradable 
they are a good choice of material for the development of drug delivery systems or 
other biomedical devices.  These polymers fall mainly into the categories of proteins 
and polysaccharides which can offer good biocompatibility.
52
  
To reduce the risk of infection in wounds,
53
 collagen (see Figure 1.2 (A)) “sponges” 
have been generated for the delivery of antibiotics.  Immobilisation of drugs into 
collagen matrices is achieved by simply soaking in antibiotic solutions,
54
 however, 
significant research into the optimisation of drug release kinetics has been described 
where the density of collagen can be increased
55
 or cross-linked
56
 therefore 
decreasing the rate of drug release.  Collagen can also be combined with other 
naturally occurring polymers such as α-hydroxy acids57 to achieve the same effect.  
Also described in the literature are collagen gels
58
 and collagen microparticulates
59
 
which can be used as drug delivery vehicles.   
The polysaccharide chitosan is perhaps the most widely researched naturally 
occurring polymer used in therapies, with approximately 6500 references found 
when entering “chitosan drug delivery” into the Scifinder database.  This material 
shows good biocompatibility and its positive charge under acidic conditions through 
protonation of amino groups
60
 (see Figure 1.2 (B)) means it can be exploited in drug 
delivery vehicles by interactions with oppositely charged cells/membranes and also 
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DNA.  Material can be encapsulated by chitosan forming colloidally stable particles 
by a variety of mechanisms which include chemical crosslinking and ionic 
crosslinking;
 61
 promising research is briefly outlined here in relation to chitosan 
based drug delivery systems.  Through a spray-drying process
62
 insulin loaded (65-
85 %) chitosan microparticles have been synthesised for nasal delivery and were 
found to be superior to chitosan solutions
63
. Chitosan based systems have also been 
effective in the delivery of growth factors via immobilisation into hydrogels 
enhancing lesion
64
 and cartilage repair
65
. Magnetic nanoparticles of chitosan have 
been developed for the targeted delivery of antibiotics. Both bleomcyin and 
neomycin were successfully encapsulated by chitosan and transported (through 
diffusion) across inner ear membranes with no detrimental effects to surrounding 
tissue.
66
 Anti-inflammatory drugs can also be delivered through chitosan based 
systems,
67, 68
 as well as antigens for parental and mucosal delivery achieved by 
chitosan based powders and nanoparticles.
69
  
Undoubtedly huge advances have been made by utilising natural polymers for drug 
delivery and steps are being taken to modify the materials to suit new applications.  
However, due to their structural complexities synthetic modification is often 
difficult.  For example, extremely strong and stable hydrogen bonding exists within 
chitosan (inter and intra molecular) from the amino and two hydroxyl groups in the 
hexosaminide repeating unit (see Figure 1.2 (B)) leading to difficulties in 
solubilising the material in organic solvents.  As it is insoluble in water, reactions 
can be carried out in aqueous organic acids (acetic and formic acid) and some 
inorganic acids generating highly viscous solutions.  The high viscosity coupled with 
the corrosiveness (requiring alkaline solutions for purification) are undesirable for 
the development of drug delivery systems; consequently new processing strategies 
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are needed in the development of new chitosan based materials.
70,71
  Other naturally 
occurring polymers which have been used specifically as drug delivery vectors are 
albumin
72, 73, 74 
and gelatin.
75, 76
  
 
Figure 1.2: Structural examples of naturally occurring polymers. Collagen (A) and 
Chitosan (B). 
1.2.2  Synthetic Polymers 
The ability to control the chemical and architectural properties of synthetic 
polymeric materials perhaps offers considerably more options than those available 
through the use of naturally occurring polymers for the purpose of drug delivery.  
Described here are some polymers which have been synthesised for use in the field 
of medicine.  The key to all systems which are intended for use in the human body is 
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biocompatibility; this may be defined as “the ability of a material to perform with an 
appropriate host response in a specific application”.77  This definition is vague as the 
number of interactions and processes between materials and biological systems is 
extremely vast and therefore a precise definition of biocompatibility does not exist 
i.e. a material may biocompatible in one application yet bioincompatible in another. 
However, for the purposes of this thesis the criteria of a material to offer good 
biocompatibility will be the acceptance to living tissue and/or blood.  The role 
polymers play in terms of haemocompatibility, immunocompatibility and also 
carcinogenicity has been researched.
78, 79
  
1.2.3  Biodegradable and non-biodegradable polymers 
Polymers used in bio-applications are not limited to those which are biodegradable; 
as non-biodegradable materials may be biocompatible and excreted by renal 
processes.
80
  Materials which are approximately 4 nm to 14 nm in diameter can 
permeate epithelial cell walls within the glomerulus and are excreted in urine.
81
  This 
size roughly equates to a molecular weight range of between 30000 to 150000 g mol
-
1
 (however, this is highly dependable on the structure and chemistry of the 
material).
82
  Those which exceed this threshold may circulate in the body for 
extended periods of time.
80
 The liver and spleen can also eliminate non degradable 
polymer whose size exceeds 200 nm via opsonisation; material is engulfed by 
phagocytes in the blood stream, yet only hydrophobic and neutral polymers tend to 
bind to the opsonin proteins.
83
  
Polymers which do not contain C-C backbones e.g. polyesters are degraded through 
hydrolysis of the chains’ backbone.  For materials which are semi-crystalline this 
hydrolysis occurs via a two step process; first the long peripheral polymer chains 
(which are amorphous) are converted to shorter (and water soluble) segments.  This 
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molecular weight reduction does not immediately impact the mechanical strength of 
the crystalline core; however, as water begins to permeate, fragmentation occurs.  
Enzymes then metabolise these fragments leading to a dramatic decrease in 
molecular weight.
84
  This process is much faster at the periphery of the material due 
to the large surface area and low molecular weight products can be completely 
removed into the surrounding fluid.  Bulk erosion of the material ensues when the 
rate of water penetration exceeds the rate of conversion to water soluble material.
85
 
This polymer erosion is inevitable (provided that the structure contains hydrolysable 
bonds), however, fast rates are often undesirable as this leads to a decrease in the 
drug delivery devices’ mechanical stability alongside risks of toxicity associated 
with large quantities of small fragments produced within short timescales.
86
   
Polymers containing ester groups within the backbone (poly(lactic acid) (PLA), 
poly(glycolic acid) (PGA) and poly(lactic acid-co-glycolic acid (PLGA)) (see Figure 
1.3) will degrade via hydrolysis, however, their metabolism may result in increased 
acidity leading to tissue irritation.
87
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Figure 1.3: Examples of polymers used in drug delivery systems. Poly(imino 
carbonate) (A), poly(phosphoester) (B), poly(lactic acid) (C), poly(glycolic acid) (C) 
and poly(lactic-co-glycolic acid) (D). 
For materials which encapsulate proteins, this increased acidity can be detrimental to 
the stability of the protein.
88
 Degradation of polyanhydrides and polyesters is 
achieved by the hydrolytic cleavage of chain backbones yet the rate of degradation 
and drug release can be affected by molecular weight, polydispersity, monomer 
choice and their relative ratios (for copolymers).
89, 90
 Polypeptides can successfully 
encapsulate drugs yet their capabilities of release are limited as certain enzymes in 
the body are necessary for their bio-degradation. To overcome this ‘pseudo’ 
poly(amino acids) can be synthesised (i.e. poly(imino carbonates) (see Figure 1.3 
(A)), which do not depend on these enzymes.
87
 Atoms of phosphorous (bonded to 
either carbon or oxygen) in poly(phosphoesters) (see Figure 1.3 (B)) means that 
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chemical modification of side chains is relatively straightforward, significantly 
affecting the rate of bio-degradation; important in terms of drug release.
91
   
In conclusion, mechanisms of bio-degradation vary with polymer composition (i.e. 
functional groups) alongside architecture, administration route, molecular weight 
distribution, morphology, pH, structure of overall delivery vehicle and its 
concentration.  This means that determination of 
toxicity/degradation/clearance/accumulation of polymeric systems is extremely 
complicated yet of high importance in order to successfully manufacture a polymeric 
drug delivery system.   
1.2.4  Monomethyl PEG 
This relatively simple molecule is usually synthesised via living anionic 
polymerisation where nucleophilic attack of the methoxide ion on an epoxide ring 
initiates the reaction,
92,93 
(see Scheme 1.1) giving molecular weight distributions 
ranging from 1.01 (Mw = 3000-5000 g mol
-1
) to 1.2 (Mw = > 20000 g mol
-1
).
94
 
However, due to the nature of living anionic polymerisation dihydroxy poly(ethylene 
oxide) is also formed (typically between 1 – 10 % of overall product depending on 
the molecular weight) due to water/oxygen and other impurities present in the 
reaction which act as initiators and/ or chain transfer agents in the polymerisation.
95
  
 
 
Scheme 1.1: Synthesis of monomethyl PEG by nucleophilic attack of an epoxide 
ring.  
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Below 1000 g mol
-1
 PEG is a viscous colourless liquid, however, at higher molecular 
weights it exists as a white waxy solid.
96, 97
  PEG is soluble in water, toluene, 
methylene chloride and many organic solvents yet is insoluble in ethyl ether, hexane 
and ethylene glycol (despite its similar structure and composition).
98
  
PEG is non-toxic and has the ability to extend the half life of active materials when 
chemically conjugated to a drug (mainly due to the increased overall molecular 
weight reducing renal clearance).
99, 100
  PEG has been shown to interact with cell 
membranes by associating with phospholipid head groups of and once fused its 
uptake is mainly through endocytosis.
101
   
Drugs can be bonded to PEG (known as prodrugs) through the activation of the 
hydroxy (or dihydroxy) groups.  When bonded, PEG increases the hydrophilicity of 
drugs which in turn reduces the toxicity of the drug; an example of this is the 
prodrug PEG-palitaxel (anti cancer drug) which when administered (5.25 µ mol 
dose) showed no acute toxicity compared to taxol® (comprising cremophor® and 
palitaxel) which is highly toxic.
99, 102
  The huge volume of research dedicated to PEG 
and its derivatives make it the polymer of choice for drug delivery systems; however, 
for the purpose of this thesis the main focus is the co-polymerisation of PEG and the 
(non-bonded) encapsulation of drugs within varied structures. 
1.3  Polymeric Drug Delivery Systems 
The majority of new drug delivery systems have sizes within the nanometre (nm) 
scale.  The advantages of these extremely small dimensions are an increased surface 
to volume ratio which is thought to improve pharmacokinetics and biodistribution of 
active substances leading to increased accumulation at preferential sites in the 
body.
103
  As research has suggested that approximately 40 % of active substances 
(i.e. drugs) are poorly water soluble,
104, 105 
nanometre sized vehicles are extremely 
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desirable.  Estimates suggest that by 2015 approximately US$1 trillion will be made 
through sales of nanotechnologies
106
 of which approximately US$53 billion is 
specifically related to medical products.
107
   
Specific polymers have been discussed in their relation to drug delivery systems, 
however, the majority of the systems have one common characteristic which is 
amphiphilicity.  In an aqueous solution a hydrophobic drug will reside/solubilise in 
hydrophobic domains and is thus encapsulated by the hydrophilic corona which is 
hydrated.  This is a very simplistic rationale; the mechanisms of vector generation 
can vary widely as well as overall vector structure/shape.    Here, examples of 
polymeric drug delivery vehicles are given. 
 
 
Figure 1.4: Representation of common polymeric drug nanocarriers in aqueous 
medium (not to scale). A) Nanoparticle B) Micelle C) Nanoemulsion D(1) Hydrogel 
D(2) Sol-gel. 
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1.3.1  Micelles 
Formed from amphiphilic block copolymers which self-assemble (see Figure 1.5), 
micelles have core shell architectures in water where hydrophobic drug may resides 
in the hydrophobic domain, shown in Figure 1.4 (B). 
 
Figure 1.5: Micelle formation.  
The driving force of micellisation is interfacial tension; at the Critical Micelle 
Concentration (CMC) the interfacial tension is minimised by the formation of 
micelles, below which polymers exist as single entities` known as unimers.  Once 
de-solvated (e.g. through dialysis) van der waals forces exist between hydrophobic 
segments and form domains which are stabilised by a hydrated corona comprised of 
the hydrophilic block segments.
108, 109
  
In addition to linear block copolymers other polymer architectures can form micelles 
such as the novel scorpion like amphiphilic macromolecules (shown in Figure 1.6) 
have been synthesised which aggregate in water and form micelles and star-like 
macromolecules which form unimolecular micelles, both of which can be used for 
drug encapsulation.
110
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Figure 1.6: Representation of a novel scorpion like macromolecule. 
As micelles are formed via self-assembly, physiological, thermal and chemical 
changes dramatically affect their stability; to overcome this it is common to crosslink 
a selected domain of the micelle.  Wooley and co-workers were the first to report 
shell crosslinked (SCL) micelles in 1996
111
 involving UV radiation although more 
recently ‘click’ chemistry has been employed by the same group to achieve 
crosslinked micelle coronas, however, the final concentrations of micelles is often 
low (approximately 0.2 mg mL
-1
) and their preparation involves multiple purification 
steps such as dialysis.
112
 The core domain of polymeric micelles can also be 
crosslinked
113, 114, 115
 and is usually achieved through the addition of a free radical 
initiator and have been shown to release drug via a pH trigger.
116
  
1.3.2  Nanoemulsions (oil in water) 
Emulsions and nanoemulsions are described as dispersions of one liquid phase in 
another immiscible liquid phase and are usually formed under mechanical 
shearing.
117, 118
 Amphiphilic copolymers can decrease the interfacial tension of oil 
droplets by partitioning themselves between the two liquids; however, the solubility 
of both polymer segments can vary considerably.
119
  Similar to micelles, 
hydrophobic drugs will reside within the oil phase (see Figure 1.4 (C)) due to 
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hydrophobic interactions and are usually dissolved within the oil prior to 
nanoemulsion formation.
120
   
1.3.3  Hydrogels 
Hydrogels are crosslinked polymers which are soluble in water and maintain a 3D 
structure.
121
  A true hydrogel is dissimilar to other drug delivery devices as they are 
comprised of water soluble polymers only, shown in Figure 1.4 (D(1)).  Crosslinking 
in hydrogels can be achieved by hydrogen bonding,
122
 covalent crosslinking,
123
 and 
physical cross-linking,
124
 between either a polymer or a small molecule
125
 or two 
oppositely charged polymers
126
 where crosslinking can be triggered by pH changes.  
Their porosity allows the loading of drugs into matrices and release is diffusion 
controlled.  Due to their low tensile strength, it has been shown that drug loading is 
limited.
127
   
Sol-gels are partially crosslinked amphiphilic materials whose hydrophobic cores 
become crosslinked at elevated temperatures.  Usually drugs are loaded into 
hydrogels and sol-gels post formation; their solutions are freeze dried and the 
material is re-dispersed in a drug containing solution followed by filtration.
128
  A 
representation of a sol-gel is shown in Figure 1.4 (D(1)). 
1.3.4  Nanoparticles 
It may be possible to consider any polymer containing system whose size is within 
the nanometre size range as a nanoparticle, including those mentioned above; these 
systems also have the potential to load material (see Figure 1.4 (A)).  For the 
purposes of this thesis polymeric nanoparticles will be defined as systems prepared 
by the methods described below; it should be noted that other methods of preparation 
exist that are not described here. 
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Figure 1.7: Nanoparticle preparation methods.  A) Emulsification-solvent 
evaporation. B) Dialysis. C) Nanoprecipitation. D) Microfluidics. 
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1.3.4.1  Synthesis by Emulsification-Solvent Evaporation  
This was the first method employed to prepare nanoparticles comprised of pre-
formed polymers.
129
 In short, emulsions from polymer solutions and volatile solvents 
such as chloroform are prepared through mechanical stirring after which solvent is 
allowed to diffuse through the continuous phase,
130
 however, coalescence is often 
observed and surfactants are utilized in the process; a representation of this process 
is shown in Figure 1.7 (A). Amphiphilic copolymers such as PEG-PLA
131
 have been 
used to generate nanoparticles using this method.  This is a two step route (emulsion 
preparation and solvent extraction) to nanoparticle production and may involve the 
use of toxic solvents and therefore it is not optimum for many applications.   
1.3.4.2  Synthesis by Emulsification Reverse Salting out  
This method is similar to that described above, however, the solvent chosen to 
dissolve the polymer must be miscible with water. Acetone is often favoured for this 
purpose.
132
 Concentrated aqueous salt solutions are employed to form the emulsion 
after which large excesses of water are added.  This induces precipitation of the 
polymer within emulsion droplets.  It is possible to encapsulate lipophilic material 
within nanoparticles by addition to the polymer solution prior to emulsification.
130
 
However, this method involves extensive purification to completely eliminate both 
the volatile solvent and the salting-out agent. 
1.3.4.3  Synthesis by Nanoprecipitation 
This method essentially consists of three components (polymer, solvent, non-
solvent) precipitation and offers an experimentally facile method of preparing 
polymeric nanoparticles.  Developed by Fessi and co-workers,
133
 nanoparticles form 
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due to an almost instantaneous solvent switch (both solvent and non-solvent must be 
miscible) where the polymer rapidly de-solvates and aggregates to form colloidally 
stable entities usually within the nanometre size range with low polydispersities.  
This phenomenon can be exploited experimentally where different experimental 
protocols can be developed to suit certain applications; some of which are outlined 
here. 
Through the simple addition of a solution of polymer in a water miscible solvent to 
water and subsequent evaporation of the organic solvent, it is possible to obtain 
colloidally stable nanoparticles; a representation of this process is shown in Figure 
1.7 (C). This method was first described by Fessi
133
 and has been used by Schubert 
and co-workers
134
 who employed a slow dripping technique to prepare stable 
nanoparticles and it is noted that parameters such as polymer concentration has a 
direct effect on nanoparticle size.
135
  
Essentially any organic solvent which is volatile and will solubilise a chosen 
copolymer and/ or drug could potentially be used in this technique as long as it is 
miscible with water, however, the time consuming dripping approach often 
employed and the extensive purification (dialysis and filtration) are drawbacks to 
this method.  
The nanoprecipitation approach has been exploited by BIND Therapeutics; 
predominantly manufacturing drug loaded nanoparticles using PEG-PLGA block 
copolymers; synthesised by the simple conjugation of COOH-PEG-NH2 and PLGA-
COOH.  By combining these block copolymers with drug in a suitable organic 
solvent, stable drug loaded nanoparticles can be prepared.  It should be noted that 
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these nanoprecipitates are in clinical trials for cancer therapies, demonstrating the 
feasibility of industrial scale production of drug loaded nanoparticles.
136, 137
 
1.3.4.4  Synthesis by Dialysis 
This simple technique involves solubilising a copolymer and/ or drug in a selected 
solvent which is transferred into a dialysis membrane and into a large volume of 
water which is changed regularly; a representation of this process is shown in Figure 
1.7 (B). It is thought that this method allows for slow solvent exchange as it often 
takes > 24 hours for complete solvent removal, however, this may be debated.  
Nevertheless many research groups have reported stable nanoparticle suspensions 
prepared by this method
138
 and is useful for micelle formation if a good solvent can 
be found for both blocks of an amphiphilic copolymer. 
1.3.4.5  Synthesis using Microfluidics 
It is possible to control the mixing of solutions of polymers in organic solvents with 
water by using microfluidic devices to achieve controlled polymer precipitation; a 
representation of this process is shown in Figure 1.7 (D).  The hydrodynamic flow is 
tunable allowing a degree of control within the system which may be advantageous 
as scale up can be easily achieved.  Drugs may be dissolved in the initial 
polymer/solvent mixture and may therefore become encapsulated in the final 
nanoparticle solution.
139
  
1.4  Polymer Architecture-Towards Drug Delivery  
Various polymerisation methods are reviewed here in order to highlight their 
advantages and limitations with respect to the generation of subsequent polymeric 
drug delivery systems.  Literature shows that polymers with complicated 
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architectures can be synthesised such as star-branched (Figure 1.8 (A)), star block
140
 
(Figure 1.8 (B) and pentablock copolymers
141
 (Figure 1.8 (C). As a general rule, the 
more complicated the architecture becomes the more synthetic/purification steps are 
necessary; therefore the likelihood of these polymers being used on an industrial 
scale will be diminished.   
 
Figure 1.8: Examples of various polymer architectures. A) Star branched polymer. 
B) Star block copolymer. C) Pentablock copolymer. 
1.4.1  Hyperbranched polymers and Dendrimers 
Dendrimers are highly branched materials synthesised using either a convergent
142
 
(Scheme 1.2 (B) (1)) or divergent
143
 approach (Scheme 1.2 (B) (1)) where 
complexity increases with each ‘generation’ or ‘layer’ of functional groups.  These 
ordered structures can produce near monodisperse materials with a large number of 
functional end groups (dependant on generation).
144
 Unfortunately dendrimer 
synthesis involves a multitude of reaction and purification steps
145
 and yields are 
often low and reactions are often incomplete.
146
  An excellent review on dendrimers 
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and dendronised materials explores new strategies to limit time consuming reaction 
steps.
147
  
 
Figure 1.9: Representation of doxorubicin-functionalised dendrimers.  
Fréchet and co-workers have reported the synthesis of novel polyester dendritic 
‘bow-tie’ molecules for drug delivery purposes.  The dendritic molecules (of various 
generations) can have various peripheral functional groups and can be coupled to 
PEG (of various chain lengths) to generate a catalogue of novel architectures.  
Coupling doxorubicin to these macromolecules has shown an increase in circulation 
time (compared to parent drug) and also significant antitumor activity; a 
representation of the structure of doxorubicin-functionalised dendrimers
148, 149
 is 
shown in Figure 1.9. 
Hyperbranched polymers can be synthesised by the Flory ABx approach (shown in 
Scheme 1.2 (A)) where AB2 monomers are very common
150
 but monomers such as 
AB3 and even AB6 have been reported using a one-pot step-growth polymerisation.  
The criteria for a successful step growth polymerisation are that A must react only 
with B without side reactions and Bx must have equal reactivity.
152
 Besides 
polyesters
153
 a wide variety of polymers can be synthesised using this 
polycondensation approach.
152
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Scheme 1.2: Representation of hyperbranched polymer and dendrimers synthesis. A) 
Polycondensation of an AB2 monomer to give a hyperbranched polymer B) 1) 
Divergent growth and 2) convergent growth giving a third generation dendrimer. 
Recently more complicated monomer combinations (such as A2 + By) can be used to 
generate complicated and multifunctional polymers.
154
  Using this approach, gelation 
can occur and is highly dependent on functionality ratio, temperature, reaction time 
etc.
155
  For these reasons it can be experimentally difficult to isolate hyperbranched 
polymers without fractionation, which can lead to sample loss and affecting polymer 
distribution.
152
 Hyperbranched polymers synthesised through polycondensation have 
also been investigated as drug delivery devices.
156, 157 
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1.5  Polymerisation Techniques 
1.5.1  Free Radical Polymerisation 
It has been reported that conventional free radical polymerisation is the most widely 
used polymerisation technique using unsaturated vinyl monomers.
158
 Briefly the 
reaction consists of three distinct steps: 
1) Initiation involves the homolytic scission of a single bond achieved either 
thermally or photolytically.  The reactive (and short-lived) radicals are capable of 
attacking monomer π bonds generating new radical centres. The most common 
initiators include peroxides,
159
 azo
160
 and photolabile compounds,
161
 yet monomers 
such as styrene and some acrylates can be thermally induced.
162
  Propagation is the 
addition of monomer units to active radical centres until termination occurs and is 
thought to be chain length independent.   Termination is an irreversible process 
terminating polymer chain growth.  This can occur either by combination of active 
chains or disproportionation by hydrogen abstraction and is also chain length 
dependant where diffusion coefficients are considered.
163
 These steps are shown in 
Scheme 1.3. 
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Scheme 1.3: Representation of individual steps of conventional free radical 
polymerisation. 
1.5.1.1  General aspects of Free Radical Polymerisation  
Free radical polymerisation is tolerable to a wide range of monomers, i.e. almost any 
monomer containing a vinyl group has the potential to polymerise.  It can also be 
carried out in bulk and many organic solvents, only limited by potential transfer 
reactions.  As shown in Scheme 1.3, propagation is extremely fast and therefore high 
molecular weight polymer chains are achieved relatively quickly and therefore at 
longer reaction times conversion will undoubtedly increase yet Mn is little affected 
(see Figure 1.10). 
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Figure 1.10: Evolution of Mn with time for conventional free radical polymerisation. 
Despite being experimentally facile, conventional free radical polymerisation has 
major limitations.  Perhaps under-reported in the literature, the initiators used in 
these reactions can often be explosive and are therefore hazardous;
164
 a scheme of 
the decomposition of the initiator azobisisobutyronitrile (AIBN) is shown in Scheme 
1.4.   Synonymous with conventional free radical polymerisation is its lack of direct 
control of specific chain lengths and the formation of monodisperse materials.  This 
is due to initiation and termination occurrence throughout the reaction.  
Polydispersities are generally > 2 if polymerisations are left to reach high 
conversion, however, this may be reduced if reactions are terminated at low 
conversion.
161
   
 
Scheme 1.4: Decomposition of AIBN producing radicals. 
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1.5.1.2  Achieving Control in Free Radical Polymerisation 
The addition of Chain Transfer Agents (CTAs) (e.g. carbon tetrabromide and thiols 
with labile hydrogen atoms) is one way to achieve some control in these reactions.  
Hydrogen abstraction of a CTA results in a terminated polymer chain, leaving a CTA 
radical capable of propagation with unreacted monomer, resulting in lower 
molecular weight polymers; reported as early as 1943.
165
 Carefully chosen, a CTA 
can also be used to gain chain-end functionality yet it is almost impossible to ensure 
every polymer chain contains a CTA as many chains will be initiated by other 
species.  It has been reported that mostly CTA capped polymer chains could be 
prepared if the initiator and the CTA contain identical functional groups, however, 
this only highlights the limited choice of materials which can be used.
166
 
It is possible to obtain copolymers using conventional free radical polymerisation, 
however, the mode of incorporation is highly dependent on steric hindrance and 
reactivity ratios of each monomer.  Theoretically if monomers are carefully chosen 
gradient copolymers could be synthesised yet block copolymers could never form by 
this method.  The use of macroazoinitiators consisting of polymeric or oligomeric 
units with one or more azo group is one way of forming block copolymers using 
conventional free radical polymerisation,
167
 yet this relies on the macroazoinitiators 
initiating all chains when it is known that monomers can often polymerise thermally.    
1.5.1.3  Branching in Free Radical Polymerisation 
Sherrington and co-workers introduced a new simple route to manipulate free radical 
polymerisation to achieve complex branched architectures using the “Strathclyde” 
approach.
168, 169
 In short they proposed that soluble branched polymers of any vinyl 
monomer (such as methyl methacrylate (MMA)) could be prepared by inclusion of a 
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bi-functional vinyl monomer (such as but-2-ene-1,4-diacrylate (BDA)) and a CTA 
(1-dodecanethiol (DDT)) depicted in Scheme 1.5. 
 
Scheme 1.5: Strathclyde route to branched polymers using a bifunctional initiator 
and CTA. 
These reactions were generally carried out in toluene and had relatively short 
reaction times (approximately 5 hours) after which polymers were precipitated into 
n-hexane.  It was reported that the molecular weight of these polymers could be 
controlled by variation of monomer: CTA: bifunctional monomer feed ratio and 
molecular weights (characterised by dual detection Gel Permeation Chromatography 
(GPC)) obtained were approximately 150000 g mol
-1
.  However, using ethylene 
glycol diacrylate (EGDA) as the bifunctional monomer with a molar feed ratio of 
MMA:EGDA:DDT 100:15:6 a soluble branched polymer was obtained with a 
molecular weight of 3774000 g mol
-1
.
170
  This process could in principal be applied 
to all vinyl monomers and branchers and has scope for developing different branched 
architectures such as core cross-linked star clusters. 
Little research has been reported with regard to nanometre structures comprised of 
polymers synthesised by this method.  Weaver et al. described pH-responsive 
nanoparticles (16 nm to 46 nm) of 2-(diethylamino)ethyl methacrylate (DEA) and 
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poly(ethyleneglycol) methacrylate (PEGMA) (Mn = 1 100 g mol
-1
) with an ethylene 
glycol dimethacrylate (EGDMA) brancher which are capable of encapsulating 
fluorescent material.
171
   
In short summary, despite this facile one-pot approach to generating branched 
polymers, absolute control of primary chain length cannot be achieved using this free 
radical polymerisation approach.   
1.5.2  Anionic Polymerisation 
Anionic polymerisation is a method which was first reported by Szwarc
172
 and the 
first example of a ‘living’ polymerisation.  Under the correct conditions there exist a 
constant number of propagating chains with anion active functionalities present 
throughout the reaction demonstrated by  linear plots of i) Mn vs. conversion; and ii) 
ln([M0/[M]) vs. time. The molecular weight distribution also remains extremely 
narrow throughout the polymerisation.  These polymerisations can also self-block 
(i.e. introducing a second monomer feed) and have tuneable chain lengths controlled 
by the monomer to initiator ratio and polymerisation will continue until all monomer 
is consumed.  In order to be an ideal ‘living’ system, termination does not occur, 
however, in practice this is extremely difficult to realise as the active chain ends can 
abstract protons from solvent and therefore it is necessary to use aprotic solvents 
which are extensively deoxygenated and are anhydrous.  Furthermore vessels must 
be dry and the reaction atmosphere must also be completely inert; these stringent 
conditions make anionic polymerisation an unfavourable synthetic method.  The 
reactions are usually initiated by organometallics reagents which have a carbanion 
capable of propagating chain ends; a simple reaction is shown in Scheme 1.6. 
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Scheme 1.6: Anionic polymerisation of styrene using sec-Butyl Lithium as the 
initiator. 
As well as benzene rings other functional groups can be incorporated into polymer 
chains such as carboxyls, hydroxyls and halogens. These groups can be placed at the 
beginning, middle or the end of (typically polystyrene) chains.  Carboxylic acid 
groups can be introduced through carboxylation of the carbanionic living group and 
hydroxyl chain ends can be prepared by a simple quenching reaction in methanol.  
Halogens can be introduced by the reaction of dihaloalkanes to the polystyryl ions 
yielding haloalkyl terminated polymers, however, this reaction is not quantitative 
and coupling of polystyrene chains also occurs.
173
  
1.5.2.1  Branching in Anionic Polymerisation 
A dendritic style of branching can be achieved using anionic polymerisation and a 
convergent process through the addition of 4-(chlorodimethylsilyl) styrene 
(CDMSS), which contains a polymerisable vinyl group in addition to a dimethyl silyl 
group, capeable of an SN2 reaction generating star shaped polymers
174 
(Figure 1.11 
(A)) or through a coupling reaction which also yields star branched polymers
175
 
(Figure 1.11 (B)).  Star polymers of polystyrene can also be prepared by a divinyl 
benzene (DVB) coupling reaction (shown in Figure 1.11 (C)), where nanometre 
sized polymers with up to 41 arms has been synthesised.  The area of branched 
polymers synthesised via anionic methods is relatively small despite the near ideal 
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nature of this polymerisation method, mostly due to the above mentioned 
experimental criteria and the limited number of suitable monomers. 
 
Figure 1.11: Methods of branching using anionic polymerisation. A) Using anionic 
and convergent synthesis. B) Coupling reaction. C) Coupling with divinyl benzene 
(DVB). 
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It has been shown that anionic polymerisation can be used to generate nano systems 
which can load drugs.  These ABC miktoarm star terpolymers form multicomponent 
micelles in solution.
 176, 177
 (shown in Figure 1.12). 
 
Figure 1.12: Example of an ABC miktoarm star terpolymer. 
 
1.5.3  Nitroxide Mediated Polymerisation (NMP) 
NMP is a controlled polymerisation first reported by Georges et al.
178
 who described 
the polymerisation of styrene using a benzoyl peroxide initiator and mediated by 
2,2,6,6-tetramethyl-1-piperidinyloxy, (TEMPO).  Other researchers successfully 
used this method utilising the reversible end-capping of chains with a controls the 
rate of monomer addition.
179
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Scheme 1.7: NMP polymerisation mechanism. 
 
Styrene and substituted styrenic monomers are the most common monomers used in 
NMP,
180, 181
 however, acrylate, acrylamide and acrylonitriles monomers can also be 
polymerised using this method where polydispersities of < 1.20 can be achieved.
182
  
Unfortunately methacrylates are not suitable monomers as irreversible termination 
can occur due to the proton transfer from methacrylates to the nitroxide radical 
species.
183 
1.5.3.1  Branching in NMP  
Branched polystyrene polymers using bifunctional divinyl benzene (DVB) can be 
synthesised using a straightforward NMP approach, where adjustment of the mole 
feed ratio of brancher can result in either soluble branched polymers or cross-linked 
gels.  Analysis of these polymers showed that molecular weights were in the range of 
150000 g mol
-1
, however, this report did not include details of linear analogues or 
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even initial initiator: monomer ratios and therefore primary chain length of these 
polymers was not be determined.
184
      
To date, polymers synthesised via NMP, have not been directly used in the 
development of drug delivery devices.  Nicolas et al.
185
 have synthesised 
amphiphilic polymers using styrene, methyl methacrylate and polyethylene glycol 
methyl ether methacrylate (PEGMA) (ethylene oxide repeat unit = 4-5) where a 
modified nitroxide and small amount of styrene were added to the reaction mixture 
to overcome methacrylate induced termination. These polymers may have the ability 
to self-assemble in water and host hydrophobic material but such properties were not 
discussed in this report.
184
   
1.5.4 Reversible Addition-Fragmentation chain Transfer Polymerisation     
(RAFT) 
RAFT is a controlled polymerisation technique introduced by Moad and co-
workers;
186
 reactions are based on the transfer of an end-group (from a RAFT agent) 
where the chain end is in equilibrium as an active and dormant species. A general 
mechanism of this reaction is shown in Scheme 1.8 (A).  Essentially RAFT is a 
conventional free radical polymerisation with the addition of a chain transfer agent 
which is usually a dithioester but can be trithiocarbonates or xanthates (general 
RAFT agent features are seen in Scheme 1.8 (C)) which controls monomer addition.  
Following initation, radical species add across the C=S bond of the RAFT agent 
generating an intermediate which fragments yielding a new radical and a dormant 
capped polymer chain.  This radical will re-initiate the polymerisation with the 
capped polymer behaving as the RAFT agent.   
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Scheme 1.8: RAFT process. A) General reaction mechanism. B) RAFT agent 
features. 
As well as styrene (and its derivatives), a wide variety of (meth)acrylate monomers 
can be utilised in RAFT polymerisation.
187
 Reactions can proceed in a controlled 
manner at temperatures ranging from ambient to 140°C and, for certain systems, 
increased reaction temperatures can yield polymers with narrow polydispersities,
161
 
however, an increased temperature in the polymerisation of MMA (using a 
trithiocarbonate RAFT agent) had no effect on polydispersity.
188
  In most 
polymerisations an increased temperature leads to an increased rate of 
polymerisation and shorter reaction times. Higher molecular weights can also be 
achieved by increasing reaction pressure (this slows the rate of radical-radical 
termination).
189
   
Reactions can be carried out in protic solvents such as alcohols and water, however, 
suitability of the RAFT agent in these solvents must be considered.
186 190
  For the 
polymerisation of vinyl acetate (VAc) and MMA (both using AIBN initiator) 
conversions of 96 % and 90 % can be achieved respectively, however, different 
RAFT agents were used for these reactions.
188
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The ability to synthesise RAFT agents with different chemistries (which must be 
compatible with the chosen monomer and solvent) gives polymer chain end 
functionality which can be highly desirable.  As a consequence, the dithioester group 
of the RAFT agent will remain at the terminus of each polymer chain which colours 
the final material.  This colour, coupled with the dithioester functionality may be 
undesirable for further reactions and/ or applications of the polymers, for example 
toxicity issues when used in drug delivery systems.
191
  These groups can be cleaved 
through aminolysis, thermal emimination and UV irradiation
192, 193 
depending on the 
individual RAFT agent. 
Statistical copolymers copolymers can be prepared by RAFT polymerisation but it 
should be noted that these are generally gradient copolymers dependant on the 
chemistry of both/multiple monomers and their reactivity ratios.
188
 It should be noted 
that the monomers used in copolymerisations must compliment the chosen RAFT 
agent.  Diblock copolymers copolymers can also be readily synthesised through 
addition of a second monomer batch after high conversion of the original monomer 
batch, and as this is experimentally facile, polymers with ABA and ABC 
compositions can be produced.
194, 195
 
1.5.4.1  Branching in RAFT Polymerisation 
A RAFT monomer with a dithioester group and a double bond has been shown to 
copolymerise with styrene (in bulk) to give highly branched structures with a 
molecular weight of 600000 g mol
-1
 at 83 % conversion (24 hours)
196
 but Perrier was 
the first to report the synthesis of PMMA hyperbranched polymers using EGDMA as 
a brancher in 2005 where near 100 % conversion could be reached.  An example of a 
dithioester RAFT agent used in this branched polymerisation
197
 is shown in Figure 
Chapter 1 
40 
 
1.13.  This one-pot system produced a branched polymer with a molecular weight of 
approximately 686 000 g mol
-1
 (polydispersity = 38.63) using a molar ratio of CTA: 
MMA: EGDMA 1: 34: 1.82 and it was also shown that this material could be 
successfully chain extended using styrene monomer.  These examples of branched 
polymerisations were found to be controlled reactions where linear plots of Mn vs. 
conversion and ln([M0/[M]) vs. time were recorded. 
 
Figure 1.13: Example of a dithioester RAFT agent bearing double bonds. 
1.5.4.2  RAFT Polymers in Drug Delivery  
There have been very few reports on the in vitro toxicity
198, 199 
and blood 
compatibility
200 
associated with polymers synthesised by RAFT, and it is thought the 
thiocarbonyl groups will have different toxicities to different tissues in the body.  
Nevertheless numerous micelles using amphiphilic copolymers synthesised via 
RAFT have been shown to self-assemble where relative ratios and block length has 
been shown to affect size, stability and CMC of the resulting micelles.
201, 202
 
Reversible shell-crosslinked micelles (with a poly(ethylene oxide) corona) have 
shown controlled release of a model drug
203
 and there have also been reports of 
pH
204
 and temperature sensitive
205
 micelles often using p(N-isopropylacrylamide) 
(NIPAAm). It has been shown that acid-degradable crosslinked core-shell particles 
with average diameters of approximately 150 - 500 nm can be generated by RAFT-
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mediated dispersion polymerisation.
206
  These consist of n-butyl acrylate cores and 
p(oligoethylene glycol acrylate) (OEGA)  shells which are acid cleavable, resulting 
in release of a hydrophobic payload.  Thermoresponsive hydrogels for use in tissue 
engineering scaffolds can be assembled using BAB triblock copolymers containing 
p(NIPAAm) and p( N, N-dimethacrylamide) synthesised using RAFT.
207
  
1.5.4.3  RAFT Limitations 
Despite the versatility of RAFT polymerisation in terms of monomer choice and 
architecture, there are a number of negative aspects which will be briefly outlined 
here.  Invariably overlooked is the widespread use of AIBN initiator, which has been 
reported to be a potentially explosive material and extra care must be taken during its 
use.
208
  Perhaps the most significant limitation is the time consuming synthesis and 
characterisation of individual RAFT agents which must compliment the chosen 
monomer making it extremely difficult during the synthesis of multicomponent and 
branched polymers.  To use these polymers in applications such as drug delivery or 
any other biomedical purpose further modification/ purification may be necessary to 
cleave the dithioester moieties present on each chain, to prevent any toxic side 
effects associated with this functional group.   
1.5.5  Atom Transfer Radical Polymerisation (ATRP) 
ATRP is a popular method of controlled free radical polymerisation.  It was 
developed independently by Sawamoto
209
 and Matyjaszewski
210
 in 1995. 13 papers 
(SciFinder Scholar) based on the technique were published in the same year; since 
then interest has increased dramatically with 929 papers published in 2012 alone 
(SciFinder Scholar).  The process is a development of Atom Transfer Radical 
Addition; a free radical addition of alkyl halides and alkenes produced in a 1:1 ratio. 
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1.5.5.1  ATRP Mechanism 
Radicals are generated by a reversible redox process which is catalysed by a 
transition metal complex (Mt
n
 – Y / Ligand) which  can abstract a halogen atom (X) 
from an alkyl halide initiator (R – X) to give an alkyl radical and an oxidised metal 
complex (X - Mt
n+1
 – Y / Ligand); this is the activation step.  As the metal complex 
is in a higher oxidation state it acts as a deactivator and will rapidly re-generate a 
halogen capped polymer chain.  A fast equilibrium between these active and dormant 
species is quickly set up where monomer addition occurs in a controlled manner 
(basic mechanism is shown in Scheme 1.9).  
 
Scheme 1.9: General ATRP mechanism. 
This outlined reversible capping of polymer chain ends is a feature similar to the 
nitroxide capping in NMP and the RAFT process (section 1.5.3 and section 1.5.4), 
the addition of monomer is similar to that found in free radical polymerisation 
(section 1.5.1).   
1.5.5.2  ATRP Rate Law 
This rate law predicts a linear relationship between ln([M]0/[M]) and conversion 
with time should be observed during an ATRP process.  The linearity indicates a 
constant concentration of radical species in the reaction and first order kinetics with 
Chapter 1 
43 
 
respect to monomer consumption.  Deviation from linearity may occur due to 
termination reactions where the concentration of Cu
II
 increases; this can happen 
when the initial concentration of Cu
II
 is not large enough to ensure fast rates of 
deactivation resulting in coupling of radicals and therefore increasing the 
concentration of Cu
II
.   
 
Equation 1.1: Rate law of ATRP. 
1.5.5.3  Molecular weight Determination  
In the case of living polymerisations, molecular weights can be pre-determined and 
predicted by tailoring of initiator: monomer ratio.  The number of monomers in a 
primary chain is referred to as the Degree of Polymerisation (DPn) and is equal to 
[M]/[I]0 and polymers with molecular weights above 100000 g mol
-1
 can be 
prepared, however, by targeting these high molecular weights termination is thought 
to occur more readily.  
As these reactions proceed in a controlled manner, i.e. only transient periods of 
monomer addition, polymer chains synthesised by ATRP have relatively narrow 
polydispersities typically 1.01 – 1.5.  The polydispersity relates to initiator (RX) 
deactivator (D), propagation rate constant (kp) and deactivation rate constant (kp) and 
monomer conversion (P) seen in Equation 1.2. 
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Equation 1.2: Polydispersity determination in ATRP. 
This equation assumes no chain termination or transfer reactions take place in the 
polymerisation, which in practice is unlikely to be the case.  Higher polydispersities 
are often found for acrylates compared to methacrylates as the former generally have 
higher rates of propagation, consistent with Equation 1.2.  Shorter polymer chains 
also tend to have larger polydispersities in comparison to long chains due to the 
higher initial initiator concentration.   
1.5.5.4  Experimental Procedure for ATRP 
ATRP polymerisations are mostly carried out in solvent but bulk ATRP has been 
shown in the literature.  Solvents aid the diffusion of polymer chains at high 
conversion when the solution becomes more viscous.  ATRP can also be carried out 
in emulsion,
211 
miniemulsion,
212
 dispersion
213
 and suspension polymerisation.
214
 For 
the purposes of this study these systems will not be discussed further.  Preparation 
for an ATRP reaction begins by the addition of either the initiator or Cu
I
 / Ligand 
complex to a deoxygenated vessel containing monomer and solvent.  ATRP is 
oxygen sensitive (as are all free radical polymerisations) but can proceed with small 
amounts of oxygen which is scavenged by the catalyst but large amounts leads to 
oxidation of catalyst reducing its concentration which decreases the polymerisation 
rate.  De-gassing the initial monomer/solvent solution and providing an inert 
atmosphere is necessary to remove oxygen as it reacts with active polymer chains 
leading to unwanted termination.  Once initiated, chain ends should remain active 
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until manual termination which is usually carried out by the addition of solvent and 
exposure to the atmosphere with stirring.   
1.5.5.5  Components of ATRP 
1.5.5.5.1  Choice of monomer 
A wide variety of monomers can be used in ATRP including (meth)acrylates,
215, 216
 
(meth)acrylamides,
217, 218
 styrenics,
219, 220
 and acrylonitriles,
221
 where 
polymerisations proceed in a controlled manner yielding polymers with narrow 
polydispersities.  All of these monomers contain a stabilising group (often carbonyl) 
which ensures limited interference with propagating radicals and catalytic systems.  
It should be noted that optimisation of concentration and catalyst may be necessary 
to ensure controlled monomer chain addition with respect to radical concentration.  
Methacrylates are favoured in ATRP as they generate highly stable radicals (due to 
their methyl group) affording more controlled reactions (when compared to 
acrylates), and n-butyl methacrylate (BuMA),
222, 223
 2-(dimethylamino) ethyl 
methacrylate (DMAEMA),
220
 2-hydroxy ethyl methacrylate (HEMA)
224, 225 
and oligo 
(ethylene glycol) methyl ether methacrylate
226
 have all been successfully 
polymerised (amongst many others) using ATRP.  
2-Hydroxypropyl methacrylate (HPMA) is a relatively unused monomer in ATRP; 
however, it has been used in free radical polymerisation
227
 and NMP.
228
 HPMA has 
interesting solution properties as the monomer is highly water soluble yet p(HPMA) 
is extremely hydrophobic.  The first report of direct p(HPMA) polymerisation using 
ATRP was in 2002
229
 where reaction kinetics were investigated in various protic 
solvent systems achieving a polydispersity of 1.09 in methanol (97 % conversion, 
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target DPn = 50).  Since then it has been used as a model monomer for investigating 
initiator efficiencies through 
13
C-radiolabelling
230
 and for performing 
polymerisations in microfluidic systems.
231
 The polymerisation of p(HPMA) has 
been shown to be facile, and when coupled with its tolerance to different 
solvents/initiators makes it an ideal candidate for further studies and its 
hydrophobicity may be exploited for the use in an amphiphilic polymer system.   
1.5.5.5.2  Choice of Catalyst 
The addition of a halogenated transition metal catalyst is necessary in ATRP to 
ensure control of the equilibrium between active and dormant moieties.  The metal 
ion must undergo a one electron transfer i.e. oxidation/reduction and must 
successfully form a complex with a suitable ligand where the metal increases its 
coordination number by one.  It must also have a strong affinity for halogen atoms 
but not hydrogen and alkyl radicals.  The first ATRP reactions used ruthenium
209
 
(Sawamoto) and copper
210
 (Matyjaszewski); since then a wide variety of metals 
including nickel,
232
 rhodium,
233
 molybdenum,
234
 palladium
235
 and iron
236
 have been 
used; however, due to its relatively low toxicity, versatility and availability copper is 
generally preferred. 
The halogenated metal and the initiator can contain the same halogen atom, however, 
it is common to used a mixed system as this can afford increased control in 
polymerisations, for example, bromine containing initiators compliment chlorinated 
catalysts.  As the Cu-Cl bond is stronger than Cu-Br, halogen exchange occurs 
following initiation where most chains are terminated by Cl atoms.
237
 Therefore the 
rate of initiation increases with respect to propagation and as such, using CuCl with a 
brominated initiator leads to better controlled polymerisations.
238
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1.5.5.5.3  Choice of ligand 
Ligands in ATRP aid the solubilisation of the transition metal catalyst and also 
control the equilibrium position between active and dormant moieties through 
adjustment of the redox potential.
239
 The most widely used are nitrogen-based, 
particularly for Cu containing systems where as phosphorous ligands are generally 
less effective.  Other ligands used in Cu mediated ATRP have been reviewed.
239 
The 
chosen ligand should form a strong complex with the transition metal and allow an 
increase in coordination number with no side reactions.  Bidentate ligands such as 2, 
2’-Bipyridine (BPY) are used in Cu mediated ATRP as its steric hindrance does not 
result in reduced catalytic activity and the nitrogen substituent is not excessively 
electron withdrawing.
237
  
1.5.5.5.4  Choice of Initiator 
The reaction of a chosen initiator influences the amount of control in a 
polymerisation and the ratio of initiator: monomer determines the primary chain 
length.  To ensure radical generation the initiator must be equally (or more) reactive 
than the propagating species. If it is highly reactive control would be lost as the 
concentration of radicals would be too high.  In short, any halide containing 
molecule with a stabilising group at the α-carbon can be used as an ATRP initiator240 
and faster initiation can occur as a result of a highly stable initiator radical.  Weak 
initiator- halogen bonds i.e. C-I do not effectively initiate reactions, conversely C-F 
bonds are too strong and the same result is found and as such C-Br bonds are found 
to be most effective.
237
   
To achieve chain end functionality, straightforward esterification reactions between 
acids (with various functional groups) and acyl halides can give a variety of ATRP 
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initiators.
226, 241
  As ATRP is highly tolerant to functional groups it is possible to 
synthesise macroinitiators in the same way.  These can be (relatively low molecular 
weight) polymers which have been previously synthesised and can be used as an 
alternative to conventional block copolymerisations.  The solubility of both segments 
may be different but both must have sufficient solubility in the solvent used in 
polymerisation.
242
   
1.5.5.5.5  Choice of Solvent 
ATRP can be carried out in bulk,
243
 however, as many polymers aren’t soluble in 
their monomer, solvents are invariably used as a reaction medium.  MMA,
244
 
PEGMA,
245
 and DMAEMA
246 
have all been polymerised in toluene.  Polar solvents 
such as dimethyl sulfoxide (DMSO),
246
 dimethyl formamide (DMF),
247
 
tetrahydrofuran (THF)
248
 and acetone
249
 have also been used in ATRP.   
In 1998 polymerisation of p(HEMA) was successfully carried out in water (40 °C)
250
 
and can now be carried out at ambient temperature shown by Armes and co-workers 
who polymerised OEGMA to 95 % conversion (1.12 polydispersity)
251, 226 
and 
Perrier et al. were able to polymerise PEGMA (higher molecular weight OEGMA) 
in the same manner.
252
   
Alcoholic solvents are also utilised in ATRP, such as isopropyl alcohol (IPA) for the 
polymerisation of 4-vinyl pyridine (40 °C, 1.1 polydispersity); Rannard and co-
workers were also able to polymerise BuMA in IPA: water mixtures.
222, 223
  
Monomers with hydroxy functionality such as HPMA and glycerol methacrylate 
(GMA) have been shown to polymerise in methanol (and methanol/water mixtures) 
in a controlled manner characterised by linear plots of Mn vs. conversion and 
ln([M0/[M]) vs. time. Using the same experimental protocol, Armes and co-workers 
Chapter 1 
49 
 
were able to use a PEG based macroinitiator (EO repeat unit = 45) to polymerise 
HPMA (target DPn = 25) to 100 % conversion at 50°C, yielding a polymer with a 
polydispersity of 1.17.
229
  The addition of water to an ATRP reaction has been 
shown to increase the rates of polymerisation;
253, 254
 thought to be due to the reduced 
concentration of the deactivator which leads to a reduction in the rate of deactivation 
and therefore monomer addition becomes faster (and less controlled).  It is reported 
that water can act as a ligand in the Cu complex thereby eliminating the halogen 
atom.  This complex becomes unable to act as a deactivator as it is no longer in a +2 
oxidation state and as such reactions proceed at a faster rate, limiting control of 
monomer addition.
237
  
1.5.5.5.6  Temperature 
As well as increasing polymerisation rate and catalyst solubility, elevated reaction 
temperatures also increase the chance of chain transfer and other undesirable side 
reactions and in some cases catalyst decomposition.
255
 Optimal reaction temperatures 
are highly dependent on monomer, catalyst and target DPn and as such can vary 
considerably.
237
 
1.6  Different Polymer Architectures using ATRP 
Outlined here are various polymer architectures prepared by ATRP which may be 
manipulated to form drug delivery vehicles.  Several graphical representations of 
these architectures are shown in Figure 1.14.  
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Figure 1.14: Representation of various polymer architectures obtained by ATRP. 
Linear polymer (A), star polymer (B), graft copolymer (C) and branched polymer 
(D). 
1.6.1  Linear Polymers 
Apart from homopolymers, various polymer compositions may be obtained through 
ATRP.  Block copolymers can be generated by either a macroinitiator approach
256, 
229 
or by the sequential addition of monomers.
257
  A decablock copolymer comprised 
of methyl acrylate (MA), ethyl acrylate (EA), n-butyl acrylate (n-BA) and t-butyl 
acrylate (t-BA) has been reported.  Each block had a target molecular weight of 2000 
g mol
-1
 achieving a final molecular weight of 21 000 g mol
-1
 (polydispersity  = 
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1.72).
258
 During each successive monomer addition some chain end functionality 
was lost, verified by low molecular weight shoulders in GPC analysis.   
1.6.2  Star Polymers 
These structures can be generated by the use of multifunctional initiators
259, 260
 
generating ‘arms’ as monomer growth proceeds away from the core initiating site 
(Figure 1.14 (B)) and may be called a ‘core-first approach’.  Star polymers may also 
be generated using an ‘arms-first’ approach where linear polymers are synthesised 
followed by addition of a crosslinking agent (such as DVB or EGDMA) leading to 
dense core formation.
261
 
1.6.3  Graft Copolymers 
Seen in Figure 1.14 (C), these structures can be obtained using three methods: 
1) Grafting onto: Polymer chains are attached to a pre-synthesised polymer chain.
262
  
2) Grafting from: The functional groups present within a polymer backbone can be 
converted to initiators followed by monomer addition.
263
  
3) Grafting through: This technique utilises macromonomers which are polymer 
chains containing a polymerisable group.
264, 265
 
Parameters such as grafting density and side chain length can be altered using this 
approach to produce polymers with desired properties. 
1.6.4  Branched Copolymers 
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ATRP can be used to prepare hyperbranched polymers using self-condensing vinyl 
polymerisation (SCVP).
266
 This utilised AB* monomers via a controlled free-radical 
process where A = vinyl group and B* = an ATRP initiator (see Figure 1.14 (D).  
Monomers such as vinyl benzyl chloride (VBC) can be polymerised using this 
method.  When B* is active a “T” shaped linkage forms and without significant 
termination the number of branch points is equal to the DPn.  Gelation can never 
occur in conventional SCVP as the chains are all tethered at one end and there is no 
inter-chain reactivity that occurs when the reaction is proceeding.  
The synthesis of soluble branched polymers using ATRP can be achieved through 
addition of a small amount of divinyl monomer (brancher) i.e. the Strathclyde 
approach.  This molecule is statistically incorporated into a propagating polymer 
chain leaving a pendant unreacted vinyl group which will react with another 
propagating polymer chain leading to irreversible linkage.  If this branching applied 
to every chain in a reaction pot an infinite network gel will be produced.  The 
amount of divinyl monomer needed to produce highly branched polymers varies and 
is dependent on several factors including the reactivity ratios monomer and brancher 
(becoming more complex when using > 1 monomer), however, it is common 
practice for the initiator/brancher mole ratio to be less than unity.
267, 268
   
If the branching process is random and provided all monomers have equal 
reactivities, it is inevitable that some chains will contain > 1 brancher molecule and 
conversely some will contain no brancher.  Intramolecular cyclisation of brancher 
may occur during polymerisation where the pendant vinyl group of a brancher reacts 
with the chain end forming a loop.  It has been shown that more dilute conditions 
increases the amount of intramolecular cyclisation.
269
  Armes and co-workers have 
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used Monte Carlo modelling to predict molecular weights, polydispersities and 
architecture as a function of time; the results from which were compared to a 
branched copolymerisation of p(HPMA) using EGDMA as a brancher.  Here it is 
shown that a multitude of architectures are formed after almost complete 
conversion.
270
  A schematic representation of the various architectures that may form 
when using a divinyl monomer in an ATRP synthesis is shown in Figure 1.15. 
 
Figure 1.15: Representation of various architectures which may be present in a 
branched ATRP reaction. 
1.6.5  ATRP Polymers for Drug Delivery 
There are few reports of the encapsulation of drugs (or indeed any hydrophobic 
material) into polymeric systems synthesised via ATRP.  However, pH responsive 
polymer micelles have been shown to successfully load and release rifampicin 
(RIF);
271
 it should be noted that these polymers also contained cellulose segments 
which were not synthesised by ATRP.  Micelles consisting of novel folic acid-
functionalised diblock copolymers synthesised by ATRP have been shown to 
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successfully load a hydrophobic drug,
272
 however, their preparation involved 
processes such as centrifugation, sonication and filtration.  These procedures are 
time consuming and scale up experiments may prove difficult.  To date, branched 
copolymers synthesised by ATRP have not been used for drug delivery purposes. 
1.7   Project Outline 
The aim of this project is to develop a strategy that will allow the controlled 
synthesis of high molecular weight amphiphilic copolymers with complex 
architectures. ATRP was chosen as the polymerisation method due to limitations of 
other systems, which are briefly highlighted here.  The synthesis and purification of 
dendrimers/dendronised polymers is highly complex and time consuming, where as 
one-pot hyperbranched polymers offer no scope of chain length control; as is the 
case for free radical polymerisation.  Monomer choice is limited in anionic 
polymerisation where reactions require extremely stringent conditions, which are 
unfavourable for this project. NMP was not utilised in this body of work as the scope 
of materials which may be synthesised using this route is limited, despite relatively 
facile polymer synthesis.  Despite the complex architectures and wide range of 
monomer choice, RAFT was not used as a polymerisation technique; this is due to 
the synthesis of RAFT agents and subsequent dithioester cleavage post-
polymerisation.  
Hydrophobic p(HPMA) was chosen as the ATRP synthesis has been shown to 
proceed in a controlled manner, with and without a hydrophilic macroinitiator using 
Cu(Cl)/BPY as the catalyst/ligand at ambient temperature.  The addition of water has 
been shown to increase the rate of polymerisation of p(HPMA), however, it was 
anticipated that complete removal of water may be experimentally difficult, 
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particularly if using a hygroscopic macroinitiator.  To ensure polymerisations 
proceed in a controlled manner, detailed kinetic analysis of linear and branched 
p(HPMA) (using EGDMA brancher) will be performed with and without a PEG 
block.  A catalogue of linear and branched polymers with varying amphiphilicity 
(through tailoring the chain lengths) will be synthesised which may be used to 
generate polymeric nanoparticles in water.  Branched polymers will form micelle-
like structures with dense hydrophobic cores without self-assembly or crosslinking 
in water and by using various nanoprecipitation approaches, aqueous nanoparticle 
dispersions comprising of these copolymers will be generated and their behaviour 
explored.  A methodical approach will be taken, aiming to control nanoparticle z-
average diameter utilising a rapid solvent exchange method, achieved simply 
through variation of concentration parameters. This work will show that these 
nanoparticles are capable of loading various hydrophobic materials including the 
human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) 
drug Lopinavir.  The ultimate goal would be to generate a universal drug carrier 
alongside tailoring its z-average diameter to suit its biological application and it is 
believed progress towards this has been achieved. 
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2. Experimental Section 
2.1 Materials used during this study.  
Hydroxypropyl methacrylate (HPMA) 97 %, ethylene glycol dimethacrylate 98 % 
(EGDMA), ethyl α-bromoisobutyrate (EBiB)  98 %, α-bromoisobutyryl bromide 98 
%, methoxypolyethylene glycol average mol wt 750, 2000, 5000 g mol
-1
, Cu(I)Cl 
>99 %, 2,2,’-bipyridyl >99 %, aluminium oxide (activated, basic), Dowex Marathon 
exchange resin, Celite, Oil Red O, ibuprofen >98 %, pyrene > 99 %, 4-
(dimethylamino) pyridine >98 %, triethylamine (TEA) >99 %, Amberlyst resin, 
anisole (anhydrous) 99.7 %, methanol (HPLC grade), tetrahydrofuran (HPLC grade), 
n-hexane, acetone (HPLC grade), toluene (anhydrous), dialysis tubing (benzoylated) 
molecular weight cut off = 2000 g mol
-1
, Whatman 200 nm PTFE syringe filters 
were all purchased from Sigma-Aldrich and used without any further purification.   
CDCl3 and d6-DMSO solvents were purchased from GOSS Scientific.  Lopinavir 
was purchased from LGM Pharmaecuticals (Chicago). 
2.2 Equipment utilised during the characterisation of linear and 
branched polymers and nanoparticles formed from the polymers 
2.2.1 
1
H NMR Spectroscopy
  
1
H NMR spectra were recorded in either DMSO-d6, CDCl3 or D2O using a 400 MHz 
Brüker Avance spectrometer. Chemical shifts (δ) are reported in parts per million 
(ppm) with respect to an internal reference of tetramethylsilane. 
NMR spectroscopy can be used to calculate Mn values using end-group analysis 
where a clear resonance from the polymer chain end-group is necessary. By 
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comparing the strength of end-group signals to signals originating from the polymer 
backbone, the ratio of end group: repeat unit can be calculated, (DPn).  Samples were 
prepared by dissolving approximately 0.05 g of product in 1-2 mL of solvent. 
This method is subject to inaccuracy, especially as chain length increases and the 
end-group signal becomes weaker.  For copolymers, the solvent also has a great 
influence, where solubility of copolymer components may be different. However, 
with appropriate solvent choice, end-group analysis can be a useful technique 
allowing determination of composition and Mn of complex structures such. 
2.2.2 Gel Permeation Chromatography  
Triple detection gel permeation chromatography (GPC) (either HPLC grade 
tetrahydrofuran (THF) stabilized with 2,6-di-tert-butyl-4-methylphenol, or HPLC 
grade acetone eluent) with a flow rate of 1 mL min
-1
 was performed using a Malvern 
Viscotek 270 Max instrument using T6000M x's 2 + guard column set.  All samples 
were dissolved at 5 mg mL
-1
 and passed through a 200 nm syringe filter prior to 
injection (100µL) with a run time of 60 minutes.  
GPC (also known as size exclusion chromatography) analysis relies on different 
hydrodynamic sizes of polymer molecules in solution which are separated.  Columns 
are packed with porous beads, and dilute samples of polymer are injected into these 
columns. Depending on polymer sizes in solution, chains are able to penetrate the 
beads and are eventually eluted.  Larger polymer chains are less able to diffuse 
through pores than small chains, therefore they pass through columns faster.  The 
smallest polymer molecules will penetrate the most pores, and are therefore eluted at 
longer retention times.  Detector signals are plotted against elution volume or time. 
Elution volume for a given molecule is given by: Ve = V0 + KeVi, where Ve is elution 
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volume, V0 is void volume; i.e. the volume between the beads.  Vi is the internal 
volume (i.e. the volume inside porous beads) and Ke is a coefficient defined by the 
partition of the polymer molecules between voids and the beads. If all chains are 
large chains are excluded from all bead pores, Ke = 0 and Ve = V0.  If all chains are 
very small and penetrate all bead pores, Ke = 1 and Ve = V0 + Vi.  For a polymer 
sample to be separated, elution volume must lie between the limits i.e. Vi<Ve< V0 + 
Vi.  
Triple detection GPC uses a concentration detector (refractive index detector (RI)) 
which is based on deflection of light passing through a dual component flow cell 
(one containing a reference solvent and the other containing solvent and sample).  
The difference in refractive index can be used to determine sample concentration 
with respect to time during polymer separation; plotted as a detector response vs. 
elution volume (or time).  For light scattering detectors to determine molecular 
weight, they use the Rayleigh Equation: 
 
Where the intensity of scattered light is equal to an optical constant (K) multiplied by 
concentration (C) and molecular weight (M).   To record the intensity of scattered 
light the measuring angle must be 0°; since this is not possible, angles close to 0° are 
used. Low angle light scattering is performed at angles typically >10 °. Right angle 
light scattering data (at 90°) is used in conjunction to viscosity measurements to 
correct the angle back to 0°.  The viscometer measures intrinsic viscosity of samples, 
which may allow determination of molecular size.  
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2.2.3 Dynamic light scattering (DLS)  
DLS studies of nanoparticle dispersions were performed using a Malvern Zetasizer 
Nano ZS equipped with a 4 mW He–Ne, 633 nm at a temperature of 25 °C and using 
plastic disposable cuvettes for aqueous dispersions.  Glass cuvettes were used for 
solutions containing organic solvents.  Malvern Zetasizer software version 6.20 was 
used for data analysis using the instruments automatic optimisation settings. It should 
be noted that measurements were taken directly from the nanoparticle dispersions 
without any additional filtration or centrifugation.   
 
2.2.3.1 Zeta potential measurements 
Carried out at 1 mg mL
-1
, at 25 °C, pH of 6.5, using disposable capillary zeta cells; 
measurements were obtained using the instruments automatic optimisation settings. 
 
2.2.4 Scanning Electron Microscopy (SEM)   
SEM images were recorded using a Hitachi S-4800 FE-SEM at 3 kV.  Aqueous 
nanoparticle solutions (50 mL, containing approximately 0.1 mg mL
-1
 polymer) were 
pipetted onto aluminium stubs. Clinical tissue was used to lightly dab the solution 
and the stubs were left to dry for approximately 3 hours. The dry samples were gold 
coated for 2 minutes at 15 mA using a sputter-coater (EMITECH K550X) prior to 
imaging.   
 
2.3 Synthesis and Characterisation of linear and branched 
p(HPMA) by Ambient Temperature Methanolic ATRP 
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2.3.1 ATRP polymerisation of linear and branched p(HPMAx) initiated 
by EBiB ATRP polymerisation of linear and branched p(HPMAx) 
initiated by EBiB  
For a typical ATRP homopolymerisation of linear p(HPMA) (target DPn = 50 
monomer units), HPMA (7.39 g, 51.26 mmol), EBiB (0.2 g, 1.03 mmol) plus anisole 
as an internal standard (20 w/v % based on HPMA feed) were added to a 100 mL 
round-bottomed flask fitted with a magnetic stirrer bar.  Methanol (HPLC grade) (50 
v/v % based on HPMA feed) were then added and the solution was degassed with a 
nitrogen purge for approximately 10 minutes whilst stirring.  Following this, Cu(I)Cl 
(0.10 g, 1.03 mmol) and BPY (0.33 g, 2.10 mmol) were weighed together and 
quickly added to the stirring solution whilst maintaining a positive nitrogen flow.  
After initiation, the nitrogen flow was removed and the flask was made air-tight 
using parafilm.  The solution was allowed to polymerise at ambient temperature.  
After approximately > 99 % conversion which was judged by 
1
H NMR spectroscopy, 
when detectable vinyl signals could not be distinguished from the baseline. The 
reactions were exposed to the atmosphere and manually terminated via THF addition 
(approximately 200 mL).  Once fully terminated, Dowex Marathon exchange beads 
(~ 10 g) were added to the solution (with stirring) for approximately 20 minutes, in 
order to remove the catalyst.  The beads were filtered off using a Buchner funnel and 
the remaining solution was passed over a basic alumina column to remove residual 
catalyst/ligand.  The mixture was concentrated under vacuum which removed the 
majority of THF and the viscous solution was precipitated into cold hexane and 
filtered to yield white powders.   For p((HPMA50)-co-EGDMA0.95), EGDMA (0.193 
g, 0.98 mmol) was added to reaction mixtures alongside monomer, where 
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copolymerisations were carried out using identical protocol as described in this 
section. 
 
2.3.2 Kinetic Studies for ATRP linear and branched polymerisation of 
p(HPMA) 
For kinetic studies, identical protocol was followed in addition to regular sampling 
via removal of ~0.5 mL of the solution where a nitrogen purge was applied.  A small 
amount of this was added to ~ 1 mL of d6-DMSO for 
1
H NMR spectroscopic 
analysis.  The remaining sample was diluted into THF (~ 5 mL) and shaken to ensure 
efficient termination followed by passing over a small basic alumina column and into 
a pre-weighed sample vial.  THF was allowed to completely evaporate and the vial 
was then re-weighed and THF was added to achieve 5 mg mL
-1
 solution for triple 
detection GPC analysis. 
The copolymerisation of branched p(HPMA) and kinetic studies of branched 
p(HPMA) were performed using the same protocol that is described above. For a 
typical polymerisation (target DPn = 50 monomer units), HPMA (7.39 g, 51.26 
mmol), EBiB (0.2 g, 1.03 mmol) and EGDMA (0.19 g, 0.97 mmol) plus anisole as an 
internal standard (20 w/v % based on HPMA feed) were utilised.  This 1: 0.95 
monomer : brancher ratio was used for all of the branching polymerisations. 
 
2.3.3 ATRP Synthesis of p(HPMA30)-b-p(HPMA50) 
For a typical ATRP chain extension polymerisation of p(HPMA30)-b-p(HPMA50), 
first block synthesis was performed as described for the homopolymerisation of 
p(HPMA).  Briefly, for a target DPn = 30 monomer units (for first block), HPMA, 
(5.62 g, 39 mmol), EBiB (0.2 g, 1.03 mmol)  plus anisole as an internal standard (20 
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w/v % based on HPMA feed) were added to a 100 mL round-bottomed flask fitted 
with a magnetic stirrer bar.  Methanol (HPLC grade) (50 w/v % based on HPMA 
feed) were then added and the solution was degassed with a nitrogen purge for 
approximately 10 minutes whilst stirring.  Following this, Cu(I)Cl (0.10 g, 1.03 
mmol) and BPY (0.33 g, 2.10 mmol) were weighed together and quickly added to the 
stirring solution whilst maintaining a positive nitrogen flow.  After initiation, the 
nitrogen flow was removed and the flask was made air-tight using parafilm.  The 
solution was allowed to polymerise at ambient temperature. HPMA (7.39 g, 51.26 
mmol) and methanol (HPLC grade) (50 w/v % based on monomer) were added to a 
glass vial (40 mL) and de-gassed separately. After approximately 85-95 % 
conversion, a positive nitrogen flow was re-introduced to the polymerisation pot, the 
HPMA/methanol solution was added rapidly to the polymerisation with vigorous 
stirring using a large (20 mL) glass syringe.  Positive nitrogen flow was maintained 
for approximately 5 minutes before removal, and reaction was sealed with parafilm.  
The polymerisation was allowed to reach > 99 % conversion before manual 
termination.  
 
2.3.4 ATRP self-block branched polymerisation of p(HPMA30)-b-
p(HPMA50-EGDMA0.95)  
EBiB initiator (0.2 g, 1.03 mmol), HPMA (4.45 g, 30.9 mmol; target DPn = 30) and 
the internal standard anisole (20 % w/v based on monomer) were placed into a 100 
mL round-bottomed flask fitted with a magnetic stirrer bar.  Methanol (HPLC grade) 
was added (50 % w/v based on HPMA monomer) and the solution was stirred and 
degassed using a nitrogen purge for approximately 10 minutes.  Cu(I)Cl (0.10 g, 1.03 
mmol) and BPY (0.33 g, 2.10 mmol) were weighed together and promptly added to 
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the flask whilst still maintaining a positive nitrogen flow. The nitrogen flow was 
removed and reaction flask sealed leaving the mixture to polymerise at ambient 
temperature.  After ~ 80 % conversion of the initial monomer feed (previous kinetic 
studies determined this approximate timing and sampling of the reaction at this time 
gave the exact conversion), HPMA (7.39 g, 51.26 mmol; target DPn = 50 monomer 
units), EGDMA (0.19 g, 0.97 mmol) and methanol (50 % v/v based on HPMA 
monomer) was degassed in a separate flask and quickly added to the reaction via a 
double-ended needle whilst maintaining a positive nitrogen flow to the reaction flask. 
The nitrogen purge was removed and the reaction was sealed and left to polymerise 
under ambient conditions only subjected to termination and purification after high 
conversion was reached.  Samples were analysed as described above. 
 
2.3.5 
1
H NMR Spectroscopic analysis of EBiB initiated p(HPMA) 
synthesised using Ambient Temperature Methanolic ATRP
  
 
Figure 2.1: 
1
H NMR (d6-DMSO - ppm) peak assignment for p(HPMA). 0.59-1.02 
(b), 1.02-1.26 (f), 1.6-2.11 (a), 3.39-3.92 (c, d), 4.51-4.91 (e). 
End group analysis could not be accurately performed due to overlap within polymer 
backbone signal (a) in Figure 2.1.
 
In branched copolymer samples, proton signals in 
EGDMA were undetectable as the ratio of HPMA:EGDMA was extremely small and 
overlapped with (a) in spectra. 
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Monomer conversion was calculated by comparing peak integrals of an internal 
aromatic standard (see Figure 2.2) (anisole protons at 6.87–7.33 ppm; d6-DMSO (a)) 
to those of the monomer vinyl signals (5.62–6.1 ppm; d6-DMSO (b)).   
 
Figure 2.2: Calculation of monomer conversion using 
1
H NMR (d6-DMSO). 
Generating a ratio between (a) and (b) signals at T= 0 allows for calculation of 
monomer conversion by simply calculating percentage difference between vinyl 
signals as anisole signals remain unchanged throughout reactions. 
 
2.3.6 Solubility testing of p(HPMA) oligomers 
Saturated aqueous solutions of p(HPMA) (target DPn =  5, 7, 10, 13, 15, 17, 20, 50, 
80 and 120 monomer units) were prepared by adding approximately 500 mg of each 
polymer to water (14 mL). Each sample was left to dissolve on a roller for three days 
at ambient temperature. After which each sample was left to stand for 2 hours, the 
supernatant (10 mL) was carefully pipetted into three pre-weighed aluminium dishes 
and left (covered) to evaporate for 1 week. After re-weighing, the subsequent 
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polymer mass was calculated and the saturated concentration was recorded as the 
average of the three samples. Saturated aqueous solutions of p(HPMA) with target 
DPn = 5, 7, 10, 13, 15, 17, 20, 50, 80 and 120 monomer units were generated by 
dissolving approximately 500 mg of each polymer in distilled water (14 mL) in glass 
vials (40 mL).  Each sample was thoroughly sealed using parafilm and left to 
dissolve on a rolling machine at ambient temperature for three days.  Sample vials 
were left to stand upright for 2 hours, the supernatant (10 mL) was carefully 
removed and pipetted into three pre-weighed aluminium dishes, which were covered 
with foil and small holes were added for evaporation.  These were left at ambient 
temperature and water was allowed to evaporate for one week. The aluminium 
dishes were re-weighed and the polymer mass was calculated.  The saturated 
concentration was recorded as the average of the three samples. 
 
2.4 Synthesis and Characterisation of linear and branched 
PEG-p(HPMA) A-B block copolymers by Ambient 
Temperature Methanolic ATRP 
2.4.1 PEG-Br Macroinitiator Synthesis 
2.4.1.1 Methods 
A typical procedure for the preparation of methoxy-capped poly(ethylene glycol) 
initiator (PEG-Br) from a poly(ethylene glycol) mono-methyl ether (PEG-OH) with 
Mn = 750 is outlined below.  
PEG-OH Mn = 750 (20 g, 26.6 mmol, 1 eq.), toluene (anhydrous) (150 mL), 4-
Dimethylaminopyridine (DMAP) (0.32 g, 2.66 mmol, 0.1 eq.), and triethylamine 
(TEA) (4.08 mL, 2.96 g, 29.26 mmol, 1.1 eq.) were placed in a round-bottomed flask 
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fitted with a magnetic stirrer bar. 2-Bromoisobutyryl bromide (3.62 ml, 2.96 g, 29.26 
mmol, 1.1 eq.) was added dropwise to the solution via a syringe over around one 
hour. The solution was stirred overnight, after which Amberlyst resin A21 (20 g) 
was added to remove residual acid bromide and the mixture stirred for about one 
hour. The solution was then filtered over celite to remove any insoluble materials. 
Solvent was removed under vacuum from the resulting clear pale yellow filtrate. The 
white oily product was dried at 60 °C in a vacuum oven overnight and stored at ~-
2°C. The method was slightly altered for the preparation of the higher molecular 
weight initiators.  Toluene was warmed to around 50 °C in order to dissolve the 
PEG-OH with molecular weights of 2000 g mol
-1
 and 5000 g mol
-1
.  These products 
were purified by evaporation of the toluene to around a third of the original volume 
before precipitation into cold petroleum ether.  The macroinitiator was collected on 
filter paper and dried under vacuum yielding white powdery products. 
 
2.4.1.2  
1
H NMR Spectroscopic analysis of PEGx-Br macroinitiators. 
 
 
Figure 2.3: 
1
H NMR (CDCl3 - ppm) analysis of a PEGx-Br macroinitiator. 
Peaks were assigned as follows: 1.94 (ester CH3) (e), 3.38 (methoxy CH3) (a), 3.50-
3.80 (PEG CH2) (b), 4.32 (CH2-O-CO) (d).   
Extent of esterification: The signal at 1.94 ppm can be attributed to the two 
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equivalent methyl groups of the tertiary bromide group.  The signal at 4.33 ppm 
corresponds to the methylene adjacent to the ester group a ratio of the integrals of 
signals to the mono-methyl end-group indicated the extent of the esterification.  
13
C 
NMR (100 MHz, D2O) δ ppm 174.0, 71.5, 70.4, 70.1, 70.0, 68.8, 58.6, 30.5. 
GPC (THF eluent): Initiators were diluted in THF or acetone (5 mL
-1
) and passed 
through a 200 nm syringe filter prior to injection. PEG17-Br could not be analysed by 
GPC, the elution time of this initiator was not within the detection limits of the 
separation columns. 
 
2.4.2 ATRP polymerisation of linear and branched linear and branched 
PEGx-b-p(HPMA) block copolymers 
In a typical synthesis, PEG117-Br initiator (0.94 g, 1.03 mmol) and HPMA (7.39 g, 
51.26 mmol; target DPn = 50 monomer units, and anisole (20 % w/v based on 
monomer) were placed into a 100 mL round-bottomed flask.  HPLC grade methanol 
was added (50 % w/v (initiator, monomer/solvent)) and the solution was 
stirred/deoxygenated using a nitrogen purge for 10 minutes. Cu(I)Cl (0.10 g,1.03 
mmol) and BPY (0.19 g, 0.97 mmol) were added to the flask whilst maintaining a 
positive nitrogen flow.  Samples of the reaction (~0.5 mL) were taken and diluted 
into THF for GPC analysis and d6-DMSO for 
1
H NMR spectroscopic analysis.  End 
group analysis could be performed when utilising PEG17, where integration of the 
methoxy chain end (3.2 ppm) and terminal methyl group of p(HPMA) (1 – 1.22 
ppm), however, this was very inaccurate and unreliable, where the peak for water 
(~3.19 ppm) could shift, resulting in peak overlap.  For copolymers with higher 
molecular weight PEG (2000 and  5000 g mol
-1
) the methoxy chain end (3.2 ppm) 
could not be distinguished from the baseline, therefore end group analysis could not 
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be performed,  For GPC analysis, HPLC grade THF as the eluent, stabilized with 2,6-
ditert-butyl-4-methylphenol, with a flow rate of 1 mL min
-1
.  Samples for analysis of 
polymerisation kinetics were purified by passing over basic alumina column before 
removal of solvent. Dried samples were re-dissolved in THF to a concentration of 5 
mg mL
-1
 and passed through a syringe filter (0.2 mm) prior to injection.  
 
2.4.2.1 
1
H NMR Spectroscopic analysis of PEGx-Br initiated p(HPMA) 
 
Figure 2.4: 
1
H NMR (CDCl3 - ppm) analysis of PEGx-Br initiated p(HPMA). 
PEG17-b-p(HPMA50): 
1
H NMR (d6-DMSO - ppm): 0.65-1.02 (d), 1.02-1.26 (c), 1.64-
2.01 (b), 3.22-3.26 (a), 3.3-3.5 (f), 3.49-3.54 (e), 3.56-3.87 (f), 4.53-4.71 (g).  
End group analysis of PEGx copolymers to determine DPn could not be accurately 
performed due to overlap with water signals and (f) the small signal also deviated 
from the baseline when spectrum scaling was increased leading to inaccurate 
integration and therefore calculated DPn.
 
In branched copolymer samples, proton 
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signals in EGDMA were undetectable as the ratio of HPMA:EGDMA was extremely 
small and overlapped with (f) in spectra. 
 
2.4.2.2 Kinetic Studies for ATRP linear and branched polymerisation of PEGx-b-
p(HPMA) 
For kinetic studies, identical copolymerisation protocol was followed, in addition to 
regular sampling via removal of ~0.5 mL of the solution where a nitrogen purge was 
applied.  A small amount of this was added to ~ 1 mL of d6-DMSO for 
1
H NMR 
spectroscopic analysis.  The remaining sample was diluted into THF (~ 5 mL) and 
shaken to ensure efficient termination followed by passing over a small basic alumina 
column and into a pre-weighed sample vial.  THF was allowed to completely 
evaporate and the vial was then re-weighed and THF was added to achieve 5 mg mL
-
1
 solution for triple detection GPC analysis. 
The copolymerisation of branched PEGx-b-p(HPMA) and kinetic studies of branched 
p(HPMA) were performed using the same protocol that is described above. For a 
typical polymerisation (target DPn = 50 monomer units), HPMA (9.61 g, 66.5 mmol), 
PEG17Br (1 g, 1.33 mmol) and EGDMA (0.25 g, 1.26 mmol) plus anisole as an 
internal standard (20 w/v % based on HPMA feed) and methanol, 50 w/v % 
(initiator+monomer/methanol) were utilised. This 1: 0.95 monomer : brancher ratio 
was used for all of the branching polymerisations. 
 
2.4.2.3 Chain Extension of PEG17-b-p(HPMAx) Block Copolymer 
A typical procedure for the chain extension of PEG17-b-p(HPMA30) to PEG17-b-
p(HPMA30)-b-p(HPMA50) is outlined here. PEG17Br initiator (1 g, 1.33 mmol), 
HPMA (5.75 g, 39.9 mmol; target DPn = 30) and the internal standard anisole (20 % 
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w/v based on monomer) were placed into a 100 mL round-bottomed flask fitted with 
a magnetic stirrer bar.  Methanol (HPLC grade) was added (50 % w/v based on 
initiator and monomer) and the solution was stirred and degassed using a nitrogen 
purge for approximately 10 minutes.  Cu(I)Cl (0.13 g, 1.33 mmol) and BPY (0.52 g, 
3.32 mmol) were weighed together and promptly added to the flask whilst still 
maintaining a positive nitrogen flow. The nitrogen flow was removed and reaction 
flask sealed leaving the mixture to polymerise at ambient temperature.  After ~ 80 % 
conversion of the initial monomer feed (previous kinetic studies determined this 
approximate timing and sampling of the reaction at this time gave the exact 
conversion), HPMA (9.57 g, 66.5 mmol; target DPn = 50 monomer units) and 
methanol (50 % v/v based on HPMA monomer) was degassed in a separate flask and 
quickly added to the reaction via a double-ended needle whilst maintaining a positive 
nitrogen flow to the reaction flask. The nitrogen purge was removed and the reaction 
was sealed and left to polymerise under ambient conditions only subjected to 
termination and purification after high conversion was reached.  Samples were 
analysed as described above. 
 
2.5 Nanoparticle synthesis and Characterisation 
2.5.1 Particle preparation by nanoprecipitation  
2.5.1.1 Rapid precipitation.   
Polymer was dissolved in acetone overnight on a rolling machine in a sealed glass 
vial (made air-tight by parafilm) to give concentrations of 10, 5 or 1 mg  mL 
-1 
 (and 
others where indicated).  To achieve a five-fold dilution, polymer+acetone (1 mL ) 
was added to distilled water (5 mL, 40 °C) using an adjustable pipette and left to stir 
overnight in a glass vial (12 mL) on a hotplate. Polymer+acetone volume was 
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adjusted, for example (0.8 mL) was added to water (5 mL) to give a dilution ratio of 
0.8 mg mL
-1
; the volume of water remained constant (5 mL) unless indicated.) 
 
2.5.1.2 Slow/dropwise precipitation. 
Polymer/acetone solutions were prepared to the concentrations and volumes as 
described above.  A syringe pump operating at 0.1 mL min 
-1
 was employed to drip 
the polymer/acetone solution slowly into the stirring water vials (12 mL), these were 
left to stir overnight on a hotplate set to 40 °C. 
 
2.5.1.3  Precipitation/dialysis. 
Following the protocol of slowly dripping the polymer/acetone solution into the 
stirring water (as described above) the entire mixture of polymer/acetone/polymer 
was carefully poured into sections of dialysis tubing (2000 g mol 
-1
 molecular weight 
cut-off) and placed into large water filled beakers for 2 days where water was 
changed approximately every 8 hours.  Nanosuspensions were carefully poured into 
glass vials for storage at room temperature (sealed). 
 
2.5.1.4  Loaded nanoparticle Preparation 
An example of a loaded nanoparticle preparation protocol is described here for the 
preparation of PEG17-b-p((HPMA50)-EGDMA0.95)/Oil red nanoparticles using a 
copolymer  starting concentration of 5 mg mL
-1
 and a final concentration of 1 mg 
mL
-1
 and an oil red starting concentration of 1 mg mL
-1
 and a final concentration of 
0.2 mg mL
-1
.   Polymer was dissolved in acetone overnight (total volume was 
variable, but was typically between 10 mL stock solutions were prepared) on a 
rolling machine in a sealed glass vial (made air-tight by parafilm) to achieve a 
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concentration of 5 mg mL
-1
, oil red was carefully weighed out (2 mg) in a clean glass 
vial (12 mL) and the polymer+acetone solution was carefully added (2 mL).  The vial 
was sealed and shaken until oil red has visually dissolved.  1 mL of this mixture was 
pipetted into warmed stirring water and left to evaporate.   Although only 1 mL of the 
polymer/acetone/oil red solution was used for nanoprecipitation, a 2 mL solution was 
prepared to overcome error in pipetting accuracy. 
 
2.5.2 Evaluation of nanoparticle stability   
2.5.2.1  Sonication 
A Covaris S2x acoustic homogenisation system was used to subject nanoparticle 
dispersions to high intensity focussed sonic waves (water-bath temperature controlled 
to 10 °C).  Nanoparticle dispersions (1 mg mL
-1 
) were initially sized using DLS then 
transferred to a glass vial and submerged into the water bath (5 °C) of the sonicator.  
After 5 seconds using 100 % intensity and a duty cycle of 100, the solution was 
promptly re-analysed by DLS.  The same sample was further sonicated and sized as 
reported above.  As the nanoparticles appeared to be highly stable to the intense 
sound waves (indicated by relatively narrow polydispersity and lack of precipitate), 
no further measurements were recorded. 
 
2.5.2.2 Aqueous stability.   
A nanoparticle dispersion (1 mg  mL 
-1
, 1 mL) was serially diluted (two-fold) with 
distilled water using an adjustable pipette followed by DLS sizing measurements 
using the technique described above to give a final concentration of 1.22 x 10 
-2
 mg  
mL 
-1
.  After this concentration was reached, extremely low scattering was observed 
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in the DLS measurements and therefore accurate measurement was no longer 
possible.  
 
2.5.2.3 Methanol addition. 
A nanoparticle dispersion (1 mg  mL 
-1
, 1 mL) was pipetted into a glass sizing 
cuvette fitted with a lid to prevent any significant evaporation where DLS 
measurements followed.  Fixed volumes of methanol were carefully pipetted into the 
glass cuvette and promptly swirled gently by hand prior to each sizing measurement.  
DLS measurements became unreliable (due to very low scattering) at a volume ratio 
of almost 1 : 1 water : methanol. 
 
2.5.2.4 Electrolyte addition. 
A nanoparticle suspension (1 mg mL 
-1
, 0.5 mL) was pipetted into a low volume 
plastic cuvette and DLS measurements were performed (an average of six 
measurements). Aliquots of an aqueous NaCl solution (0.5 M, 0.2 µL) were added 
and the cuvette was gently shaken by hand to ensure a homogeneous mixture.  The 
cuvette was rapidly returned to the DLS instrument and sized as described above. A 
total of eight aliquots were added and subsequently measured.  
 
2.5.2.5 Loaded Nanoparticle stability evaluation 
Unstable nanoparticles were characterised by the visual appearance of precipitated 
material at the bottom of sample vials.  Samples were also determined to be unstable 
if DLS measurements could not be performed.  This occurred when the instrument 
measurement criteria could not be met e.g. due to the presence of aggregating 
material.  
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nanoparticles prepared by rapid nanoprecipitation.” 
R. A. Slater, T. O. McDonald, D. J. Adams, E. R. Draper, J. V. M. Weaver and  
S. P. Rannard. 
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3. Linear and Branched ATRP of 2-
Hydroxypropyl Methacrylate 
3.1  Introduction 
The ATRP of HPMA using different initiator:monomer ratios was studied here in 
order to optimise the reaction conditions for linear polymerisation, which could then 
be applied to further branched copolymerisations.  Although many monomers have 
been shown to be successful using ATRP including methacrylates, methacrylamides, 
acrylonitriles and styrenes,
1, 2
  The HPMA monomer was chosen as it has been 
shown to polymerise well using ATRP
3
 but as yet has not been widely reported in 
the literature using this method of polymerisation.  
 
Scheme 3.1: Preparation route to HPMA monomer.  Due to the poor regioselectivity 
of this reaction, both 2-hydroxypropyl methacrylate and 1-hydroxyisopropyl 
methacrylate isomers are formed. 
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HPMA has, however, been reported in polymerisations using nitroxide-mediated 
radical polymerisation (NMP),
4
 free radical chemistry,
5
 dispersion
6 
and suspension 
techniques.
7
  
 
Scheme 3.1 depicts the nucleophilic attack of propylene oxide by methacrylic acid.  
This can occur at two positions on the epoxide; reaction at the secondary carbon 
gives the major product 2-hydroxypropyl methacrylate whilst attack of the tertiary 
carbon yields the minor 1-hydroxyisopropyl methacrylate.  As these two isomers co-
exist in the commercial monomer feed, homopolymerisations should be properly 
described as statistical copolymerisations
3
 when using this monomer. 
Figure 3.1(A) shows a 
1
1 H NMR spectrum of HPMA in D2O where integration of 
the vinyl proton resonances (5.6-6.1 ppm) and terminal CH3 protons (1.2 ppm) give 
a ratio of 2:3; other proton environments are also highlighted.  As HPMA is a 
mixture of two isomers, the separate protons of the two different C=C double bond 
environments can be distinguished; shown in Figure 3.1(B).  Integration indicates a 
ratio of the proton environments to be approximately 73/27. 
3.2 Homopolymerisation of Linear p(HPMAx) (x = 50, 80, 120) 
Methanol was chosen as a solvent for the ATRP synthesis of p(HPMAx) as it has 
previously been reported,
3 
although the same research group also conducted 
polymerisations of HPMA in methanol/water mixtures, achieving good control.  It 
has been shown in the literature that this solvent system has been successful in other 
studies also.
8,9 
The concentration of solvent was kept at 50/50 w/v %  
(monomer/solvent) throughout the polymerisation studies, as this has also been 
previously reported
10
  and further dilutions were deemed unnecessary.  Varying 
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dilution would also impact the reaction kinetics, leading to possibly slower reaction 
rates and more polydisperse materials.  
 
 
Figure 3.1: 
1
H HMR spectra of HPMA monomer in D2O. (A) Entire spectrum. (B) 
HPMA vinyl signals. 
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The commonly used ethyl 2-bromoisobutyrate (EBiB) was chosen as the initiator for 
these polymerisations as it has been widely utilised for many methacrylate ATRP 
reactions.
11,12 
 It has been used effectively as an initiator to polymerise HPMA.
10
 
EBiB has several advantages; it is commercially available and due to its relatively 
small size and inert chemistry, it allows the investigation of polymer properties 
without any significant role being played by the presence of the initiator residue at 
the chain end.   
Cu(I)Cl/BPY was chosen as the catalyst/ligand system due to reports of its 
compatibility in ATRP systems,
13
 the commercial availability of both materials and 
the widespread success within a range of polymerisations.  Armes and co-workers 
generally utilise this catalyst/ligand system in their ATRP reactions for 
methacrylates
14
 as well as Sherrington and co-workers
15
 and many other groups 
worldwide. 
Initial polymerisations in methanol at ambient temperature (see Chapter 2 section 
2.3.1), were investigated utilising EBiB as the initiator.  The reaction protocol was 
chosen to allow > 99 % monomer conversion, to be judged by 
1
H NMR spectroscopy 
followed by manual termination, purification and subsequent analysis by triple 
detection GPC using tetrahydrofuran (THF) as eluent.  The aim of these experiments 
was to identify reaction conditions that would allow the facile synthesis of polymers 
with identical chemistry but with varying chain lengths.  All of the polymerisations 
were left to reach > 99 % conversion, rather than terminating at lower conversions 
whilst chains are still propagating and significant monomer remains in solution, as 
this allows all chains the potential to incorporate the entire monomer feed and 
therefore fully achieve the original target DPn.  Reaction kinetics can be followed to 
determine if reactions proceed in a controlled manner; final number average 
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molecular weights should be close to the predicted number average molecular weight 
(targeted by initiator:monomer feed ratios) and a relatively low molecular weight 
distribution should be found throughout the reaction.  Assuming the reactions are 
controlled and reach > 99 % conversion, it is believed this experimental protocol is 
extremely facile and would be able to achieve polymer chains with varying chain 
length. The process is represented in Scheme 3.2. 
 
 
Scheme 3.2: A simple schematic representation of three linear polymers consisting of 
EBiB initiator (yellow spheres) and HPMA monomer (red spheres) of varying chain 
length (or DPn). 
Prior to any kinetic analysis of p(HPMA) reactions, three polymerisations were 
conducted with target DPn = 50, 80 and 120 monomer units; achieved simply by 
simply adjusting the initiator:monomer ratio.  These reactions were left for 
approximately 15 hours after which 
1
H NMR spectroscopic analysis revealed that 
monomers had reached full conversion as judged by no detectable vinyl signals at 
5.6-6.1 ppm (DMSO-d6).  These reactions were manually terminated and purified as 
explained in the Chapter 2 section 2.3.1.  DPn could not be estimated directly using 
1
H NMR as the CH2-CH3 protons in the initiator overlapped with 
1
H signals from 
p(HPMA).    
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Figure 3.2: 
1
H HMR spectrum of p(HPMA50) in DMSO-d6. 
 
The 
1
H NMR spectrum (DMSO-d6) of a purified sample of p(HPMA50) is shown in 
Figure 3.2 highlighting the various proton environments. The three p(HPMA) 
polymers with increasing targeted DPn values were diluted to reach a concentration 
of 5 mg mL
-1
 in THF and subjected to triple detection GPC analysis, shown in Figure 
3.3.
 
Figure 3.3: GPC (THF) chromatograms for linear homopolymers.  p(HPMA50) (solid 
line), p(HPMA80) (medium dashed line), p(HPMA120) (small dashed line). 
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As expected for a controlled polymerisation, the chromatograms are symmetrical and 
move to a lower retention volume with increasing target DPn; indicative of formation 
of higher molecular weight material.  A small summary of the data obtained from 
these polymers is shown below in Table 3.1. 
 
Sample 
Mn (g mol
-1
) 
(theory) 
Mn (g mol
-1
) 
(GPC) 
Mw (g mol
-1
) 
(GPC) 
Mw/Mn 
Conversion 
(%) 
      
p(HPMA50) 7400 7900 11900 1.18 > 99 
p(HPMA80) 11700 15200 19100 1.16 > 99 
p(HPMA120) 17300 18100 29000 1.60 > 99 
      
      
Table 3.1: Data obtained via triple detection GPC (THF eluent) for the 
homopolymerisation of p(HPMAx). 
 
Observed Mn values for p(HPMA50) and p(HPMA80) are extremely close to those 
predicted, with low molecular weight distributions obtained, which was expected 
using ATRP.  The longest targeted chain length (DPn = 120 monomer units) 
produced a polymer with a significantly higher Mn value of 18100 g mol
-1
 in 
comparison to the targeted value of 17300 g mol
-1
.  The observed variation in Mn 
may be due to some initiator inefficiency, where the polymerisation had a lack of 
initiating sites at the beginning of the reaction and therefore more monomer was 
added to fewer than expected chains.  It is also possible that termination by 
combination of active polymer chains occurred at extremely high conversion; chain 
mobility will be reduced at high conversions due to the high viscosity of the solution, 
leading to end-group radical reaction and causing an increase in the observed Mw 
and, thereby, affecting the overall molecular weight distribution. The dispersity value 
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of 1.60 for this sample which was notably higher than those found for the shorter 
targeted chains (DPn = 50, 80 monomer units).   By overlaying the outputs of the 
Refractive Index (RI), Right Angle Light Scattering (RALS), Low Angle Light 
Scattering (LALS) and the Intrinsic Viscosity (IV) detectors of the linear polymer 
analysis, it is found that all traces are monomodal and symmetrical indicating no 
high, or indeed extremely low, molecular weight material is present in any of the 
samples prepared across the different chain lengths, demonstrated in Figure 3.4.  
 
 
 
Figure 3.4: GPC chromatogram of p(HPMA50) showing RI (black line), RALS (blue 
line), LALS (red line) and Intrinsic Viscosity (green line) responses. 
 
Excellent agreement of targeted and observed number average molecular weight was 
found for p(HPMA50), p(HPMA80) and p(HPMA120), with relatively low molecular 
weight distributions obtained, and therefore these reaction conditions were accepted 
for future polymerisations. No further experiments to target higher chain lengths 
were explored in this work.  
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3.2.1 Reproducibility of ATRP to form linear p(HPMAx) homopolymers 
(x = 50, 80, 120) 
To investigate the reproducibility of ATRP polymerisation of HPMA under ambient 
methanolic conditions, The formation of p(HPMA50), p(HPMA80) and p(HPMA120) 
was repeated on two separate occasions using the same experimental protocol as 
previously described. Polymer concentration in (THF) for analysis via triple 
detection GPC was also kept constant at 5 mg/ml.  In principle, signals observed by 
each of the detectors attached to the GPC instrument should be identical, but due to 
experimental error complete overlap was not observed. The overlap was, however, in 
very close agreement and examples of the RI chromatograms or the six polymers (2 
repeats of each polymerisation) are shown in Figure 3.5. 
Good agreement is found for each targeted DPn, although the polymerisations were 
conducted at ambient temperature which was therefore not controlled between 
polymerisations. Differences in temperature, when conducting the repeat 
experiments, would affect the reaction kinetics and lead to deviation of molecular 
weights and molecular weight distributions.  
It should also be noted that there are no literature reports on the reproducibility of 
p(HPMA) synthesis using methanolic ATRP under identical feed ratios and, as such, 
to the best of our knowledge, this is the first report of its type.   
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Figure 3.5: GPC (THF eluent) chromatograms of p(HPMA) homopolymers 
synthesised on separate occasions. A) p(HPMA50).  B) p(HPMA80).  C) p(HPMA120). 
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3.2.2 Kinetic Studies for the Linear Homopolymerisation of HPMA (DPn 
= 50, 80, 120)  
To confirm the previously synthesised polymers proceeded under controlled radical 
polymerisation conditions, homopolymerisation kinetics studies were conducted for 
the linear polymerisations with number average degree of polymerisation values of 
50, 80 and 120 monomer units, utilising EBiB as the initiator.  
 
Figure 3.6: Kinetics studies of HPMA ATRP polymerisation. (A) Conversion vs. 
Time plot for p(HPMA50) (circle), p(HPMA80) (triangle) and p(HPMA120) (square). 
(B) Semi-logarithmic plot for (HPMA50) (circle), p(HPMA80) (triangle) and 
p(HPMA120) (square). 
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 Kinetic experiments were carried out in parallel, ensuring the molar ratio of EBiB 
was constant and the molar ratio of HPMA monomer was varied in order to achieve 
the desired target DPn.  The reactions were monitored for eight hours with regular 
hourly sampling of the polymerisation mixture and analysed by 
1
H NMR 
spectroscopy and triple detection GPC (THF eluent). 
Figure 3.6(A) shows percentage conversion as a function of time for the three 
polymers p(HPMA50), p(HPMA80) and  p(HPMA120).  For p(HPMA50), 42 % of the 
monomer has been polymerised within the first hour, compared to 23 % for 
p(HPMA80), and just 16 % for p(HPMA120).  Despite these seemingly different 
conversions (for the same given time), the three polymerisations produced chains 
containing approximately 21 monomer units.  It may have been expected that these 
figures would be more similar, given that the components are identical in the three 
reactions.  The semi-logarithmic plots shown in Figure 3.6(B) all increase linearly 
with time, indicating the absence of termination and a constant concentration of 
propagating radicals within the polymerisation.  If any termination was present, it 
was not seen within this experiment.   
It is clear that under these polymerisation conditions, the rate of polymerisation is 
related to targeted chain length, where higher conversions are reached within shorter 
reaction times, when the targeted primary chain length is shorter.  Alongside this, 
reaction rates decrease as target DPn increases (Figure 3.6(B)).  These results are in 
near complete contrast to Armes and co-workers who report reduced reaction times 
and increased reaction rates with increasing primary chain length (when 
polymerising 2-methacryloyloxyethyl phosphorylcholine utilising an oligo(ethylene 
glycol)-based water-soluble initiator).
16
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This clearly demonstrates how dramatically different kinetic data can be obtained 
when using different monomers and initiators (both reactions were carried out in 
methanol).  Varying temperature leads to altered rates within ATRP systems
17
 and 
from the outset, this could be believed to be the reason for the different observed 
reaction rates, as they were carried out at ambient temperature, which could have 
changed slightly when performing each experiment.  However, the reactions were 
performed within one week of each other, and the possibility of dramatic 
temperature change was discarded.  In order to rationalise the differences observed 
during reactions, it is proposed that reaction kinetics are affected by the 
concentration of initiator in the monomer solution.  As stated previously, a ratio of 
50 w/v % (monomer/solvent) was utilised and as such, despite varying the target DPn 
of the polymer chain, there remains the same monomer/solvent ratio, discounting the 
possibility of this ratio affecting the kinetic differences between reactions.  However, 
by keeping the monomer/ solvent ratio constant, the concentration of initiator within 
the reaction becomes unavoidably changed when altering the target DPn.  As the 
target DPn increases, the concentration of initiator becomes reduced with respect to 
monomer and solvent.   
As a result, the concentration of Cu(I)Cl and BPY also becomes inevitably reduced 
in the solution.  Both of these lead to changes in propagating radical concentration 
which would have a dramatic impact on the observed reaction rates between the 
three polymerisations with different targeted primary chain length. 
Figure 3.7 shows that the molecular weight distribution decreases during the 
formation of p(HPMA80) ranging from 1.55 (23 % conversion) to 1.17 (99 % 
conversion).  At low conversion higher molecular weight distributions are observed, 
Chapter 3 
108 
 
due the statistical nature of the catalyst activation/deactivation during propagation 
and the need to establish a significant Cu(II) concentration before a stable 
equilibrium can be achieved. Different numbers of monomer units are therefore 
added to the chain ends during each activation step within the early stages and the 
initiators are not activated simultaneously but rather a time period is required for a 
steady state of propagating radicals to be formed.  The chains eventually become 
more uniform throughout the reaction due to the statistical nature of the continuous 
activation/deactivation reactions; eventually, all chains will have propagated for 
approximately the same time periods.   
Mn increases nearly linearly over time, suggesting monomer is being consumed at a 
relatively steady rate throughout the reaction.  The behaviour seen here is 
characteristic of a fast initiation step with an insignificant amount of chain transfer or 
termination and good exchange of active species.   
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Figure 3.7: Evolution of molecular weight with conversion over time for the 
homopolymerisation of p(HPMA80). 
 
Figure 3.8 shows the development of molecular weight with time for p(HPMA50), 
p(HPMA80) and p(HPMA120).  Molecular weight distributions are narrow, 
monomodal and shift to a lower retention volume with time (and conversion) 
corresponding to higher molecular weights as expected for a controlled 
polymerisation. There is no obvious broadening of peaks, which would have 
indicated an increase of the molecular weight distribution of the polymers. 
Chapter 3 
110 
 
 
Figure 3.8: Evolution of molecular weight during the ATRP of HPMA (GPC (THF) 
chromatograms) (A) p(HPMA50), (B) p(HPMA80), (C) p(HPMA120). 
Conversion of monomer to polymer in the kinetic studies of p(HPMA) was 
calculated using a ratio of the aromatic signals from the internal standard anisole and 
an average of the two vinyl signals from HPMA monomer.  Anisole was chosen as 
an internal standard due to its non-reactivity in the polymerisation and its clear 
Chapter 3 
111 
 
aromatic signals at 6.9 and 7.3 ppm.  The terminal protons of the EBiB initiator on 
polymer chains would also prove difficult to quantify; the single proton signal at 2.5 
ppm would not be sufficiently well resolved to allow any accuracy in determination 
of chain length using conventional chain-end analysis.  The other proton shifts 
unfortunately overlap with those in the main chain. Figure 3.9 indicates the 
consumption of vinyl bonds during polymerisation. 
 
 
Figure 3.9: 
1
H NMR spectra (DMSO-d6) of samples taken for the kinetic study of the 
ATRP of HPMA - target p(HPMA50). 
 
Having found that polymerisation in methanol produced well-defined polymers with 
low molecular weight distributions, over a range of target DPn (50, 80 and 120 
monomer units) it seemed unnecessary to alter any reaction conditions.  It has been 
reported
 
that the addition of water to the polymerisation of p(HPMA) increased the 
rate
3
, although it also incurred a loss of control, resulting in higher molecular weight 
distributions of the polymers.  Using methanol as the sole solvent also made the 
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work-up of polymers more experimentally facile, as higher temperatures/extraction/ 
freeze drying would be necessary for complete removal of any added water.   
The data generated suggests that increasing the targeted DPn leads to increases 
molecular weight distribution at high conversion (Figure 3.8).  ATRP 
polymerisations are often terminated at approximately 80 % conversion when chain 
end functionality is still very high, and molecular weight distribution is narrow.  The 
data in this chapter shows molecular weight distribution increases at high 
conversion, which is attributed to bimolecular termination of active chains which are 
starved of monomer (when conversion reaches > 99 %), however, the aims of the 
project are to utilise branched vinyl polymerisation to form complex architectures 
and therefore very high conversions are required.   
Abstraction of protons from solution, leading to terminated chains, would not result 
in this broadening of GPC traces and it is therefore believed that it is due to radical-
radical combination.  Although this has not been widely reported in the literature, 
Matyjaszewski and others have demonstrated this occurrence in their ATRP 
reactions.
18,19 
In summary, three linear p(HPMA) polymers have been synthesised with their 
individual kinetics explored. Conventional ATRP mechanisms and controlled 
polymerisation appears to operate under the chosen conditions, even though no direct 
control of temperature was employed.  
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3.2.3 Linear Chain Extension of p(HPMA30) to p(HPMA30)-b-
p(HPMA50). 
In order to investigate the control present within the ATRP polymerisations further, 
chain extension experiments were conducted.  In this study a chain extension or 
“self-blocking” experiment in methanol was performed using EBiB as the initiator. 
A linear block of p(HPMA) (target DPn = 30 monomer units) was synthesised to 
relatively high conversion (~ 80-95 %) after which, a second HPMA monomer feed 
(equivalent to a target DPn = 50 monomer units) was added to the polymerising 
solution (see Chapter 2 section 2.3.4). Complete chain extension should occur 
provided that polymer chain ends are either active or capped with halogen atoms and 
significant termination had not occurred. Monomer will therefore add to all 
propagating chains in a controlled fashion (as was the case with the original polymer 
chain) to give a final polymer with an overall DPn of 80 monomer units.  Analysis by 
GPC (THF eluent) was performed on a sample taken of the polymerising solution 
prior to second aliquot addition; samples were also taken post addition until 
polymerisation reached high conversion.  In this case, the polymer is denoted 
p(HPMA30)-b-p(HPMA50).  
 
Scheme3.3: Representation of the chain extension process in methanol for linear 
p(HPMA) employing EBiB as the initiator.  (Initiator: monomer feed is not to scale). 
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Scheme 3.3 aims to show the chain extension process of p(HPMA) where red 
spheres represent the first HPMA monomer feed (target DPn = 30 monomer units), 
which is polymerised until approximately 80-95 % conversion has been reached, 
after which the second batch of HPMA monomer (represented by the maroon 
spheres) is added to the reaction and left to polymerised until > 99 % conversion has 
been reached overall. 
 
 
Figure 3.10: Kinetic data results for the polymerisation of p(HPMA) (target DPn = 
30 monomer units).  A)  Conversion vs. time plot.  B)  GPC (THF eluent) analysis. 
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In order to determine when approximately 80-95 % had been reached for the 
polymerisation of p(HPMA30) (the first block); a simple kinetics experiment was 
conducted.  This was performed using the same protocol as the previous kinetics 
experiments.  It was assumed the reaction would reach full conversion in a relatively 
short space of time in comparison to p(HPMA50) as there are fewer monomer units 
per chain, and therefore an extra sample was taken after 30 minutes reaction time (as 
well as after 1 hour and 2 hours).  The kinetic analysis for the reaction of p(HPMA30) 
showed > 99 % conversion after only 2 hours with a linear semi-logarithm plot 
indicating a constant concentration of radicals and therefore the reaction was 
assumed to have proceeded in a controlled manner (Figure 3.10(A)).  In addition, 
GPC analysis of the polymer reveals a final Mn of 4400 g mol
-1
 and a relatively low 
molecular weight distribution of 1.18 (Figure 3.10 (b)).   
As a comparison, the polymerisation of p(HPMA50) should reach an approximate Mn 
= 4400 g mol
-1
 after 2 hours, given the kinetic analysis presented earlier although the 
conversions for each polymerisation are considerably different at this number 
average molecular weight, i.e. > 99 % conversion  for the p(HPMA30) 
polymerisation and only 68 % conversion for pHPMA50. As can be seen from Figure 
3.11, after chromatograms taken at these timepoints for the different ATRP 
polymerisations overlap well; the polymerisation targeting p(HPMA50) had reached 
an Mn value of 5100 g mol
-1
 with a dispersity of  1.27. These values are similar to the 
p(HPMA30) polymerisation at > 99 % conversion, which achieved an Mn of 4400 g 
mol
-1
 and a molecular weight distribution of 1.18. 
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Figure 3.11: GPC (THF eluent) chromatograms of p(HPMA30) at 99 % conversion 
(solid line) and p(HPMA50) at 68 % conversion (dashed line). 
 
The polymerisation was monitored further after the addition of the second monomer 
feed. Figure 3.12 shows the evolution of molecular weight for this reaction, where 
the black trace is the sample taken prior to addition of the second monomer batch 
and, as expected, this trace is monomodal and symmetrical with a measured 
monomer conversion = 88 %.  Similarly, the subsequent polymer samples are also 
monomodal and their retention volumes decrease as polymerisation reaches high 
conversion.  
1
H NMR spectroscopy was used alongside GPC analysis to monitor this 
reaction and in similar fashion to the analysis of the kinetics for 
homopolymerisation, anisole was used as an internal standard and allowed 
conversion to be calculated throughout the polymerisation.   
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Figure 3.12: GPC (THF eluent) chromatograms for the chain extension of 
p(HPMA30) to a final (p(HPMA30)-b-p(HPMA50)). 
 
 
 
Figure 3.13: 
1
H NMR spectra in DMSO-d6 for the kinetic study of p(HPMA30-b-
HPMA50) over time. 
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As can be seen from Table 3.2, low molecular weight distributions are seen 
throughout the experiment, suggesting monomer is added to the growing chains in a 
controlled manner, yielding a polymer with a final molecular weight of 16000 g 
mol
-1
 and a molecular weight distribution of 1.09.  The observed Mn is significantly 
higher than the expected molecular weight of 11500 g mol
-1
, this increase can be 
attributed to insufficient initiation during the first polymerisation (where a lower 
than expected molecular weight was found) and therefore more monomer was added 
to fewer active chains during the second stage of polymerisation.   
 
Sample Mn 
(g mol
-1
 ) 
(theoretical) 
Mn 
(g mol
-1
) 
(GPC) 
Mw 
(g mol
-1
) 
(GPC) 
Mw/Mn Conversion 
(%) 
      
p(HPMA30) 3500 3 800 4200 1.11 88 
      
p(HPMA30)-b-
(HPMA50) 
5800 8000 9600 1.20 50 
p(HPMA30)-b-
(HPMA50) 
10200 15300 18400 1.20 88 
p(HPMA30)-b-
(HPMA50) 
11500 16000 17600 1.08 99 
 
Table 3.2:  Data for the chain extension of p(HPMA). *Theoretical Mn (g mol
-1
) is 
based on the conversion values that were measured. 
 
This is also supported by the fact that molecular weight distribution remains 
monomodal and the dispersity values are relatively low during all stages of the 
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polymerisation, therefore suggesting the majority of chain ends remained active and 
continued to polymerise effectively after the second batch of monomer was added.   
To show how apparent the difference is to the homopolymerisation of a single batch 
of HPMA monomer to a target DPn of 80 monomer units, Figure 3.14 shows 
chromatograms of both p(HPMA30)-b-(HPMA50) and p(HPMA80). 
 
Figure 3.14: GPC (THF eluent) chromatograms for p(HPMA80) (solid line) and 
p(HPMA30)-b-(HPMA50) (dashed line). 
Figure 3.14 shows that the homopolymer produced through a single monomer 
addition elutes at higher retention volumes, and therefore lower molecular weight 
than that of the self-blocked polymer at a nominal identical chain length. The self-
blocked polymer also shows an absence of peaks at high retention volumes which 
would indicate blocking inefficiency.  Although both GPC chromatograms peak at 
very similar retention volumes (approximately 18.5 mL), it is interesting that the 
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self-blocked copolymer (despite reaching > 99 % conversion), actually has a lower 
molecular weight distribution (1.09) than the homopolymer (1.18).    
 
3.3 Copolymerisation of HPMA and EGDMA to form 
Branched (p((HPMAx)-co-EGDMA0.95)) (x = 50, 80, 120) 
  
Herein the synthesis and characterisation of branched statistical copolymers 
comprising EGDMA and HPMA (p((HPMAx)-co-EGDMA0.95)) utilising EBiB as 
the initiator in methanol at ambient temperature is introduced.  A simplistic approach 
to generating high molecular weight materials is used, in which the synthetic 
protocol is identical to approach employed to generate linear p(HPMA) 
homopolymers, apart from the addition of the EGDMA brancher within the HPMA 
monomer feed.  
The controlled radical copolymerisation of a monovinylic monomer and a small 
amount of divinyl brancher inevitably generates a polymer with a branched 
architecture.  This occurs via incorporation of one of the vinyl groups of the brancher 
into the growing copolymer chain followed by the reaction of the pendant vinyl 
group intermolecularly to form a covalent branch to another polymer chain.  That is, 
unless the pendant group reacts with the radical chain end of the copolymer chain in 
which case may react intramolecularly and form a cycle.
20
 The consumption of 
brancher in this way diminishes the copolymers’ ability to reach high molecular 
weights. Analysis via GPC does not conventionally indicate the presence of 
intramolecular cycles, although Armes and co-workers have utilised 
1
H NMR 
spectroscopy to investigate and quantify how much brancher is incorporated in the 
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reaction of MMA and a disulfide-based cleavable bifunctional monomer.
21
 The 
number average and weight average molecular weight of copolymers increases 
dramatically as lightly branched polymers become covalently bonded at high 
conversion.
22
 A complex copolymer architecture will ensue if enough brancher has 
been added and it is predominantly incorporated intermolecularly.
23
 If too much 
brancher is added, an insoluble polymer network will form, often described as a 
crosslinked gel. 
The conditions for the copolymerisations are identical to those described above for 
linear polymerisation of HPMA with the exception of using a molar ratio of 1:0.95 
for the initiator and brancher, respectively (see Chapter 2 section 2.3.1).  The aim 
was to avoid gelation of the copolymer and form a highly branched soluble 
hydrophobic material. Although controlling the brancher molar ratio is unfortunately 
not sufficient to completely ensure that gelation does not occur, the key ratio is 
actually the molar ratio of reacted brancher to primary polymer chains; if the 
copolymer system has a low initiator efficiency it is highly likely to form a gelled 
network, despite an apparent feed ratio of brancher to initiator which is equal to < 1.  
This is due to the amount of reacted brancher being larger than the amount of 
primary chains produced.  Additionally, if the copolymerisation is too concentrated 
(with respect to solvent), gelation can also ensue despite monomer to brancher ratios 
being below 1: 1.
24
 Within the reactions described below, no gelation occurred and it 
is thought that a relatively high initiator efficiency was evident and therefore an 
inititator to brancher ratio of 1:0.95 was used throughout the range of reported 
polymerisations.  The consistency of concentrations and initiator:brancher ratios 
allows a series of distinct comparisons to be made whereas any alterations would 
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undoubtedly lead to different architectures and reaction kinetics, leading to 
inaccurate comparisons between branched copolymers. 
This method of forming soluble branched polymers is dissimilar to the work 
described by Sherrington and co-workers using conventional free radical 
polymerisation,
25
 where very high molecular weight copolymer chains are obtained 
at low conversion. In this case branched copolymers are generated in early 
polymerisation stages in complete contrast to controlled radical polymerisation.  In 
ATRP, it is suggested that the degree of branching is negligible at low conversions; 
in the early stages of copolymerisation, propagating chains are more likely to 
incorporate mono-vinylic monomer than successfully link two chains through 
intermolecular reaction.  The fundamental question of at what conversion branching 
becomes significant will be investigated in this study.  This is achieved by periodic 
sampling of three copolymerisations and their analysis by triple detection GPC (THF 
eluent) and 
1
H NMR spectroscopy (DMSO-d6). 
Primary chain lengths of DPn = 50 (p((HPMA50)-co-EGDMA0.95)), 80 (p((HPMA80)-
co-EGDMA0.95)) and 120 (p((HPMA120)-co-EGDMA0.95)) monomer units were 
targeted.  Reactions were left to copolymerise until vinyl monomer resonances ere 
not detectable within the 
1
H NMR spectroscopic analysis (> 99 % conversion) and 
subsequently terminated via exposure to the atmosphere and addition of oxygenated 
methanol.  Under these conditions (1:0.95 monomer:brancher, 50 w/v % 
(monomer/solvent) all three copolymers remained soluble in THF and methanol with 
no visual gelation detectable, although the viscosity increased dramatically in the 
latter stages of copolymerisation.  Copolymers were analysed by triple detection GPC 
in THF and their GPC chromatograms are shown in Figure 3.15. It should be noted 
that although it was possible to obtain soluble branched polymers at > 99 % 
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conversion, copolymerisations formed gel-networks when left for a significant period 
of time after reaching this conversion.  This suggests after complete monomer 
consumption, the active chain ends (of the soluble branched copolymers) react with 
each other in a termination by combination type reaction, resulting in insoluble gel-
networks.  This type of reaction has also been postulated in Section 3.2.3 for linear 
polymers (due to the increase in molecular weight distribution at high conversion).    
The broad traces seen in Figure 3.15 are indicative of very high molecular weight 
materials within the copolymer samples; eluting as low at 10 mL for p((HPMA120)-
co-EGDMA0.95).  It is also noted here that a large fraction of these polymer samples 
appears to be of linear architecture, eluting at much higher retention volumes (18-20 
mL).   
 
Figure 3.15: GPC (THF eluent) chromatograms for branched copolymers prepared by 
ambient methanolic ATRP and varying in primary chain target DPn   p((HPMA50)-
co-EGDMA0.95) (solid line), p((HPMA80)-co-EGDMA0.95) (medium dashed line), 
p((HPMA120)-co-EGDMA0.95) (small dashed line). 
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Table 3.3 shows molecular weights and molecular weight distributions of branched 
copolymers where the data suggests that as target DPn increases for the primary 
chains, branched copolymer molecular weight and dispersity increase. 
      
Sample 
Mn (g mol
-1
) 
(theory) 
Mn (g mol
-1
) 
(GPC) 
Mw (g mol
-1
) 
(GPC) 
Mw/Mn 
Conversion 
(%) 
      
p((HPMA50)-co-
EGDMA0.95 ) 
/ 57600 374400 6.5 > 99 
p((HPMA80)-co-
EGDMA0.95) 
/ 169000 1217000 7.2 > 99 
p((HPMA120)-co-
EGDMA0.95) 
/ 230000 2392000 10.4 > 99 
      
      
Table 3.3: Data obtained via triple detection GPC (THF eluent) for the 
copolymerisation of p((HPMAx)-co-EGDMA0.95) with increasing target DPn. 
 
It is important to note that analysis by GPC utilises RALS, LALS and IV detectors.  
Similarly to section 3.2, the signals from all detectors are shown for p((HPMA50)-co-
EGDMA0.95) as a comparison with previous results, Figure 3.16. 
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Figure 3.16: GPC (THF eluent) chromatograms of p((HPMA50)-co-EGDMA0.95) 
showing RI (black line), RALS (blue line), LALS (red line) and Intrinsic Viscosity 
(green line) responses. 
 
The data in Figure 3.16 suggests the presence of very high molecular weight 
material.  Both RALS and LALS detector responses are much more heavily weighted 
towards lower retention volumes, due to the higher amount of scattering for large 
highly branched materials.  It should be noted that similar to RI detector response, the 
RALS and LALS detectors show lower molecular weight material present within the 
sample.  
Figure 3.15 and Figure 3.16 both suggest high molecular weight material is formed 
during the copolymerisation of HPMA and EGDMA with no experimental difficulty, 
however, investigation into the kinetics of these copolymerisation is extremely 
important in order to determine when branching is occurring and at what point it 
becomes significant in these systems with respect to the ATRP mechanism, if at all.   
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3.3.1 Kinetic Studies for the Branched Copolymerisation of p((HPMAx)-
co-EGDMA0.95), (x = 50, 80, 120) 
 
Primary chains with target DPn values of 50, 80 and 120 monomer units were chosen 
to study branched copolymer kinetics as these are easily comparable to the linear 
kinetics data described in section 3.2.2.  All three reactions were performed within 
one week and regular sampling at hourly intervals was performed to allow analysis 
by 
1
H NMR spectroscopy (DMSO-d6) and triple detection GPC (THF eluent). (see 
Chapter 2 section 2.3.2). 
A linear semi-logarithmic plot is observed in the branched copolymerisation of 
HPMA  and EGDMA with a target primary chain  DPn of 50 monomer units (shown 
in Figure 3.17) indicating a constant concentration of radicals throughout the 
polymerisation, along with a high rate of conversion in the early stages of the 
reaction.  It appears the reaction is typical for ATRP and that addition of EGDMA 
has not affected reaction kinetics.  Kinetic experiments were conducted in the same 
manner for target DPn of 80 and 120 monomer units with similar behaviour (seen in 
Figure 3.18 and Figure 3.19. 
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Figure 3.17 Kinetics plot for the synthesis of p((HPMA50)-co-EGDMA0.95) in 
methanol by ambient ATRP. 
Similar to the linear homopolymerisation kinetic study in section 3.2.2, the reaction 
rate appears to reduce as target DPn increases. As the reactions have an equal molar 
ratio of monomer, this is clearly evident, however, a lower radical concentration is 
the probable cause due to the targeting of longer primary chains. The period of time 
necessary to reach higher conversion was found to be considerably longer for 
copolymerisations with higher target DPn (Figure 3.18). 
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Figure 3.18: Conversion vs. Time for the copolymerisation of HPMA and EGDMA 
by methanolic ambient ATRP. p((HPMA50)-co-EGDMA0.95) (circle), p((HPMA80)-
co-EGDMA0.95) (triangle), and p((HPMA120)-co-EGDMA0.95) (square). 
 
Similar to linear homopolymerisations, the semi-logarithmic plots for branched 
copolymerisations are linear (Figure 3.19); it is therefore assumed the radical 
concentration is constant throughout each reactions and first order kinetics are 
observed during the polymerisation. The gradient of the plots decrease as target DPn 
increases (comparable to linear homopolymerisation) due to the diminishing 
concentration of propagating radicals in the copolymerisation reaction as target DPn 
increases.  The difference in reaction rate is dramatically affected when the targeted 
DPn varies from 50 to 80 monomer units, compared to linear homopolymerisations, 
where rate retardation is most affected when target DPn varies from 80 to 120 
monomer units. 
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Figure 3.19: Semi-logarithmic plot for the copolymerisation of HPMA and EGDMA 
by methanolic ambient ATRP. p((HPMA50)-co-EGDMA0.95) (circle), p((HPMA80)-
co-EGDMA0.95) (triangle), and p((HPMA120)-co-EGDMA0.95) (square). 
 
Figure 3.20 shows the comparison between the reaction kinetics of a linear and 
branched copolymerisation with a target DPn of 50 monomer units for both the linear 
polymer and the primary p(HPMA) chains of the branched copolymer.  The data 
suggests that despite the addition of EGDMA, reaction kinetics remain relatively 
similar.  The copolymerisation of p((HPMA50)-co-EGDMA0.95) is slightly slower 
than its linear counterpart, possibly due to the change in concentration of the 
monomer in the copolymerisation reaction (due to addition of brancher).  It cannot 
be due to changes in the concentration of initiator, as they were identical in both 
reactions.  Similar results have been shown by Rannard and co-workers where 
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retardation of reaction rate was observed due to the addition of EGDMA brancher in 
comparison to a linear counterpart.
10
  
 
 
Figure 3.20: Comparison of the kinetics studies for the linear homopolymerisation 
and copolymerisations of HPMA and HPMA/EGDMA by methanolic ambient 
ATRP.  p(HPMA50) (circles) and p((HPMA50)-co-EGDMA0.95) (triangles). 
 
Figure 3.21 displays the GPC chromatograms of copolymer samples taken from the 
reaction of p((HPMA50)-co-EGDMA0.95) over eight hours of copolymerisation. It is 
noted that peaks begin to broaden significantly after around 4 hours of 
copolymerisation (corresponding to a conversion of 84 %), however, slight peak 
broadening is seen prior to 4 hours reaction. Chromatograms continue to broaden 
throughout the copolymerisation until 8 hours reaction time (98 % conversion). GPC 
chromatograms performed for the kinetic studies of p((HPMA80)-co-EGDMA0.95) 
and p((HPMA120)-co-EGDMA0.95) are found in Appendix 3.1 and 3.2, respectively. 
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Figure 3.21:  GPC (THF eluent) chromatograms for the kinetics study of the 
copolymerisation of HPMA and EGDMA by methanolic ambient ATRP to form 
p((HPMA50)-co-EGDMA0.95). 
 
Figure 3.22 shows the overlay of the GPC chromatograms of p(HPMA50) and 
p((HPMA50)-co-EGDMA0.95), showing significant peak overlap at high retention 
volumes (approximately 18-20 mL). This clearly suggests the presence of a clear 
linear fraction within the molecular weight distribution of the branched material.  
This also occurs in GPC chromatograms for DPn = 80 and 120 monomer units, 
shown in Appendix 3.3 and 3.4 respectively. 
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Figure 3.22 Overlaid GPC chromatograms of p(HPMA50) (solid line) and 
p((HPMA50)-co-EGDMA0.95) (dashed line). 
 
This mixture of linear and branched material existing in branched ATRP 
copolymerisations agrees well with the work reported by Armes and co-workers
26
 
whose Monte Carlo simulation models of branched systems concluded that 
statistically, there exist multiple copolymer architectures existing when a divinyl 
branched is incorporated such as linear material, highly branched material and chains 
containing intramolecular loops.  In their previous reports investigating branched 
p(HPMA),
10
 Armes and co-workers do not report significant overlap of GPC 
chromatograms for linear and branched material, unlike the data reported here.  
Other literature also report a complete shift in elution volume (suggesting a complete 
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architectural change from linear to branched polymer) when copolymerisations reach 
high conversion.
22, 23 
Some possibilities as to why branched copolymers contain linear material are: 
1. Multiple branchers reacting between two primary chains intermolecularly, 
therefore reducing the number of pendant vinyl groups for reaction with other 
propagating chains. 
2.  Cyclisation within linear copolymer chains to yield copolymers unable to 
react intermolecularly with growing branched polymers. These would not be 
readily detectable via GPC analysis.  
 
 
 
Scheme 3.4: Representation of proposed reactions leading to branched copolymer 
samples containing linear material. 
 
In Scheme 3.4, two copolymerisation structures are proposed, which may ultimately 
contribute to the presence of linear material within branched copolymer samples.  If 
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Scheme 3.4(1) occurs, it would be highly likely that gelation would also occur, 
causing network formation or microgelation. Gelation did not occur in branched the 
copolymerisations, either visually or observed within the GPC analysis. Micro-
gelation may have occurred, with material being removed prior to injection or by the 
guard column in the GPC instrument, however, during sample filtration prior to 
injection, no adverse pressure was observed.  If Scheme 3.4(2) is occurring, it is 
thought it would be most significant in the early stages of the polymerisation, as 
reaction mixtures becomes highly viscous at high conversion where monomer 
addition becomes diffusion controlled.  It is proposed intramolecular cyclisation 
would be hindered where active chain ends are much more likely to react with other 
chains rather than with themselves.
20
  
The formation of cycles is also predicted by Monte Carlo theory and very small 
differences in conversion, attained prior to deliberate termination of the reaction, can 
generate large differences of Mn and Mw in copolymer samples, due to the steep 
gradient of increasing molecular weight at very high conversion. 
As expected, all three branched copolymers experienced a considerable increase in 
the observed number average molecular weights, weight average molecular weights 
and molecular weight distributions as reactions proceeded to high conversions, due 
to the covalent bonding of multiple linear chains. As seen in Figure 3.23, molecular 
weight distribution in the branched copolymerisation of p((HPMA50)-co-
EGDMA0.95) increases dramatically with conversion, consistent with the theory of 
chain linking occurring with monomer depletion. Similar relationships for 
p((HPMA80)-co-EGDMA0.95) and p((HPMA120)-co-EGDMA0.95) can be found in 
Appendix 3.5 and 3.6, respectively. 
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Figure 3.23:  Weight average molecular weight and dispersity vs. conversion (%) 
plots determined during the kinetics study of the copolymerisation of HPMA and 
EGDMA by methanolic ambient ATRP to form p((HPMA50)-co-EGDMA0.95).  
Figure 3.24 shows, the dramatic variation of number average molecular weight 
during the branched copolymerisation.  Mn begins to increase exponentially when 
conversion reaches > 80 % conversion where branching dominates the latter part of 
the reaction and HPMA monomer concentration is significantly reduced.  As noted 
previously, when left at high conversion for extended periods, reactions become 
insoluble gelled networks, where it is proposed active chain ends of the branched 
copolymers terminate by combination.  
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Figure 3.24: Mn vs. conversion plot for the copolymerisation of HPMA and EGDMA 
by methanolic ambient ATRP polymerisation to form p((HPMA50)-co-EGDMA0.95). 
 
3.3.2 Proposed Mechanism of Branched Vinyl Polymerisation using 
ATRP.  
Scheme 3.5 represents the proposed mechanism of branching within the ATRP 
synthesis of p((HPMAx)-co-EGDMA0.95)).  The reaction has been separated into 
three phases; Phase I represents the essentially linear growth of copolymer chains 
where the concentration of EGDMA is insignificant in comparison to the unreacted 
HPMA monomer; no branching behaviour is observed as EGDMA acts almost 
identically to the HPMA monomer with only one vinyl group predominantly 
undergoing polymerisation.  When incorporated into a propagating chain, the second 
vinyl group in EGDMA is pendant to the growing linear chain.  Phase II represents 
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the onset of branching as observed in the experimental deviation from linearity of Mn 
vs. conversion curves and an increase in dispersity.  Intramolecular coupling of linear 
copolymer chains begins via reaction of pendant vinyl groups of EGDMA with other 
growing linear copolymer chains.  Here the concentration of the pendant vinyl 
groups becomes sufficient to allow intermolecular reaction between chains.  Within 
Phase III, copolymer primary chains continue to grow linearly yet the molecular 
weight increase is dominated by the growing number of branch points between 
chains until all monomer has been depleted.  
 
 
Scheme 3.5: Schematic representation of p(HPMA) branched copolymerisation. 
Phase I (oligomer formation), Phase II (initial inter-chain reaction), Phase III 
(intermolecular branching at high conversion) – chain-end oligomers formed at low 
conversion (i) and high conversion (ii) and long chain end groups (iii and iv) are 
highlighted. 
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In summary the synthesis of soluble, high molecular weight copolymers has been 
reported using a one-pot ATRP methodology. Reaction kinetics have been explored 
with varying target DPn and compared to their linear homopolymer data, followed by 
a proposed mechanism of branching. 
 
3.3.3 Chain Extension using Branched Copolymers of HPMA and 
EGDMA – Exploring the Variation of Architecture by Sequential 
Monomer Addition. 
Section 3.2.3 reported the chain extension, or self-blocking, of linear p(HPMAx) 
generating a block copolymer with low molecular weight distribution, with no 
experimental difficulty.  This section aims to investigate whether chain ends in 
branched copolymerisations still remain active after sequential addition of additional 
monomer feeds.  This may be done in three ways, one of which would be to 
copolymerise chains of branched polymers and after reaching high conversion, add 
another batch of monomer and brancher to give a doubly branched copolymer.  
 This reaction was not performed as it was highly likely that a gelled network would 
result, due to previous experiments where insoluble copolymer mass was formed 
after leaving copolymerisations which had reached > 100 % conversion. 
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Scheme 3.6 represents some of the different architectures which could be generated 
by varying the order of monomer and brancher addition.  A) may be seen as an 
“arms-first” approach, B) and C) both could be seen as a “core-first” approach to 
generate branched block copolymers where maroon spheres represent the outer (or 
second) block of monomer.  B) was attempted several times; despite successful 
addition of the second linear block, all reactions gelled.  The exact reason for this is 
unclear but the presence of unreacted pendant vinyl groups which become available 
when the second monomer feed is added may lead to further branching and gelation. 
This would occur if, rather adding and an essentially linear chain to the branched 
polymer end groups, the longer chain ends are able to access hidden pendant reactive 
functionality.  It may also be that the polymerisation reactions were left for too long 
after high conversion of the second monomer feed and gelation occurred due to 
termination by combination reaction.  It is proposed that if reactions are terminated 
before gelation ensues, the architecture will be more similar to those previously 
synthesised rather than the block copolymer depicted in Scheme 3.6(B).  
Route (A) shown in Scheme 3.6, was conducted with the initial formation of 
p(HPMA30) chains (red spheres) and, after achieving relatively high conversion, a 
second batch of HPMA monomer (equivalent to a DPn = 80 monomer units) 
containing EGDMA brancher (green spheres) at an initiator:brancher ratio of 1:0.95 
was added.  The second aliquot of monomer is represented in Scheme 3.6(A) by 
maroon spheres and a controlled copolymerisation was expected, however, the 
resulting copolymer was also expected to form a dramatically different architecture 
when compared to the formation of a branched copolymer from the direct 
copolymerisation of HPMA and EGDMA with a primary chain target DPn = 80 
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monomer units. The synthesis of a soluble branched copolymer was expected, as 
only a small quantity of brancher was added and hypothetically, the introduction of a 
short chain of p(HPMA) prior to the addition of brancher should have no negative 
impact on the polymerisation and crosslinking should not occur. 
1
H NMR 
spectroscopy and GPC analysis were used to monitor the reaction over time, with a 
sample taken just before addition of the second monomer batch to ensure relatively 
high conversion had been reached.  Triple detection GPC (THF eluent) was used to 
analyse the samples, as shown in Figure 3.25. 
 
Figure 3.25: GPC chromatograms at varying points during a branched chain 
extension using methanolic ATRP to form p((HPMA30)-b-((HPMA50)-co-
EGDMA0.95)). 
It is clear from Figure 3.25 that high molecular weight material is formed, due to 
brancher introduced within the second batch of monomer.  Molecular weight 
distribution increases as conversion increases suggesting that branching dominates at 
extremely high conversion.  Again, as previously noted, a linear peak appears at high 
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retention volume, suggesting a proportion of these copolymer chains are not 
branched, even at high conversion. Importantly, no linear polymer from the initial 
formation of the linear p(HPMA30) chains are observed in the final polymer. This 
suggests a very efficient propagation of the second mixed monomer:brancher feed 
without termination of the initial propagating chains.  The presence of linear polymer 
in the final branched polymer sample must therefore be derived from the addition of 
the second HPMA monomer feed but without successful intermolecular branching of 
these chains.   
Table 3.4 displays the data obtained during this reaction where no theoretical 
molecular weights could be calculated as EGDMA incorporation is statistical.  Very 
high number average and weight average molecular weight was obtained (Mn = 
185000 g mol
-1
, Mw = 1128500 g mol
-1
) alongside a molecular weight distribution of 
6.1 when > 99 % conversion had been reached.   
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Sample 
Mn (g mol
-1
) 
(theoretical)* 
Mn (g mol
-1
) 
(GPC) 
Mw (g mol
-1
) 
(GPC) 
Mw/Mn 
Conversion 
(%) 
      
p(HPMA30) 3500 3300 3600 1.09 81 
      
p(HPMA30)-b-
p((HPMA50)-co-
EGDMA0.95) 
/ 25400 51200 2.10 57 
p(HPMA30)-b-
p(HPMA50)-co-
EGDMA0.95) 
/ 50000 245000 4.90 78 
p(HPMA30)-b-
p(HPMA50)-co-
EGDMA0.95) 
/ 185000 1128500 6.10 99 
 
Table 3.4:  Data for the branching chain extension of p(HPMA) using a statistical 
copolymerisation of HPMA and EGDMA utilising methanolic ATRP. *Theoretical 
values are based on the measured conversion values using 
1
H NMR (DMSO-d6). 
 
Similar to Section 3.2.3 where, linear block copolymers, synthesised from a self-
blocking experiment with an overall target DPn = 80 monomer units, were compared 
to p(HPMA80) synthesised in a single reaction,  Figure 3.26 shows the GPC 
chromatograms (RI detector response) of p((HPMA80)-co-EGDMA0.95) overlaid with 
the same chromatogram from p(HPMA30)-b-p((HPMA50)-co-EGDMA0.95).  The 
branched self-blocked copolymer begins to elute at a lower retention volume in 
comparison to the branched copolymer prepared with EGDMA being present at all 
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times. Previous analysis of the RI chromatograms of branched polymers synthesised 
during this study have shown that a significant fraction of linear polymer is present 
in the final branched copolymers. The overlaid chromatograms in Figure 3.26 also 
suggest the presence of linear polymers, however, despite the nominal equivalent 
chain length of the linear polymers (DPn = 80 monomer units), when EGDMA is 
added in the second monomer feed, the linear fraction of the polymer distribution 
can be seen at a lower elution volume.   
 
 
Figure 3.26: Overlaid Refractive Index chromatograms from GPC analysis (THF 
eluent) of p((HPMA80)-co-EGDMA0.95) (solid line) and p(HPMA30)-b-p(HPMA50)-
co-EGDMA0.95) (dashed line). 
 
The presence of longer DPn linear chains may contribute to the observed  decrease in 
dispersity of 6.1 for p((HPMA30)-b-p(HPMA50)-co-EGDMA0.95)) compared to 7.2 
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for p((HPMA80)-co-EGDMA0.95).  The reason for the higher molecular weight 
fraction in the chain extended copolymer is not clear; as this reaction was only 
performed once, it may be that temperature and/or experimental protocol were 
slightly different.  Homogeneity of the reaction mixture will be altered as the second 
monomer feed is added, and as diffusion may be hindered it may lead to less than 
ideal EGDMA incorporation.   
Figure 3.27 shows the GPC chromatograms for p(HPMA30)-b-p((HPMA50)-co-
EGDMA0.95) and p((HPMA120)-co-EGDMA0.95), where near complete overlap of 
peaks at approximately 18 mL is noted.   
 
Figure 3.27: Overlaid Refractive Index chromatograms from GPC analysis (THF 
eluent) of p((HPMA120)-co-EGDMA0.95)) (solid line) and p(HPMA30)-b-
p((HPMA50)-co-EGDMA0.95)) (dashed line). 
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The data suggests that the linear material present within the chain extended 
copolymer is much more likely to have a DPn of approximately 120 monomer units, 
suggesting that despite an overall target DPn of 80 monomer units, the generation of 
linear material of a higher chain length is formed.  It is possible that these are lightly 
branched chains or possibly dimers, produced by linear chains of DPn = 80 monomer 
units and enhanced incorporation of EGDMA is seen through this approach. 
3.4  Summary  
This chapter has reported the facile ATRP synthesis of linear p(HPMAx) 
homopolymers where detailed kinetic experiments were performed, confirming 
reactions proceeded in a controlled manner.  A self-blocking experiment also 
confirmed that chain end functionality was maintained at relatively high conversion, 
generating block copolymers with a narrow molecular weight distribution and 
accurate molecular weight. It is believed this is the first report of branched p(HPMA) 
copolymer synthesis investigated in significant detail.   
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Figure 3.28: Representation of the range of materials believed to be present within 
p((HPMAx)-co-EGDMA0.95) samples. 
From kinetic GPC analysis, a mechanistic scheme of the branching process has been 
proposed.  High molecular weight soluble materials have been synthesised simply by 
controlling the monomer:brancher ratio.  It has been noted that leaving these 
polymerisations to stand whilst still active induces gelation, yet by monitoring 
reaction kinetics, this can be suppressed and reactions can be manually terminated at 
> 99 % conversion. It is thought that the Monte Carlo modelling approach clearly 
correlates with the observed branching process; essentially based on statistics and 
predicting intramolecular cyclisation, linear chains and as branched copolymers, all 
of which are believed to be present in p((HPMAx)-co-EGDMA0.95) copolymer 
samples. 
Figure 3.28 maps out a range of architectures believed to be synthesised during the 
branching process.  This diverse range of architectures is due to the extreme 
retention volume ranges seen during GPC analysis.  It may be possible to fractionate 
linear material to give purely branched copolymers, but this was not attempted.   
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4. Synthesis of Polymeric Nanoparticles using 
p(HPMA) 
4.1 Introduction 
The formation of nanoparticles from amphiphilic block copolymers has been 
reported using several methods.
1, 2
  For hydrophobic homopolymers and copolymers, 
the use of nanoprecipitation has been shown to be particularly successful if 
conditions can be found to prevent macrophase separation and guarantee the 
formation of colloidally stable sub-micron particles. Polymers such as polystyrene
3
 
and poly(D,L-lactide-co-glycolide)
4
 have been shown to produce near monodisperse 
nanoparticles in surfactant-free procedures and without obvious hydrophilic 
stabilising chains. 
In this chapter, the formation of nanoparticles from linear and branched p(HPMA) 
was evaluated using various precipitation methods.  Mechanisms of formation are 
postulated and a range of studies are used to investigate the aqueous nanoparticle 
stability and the effects of polymer architecture.   
4.2 Nanoprecipitation of Linear p(HPMAx) (x = 50, 80, 120) 
Linear polymers comprising different lengths of p(HPMA) (50, 80, 120 monomer 
units), synthesised using methanolic ATRP, were subjected to a solvent switch in 
order to generate nanosupensions in water.  It should be noted here that no additional 
surfactants were added at any stage, and therefore the stability of the nanoparticles 
can only be attributed to the experimental protocol, polymer chemistry and 
concentration, giving a true insight into the process.  Following nanoparticle 
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preparation, our aim was to avoid additional purification techniques (including 
dialysis, filtration, centrifugation and dilution) as although these may be common 
practice, these processes eliminate polymer mass and the final concentration is often 
unknown or unstated within literature reports.
5 
 Such purification techniques are also 
costly and time-consuming.  It was believed a bottom-up approach to these 
experiments was required in this research, especially as materials of this nature have 
not been widely researched, and in this way experiments can be built upon based on 
the generated data results. 
Schubert and co-workers often use dialysis or a slow dripping method for the 
preparation of nanoparticles
6
 by nanoprecipitation and in order to initially investigate 
the full spectrum of nanoprecipitation techniques it was decided the first experiments 
would be based around these two methods.  Representations of these processes are 
shown in Scheme 4.1 and Scheme 4.2 and individual experimental protocols are 
found in Chapter 2 section 2.5.1.2 and section 2.5.1.3. 
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Scheme 4.1: Representation of nanoparticle production via dialysis using solvated 
linear homopolymers in acetone in a dialysis membrane and continual water 
exchange for > 48 hours. 
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Scheme 4.2: Representation of the dripping method where linear 
homopolymer/acetone solution is dripped into stirring water over approximately ten 
minutes. 
To investigate these two methods of nanoparticle preparation one polymer was 
selected p(HPMA80) and dissolved in acetone at a concentration of 5 mg mL
-1
 in a 
sealed vial and placed on a rolling machine overnight.  The polymer/acetone solution 
was separated into two identical samples (2 x 1 mL) and individually slowly dripped 
into two vials filled with 5 mL of distilled stirring water using syringe pumps 
operating at 0.1 mL min
-1
.  One of these samples was subsequently transferred into 
dialysis tubing and left in a 1 L beaker filled with distilled water.  After exchanging 
water for two days the sample was collected and analysed by DLS (see Figure 4.1).  
The other sample was left stirring overnight at 40°C to remove acetone and was also 
analysed by DLS, shown in 4.1.  
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Figure 4.1: Z-average diameter analysis of nanoparticles comprising of p(HPMA80) 
at 1 mg mL
-1
 using two methods; dripping method (solid line) and dialysis (dashed 
line). 
These results seemed promising as Figure 4.1 shows monomodal distributions of  
nanoparticles have indeed been formed from the hydrophobic linear polymer.  The 
dripping method with subsequent solvent evaporation formed nanoparticles with a 
very low polydispersity (0.021) in comparison to those from the dialysis method 
(0.235).  The z-average diameters of these dispersions are dramatically different (114 
nm and 261 nm for dripping/evaporation and dialysis, respectively), thus 
demonstrating a degree of control over z-average diameter by using different 
experimental procedures.  However, upon leaving these samples standing for 
approximately three hours, precipitate began forming until very large amounts were 
present at the bottom of the sample vials after approximately five hours.  This was 
rather unsurprising as there is no apparent stabilising force to prevent aggregation as 
these are solely comprised of hydrophobic starting materials. However, another 
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method to form stable nanoparticles using linear chains was attempted.  This 
approach was significantly less time consuming in the hope that by drastically 
altering the way in which solvent exchange occurs this may affect nanoparticle z-
average diameter, polydispersity and stability.  This simplistic approach is 
essentially identical to the dripping method apart from the transfer of the 
polymer/acetone solution into the stirring water.  Rather than a very slow dropwise 
addition, the entire volume was added rapidly (over less than two seconds), into pre-
heated (40°C) water and left overnight to remove residual acetone.  
1
H NMR 
spectroscopy was performed on a nanoparticle suspension comprised of 
p((HPMA80)-co-EGDMA0.95) in D2O where the acetone resonance (2.22 ppm) was 
not evident (see Appendix 4.1). 
To investigate this rapid approach to generating nanoparticles, three linear polymers, 
p(HPMA50), p(HPMA80), p(HPMA120), were dissolved in acetone at 10 mg mL
-1 
overnight on a rolling machine in sealed vials in order to reduce any acetone 
evaporation.  The entire sample (1 mL) was rapidly added to stirring warmed water 
(5 mL, 40°C) using an adjustable pipette.  Following overnight acetone evaporation, 
precipitation was not evident and the 2 mg mL
-1
 nanosuspension were analysed via 
DLS (see experimental).  Filtration/centrifugation was deemed unnecessary as DLS 
measurements failed to detect any large aggregates and/or dust particles, which 
would have led to failed measurements.  DLS characterisation of the three 
nanoparticle suspensions comprised of p(HPMA50), p(HPMA80) and p(HPMA120) are 
shown in Figure 4.2. 
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Figure 4.2: DLS characterisation of rapidly nanoprecipitated linear polymers from a 
starting concentration of 10 mg mL
-1
 in acetone giving a final aqueous concentration 
of 2 mg mL
-1
. p(HPMA50) (solid line), p(HPMA80) (large dashed line)and 
p(HPMA120) (small dashed line). 
All of the DLS measurements shown in Figure 4.2 exhibit relatively low 
polydispersities (0.16 to 0.26) and interestingly the nanoparticles made from 
p(HPMA50) are approximately five times larger than those comprised of 
p(HPMA120) despite the same mass of polymer present in the final solution.  The 
rationale behind this trend will be discussed later in Section 4.4.4.  Initially this 
experiment seemed to provide an effective route to prepare nanoparticles consisting 
solely of hydrophobic polymer, yet several hours after these measurements were 
conducted and sample vials were allowed to rest unstirred at room temperature, large 
amounts of precipitate began to form.  This is expected due to the hydrophobic 
nature of the polymers.  To try to overcome the precipitation, or at least reduce the 
rate of precipitation, a further experiment with the same three linear polymers was 
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conducted.  It has been suggested that lower concentrations might be preferred in 
order to produce more stable nanoparticles, as they would be better dispersed in the 
initial solvent.
6
  The same precipitation protocol was followed but the initial polymer 
concentration in acetone was reduced to 5 mg mL
-1
 and was subsequently diluted 
five-fold (5 mL water) to give a final concentration in water of 1 mg mL
-1
 after 
acetone removal.  It was thought that the nanoparticles would remain more stable by 
lowering the actual mass present in the sample, and that aggregation would be 
reduced.  Again these samples were able to be analysed using DLS and these 
measurements are shown in Figure 4.3. 
 
Figure 4.3: DLS characterisation of nanoprecipitated linear polymers from a starting 
concentration of 5 mg mL
-1
 in acetone giving a final aqueous concentration of 1 mg 
mL
-1
.   p(HPMA50) (solid line), p(HPMA80) (large dashed line)and p(HPMA120) 
(small dashed line). 
The DLS analyses shown in Figure 4.3 are all monomodal with very low 
polydispersities (approximately 0.15); lower polydispersities compared to their 
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counterparts in the previous experiment which used double the mass of polymer 
within the nanoprecipitation experiments.  Having less material present in the 
original acetone solution (5 mg mL
-1
) and obtaining similar nanoparticle z-average 
diameters compared to a more saturated solution (10 mg mL
-1
) may suggest fewer 
actual particles are being formed.  As this process is a nucleation and growth 
mechanism these results suggest there are fewer nucleation events and potentially a 
more controlled precipitation rate, which may also account for the increased 
uniformity of particle z-average diameters formed when using a more dilute 
polymer/acetone solution.  This process is not explored in much detail here, but will 
feature heavily in later discussion.  As observed previously, and also unsurprisingly, 
all nanoparticle samples began to precipitate out of solution after several hours 
standing, exhibiting metastability.  From these experiments it has been shown that 
simply using a rapid solvent switch method of forming nanoparticles comprised of 
linear hydrophobic polymers was successful, however, the particles were unstable to 
even limited storage times and no further adjustments to the experimental protocol 
were attempted.  
 
4.3 Nanoprecipitation of p((HPMAx)-co-EGDMA0.95) (x = 50, 
80, 120) using Dialysis and Dripping methods 
The formation of stable nanoparticles via rapid nanoprecipitation was highly 
unsuccessful for linear polymers of various chain lengths of p(HPMAx), but herein 
the extremely high stability of those formed from their branched counterparts is 
reported.  Previous reports on polymer nanoparticle formation mainly focuses on 
using either dialysis or a dropping method in which polymer is firstly dissolved in a 
suitable solvent and then slowly dripped into a non-solvent (namely water) after 
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which the polymers self-assemble into nanostructures.  In section 4.2, all attempted 
methods of nanoprecipitation were unsuccessful in forming stable materials, but it 
was not assumed this would be the case for branched copolymers as, although 
chemically identical, their architectures are dramatically different and may affect 
their behaviour during precipitation.  A schematic representation of nanoparticle 
formation using branched copolymers is shown in Scheme 4.3 (dialysis) and Figure 
4.4 (dripping method). 
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Scheme 4.3: Representation of nanoparticle production via dialysis using solvated 
branched copolymers in acetone in a dialysis membrane and continual water 
exchange for > 48 hours. 
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Scheme 4.4: Representation of the dripping method where branched 
copolymer/acetone solution is dripped into stirring water over approximately ten 
minutes. 
 
To determine which method was most suitable for these copolymers, all of the 
aforementioned methods were compared by using p((HPMA80)-co-EGDMA0.95) 
dissolved in acetone at a concentration of 5 mg mL
-1
 and precipitating into distilled 
water (5 mL) finally giving a copolymer concentration of 1 mg mL
-1
.     
The three nanoparticle suspensions remained very stable without obvious 
precipitation and therefore analysis was performed after the acetone had been 
completely removed, their DLS measurements are shown in Figure 4.4. 
Chapter 4 
165 
 
 
Figure 4.4: DLS measurements of nanoparticles (1 mg mL
-1
) formed from 
p((HPMA80)-co-EGDMA0.95) via three different preparation routes.  Dialysis (sold 
line), Dropwise (medium dashed line), Rapid (small dashed line). 
The particles formed using dialysis were considerably larger when compared to the 
other two methods and displayed a higher polydispersity (610 nm and 0.22, 
respectively). Similar observations have been previously reported.
7
  Particles formed 
by the slow addition/evaporation are markedly larger than those of the rapid 
addition/evaporation (72 nm and 127 nm, respectively).  Both polydispersities are 
extremely low 0.05 and 0.02 for the dripping and rapid addition, respectively.  The 
range of particle z-average diameters that have been formed from this single polymer 
is dramatic and, due to the larger z-average diameters produced as well as being 
more experimentally demanding, further dialysis experiments were not performed 
(indeed generating 1 nanoparticle sample takes > 48 hours and approximately 3 litres 
of distilled water and dialysis tubing).  The wide range of z-average diameters 
recorded from a single copolymer solution concentration strongly suggests a self-
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assembly of smaller entities, driven by a reduction in interfacial tension.  The 
mechanism of the postulated self-assembly will be discussed in Section 4.4.4.     
A further experiment was conducted using the more conventional dripping method to 
investigate concentration dependence on final nanoparticle dispersions.  
p((HPMA50)-co-EGDMA0.95) was dissolved in acetone at two different 
concentrations (10 mg mL
-1 
and 5 mg mL
-1
).  Using two separate syringe pumps, 
solutions (1 mL) were dripped into stirring water (5 mL) achieving identical five-
fold dilutions but with different final copolymer concentrations in water. Figure 4.5 
shows the DLS analysis data. 
 
Figure 4.5: Comparison of nanoparticles formed from p((HPMA50)-co-EGDMA0.95) 
using two different starting copolymer/acetone concentrations each achieving a five-
fold dilution.  5 mg mL
-1
 (dashed line), 10 mg mL
-1
 (solid line). 
 
Here it is shown that varying the initial copolymer/acetone solution produces 
nanoparticles of differing z-average diameters via the dripping method for the same 
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dilution level.  The sample with an initial concentration of 10 mg mL
-1
 led to 
particles with a z-average diameter of 203 nm whereas starting with a 5 mg mL
-1
 
gave particles with a z-average diameter of 146 nm.  This led us to believe that a 
degree of control of particle z-average diameter is apparent simply by varying the 
starting copolymer concentration, where higher concentrations lead to larger 
particles due to increasing the number of molecules per unit volume in the initial 
solvent.
8
  This control is explored in detail in further studies later in this chapter, 
although using rapid precipitation rather than the dripping method. It would appear 
that the dripping technique is favourable due the extremely low polydispersities 
generated (in comparison to the rapid precipitation), yet this method (which is 
widely utilised),
6, 9, 10, 11
 was not chosen for a more detailed nanoparticle production 
investigation during this study.  The reasoning for this is two-fold;  
1. The slow dripping/evaporation process is time consuming, taking 
approximately 10 minutes to produce a 5 mL sample, excluding preparation 
time and evaporation.   
2.  Syringe pumps were utilised to controllably and slowly drip the 
copolymer/acetone solution into water and availability limited the number of 
samples that could be generated and evaluated.   
Due to these reasons, it was felt that rapid precipitation was the most appropriate 
method for a detailed study as this generates large numbers of variable volumes of 
low polydispersity samples that are not considerably different to the slower 
technique.  Although all of the branched copolymer nanoparticles generated by these 
three different methods were stable relative to their linear counterparts, it was felt 
rapid precipitation outweighed the more conventional dripping method, and this was 
chosen to produce all of the remaining nanoparticle samples. 
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4.4 Nanoprecipitation of p((HPMAx)-co-EGDMA0.95) (x= 50, 
80, 120) using a Rapid Solvent Switch 
Although the linear p(HPMA) polymer nanoparticles precipitated when left standing 
unstirred for  several hours, their DLS data suggested a trend whereby increasing the 
target DPn of the polymer chain produced smaller nanoparticles.  To further 
investigate this possible trend, their branched copolymer counterparts, p((HPMA50)-
co-EGDMA0.95), p((HPMA80)-co-EGDMA0.95), p((HPMA120)-co-EGDMA0.95), were 
subjected to rapid nanoprecipitation using an initial copolymer concentration in 
acetone of 5 mg mL
-1
 and adding 1 mL of this solution to water (5 mL at 40°C) to 
give a final copolymer concentration in water of 1 mg mL
-1
.  Overnight the acetone 
was evaporated using a hotplate stirrer set to 40 C as this was warm enough to 
provide sufficient acetone evaporation yet would not allow excessive water 
evaporation; indeed no significant water loss occurred after samples were collected.  
After the samples were left to stand and adjust to room temperature, 1 mL was 
analysed using DLS.  Precipitation was not observed after approximately 1 hour of 
standing as observed with the linear nanoparticle samples (where the onset of 
precipitation occurred after several hours of standing) and no further purification was 
necessary to obtain good quality measurements.  Their analysis is shown in Figure 
4.6 where the three samples are displayed. 
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Figure 4.6: DLS measurements for the nanoparticles of p((HPMA50)-co-EGDMA0.95) 
(solid line),  p((HPMA80)-co-EGDMA0.95) (large dashed line) and p((HPMA120)-co-
EGDMA0.95) (small dashed line) prepared using rapid nanoprecipitation (starting 
copolymer concentration = 5 mg mL
-1
, final copolymer concentration = 1 mg mL
-1
). 
The same trend also appeared in this experiment, with the largest particles being 
formed from the copolymer with a primary chain length of 50 monomer units (146 
nm, 0.034 polydispersity) reducing to 72 nm for 80 monomer units and the smallest 
nanoparticles (68 nm) obtained using copolymers with 120 monomer units in the 
primary chain showing that the smallest particles are forming from the sample which 
has the longest primary chain (120 monomer units).  All traces are monomodal with 
extremely low polydispersities and did not precipitate after several hours of standing 
unlike their linear counterparts (this observation will be discussed later).  
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4.4.1 Adjustment of Branched Copolymer Concentration 
The use of a wt/vol % ratio to describe copolymer solution concentration during 
comparative nanoprecipitations of varying copolymer molecular weights or DPn, 
may not be strictly appropriate. Many literature reports of nanoprecipitation discuss 
nanoparticles formed from different polymers whilst keeping the wt/vol % constant 
and this appears to be the standard approach.
12
  Considering a sample of linear 
polymer chains with a DPn of 50 monomer units; there would be many more chains 
in the solution for any given polymer mass compared to samples where polymer 
chains have a DPn of 120 monomer units.   If a p(HPMA) polymer chain with 50 
monomer units has an Mn of approximately 7200 g mol
-1
 then there would be 
approximately 1.388 e
-4
 moles of chains in a 1 g sample whereas a chain with 120 
monomer units with an approximate Mn of 17300 g mol
-1
 would contain 
approximately 1.5780 e
-5
 moles in a 1 g sample.  To ensure an equal molar 
concentration of polymer chains, and allow a comparative molar nanoprecipitation, 
the initial masses would therefore need to be adjusted.  To account for this, the 
masses of the branched polymers in acetone were normalised to the ratio of DPn of 
the corresponding primary chains.  Two experiments were conducted, attempting to 
reflect the number of species in the solution, assuming the number of primary chains 
which form the branched copolymers was similar across the molecular weight 
distributions of different copolymers, and target primary chain length was achieved. 
This would lead to a normalised molar concentration of branched copolymer in each 
nanoprecipitation.  A p(HPMA) primary chain with a DPn of 80 monomer units 
(DP80) is 1.6 times longer than that of a DP50 chain and 0.666 times as long as a 
DP120 chain, therefore the concentrations of p((HPMA50)-co-EGDMA0.95) and 
p((HPMA120)-co-EGDMA0.95) in acetone were changed to 3.125 mg mL
-1
 and 7.5 
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mg mL
-1
, respectively and these were subsequently diluted (five-fold) into water to 
give final aqueous dispersions of 0.625 mg mL
-1
and 1.5 mg mL
-1
, respectively.  This 
adjustment led to a dramatic change in their nanoparticle z-average diameters and 
these are shown in Figure 4.7. 
 
Figure 4.7: DLS nanoparticle distributions with adjusted initial concentrations for 
primary chain lengths. p((HPMA50)-co-EGDMA0.95) (3.125 mg mL
-1 
starting 
concentration, 0.625 mg mL
-1
 final concentration) (short dashed line), p((HPMA80)-
co-EGDMA0.95) (5 mg mL
-1 
starting concentration, 1 mg mL
-1
 final concentration) 
(medium dashed line) and p((HPMA120)-co-EGDMA0.95) (7.5 mg mL
-1 
starting 
concentration, 1.5 mg mL
-1
 final concentration) (solid line). 
As with the previous experiments at consistent mg/mL ratios, all samples have 
extremely low polydispersities and this experiment provides a more intuitive order of 
increasing nanoparticle z-average diameters.  As expected, from a molar basis, 
copolymers with lower primary chain length produce smaller nanoparticles, 
completely opposite to the previous experiment which provided the smallest particles 
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from the longest primary chains (120 monomer units).  Yet this data fails to provide 
sufficient evidence that this assumption is valid and true.  Research into 
nanoprecipitation of copolymers usually reports wt/vol ratios of dissolved copolymer 
in solvent,
13,14,15
 and although no research into nanoparticle production using 
hydrophobic branched copolymers has been conducted to date, it was thought using 
this format would provide at least some comparison to the work already published in 
this area.  Therefore no further experiments using molar ratios of primary chain 
length of copolymers were conducted. 
 
4.4.2 Reproducibility and scale up of Nanoprecipitation using 
p((HPMA80)-co-EGDMA0.95)  
To demonstrate the reproducibility of the rapid nanoprecipitation of branched 
copolymers three separate experiments were conducted over a period of three 
months using p((HPMA80)-co-EGDMA0.95) to generate nanosuspensions using a 5 
mg mL
-1
 starting concentration of copolymer in acetone and leading to a final 
aqueous concentration of 1 mg mL
-1
.  The samples were all left overnight for acetone 
evaporation and were subsequently analysed using DLS where z-average diameter 
and polydispersity were recorded as an average of six measurements.  Their 
measurements are reported in Figure 4.8. 
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Figure 4.8: DLS measurements of rapidly precipitated nanoparticles comprising of 
p((HPMA80)-co-EGDMA0.95) (5 mg mL
-1
 starting concentration; 1 mg mL
-1
 final 
concentration)  prepared on three separate occasions. 
Figure 4.8 demonstrates high reproducibility of generating nanoparticle suspensions 
using rapid precipitation of p((HPMA80)-co-EGDMA0.95).  A difference of only 6 nm 
is shown between the z-average diameters of the three samples with polydispersities 
ranging from 0.051 to 0.114.   
All of the experiments thus far conducted have involved taking a 1 mL 
copolymer/acetone solution and diluting into 5 mL of distilled water.  This was 
deemed an adequate volume as DLS measurement requires 1 mL of the suspension.  
To investigate whether these nanoprecipitations could be scaled up and yield 
reproducible nanoparticles with consistent z-average diameters, a further experiment 
in which a 10 mL sample of p((HPMA80)-co-EGDMA0.95) (5 mg mL
-1
) was rapidly 
precipitated into warmed stirring water (50 mL) and left at 40 °C until the acetone 
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had evaporated.  The two suspensions were compared (z-average diameter and 
polydispersity) using DLS (Figure 4.9). 
 
Figure 4.9: DLS characterisation of nanoprecipitated p((HPMA80)-co-EGDMA0.95) 
using  5 mg mL
-1
 starting concentration; 1 mg mL
-1
 final concentration.  1 mL 
starting volume; 5 mL final volume (solid line), 10 mL starting volume; 50 mL final 
volume (dashed line). 
The two traces show almost identical traces confirming that indeed these 
precipitations can be performed on much larger scales, which may be useful for 
future nanoparticle applications.   
This section has shown that synthesis of nanoparticles comprised of branched 
material is reproducible, where three separate nanoprecipitations gave extremely 
similar z-average diameter data.  The scale up experiment where 50 mL of a 1 mg 
mL
-1
 nanoparticle suspension was generated is believed to be an unusually high 
volume of nanosuspension to be reported. 
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4.4.3 Control of Nanoparticle z-Average Diameter using Rapid 
Nanoprecipitation 
The trend towards the possible control of nanoparticle z-average diameter was 
observed in previous experiments where both the starting concentration of 
copolymer/acetone solution, and the dilution of the solution were varied 
independently; yielding differing nanoparticle z-average diameters.  To expand on 
these observations, branched copolymers were subjected to rapid precipitation; 
achieving a variety of target dispersion concentrations.  p((HPMA50)-co-
EGDMA0.95), p((HPMA80)-co-EGDMA0.95), and p((HPMA120)-co-EGDMA0.95) were 
dissolved in acetone at three different concentrations (wt/vol) (10, 5 and 1 mg mL
-1
) 
and subsequently individually precipitated into water at six different dilution ratios 
(1, 0.8, 0.4, 0.2, 0.05, 0.01).  Dilution ratios were calculated as Final Concentration/ 
Initial concentration, e.g. Final Concentration (4 mg mL
-1
)/ Initial concentration (5 
mg mL
-1
) gives a dilution ratio of 0.8.  These were selected as they represent a wide 
range of dilutions from zero to one hundred-fold, thus allowing a much more 
detailed insight into copolymer self-assembly during nanoprecipitation than 
previously reported, and would perhaps allow the limits of this process to be 
explored.  Table 4.1 shows the data obtained from these experiments and a number 
of trends are readily observed from this large data set.   
1.  For each branched copolymer, using a starting concentration of 10 mg mL-1 
generated the largest nanoparticles despite varying the dilution ratio and 
conversely the smallest particles are formed when initial copolymer 
concentration was at its lowest value (1 mg mL
-1
).   
Chapter 4 
176 
 
2. Increasing the dilution factor within each set of dilution ratios produced 
smaller nanoparticles. 
3. The lowest DPn values for primary copolymer chains generated the largest 
nanoparticles (already been noted in previous experiments). 
4. Polydispersity of copolymer nanoparticles decreased as dilution increased i.e. 
the particles with the lowest polydispersities were generally obtained when 
the largest dilution was applied.  
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Initial 
concentration 
(mg mL
-1
) 
Final 
concentration 
(mg mL
-1
) 
Dilution 
ratio 
Primary chain length of branched copolymer p((HPMAx)-co-EGDMA0.95 
HPMA DPn = 50 HPMA DPn = 80 HPMA DPn = 120 
Diameter 
(nm) 
Polydispersity 
Diameter 
(nm) 
Polydispersity 
Diameter 
(nm) 
Polydispersity 
10 10 1 786 0.435 564 0.326 273 0.116 
 8 0.8 432 0.070 322 0.152 157 0.074 
 4 0.4 200 0.030 161 0.051 88 0.080 
 2 0.2 203 0.024 85 0.061 92 0.096 
 0.5 0.05 175 0.006 80 0.057 58 0.079 
 0.1 0.01 177 0.008 82 0.096 92 0.051 
5 5 1 427 0.205 247 0.240 154 0.118 
 4 0.8 226 0.168 223 0.153 107 0.038 
 2 0.4 178 0.011 108 0.112 91 0.049 
 1 0.2 146 0.034 72 0.051 68 0.012 
 0.25 0.05 144 0.015 65 0.062 69 0.057 
 0.05 0.01 144 0.023 71 0.095 66 0.009 
1 1 1 273 0.115 181 0.055 150 0.037 
 0.8 0.8 178 0.012 146 0.034 129 0.250 
 0.4 0.4 180 0.009 88 0.084 108 0.053 
 0.2 0.2 145 0.020 62 0.110 65 0.069 
 0.05 0.05 144 0.014 59 0.139 69 0.111 
 0.01 0.01 146 0.008 121 0.253 73 0.049 
 
Table 4.1: Formation of branched copolymer nanoparticles generated using rapid nanoprecipitation from acetone. 
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This large data set provides an indication that branched copolymer nanoparticles 
comprising hydrophobic p(HPMA) can indeed be generated and moreover, the 
particle diameter can be tuned simply be altering the copolymer concentration in 
solution prior to nanoprecipitation and the range of dilutions involved in the 
nanoprecipitation process.  Here we have produced particles with remarkably 
different z-average diameters from approximately 60 nm to 800 nm using the same 
simple rapid nanoprecipitation method and only three copolymers. 
Figure 4.10 (A) shows z-average diameters of p((HPMA50)-co-EGDMA0.95) 
nanoparticles using various starting concentrations in acetone (10 mg mL
-1
, 5 mg 
mL
-1
 and 1 mg mL
-1
) where dilution ratio is varied; indicating the largest particles 
are formed using starting concentrations of 10 mg mL
-1
 and 5 mg mL
-1
 and dilution 
ratios of 1 and 0.8.  This same trend is found for p((HPMA80)-co-EGDMA0.95) and 
p((HPMA120)-co-EGDMA0.95) (see Appendix 4.2 and 4.3 respectfully).  Individual 
DLS chromatograms are found in Appendix 4.4. 
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Figure 4.10: Z-average diameters of nanoparticles prepared using rapid 
nanoprecipitation from acetone. (A)  Control of particle z-average diameter by 
varying initial copolymer concentration in acetone for p((HPMA50)-co-EGDMA0.95). 
(B)  DLS characterisation of nanoprecipitated p((HPMAx)-co-EGDMA0.95).  
Demonstrating control of nanoparticle z-average diameter by varying primary chain 
length.  DPn =50 (circles), 80 (triangles), 120 (squares). 
 
By utilising Scanning Electron Microscopy (SEM), it is possible to obtain images of 
these particles and Figure 4.11 shows the dispersions of particles formed using 
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p((HPMA80)-co-EGDMA0.95) with an initial concentration of 5 mg mL
-1
, leading to 
final concentrations of 5 mg mL
-1
, 2 mg mL
-1 
and 1 mg mL
-1
 (see Chapter 2 section 
2.2.4).   In the DLS measurements, polydispersity decreased dramatically upon 
increasing the dilution and this correlates well with SEM images.  
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Figure 4.11: Scanning electron microscopy images of nanoprecipitated p((HPMA80)-
co-EGDMA0.95) and histogram distributions derived from the analysis of 250 
individual nanoparticles.  Variation of dilution from an initial concentration of 5 mg 
mL
-1
 in acetone to give final concentrations of; 1 mg mL
-1
 (A and D) (mean 77 nm, 
sd 13.8 nm), 2 mg mL
-1
 (B and E) (mean 75 nm, sd 26.2 nm) and 5 mg mL
-1
 (C and 
F) ( mean 173 nm, sd 83.8 nm). 
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As the dilution increases, it is clearly visible from the SEM images that 
polydispersity decreases. This is supported by direct measurement of nanoparticles 
from the SEM images (n = 250 in each analysis) generating histograms where it is 
clear that monodispersity increases with decreasing dilution factor (i.e. higher 
dilution).  Along with polydispersity, the images show how nanoparticle z-average 
diameter differs upon changing dilution factor, with the smallest being formed when 
the highest dilution is employed; conversely at the lowest dilution (Figure 4.11 (C)) 
the largest particles are clearly visible.  Although the individual particle structure is 
not visible, all particles appear to be homogenous in composition, which is similar to 
a previous report of the nanoprecipitation of linear polymers.
16 
 Figure 4.12 shows 
further SEM images of copolymer nanoparticles, these images were expanded to 
show a larger surface area conveying the homogenous nature of nanoparticles. 
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Figure 4.12: Further scanning electron microscopy images of nanosuspensions comprising of p(HPMA80)-co-EGDMA0.95) with 
variation of dilution from an initial concentration of 5 mg mL
-1
 in acetone to give final concentrations of; 1 mg mL
-1
 (A), 2 mg mL
-1
 (B) 
and 5 mg mL
-1
 (C). 
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4.4.4 Proposed Mechanism of Nanoparticle Formation  
Due to the large range of nanoparticle z-average diameters generated by simply 
changing the initial copolymer/acetone concentration it is proposed that a nucleation 
and growth mechanism occurs during precipitation.  Simple collapsing of single 
branched copolymer chains to form single-chain nanoparticles is discounted, as it has 
been shown that although a large proportion of the branched copolymer samples 
have extremely high molecular weights composed of multiple chains, the 
polydispersity of branched copolymers is so large that a significant amount of lower 
molecular weight and also linear material present.  If these were to individually 
collapse as precipitation occurs the resulting particles would be expected to have a 
wide range of z-average diameters.  Indeed, it has already been shown that linear 
polymer samples are not stable and precipitate out of solution and as this does not 
occur in the branched copolymer samples (which contain linear material).   
If the collapsing of a mixture of individual multiply-branched and linear chains 
occurred it would be expected that some precipitation would ensue, which is not the 
case here.  Supporting the nucleation and growth concept is the DLS characterisation 
of branched copolymers dissolved in acetone.  Three branched copolymers, 
p((HPMA50)-co-EGDMA0.95), p((HPMA80)-co-EGDMA0.95) and p((HPMA120)-co-
EGDMA0.95) were dissolved in acetone at 10 mg mL
-1
 overnight and subsequently 
analysed by DLS (Shown in Figure 4.13). 
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Figure 4.13: DLS characterisation of branched copolymers in acetone at 10 mg mL
-1
.  
p((HPMA50)-co-EGDMA0.95) (solid line), p((HPMA80)-co-EGDMA0.95) (medium 
dashed line), p((HPMA120)-co-EGDMA0.95) (small dashed line). 
 
Copolymer 
Peak 1 
Diameter 
(nm) 
Peak 2 
Diameter 
(nm) 
Peak 3 
Diameter 
(nm) 
Polydispersity Attenuator 
Derived 
Count 
Rate 
(kcps) 
 p((HPMA50)-
co-
EGDMA0.95) 
10 38 - 0.245 9 19664.5 
p((HPMA80)-
co-
EGDMA0.95) 
9 45 - 0.263 8 16636.1 
p((HPMA120)-
co-
EGDMA0.95) 
11 40 226 0.46 7 16123.4 
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Table 4.2: Data from the measurement of branched p(HPMA) copolymers in acetone 
at 10 mg mL
-1
. 
 
All three traces are multi modal showing that at least two distinct species are present, 
with a definitive peak at around 10 nm (peak 1) which is assigned to single solvated 
linear polymer chains.  Alongside this are peaks with sizes ranging from 38 nm to 45 
nm and, in the case of p(HPMA120)-co-EGDMA0.95), a third peak with a size of 226 
nm.  This data may suggest single linear polymer chains (peak 1) and branched 
copolymer chains (peak 2 and peak 3) and/or possible aggregation in the solution or 
multiple scattering. It should also be noted from Table 4.2 that the attenuator is very 
high in all of these experiments (7 to 9) and indicates very low scattering, consistent 
with solubilised copolymer with very little refractive index difference.  The data here 
shows that it is very unlikely that subsequent nanoparticles consist of single polymer 
chains.   
Scheme 4.5 demonstrates the proposed processes involved during the 
nanoprecipitation of branched copolymers.  Initially, it is thought each copolymer 
within the large volume of copolymer/acetone begins to collapse as the acetone/ 
water gradient rapidly changes.  This continues as copolymers enter into a water rich 
environment until a critical point where aggregation of these collapsed chains occurs.  
At this point the collapsed copolymers associate until a size that is commensurate 
with colloidal stability is reached and are, thereafter, able to remain dispersed 
without further aggregation and subsequent precipitation.  The rationale of this 
behaviour is consistent with other reports of nanoprecipitation.
17, 18, 19 
The data 
suggest that the smaller nanoparticles form when the initial copolymer/acetone 
concentration is low and contains fewer collapsed branched copolymers.  
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Conversely, higher initial concentration results in larger particles containing more 
copolymers per particle.  Their higher polydispersities are attributed to the loss of 
control when collapsed branched copolymers aggregate as the copolymers are in a 
much closer proximity as the acetone/water gradient shifts resulting in some particles 
containing many more copolymer chains, yet in our studies they do not reach sizes 
which are large enough to result in their sedimentation.    
 
Scheme 4.5:  Proposed mechanism of the nanoprecipitation process using the rapid 
precipitation method from acetone. 
 
4.4.5 Aqueous Stability of p((HPMA80)-co-EGDMA0.95) 
As discussed previously, it is strongly believed that particles are formed by 
aggregation of smaller components as z-average diameters have been shown to vary 
substantially.  As such, it was investigated whether dilution would lead to 
disassembly as would be expected if the particles have a critical aggregation 
concentration.  To identify how stable these nanoparticles are, it was decided to 
serially dilute a suspension and monitor any change in z-average diameter and 
polydispersity to determine at what point these systems cease to behave as 
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nanoparticles.  This experiment aims to identify an aggregation concentration to 
discover if these particles are reversibly aggregated like colloidal particles.   
For the aqueous dilution experiment, p((HPMA80)-co-EGDMA0.95) was rapidly 
nanoprecipitated into water from a starting concentration of 5 mg mL
-1
 to give a final 
concentration of 1 mg mL
-1
.  1 mL of this sample was analysed by DLS giving a z-
average diameter and polydispersity which were extremely similar to previous data 
(74.5 nm, 0.05 polydispersity).  This was then diluted to give a concentration of 0.5 
mg mL
-1
 and then again diluted serially to give a final concentration of 0.0078 mg 
mL
-1
.  
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Figure 4.13: Serial dilution data for the nanoparticles comprised of p((HPMA80)-co-
EGDMA0.95) with a starting and finishing concentration of 5 and 1 mg mL
-1
, 
respectively.  A) Nanoparticle diameter and polydispersity vs. Concentration of 
suspension.  B)  Derived count rate and Attenuator vs. Concentration of suspension. 
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Figure 4.13 (A) shows that these particles are stable to dilution in respect to particle 
diameter and also polydispersity as subjecting these to a two hundred and fifty-fold 
dilution led to almost no difference in either of these measurements, suggesting these 
are highly stable materials.  Throughout the experiment the DLS detector also 
recorded attenuator levels and the derived count rate (shown in Figure 4.13 (B)).  
The former is indicative of the concentration of the overall solution whereby the 
attenuator must increase as solutions become more dilute in order to achieve reliable 
analysis measurements.  This data shows that indeed the solution is becoming more 
dilute.   Apart from z-average diameter and polydispersity measurements, the DLS 
detector also records a derived count rate during each measurement.  This figure is 
indicative of the number of particles present in the suspension and is directly related 
when the attenuator is set at a single value, unsurprisingly this figure drops 
dramatically and almost linearly as the sample is serially diluted; this suggests that 
besides becoming diluted, these particles are not dissociating.  If dissociation was 
occurring, the derived count rate would be expected to increase as the number of 
species present would have increased on break up of any aggregated nanoparticles.  
From this experiment it is clear highly stable materials (with respect to aqueous 
dilution) have been synthesised and further dilutions were abandoned due to the 
attenuator reaching > 9 where measurements become unreliable as the machine is 
unable to analyse the highly dilute sample. 
 
4.4.6 Solvent Stability of p((HPMA80)-co-EGDMA0.95) 
As well as aqueous stability, investigation into particle stability with increasing 
volumes of organic solvent was also explored.  Adding solvent to the particles 
should ultimately lead to particle dissolution to give similar DLS measurements as 
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when they are dissolved in acetone alone.  Due to the fact that these copolymers are 
soluble in a range of solvents, it was expected that the particles would become more 
solubilised as the ratio of solvent in the aqueous sample increased.  It was thought 
that perhaps the reverse of the actual precipitation process could occur, where the 
gradual switching of solvent would initially swell the particles and lead to 
dissociation of the branched copolymers in the particles into individual branched 
copolymer chains.  Acetone was used in preparation of the particles but due to its 
high volatility, experimentally adding small aliquots over an extended period of time 
would undoubtedly lead to inaccurate results as significant evaporation would occur 
despite using a lid on the sizing cuvette.  Therefore methanol was chosen as this is 
also a good solvent for p(HPMA), indeed it was used in the synthesis of these 
copolymers and minimal evaporation would be expected to occur during DLS 
analysis.  In this experiment a 1 mL sample of a 1mg mL
-1 
nanoparticle suspension 
comprised of p((HPMA80)-co-EGDMA0.95) prepared by rapid precipitation was 
diluted with methanol over time until 910 µL had been added.  When an aliquot of 
methanol was added, the glass sizing cuvette was manually swirled gently prior to 
sizing to attempt to evenly distribute the methanol (see Chapter 2 section 2.5.2.3).  It 
should also be noted that the sample remains in the DLS machine for approximately 
4-5 minutes while sizing measurements are taking place and giving sufficient time 
for the sample to equilibrate.   
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Figure 4.14: Studies into the response of methanol addition to nanoprecipitated 
p((HPMA80)-co-EGDMA0.95) (5 mg mL
-1
 initial concentration; 1 mg mL
-1
 final 
aqueous concentration.  (A) Z-average diameters and polydispersity. (B) Derived 
count rate and Attenuator both measured using DLS. 
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As can be seen in Figure 4.14 (A), the branched copolymer nanoparticles continually 
increase in z-average diameter with addition of methanol from approximately 80 nm 
to 185 nm where 910 µL has been added to the 1 mL sample.  The particles 
increased almost linearly for the first 250 µL of methanol after which the gradient 
decreased whilst a further 120 µL was added followed by an increase until the last 
measurement was recorded.  Accompanying this data, polydispersity, although 
remaining low throughout the experiment did fluctuate until around 370 µL had been 
added after this it remained almost constant until the end of the experiment.  This 
data may suggest these particles are uniformly swelling (increase in z-average 
diameter, low polydispersity) followed by reorganisation of the particles due to 
methanol uptake (plateau in z-average diameter) and finally uniform swelling until 
910 µL has been added.  Supporting this theory is the plot of derived count rate and 
attenuator seen in Figure 4.41 (B).  Similar to the aqueous dilution of p((HPMA80)-
co-EGDMA0.95) nanoparticles, the derived count rate decreased throughout the 
experiment suggesting that the amount of scattering is reducing as dilution occurs, 
and this is directly proportional to the concentration as long as the attenuator is 
constant and although it is not the case here, where the appropriate attenuator is 
automatically determined by the Zetasizer instrument, it supports the theory that 
particles are not dissociating with increasing dilution.  It is shown that the attenuator 
increases during this experiment as the intensity of the scattered light from particles 
must be within a range for the detector to measure. The intensity would also be 
expected to decrease as the particles swell and affect the density with a change in 
refractive index, however, a larger particle would be expected to provide higher 
scattering. When samples do not scatter much light, as may be the case with low 
concentrations and/or when very small particles are present, the attenuator will 
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automatically allow more laser light into the sample and therefore the attenuator 
figure will increase, which is found on the recorded data.   Taking into account all of 
the data shown in Figure 4.14, it is strongly suggestive that particles are swelling due 
to the uptake of methanol, without dissociating.  Both organic and aqueous dilution 
of nanoparticles demonstrates their robustness and further dilution analysis was only 
limited due to experimental techniques. 
Chapter 4 
195 
 
 
 
 
Scheme 4.6: Representation of nanoparticle swelling during methanol addition where both small and large particles are taken into 
account. 
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4.4.7 Long-term Stability of Nanoparticles (p((HPMA80)-co-
EGDMA0.95) 
Branched copolymer nanoparticles remained stable on standing at room temperature 
for several days assessed by no noticeable precipitate forming in sample vials.  In 
order scale up to investigate long term stability, p((HPMA80)-co-EGDMA0.95) 
nanoprecipitates prepared by rapid precipitation from a starting concentration of 5 
mg mL
-1
 to final concentrations of 5 mg mL
-1
, 4 mg mL
-1
, 2 mg mL
-1
, 1 mg mL
-1 
and 
0.25  mg mL
-1
 were analysed after one day and seven months.   
 
Figure 4.15: Z-average diameter and polydispersity measurements of nanoparticles 
comprised of p((HPMA80)-co-EGDMA0.95) using a starting concentration of 5 mg 
mL
-1
 and varying the dilution ratio from 1 to 0.05  Solid symbols indicate 
measurements after one day, open symbols indicate measurements after seven 
months. 
The z-average diameters of nanoparticle suspensions comprising p((HPMA80)-co-
EGDMA0.95) after seven months were in good agreement with their counterparts 
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which were analysed after one day, as shown in Figure 4.15.  Polydispersity had 
increased slightly within each dilution ratio, however, the z-average diameters of 
these materials were almost unchanged with the majority only increasing slightly.  
These data show the nanoparticles are extremely stable over extended periods of 
time with varying nanoparticle concentration.  Linear counterparts to these samples 
showed onset of precipitation after several hours with significant precipitation after 2 
weeks and were therefore unable to be assessed in this way.  The dramatic difference 
in the appearance of stored samples of linear and branched nanoparticles, with 
decreasing dilution ratio (starting at 5 mg mL
-1
), is shown in Figure 4.16. 
 
Figure 4.16: Comparison of nanoprecipitated p(HPMA) from an initial concentration 
of 5 mg mL
—1
 in acetone to give varying final aqueous dispersions from 5 mg mL
-1
 
(far left), 4 mg mL
-1
, 2 mg mL
-1
, 1 mg mL
-1
, 0.25 mg mL
-1
 (far right). (A) p(HPMA-
80-co-EGDMA0.95) branched copolymer seven months after nanoprecipitation; (B) 
p(HPMA80) linear polymer two weeks after nanoprecipitation. 
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The change in transparency from high to low dilution ratio within Figure 4.16 is also 
evident where samples of 5 mg mL
-1
 are completely opaque and upon decreasing the 
dilution ratio, they become more transparent.  This is expected due to the mass of 
copolymer present in the far left samples scattering much more light, and as the 
sample becomes more dilute, scattering reduces. 
4.4.8 Thermal Stability of Nanoparticles prepared from p((HPMA80)-co-
EGDMA0.95) 
To investigate their stability further, suspensions of nanoparticles comprised of 
p((HPMA80)-co-EGDMA0.95) were subjected to a gradual temperature increase to 
investigate whether changes in this parameter has any effect on their properties in 
solution.    
In this experiment the aqueous dispersion was heated from 25 °C to 78 °C using 
settings within the DLS instrument; as with previous sizing measurements the 
recorded data is an average taken from six measurements.  As can be seen in Figure 
4.17, increasing the temperature has no effect on the z-average diameter or the 
polydispersity of the particles as they remained constant throughout the temperature 
range.  This small and simple experiment demonstrates the particles stability and 
their ability to withstand temperature changes.   
 
 
Chapter 4 
199 
 
 
Figure 4.17: Temperature studies on nanoprecipitated p((HPMA80)-co-EGDMA0.95) 
prepared by rapid precipitation (5 mg mL starting concentration; 1 mg mL final 
concentration). z-average diameter (circles) and polydispersity (triangles). 
 
4.4.9 Sonication Stability of nanoprecipitates prepared from 
p((HPMA80)-co-EGDMA0.95) 
Prior investigations into the stability of our branched copolymer nanoparticles 
showed they are extremely robust.  In an attempt to fully dissociate the particles, 
introducing extreme external force was necessary in order to give better insight into 
how these particles are remaining stable for such extended periods of time.  Using 
ultrasound waves in this manner has not been widely researched; to our knowledge 
only three reports in the literature has investigated how sound waves impart force 
and fragment polymeric nanomaterials.  One report refers to shell crosslinked 
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micelles where no z-average diameter change is apparent after 20 minutes of 
sonication (40 W) unlike their un-crosslinked counterparts which begin to fragment 
after just 1 minute.
20
 Another report shows that the weight average length of 
sonicated micelles decreases as a function of sonication time
21 
and the final 
publication reports the splitting of polymeric aggregates into monodisperse 
micelles.
22
 The literature therefore suggests that materials reduce in z-average 
diameter as a consequence of sonication and due to the high stresses causing 
fragmentation.   
Prior to carrying out this experiment, four possible outcomes were considered: 
1. Significant cleavage of the nanoparticles resulting in significantly sized 
nanoparticles (e.g. half or a quarter of the original nanoparticle) present in 
solution.  Fragments of the nanoparticles would be suspended in water, 
possibly in the size range of 10-50 nm, and would be detectable in DLS 
characterisation.  This would also cause the attenuator to decrease as the 
overall concentration of particles would increase along with the derived count 
rate increasing due to increased scattering.   
2. Peripheral fragmentation of the nanoparticles, with very small particles 
becoming more significant as sonication time increases.  This would cause an 
increase in the derived count rate as scattering increases yet may not affect 
the attenuator as only very small polymer fractions would fragment with time 
and therefore the scattering may not increase significantly.  The measured z-
average diameter may remain very similar, but a decrease would be expected 
as sonication time increases, leading to a larger overall copolymer fragment 
population.  Significant scattering from very small fragments may not be 
detectable by DLS depending on the size of the fragments formed. 
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3. Nanoparticle fragmentation (significant cleavage or small fragments) forming 
unstable materials with subsequent aggregation of material leading to 
precipitation.  Material that has become dissociated from the nanoparticles 
may aggregate due to their hydrophobic nature, causing them to precipitate 
out of solution.  This would be visually observable in the sample vial and 
associated with subsequent increasing attenuator values to counteract the 
lessening scattering intensity due to less dispersed material.  DLS 
measurements assume particles are spherical and the average size of particles 
may be unaffected until a significant proportion of material has been 
fragmented, after which the z-average diameter of nanoparticles would 
reduce.  
4. Single collapsed branched copolymers, which dissociate from particles into 
the surrounding solution.  This is proposed as the literature suggests 
aggregated materials which are not covalently bound to each other, can 
dissociate into their single components.
22
  It has been suggested nanoparticles 
are composed of multiple branched copolymers, and if sonication causes 
these to become single entities, a dramatic reduction in the z-average 
diameter of particles would occur as sonication increases, assuming these 
single branched copolymers are stable in aqueous solution.  As the 
concentration of material present would increase, as stated previously, this 
causes more scattering, causing the derived count rate to increase and the 
attenuator to lower.  
A preliminary sonication experiment was conducted due to the lack of literature 
reports describing the sonication of copolymer aggregates without a probe. It was 
believed that the high intensity could immediately fragment the particles without 
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being able to monitor the process effectively; therefore a duty cycle of 100 and 50 % 
intensity was selected as the treatment parameters on the sonicator software.  A 
nanosuspension comprising of p((HPMA80)-co-EGDMA0.95) (5 mg mL
-1
 starting 
concentration; 1 mg mL
-1
 final concentration) was subjected to sonication using 
focused ultrasound waves in a water-bath with a controlled temperature of 10 °C for 
5 seconds, where the sample was promptly resized.  As no significant changes to the 
DLS size distribution occurred, the same sample was transferred back into the water-
bath and sonicated for a further 60 seconds and, again, no significant change in z-
average diameter was apparent, however, a slight trend to larger z-average and 
increased polydispersity was seen. This process was repeated once more where the 
sample remained in the sonicator for further 300 seconds, giving a total sonication 
time of 365 seconds, after which the appearance of the sample was visually 
unchanged. For full experimental protocol, see Chapter 2 section 2.5.2.1. 
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Figure 4.18: DLS characterisation of sonicated p((HPMA80)-co-EGDMA0.95) 
nanosuspension prepared by rapid precipitation (5 mg mL
-1
 starting concentration; 1 
mg mL
-1
 final concentration) using 50 % intensity over 365 seconds. 
Figure 4.18 shows clearly that fragmentation leading to smaller nanoparticles has not 
occurred as major decreases in the z-average diameter (with increasing 
polydispersity) would have been seen compared to the unsonicated trace.  After 365 
seconds the z-average diameter of particles increased by only 28 nm and 
polydispersity increased from 0.057 to 0.182.  Surprisingly this preliminary 
experiment suggests these materials are highly stable when subjected to sonication.  
It was thought this sample may not fragment sufficiently using only 50 % intensity 
or it may have taken an extended period of exposure.  Therefore a new sample of  
p((HPMA80)-co-EGDMA0.95) was prepared (identical nanoprecipitation protocol) 
and sonicated using 100 % intensity as it was thought monitoring of the sonication 
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process would allow a better insight to the stability of the suspension over a series of 
shorter exposure times.  
The 1 mg mL
-1
 sample was first analysed and then subsequently transferred into the 
Covaris S2x and sonicated for 5 seconds using 100 % intensity and a duty cycle of 
100 and then promptly re-analysed.  This process was repeated until the sample had 
been sonicated for approximately 4 minutes.  The DLS measurements during this 
process are reported in Figure 4.19 over the course of the experiment. 
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Figure 4.19: Sonication studies of nanoprecipitated p((HPMA80)-co-EGDMA0.95) 
aqueous suspension. (5 mg mL
-1
 initial concentration; 1 mg mL
-1
 final 
concentration). (A) Z-average diameter and polydispersity vs. sonication time. (B) 
DLS characterisation of particles at various sonication times.  Time = 0 seconds 
(solid line) 5 seconds (medium dashed line), 225 seconds (small dashed line). 
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According to data shown in Figure 4.19 (A) the nanoparticles do not completely 
dissociate when exposed to sonication.  Indeed they increase in diameter from 72 nm 
to 111nm.  The first three sonication exposures (15 seconds total sonication) showed 
little effect on the nanosuspension but after a total sonication time of 115 seconds the 
particles had reached 98 nm which is approximately a 50 % increase in particle 
diameter.  Further sonication (total time from 115 seconds to 225 seconds) led to 
only a moderate increase in z-average diameter of particles (98 nm) to give a final 
diameter of 111 nm. Polydispersity of the nanoparticles increased from 0.078 to 
0.198. DLS measurements for three sonication times were selected (time = 0 
seconds, 5 seconds and 225 seconds) and are shown in Figure 4.19 (B) which also 
displays both z-average diameter and polydispersity increase with sonication.  
As well as z-average diameter and polydispersity, the derived count rate was also 
recorded during the experiment and is shown in Figure 4.20. As explained 
previously, this is directly related to the amount of scattering of the nanosuspension 
and can be a measure of nanoparticle concentration at constant attenuator values. 
The attenuator remained (automatically) at a value of 5 throughout the experiment, 
indicating that the instrument did not require adjustment.  
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Figure 4.20: Sonication studies of nanoprecipitated p((HPMA80)-co-EGDMA0.95) 
aqueous suspension. (5 mg mL
-1
 initial concentration; 1 mg mL
-1
 final 
concentration).  Derived count rate against total sonication time. 
 
4.4.9.1 Rationale of stability during sonication 
Analysis of the experimental data has shown that none of the expected behaviour 
occurred.  Significant cleavage of copolymer from nanoparticles was discounted as 
the z-average diameter of particles increased throughout the experiment.  If major 
cleavage had occurred, the attenuator would automatically be lowered in order to 
reduce the amount of scattered light reaching the detector.  The attenuator remained 
constant (automatically) throughout the experiment, showing that the scattering has 
not increased considerably and indicating concentration of material present did not 
change significantly and the derived count rate increased but not over a large range. 
Large scale cleavage was therefore thought to be minimal.  
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If the particles within the sample remained substantially intact as imagined, the 
derived count rate would be extremely similar throughout the experiment.  Yet it is 
seen to gradually increase from 225996 kcps to 318857 kcps (Figure 4.20), 
suggesting only a slight increase in scattering is occurring as sonication time 
increases; the range over which this change is occurring is relatively small and the 
same order of magnitude of scattering is seen throughout the sonication treatment. 
The data presented suggests two possible scenarios: 
1) Fragmentation of peripheral copolymer units, which associate/aggregate onto 
nearby nanoparticles.  This may occur as the small fragments would not be large 
enough to sediment but are also not stable enough to exist within the solution.  
Initially no significant z-average diameter change is apparent when these small 
fragments are transferring to other particles as the DLS measurements assume 
particles are perfect spheres and a small addition to a larger nanoparticle would be 
within the error of the measurement. Yet over time as more fragmentation occurs, a 
larger z-average diameter and polydispersity will ensue, due to some particles 
(perhaps the smallest) fragmenting more, and therefore the larger particles gain more 
copolymer fragments causing an increase in their z-average diameter.  The derived 
count rate is thought to increase due to the larger particles now present in the 
solution scattering slightly more light. 
2) Reordering of the internal nanoparticle structure.  Sound waves penetrating the 
nanoparticles may cause motion within the individual components of the 
nanoparticles resulting in less dense nanoparticles after a rearrangement of the 
packing but without fragmentation of the nanoparticle.  This was proposed due to the 
steady increase in the diameter of particles as sonication time increases, yet with 
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relatively small change in polydispersity.  The increased derived count rate may, 
again, be due to the larger size of the particles and hence more scattering.   
It is not clear which process is occurring within the nanoparticles during sonication, 
however, the materials appear to be highly robust with the ability to withstand 
extremely high and lengthy sonication. 
 
4.4.10 Determination of Charge Stabilisation of Nanoparticles  
Nanoparticles comprised of branched copolymers have been shown to be highly 
stable i.e. little change in z-average diameter or polydispersity over time.  The 
reasons for this could be either steric repulsion, electrostatic repulsion or a 
combination of both.  To investigate whether these particles have surface charge, 
nanoparticle suspensions were prepared by rapid nanoprecipitation (p((HPMAx)-co-
EGDMA0.95)) (x = 50, 80, 120) (5 mg mL
-1
 starting concentration; 1 mg mL
-1
; final 
concentration) and zeta potential measurements were performed.  Experimental 
procedure is found in Chapter 2 section 2.2.3.1. 
Copolymer 
Zeta Potential 
(mV)
 
  
p((HPMA50)-co-EGDMA0.95) -41.1 
p((HPMA80)-co-EGDMA0.95) 
p((HPMA120)-co-EGDMA0.95) 
-34.0 
-44.5 
Table 4.3: Zeta Potential results for nanoparticles comprised of p((HPMAx)-co-
EGDMA0.95) (x = 50, 80, 120) prepared by rapid nanoprecipitation (5 mg mL
-1
 
starting concentration; 1 mg mL
-1
; final concentration). 
 
Table 4.3 shows that nanoparticles are negatively charged (irrespective of p(HPMA) 
primary chain length) with no clear trend between samples, suggesting that stability 
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of suspensions arises from electrostatic repulsion.  The exact reasons for negative 
surface charges is unknown but may be due to slightly negatively charged hydroxyl 
groups present in p(HPMA) chains.  Hydrolysis of p(HPMA) chains (producing 
methacrylic acid) may also be a possible reason, however, this has not been 
investigated. 
 
4.4.11 Branched Copolymer Nanoparticle Stability to Salt Addition   
The effect of electrolyte addition to nanoparticles was studied due to the observed 
negative zeta-potential in previous experiments suggesting charge stabilisation as the 
likely mechanism for colloidal stability. Salt addition should lead to de-stabilisation 
through the screening of negative electrostatic repulsion between the nanoparticles. 
A sample of p((HPMA80)-co-EGDMA0.95) was nanoprecipitated, as previously 
described, and subjected to successive additions of small aliquots (2 µL) of aqueous 
NaCl (0.5M); achieving a total addition of 16 µL.  After each addition the sample 
cuvette was gently shaken to distribute the electrolyte throughout the solution (see 
Chapter 2 section 2.5.2.4.  Prompt analysis was performed afterwards and the 
recorded data are displayed in Figure 4.21.       
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Figure 4.21: DLS characterisation of nanoprecipitated p((HPMA80)-co-EGDMA0.95) 
5 mg mL
-1
starting concentration; 1 mg mL
-1
 final concentration.  Response to 
electrolyte (0.5M NaCl) addition. (A) Z-average diameter (solid circles), 
Polydispersity (open circles) (B) Attenuator (solid triangles), Derived count rate 
(open triangles). 
It is clear that small amounts of NaCl impart a great effect on z-average diameter, 
polydispersity and derived count rate.  The z-average diameter increased slowly 
(from 75 nm) until 12 µL had been added (572 nm), after which the z-average 
diameter increased dramatically with observable precipitation. Measurements by 
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DLS of nanoparticles > 1000 nm are unreliable, however, the very high 
polydispersity (approximately 0.5) and nanoparticle diameter, is highly indicative of 
the response to the electrolyte.  The initial additions of salt led to increasing 
polydispersity, with large amounts of precipitate forming in the sample vial. As the 
attenuator value remained constant throughout the majority of the experiment we can 
infer that the derived count rate is responding to the decrease in the concentration of 
nanoparticles (through association and precipitation) even though a subsequent 
increase in scattering would be expected from the larger materials. 
 
4.4.12 Rationale of Nanoparticle Stability  
Clearly the dramatic architectural difference between linear and branched 
p((HPMA)-co-EGDMA0.95) copolymers is the reason behind the aqueous stability of 
branched copolymer nanoparticles.   Despite their predominantly identical chemistry, 
copolymers formed from multiple linear chains (branched) have produced stable 
nanosuspensions for more than seven months where as their linear counterparts 
aggregated and precipitated after only several hours.  It is possible that these 
copolymers exert some affinity for their aqueous environment, despite p(HPMA) 
being highly insoluble in water.  The development of branching in the 
copolymerisation of p(HPMA) was studied in more detail in an attempt to rationalise 
the different behaviour observed in nanoparticle stability. 
Initially, the synthesis of branched vinyl polymers was considered to establish 
whether common features of the mechanism would lead to architectural similarities 
between polymers with different target primary chain lengths. The branched 
copolymerisation will undergo three clear phases during the propagation of 
p(HPMA) and the growth of branched copolymers. 
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Scheme 4.7: Schematic representation of the development of branching during 
ATRP copolymerisation.  Phase I oligomer formation), Phase II (initial inter-chain 
reaction), Phase III(intermolecular branching at high conversion) – chain-end 
oligomers formed at low conversion (i), high conversion (ii) and long chain end 
groups (iii and iv). 
 Scheme 4.7 shows the proposed stages during the branching copolymerisation Phase 
1 involves statistical incorporation of EGDMA (with an un-reacted pendant vinyl 
group) into a primary chain before branching becomes significant.  Therefore a 
proportion of the EGDMA will become incorporated at an early stage (low 
conversion) when small oligomers predominate within the reaction.  This generates a 
small oligomeric chain preceding the branching point shown as (i) in Scheme 4.7.  
Conversely those chains where EGDMA is initially incorporated at a later stage 
(higher conversion) will produce longer pendant chains after significant branching 
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has occurred, indicated as (iii) in Scheme 4.7.  In Chapter 3 section 3.3.1 it was 
shown that at high conversion, inter-chain branching predominates rather than linear 
chain growth, indicated by the dramatic increase in molecular weight at high 
conversion.  Scheme 4.7 (ii) represents chain ends formed when an active chain end 
reacts with a pendant double bond within an environment of low monomer content 
and produces short oligomeric chains after the introduction of the branch point.  As 
conversion approaches 100 %, small chain ends are guaranteed to form.  Small chain 
ends containing approximately 10 monomer units (or less) should form after branch 
points which have been generated above 80 % conversion where the target DPn of 
the primary chain is 50 monomer units (i.e. only 10 monomer units are left to add to 
the propagating chains).  Similarly for this example, inter-chain branching at 90 % 
conversion would generate small chain ends comprising of five monomer units or 
less.  Therefore during Phase III extremely high molecular weight material is 
generated as linear copolymer chains become covalently bonded, but as a 
consequence of this, short oligomeric chain ends are also formed.  However, as 
previously mentioned, not all chain ends will be oligomeric. 
4.5 Synthesis of Oligomeric p(HPMA) 
In simulation studies of linear, star and branched copolymers, specifically to 
understand solubility,
23
 chain ends have been shown to be highly mobile and able to 
interact with solvent environments to a far greater extent than other areas of the 
polymer chains.  In lightly branched structures, considerable immobility of chains is 
noticed over considerable timescales; therefore the chain ends described above may 
have a considerable impact on the behaviour of the branched copolymers.  HPMA is 
a water soluble monomer, however, as molecular weight increases during its 
polymerisation it rapidly becomes insoluble.  To our knowledge there are no reports 
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in the literature which have systematically investigated onset of insolubility (or 
molecular weight) of HPMA during polymerisation.  As a result, a series of 
oligomers with target DPn = 5, 7, 10, 13, 15 and 17 monomer units were synthesised 
using the same experimental protocol as described for previously synthesised linear 
p(HPMA) materials in order to investigate the aqueous solubility of p(HPMA) 
oligomers (see Chapter 2 section 2.3.1). 
Target 
DPn 
Mn 
(g mol-1) 
(GPC, 
acetone) 
Mw/Mn 
(GPC, 
acetone) 
Calc 
DPn 
(GPC, 
acetone) 
Mn 
(g mol-1) 
(GPC, 
THF) 
Mw/Mn 
(GPC, 
THF) 
Calc DPn 
(GPC, 
THF) 
Calc DPn 
(1H NMR, 
d6-DMSO) 
5 1800 1.17 12 1900 1.5 13 7 
7 2300 1.15 15 3000 1.6 20 8 
10 2600 1.12 18 3300 1.3 22 10 
13 3200 1.06 22 1900 1.18 13 14 
15 3200 1.06 22 2200 1.18 15 16 
17 3300 1.09 23 2400 1.12 17 18 
 
Table 4.4: GPC and 
1
H NMR spectroscopic analysis of p(HPMA) oligomers using 
ambient methanolic ATRP. 
Table 4.4 shows the molecular weight analysis of the targeted oligomers after 
purification via precipitation into cold n-hexane.   Triple detection GPC (acetone 
eluent) analysis gave relatively high molecular weights (and therefore calculated 
DPn) for these polymers, despite polydispersity remaining low across all samples 
(see Figure 4.22 (B)). A second analysis using THF as an eluent was performed and, 
again, the calculated DPn for the oligomers was higher than predicted, where the 
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highest was DPn = 22 monomer units for a target DPn of 10 monomer units, 
individual GPC chromatograms are shown in (see Figure 4.22 (A)).  The measured 
molecular weight distributions were generally higher when using THF than those 
recorded when using acetone as the eluent; nevertheless, all GPC traces were 
monomodal and the molecular weight increased steadily with increasing target DPn.   
 
Figure 4.22: Triple Detection GPC analysis of p(HPMA) oligomers.  THF eluent 
(A). Acetone eluent (B). 
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Unsurprisingly, the DPn values calculated by 
1
H NMR spectroscopy are extremely 
similar to the target DPn, as this only confirms the reaction of vinyl groups in the 
monomer, and assuming this is close to 100 % (as has been shown to be the case in 
previous polymerisations of p(HPMA)), then it is likely to be very close to the target 
DPn.  Also, the presence of unreacted initiator will lead to an underestimation of DPn 
using NMR techniques.  The higher than expected molecular weights generated 
during these experiments are likely to be due to initiator efficiency, where fewer 
chains were initially generated and therefore longer chains were formed.  Although 
the EBiB initiator has been used extensively in the previous chapter, with little 
inefficiency in the resulting polymer analysis, the target DPn values were 
significantly higher than those targeted here (50, 80, 120 monomer units).  It 
becomes extremely difficult to obtain narrow molecular weight distributions at low 
target DPn using ATRP as the initiator efficiency needs be extremely high and the 
dormant/active nature of the equilibrium does mean that any differences in chain 
propagation (i.e. not all chains initiate and propagate at the same time) during the 
early stages of polymerisation do not balance/average across all chains, as would be 
expected for longer chain lengths and polymerisation times.  Also, at low target DPn, 
differences of one-five monomer units represent a large percentage of the overall 
targeted chain length, hence affecting the molecular weight distribution dramatically.   
The oligomers synthesised here do, however, represent a series of systematically 
varying chain lengths to facilitate the solubility of p(HPMA) oligomers.  
4.5.1 Aqueous Solubility of Oligomeric p(HPMA)  
The aqueous solubility of the oligomeric p(HPMA) chains and linear p(HPMA50), 
p(HPMA80) and p(HPMA120) were investigated. Saturated aqueous solutions of the 
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aforementioned polymers were prepared by attempting to dissolve approximately 
500 mg of each sample into distilled water (14 mL).  Removal of the supernatant (10 
mL) after three days, and transfer of the solution into three pre-weighed aluminium 
dishes, allowed the dissolved polymer to be quantified after water evaporation 
(covered) at room temperature for one week. The dishes were re-weighed and the 
saturated concentration was recorded as an average of the three samples (see Chapter 
2.3.6). 
 
Figure 4.23: Aqueous solubility study of p(HPMA) with varying chain length (DPn). 
DPn values calculated by 
1
H NMR spectroscopy were used to plot the solubility 
curve in Figure 4.23; however, using values obtained by GPC (acetone or THF 
eluent) also generate the same curve with the difference being that the X axis is 
shifted slightly. Data shown in Figure 4.2, demonstrate how p(HPMA) does indeed 
exhibit some aqueous solubility which increases as chain length decreases.  A 
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concentration of 0.905 mg mL
-1
 was found for the lowest recorded p(HPMA) chain 
(DPn = 7 by 
1
H NMR spectroscopy).  Aqueous solubility drastically decreased as 
chain length increased until the chain lengths reach approximately 18 monomer 
units, after which solubility is negligible.  This data is intuitive with monomeric 
HPMA being soluble in water and suggests a potential role for the oligomeric chain 
ends within the branched polymer architectures (unlike their linear counterparts) 
possessing some affinity for an aqueous environment.   
4.5.2 LCST Behaviour of Oligomeric p(HPMA) 
To study the hypothesis that small oligomeric p(HPMA) chains are present within 
branched p(HPMA) copolymers imparting aqueous solubility and allowing  
nanoparticles to remain stable, a crude Lower Critical Solution Temperature (LCST) 
experiment was performed to determine a cloud point value.  An aqueous solution (1 
mL, 0.57 mg mL
-1
) of p(HPMA) (DPn = 8 monomer units according to 
1
H NMR 
spectroscopy)  was placed into the DLS instrument where the temperature was set at 
25 °C and the sample was analysed during increasing temperature at increments of 3 
°C until the temperature reached 55 °C.  It should be noted that, as with previous size 
analyses, the data recorded are averages of six measurements and are shown in 
Figure 4.24. 
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Figure 4.24: Study of the effect of temperature on an oligomer of p(HPMA) (DPn = 8 
by 
1
H NMR spectroscopy).  Derived count rate and attenuator measure during 
heating within the DLS instrument. 
As the oligomer is extremely small and the concentration is low, the observed 
scattering is extremely low and z-average diameters could not be recorded, however, 
we believe the derived count rate and the attenuator give some indication of the onset 
of LCST behaviour.  From 25 °C to 31 °C virtually no scattering was observed, 
judged by the extremely high automatic attenuator setting (11) which substantially 
decreases upon temperature increase and remains between 6 and 7 for the remainder 
of the experiment indicating a much higher amount of scattering occurring and also 
correlating with values in previous experiments.  The derived count rate shows a 
sharp increase from 197 kcps to 11095 kcps from 25 °C to 31 °C reaching 65574 
kcps at 43 °C.  Above this temperature the derived count rate falls dramatically until 
the final temperature is reached (55 °C).  Although only two parameters were 
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examined, both indicate that oligomers of p(HPMA) potentially possess LCST 
behaviour, and subsequent interaction with water, and therefore may have the 
potential to provide aqueous stability to branched polymer nanoparticles independent 
of the main branched polymer core via a small amount of steric repulsion.  The 
LCST behaviour of oligomeric p(HPMA) does not correlate with the thermal 
stability data shown in section 4.4.8, where no significant change in z-average 
diameter or polydispersity was observed, however, the observed highly negative zeta 
potential is clearly also playing an important role.  
4.6 Removing the Impact of Oligomeric Chain Ends  
To investigate the role of the short oligomeric chains in greater detail, the removal of 
a large number of the chains formed during the early stages of the branching process 
was conducted. As described previously in Chapter 3 section 3.3.3, a linear-branched 
chain extension reaction was conducted to study the kinetics and control during 
branhced polymerisation. This leads to a more architecturally complex branched 
copolymer being synthesised.  It is very difficult to completely prevent oligomeric 
p(HPMA) chains being formed during the branched copolymerisation, however, the 
synthesis of p((HPMA30)-b-p((HPMA50)-co-EGDMA0.95)) does eliminate the 
oligomers that are formed during Phase I of Scheme 4.7.  The architectural 
differences between linear, branched  and the modified branched block copolymer 
are shown in Scheme 4.8. 
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Scheme 4.8: Representation of three synthesis strategies of p(HPMA). (a + b) 
generates linear polymers.  (a +c) generates branched polymers.  (a + d) generates 
linear-b-branched copolymers.  Chain-end oligomers formed at low conversion (i), 
high conversion (ii) and long chain end groups (iii and iv). 
Two chain extension (or self-blocking) experiments were carried out in parallel; the 
first generated a linear p(HPMA30-b-HPMA50) (equivalent to p(HPMA80)) and the 
second generated p((HPMA30)-b-p((HPMA50)-co-EGDMA0.95)) (see Chapter  2 
section 2.3.3 and 2.3.4. In the former experiment, after approximately 88 % 
conversion (as judged by 
1
H NMR spectroscopy) of the first block with a target DPn 
of 30 monomer units, a second batch of monomer (with a target DPn of 50 monomer 
units) was added to the reaction mixture and left to polymerise until > 99 % 
conversion had been reached.   An identical protocol was used in the second 
experiment with the addition of EGDMA in the second batch addition to induce 
branching (1: 0.95 monomer:brancher) where conversion had reached 81 %.   
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Sample Description 
Mn (g mol
-1) 
(GPC) 
Mw (g mol
-1) 
(GPC) 
Mw/Mn 
Conversion 
(%) 
p(HPMA30) Linear 3800 4200 1.11 88 
p(HPMA30-b-HPMA50) 
2nd monomer 
addition 
15300 18400 1.20 88 
p(HPMA30)-b-(HPMA50) 
Purified linear 
polymer 
16000 17500 1.09 > 99 
p(HPMA30) Linear 3300 3600 1.09 81 
p(HPMA30-b-(HPMA50-co-EGDMA0.95)) 
2nd monomer 
and 
brancher 
addition 
50000 319300 6.40 77 
p(HPMA30-b-(HPMA50-co-EGDMA0.95)) 
Purified 
branched 
polymer 
98300 1550000 15.77 > 99 
 
Chapter 4 
224 
 
Table 4.5: Triple detection GPC analysis of self-blocked linear p(HPMA) and self blocked linear-b-branched p(HPMA).
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Table 4.5 shows the dramatic difference in molecular weights between the two 
blocking experiments; where EGDMA is not incorporated in the second block, an Mn 
of 16000 g mol
-1
 is achieved (which is comparable to the synthesis of p(HPMA80)), 
where an Mn of 11700 g mol
-1 
was found in Chapter 3 section 3.3; an Mn of 98300 g 
mol
-1
 was found for the sample which has EGDMA incorporated.  Their molecular 
weight distributions also show a marked difference; 1.11 was found for the linear 
polymer sample, which is well within the range for a general linear ATRP reaction 
where as the branched counterpart gave a molecular weight distribution of 15.77 
clearly demonstrating that branching has occurred which has generated a wide range 
of molecular weights.  
Figure 4.25 demonstrates the dramatic molecular weight differences between the two 
blocking experiments, where the initial linear block (target DPn = 30) in both cases 
has low polydispersity and have extremely close retention volumes, correlating well 
with their similar conversions.  It should also be noted here that linear material exists 
in the p(HPMA30-b-(HPMA50-co-EGDMA0.95)) polymer sample indicated by an 
almost identical peak at approximately 18.5 mL elution volume, which has been 
found with previous branching experiments (Chapter 3 section 3.3).  This experiment 
demonstrates the ability to self-block p(HPMA), with linear blocked polymer 
(p(HPMA30-b-HPMA50)) achieving a similar molecular weight to its unblocked 
counterpart (p(HPMA80)) and also maintaining a low molecular weight distribution 
throughout polymerisation. 
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Figure 4.25: GPC chromatograms (THF eluent) of p(HPMA) blocking experiments.  
Linear-b-linear; block 1 (88 % conversion) (blue line), final block copolymer (> 99 
% conversion) (dark blue line).   Linear-b-branched; block 1 (81 % conversion) (red 
line), final branched block copolymer (> 99 % conversion) (dark red line). 
Although both p((HPMA80)-co-EGDMA0.95) and p((HPMA30)-b-(HPMA50-co-
EGDMA0.95)) have target primary chain lengths of 80 monomer units, structurally, 
the latter polymer is guaranteed to contain chain ends of approximately 30 monomer 
units due to the first linear block which has no appreciable water solubility 
(according to section 4.5.1).  Therefore it is assumed that branching in p((HPMA30)-
b-(HPMA50-co-EGDMA0.95)) is now restricted to the last 62.5 % of the primary 
chains (if each chain has a combined DPn of 80 monomer units) and may result in 
more densely branched materials.  Statistically there will be some short oligomeric 
chain ends present within this modified branched polymer sample (indicated by (ii) 
in Scheme 4.8, but here it is assumed the number of these is now limited.   
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Both p((HPMA80)-co-EGDMA0.95)  and p((HPMA30)-b-(HPMA50-co-EGDMA0.95)) 
were subjected to rapid precipitation from acetone (5 mg mL
-1
 initial concentration; 
1 mg mL
-1
 final concentration) to investigate whether the resulting nanoparticles 
behave differently in terms of stability.   
 
Figure 4.26: DLS characterisation of p((HPMA30)-b-(HPMA50-co-EGDMA0.95)).  A) 
p((HPMA80)-co-EGDMA0.95) (solid line) and p((HPMA30)-b-(HPMA50-co-
EGDMA0.95)) (dashed line). B) p((HPMA30)-b-(HPMA50-co-EGDMA0.95)) 
nanoparticle analysis over time. (5 mg mL
-1
 starting concentration; 1 mg mL
-1
 final 
concentration). 
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The modified block branched copolymer p((HPMA30)-b-(HPMA50-co-EGDMA0.95)) 
successfully formed nanoparticles which had a z-average diameter of 128 nm and a 
molecular weight distribution of 0.106 which are both markedly higher than the un-
blocked branched counterpart (p((HPMA80)-co-EGDMA0.95)).  The reason for this 
difference is unknown, but can only be attributed to the architectural difference in 
copolymer structure.  The nanoparticle suspension (1 mg mL
-1
) was characterised 
using DLS over ten days, with measurements performed after one, three, seven and 
ten days (see Figure 4.26 (B).  After three days, both z-average diameter and 
polydispersity increases; which may be attributed to the onset of particle 
aggregation.  Following this measurement small copolymer precipitate began to 
appear in the bottom of the sample vial; nevertheless DLS measurements were 
performed using the supernatant of the sample.  At seven and ten days, DLS 
measurements are bimodal; with distinct peaks < 100 nm.  The reason for this is 
unknown, but it is speculated that that these small nanoparticles are not involved 
during the onset of precipitation.  
Nevertheless, the nanoparticle suspension comprised of p((HPMA30)-b-(HPMA50-
co-EGDMA0.95)) showed significantly different stability behaviour when compared 
to p((HPMA80)-co-EGDMA0.95).  This supports the theory that small oligomeric 
p(HPMA) chains within branched copolymer samples exert some aqueous solubility 
and stability to the nanoprecipitates.  Increasing the chain length of the oligomeric 
p(HPMA) chains (through blocking) may have reduced the overall aqueous 
interactions of nanoparticles leading to aggregation and subsequent precipitation.  
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4.7 Summary 
Different methods of precipitation have been investigated, utilising both linear and 
branched p(HPMA) with linear polymer nanoparticles showing little aqueous 
stability.  Branched copolymer nanoparticles have been shown to be highly stable 
with respect to dilution (aqueous and methanolic), time, temperature and sonication. 
Z-average diameters and polydispersity can also be systematically controlled through 
variation of concentration parameters, using a rapid solvent switch approach.   
Nanoparticle formation has been shown to be highly reproducible with a nucleation-
growth mechanism proposed as the method of nanoparticle formation.  Data has 
suggested that nanoparticle stability arises from electrostatic repulsion whereby 
nanoparticles de-stabilise during the addition of a salt solution. It has been proposed 
that small oligomeric units of p(HPMA) present within branched copolymer samples 
exert some aqueous stability and branched-block copolymers were synthesised to  
remove these chains and test the hypothesis.  Subsequent nanoparticles showed 
limited stability, characterised by precipitation after approximately seven days 
supporting this theory.  
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5. Linear and Branched ATRP of 2-
Hydroxypropyl Methacrylate using PEG 
Macroinitiators 
5.1  Introduction 
The aim of this work was to synthesise a series of copolymers with well-defined 
compositions and structures in order to investigate the effect of architectural 
variation, and also introduce variability within hydrophobic/hydrophilic content, on 
the resultant nanoparticle properties.  Copolymerisation was carried out using one-
pot methanolic ATRP and a range of hydrophilic initiators were utilised in the 
synthesis of hydrophobic polymer chains of p(HPMA). The reaction kinetics of 
model systems were investigated using three types of hydrophilic initiator and one 
target primary chain length, to ensure adequate control of the polymerisations was 
achieved for linear and branched systems.  A series of copolymers containing 
poly(ethylene oxide) and 2-hydroxypropyl methacrylate have been successfully 
prepared, with nine compositions and two different architectures; a total of eighteen 
linear and branched copolymers. 
A macroinitiator approach to generate hydrophilic/hydrophobic block copolymers 
was chosen rather than the polymerisation of a hydrophilic block and the sequential 
addition of a second hydrophobic monomer to the reaction;
1
 in all cases, 
experimental simplicity (all copolymer components present at the time of initiation) 
would considerably aid reproducibility.
2, 3
 In this way, the reaction can be left to 
polymerise undisturbed until sufficient conversion has been reached, at which point 
manual termination via exposure to air plus suitable solvent addition is performed. 
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As methanol dissolves both PEG and HPMA and is a suitable ATRP solvent for 
vinyl monomers,
1, 4, 5
 it was chosen as the solvent for all ATRP reactions conducted 
during this part of the current study, in addition to the synthesis of linear and 
branched pHPMA, found in Chapter 3 (sections 3.2 and  3.3). 
Armes and co-workers investigated ATRP with HPMA in various solvents (aqueous, 
methanolic and water/methanol solution).
2
  They reported molecular weight 
distributions as low as 1.09 within a few hours using methanol, with reaction time 
significantly reduced when a 50/50 water/methanol mixture was introduced, 
although slightly higher molecular weight distributions were obtained (Mw/Mn = 
1.17).  Another rationale for using solely methanol is the high aqueous solubility of 
PEG. It can be extremely difficult to sufficiently remove water during the work up of 
the copolymer requires one or more of the following: freeze drying, precipitation, 
extraction with other solvents, and/or prolonged heating during rotary evaporation. 
The Armes group was the first to investigate aqueous ATRP at ambient temperature, 
demonstrating the well-controlled polymerisation of monomethoxy-capped 
oligo(ethylene glycol) methacrylate (OEGMA) in water at 20 °C
6,7
 where 95 % 
monomer conversion was reached after 30 minutes, with molecular weight 
distributions as low as 1.12.  DMAEMA and 2-(diethyl amino)ethyl methacrylate 
(DEAEMA) have also been shown to polymerise well in water.
8
  This work does not 
focus on investigating optimum conditions for ATRP of PEG containing p(HPMA) 
polymers, a simple reaction procedure and work up is favoured, however, studies of 
the success of each reaction are made.  In Chapter 3 (section 3.2.2), plots of 
ln([M0]/[M]) vs. time for the homopolymerisation of HPMA (linear and branched) in 
methanol suggested a controlled polymerisation with fast initiation and insignificant 
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termination.  It was proposed that similar results would be observed for copolymers 
synthesised using PEG macrointiators. 
5.2  Synthesis and characterisation of monomethoxy 
poly(ethylene oxide) (PEG-OH) macroinitiators. 
A range of PEG-Br macrointiators have been prepared by reacting the corresponding 
hydroxyl group of commercially available monomethoxy poly(ethylene oxide) with 
2-bromoisobutyryl bromide in the presence of triethylamine (TEA) and 4-
dimethylaminopyridine (DMAP). This esterification reaction is based on a method 
reported by Jankova et al.
9
 Three commercially available PEG-OH materials were 
used to generate initiators, with reported number average molecular weights of 750, 
2000 and 5000 g mol
-1
.  Full experimental protocol is found in Chapter 2 section 
2.4.1. 
 
 
Scheme 5.1: General esterification of hydroxyl containing species, R-OH, generating 
an ATRP initiator R-OCO(CH3)2Br. 
 
Scheme 5.1 shows the general esterification reaction to convert the mono-methyl 
PEG-OH into an ATRP initiator.  Before carrying out any reactions, 
1
H NMR 
spectroscopy was used to confirm the precursor PEG-OH number average degree of 
polymerisation (DPn). The ratio of the integration of the methoxy end-group and the 
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methylene signal should generate a number average degree of polymerisation for 
each polymer. DPn was therefore calculated by the integration of the terminal methyl 
signal at 3.38 ppm to the O-CH2-CH2 repeat unit at 3.64 ppm, where DPn = 4
3 b
a

 
(see Figure 5.1). It was found that the DPn of PEG17-OH was 17.5 ethylene oxide 
repeat units corresponding to a number average molecular weight of 770 g mol
-1 
(by 
multiplying DPn by the molecular weight of the ethylene oxide repeat unit (44 g mol
-
1)); in close agreement with the manufacturer’s description.  Applying the same 
method, a DPn value of 47.9 ethylene oxide repeat units was determined for PEG45-
OH (number average molecular weight = 2100 g mol
-1
) and a DPn value of 126.3 
ethylene oxide repeat units was found for PEG113-OH (number average molecular 
weight = 5600 g mol
-1
). All values are slightly higher than the averaged values 
reported by the manufacturer. 
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Figure 5.1: 
1
H NMR spectra in CDCl3 of PEGx-OH. (A) PEG17-OH. (B) PEG45-OH. 
(C) PEG113-OH. 
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Figure 5.2(A) shows a 
1
H NMR spectrum of a monomethoxy PEG-OH where proton 
environments are assigned.  After esterification a new signal at 1.95 ppm appears as 
shown in Figure 5.2(B) from the new equivalent methyl resonances of the tertiary 
bromide group.  The resonance at 4.33 ppm is attributed to the CH2 group adjacent to 
the ester.  
 
Figure 5.2: 
1
H NMR spectra of (A) monomethoxy PEG-OH and (B) Esterified 
monomethoxy PEG-Br recorded in CDCl3. 
 
The extent of esterification was calculated using the ratio of the monomethoxy CH3 
and ester CH2 signals, which should give a ratio of 3:2. Theoretically, the percentage 
esterification should be < 100 %, yet the ratio of monomethoxy CH3 and ester CH2 
signals in Figure 5.3 is slightly higher, suggesting that extremely high conversions 
have been reached in conjunction with integral error. 
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Figure 5.3: 
1
H NMR spectra in CDCl3 of PEGx-Br. A) PEG17-Br. B) PEG45-Br. C) 
PEG113-Br. 
Figure 5.3 (A) suggests 100 % esterification has been reached for PEG17-Br, 
however, integration gives values > 2 protons for the ester methylene for PEG45-Br 
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and PEG113-Br, (2.1 and 2.4 respectively) (Figure 5.3(B)&(C)). The extent of 
esterification was not calculated using a ratio of the monomethoxy and the two 
methyl groups of the bromo end group as this does not confirm the reaction.  This 
peak may also contain proton signals from other materials such as hydrolysed 
bromoisobutyric acid. 
Mn, Mw and molecular weight distributions were measured by triple detection GPC 
(THF eluent) after esterification for PEG45-Br and PEG113-Br which showed 
relatively narrow molecular weight distributions and accurate molecular weights 
with respect to those calculated.  
 
Figure 5.4: GPC chromatograms of two PEG macroinitiators. PEG45-OH (Mn = 
2100; Mn theory = 2000; dashed line) and PEG113-OH (Mn = 5600, Mn theory = 5000; 
solid line). 
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The GPC chromatograms are shown in Figure 5.4.  Unfortunately the PEG17-Br 
initiator could not be analysed using this method due to its low molecular weight 
being beyond the elution limit of the columns; however it is possible to analyse 
polymers of this molecular weight using different columns designed for low 
molecular weight analysis but these were not available here.  PEG45-OH eluted 
extremely close to the solvent front and therefore the accuracy of molecular weight 
determination was not high. A summary table of the GPC data of these polymers is 
shown in Table 5.1. 
 
Sample  Nominal 
 1
H NMR  GPC 
 
 Mn  
(theory g mol
-1
) 
DPn 
 Mn 
(g mol
-1
) 
DPn 
 Mn 
(g mol
-1
) 
Mw 
(g mol
-1
) 
Mw/Mn 
           
PEG-OH  750 17  770 17.5  / / / 
PEG-Br  840 17  748 17  / / / 
PEG-OH  2000 45  2 100 48  / / / 
PEG-Br  2080 45  1940 44  2200 3100 1.36 
PEG-OH  5000 113  5600 126.3  / / / 
PEG-Br  5080 113  4900 111  5100 7200 1.3 
 
Table 5.1:Summarising data obtained via 
1
H NMR and GPC for the commercial 
PEG-OH (Mn 750, 2000 and 5000 g mol
-1
) and their respective macroinitiators. 
 
5.3  Synthesis of PEGx-b-p(HPMAy) block copolymers  (x = 17, 
45, 113, y = 50, 80, 120) 
Using macrointiators rather than sequential A-B block copolymerisation can be seen 
as more experimentally facile, as a second monomer is not added and reactions can 
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be left until all monomer is consumed, as determined by 
1
H NMR spectroscopy, 
avoiding gradient copolymer formation and assuring distinct block segments.  
HPMA monomer was chosen as the hydrophobic segment due to its 
biocompatibility, commercial availability, and previous successful synthesis by 
ATRP in other research groups. 
For each macroinitiator synthesised, three subsequent polymerisations were carried 
out, utilising HPMA monomer at varying target chain lengths (target DPn = 50, 80, 
120 monomer units).  In short, the initiator was first dissolved in methanol (50 w/v 
%) (monomer/solvent) after which the monomer feed was added (50 w/v %) 
(monomer/solvent), reactions were stirred and carefully degassed using a nitrogen 
purge for approximately 10 minutes at room temperature.  Reactions were initiated 
after the addition of Cu(I)Cl/BPY  in a ratio of 1/2.5 and left until > 98% conversion 
had been reached as assessed by 
1
H NMR spectroscopy.  The reactions were purified 
as stated in the Chapter 2 section 2.4.2.  A total of nine polymers were synthesised 
and a schematic representation of the effect of varying both components of the 
polymer chains is shown in Figure 5.5. 
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Figure 5.5: Representation of amphiphilic copolymers with varying both hydrophilic 
(PEG) (A) and hydrophobic (HPMA) (B) content 
 
Figure 5.5 is not directly to scale in terms of actual PEG/HPMA content in the 
polymer chains; there are three ways to depict the content of each polymer block 
(shown below) where the polymer PEG113-b-p(HPMA50) was chosen as an example. 
 
1) Mole ratio of monomers = ethylene oxide repeat unit/HPMA repeat unit = 
113/50 = 2.26 
2) Mole ratio of each polymer = HPMA50/PEG113 = 1/1 = 1  
3) Weight ratio of each polymer = HPMA50/PEG113 = (50 x 144.2)/(113 x 44) = 
7200/5000 = 1.44 
 
The three different calculations above give useful information which shows the 
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relative ratios of each polymer component in these amphiphilic copolymers.  1) 
shows that, for this particular polymer, the PEG segment is approximately 2.26 times 
as long as the p(HPMA) chain, although this does not take into account the 
molecular weight of each repeat unit.  2)  is simply the calculation which is used to 
calculate the target DPn of the primary chain length, where there is one initiator per 
chain and x number of HPMA monomer units.  3)  takes into account the relative 
molecular weights of each polymer segment, where PEG is approximately 5000 g 
mol
-1
 and HPMA is 7200 g mol
-1
 for this polymer example, therefore in the overall 
copolymer the HPMA chain has approximately 1.44 times the mass of the PEG 
containing initiator.  Out of all nine copolymers synthesised, PEG113-b-p(HPMA50) 
has components whose weight ratios are closest to 1.  Conversely in PEG17-b-
p(HPMA120) the weight ratio of p(HPMA) is approximately 23 times higher than that 
of the PEG initiator, providing the most “un-balanced” copolymer in terms of their 
respective molecular weights.  By synthesising this diverse range of polymers it is 
believed that useful insight can be gained into their individual reactions, subsequent 
copolymer characteristics and optimisation of reaction conditions using PEG 
containing copolymers by ATRP. 
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Figure 5.6: 
1
H NMR spectrum of PEG17-b-p(HPMA50) in DMSO-d6. 
 
The 
1
H NMR spectrum of PEG17-b-p(HPMA50) (Figure 5.6) shows the integration 
and assignment of the protons present in the copolymer.  It should be noted that 
residual solvents still remain; acetone is present due to insufficient drying after the 
cleaning of the NMR tube, it is believed H2O is present due to the hygroscopic 
nature of the PEG and DMSO was the solvent in which the analysis was performed.  
The DPn of the p(HPMA) polymer can be calculated by several methods to double 
check values achieved, using the ratio of either the terminal methyl group (a) or the 
ethylene oxide repeat unit (e) of the initiator against any of the HPMA proton 
environments (b, c, d, f, g).  For example,  
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using A) gives a DPn of 50 monomer units whereas B) gives a DPn of 45 for this 
polymer.  These figures should be identical as both (c) and (d) come from HPMA 
protons, and highlights the inaccuracy of 
1
H NMR spectroscopic analysis.  It should 
be noted that these equations are correct when the integral of the methoxy CH3 is set 
to 3.  DPn was not calculated using the ethylene oxide repeat units in the initiator due 
to the significant overlap of the CH2 and CH groups in HPMA, and in turn these 
signals (f) could not be used themselves to give any accurate values.  The integral of 
protons (g) was also not used in analysis as it is believed there was significant 
exchange with water and as such the values calculated using this signal are markedly 
lower than those using (c) or (d).  Copolymer analysis by 
1
H NMR spectroscopy is 
best used to determine conversion of monomer to polymer through the depletion of 
vinyl signals from the monomer.   When analysing the final recovered polymer, a 
ratio of initiator to polymerised monomer may be hampered by unreacted initiator 
residues which cannot be easily determined. In addition, no information of the 
molecular weight distribution is available. 
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Figure 5.7: GPC chromatograms of PEGx-Br initiated linear pHPMA copolymers.  
(A) PEG17-p(HPMAx) (B) PEG45-p(HPMAx) (C) PEG113-p(HPMAx).  DPn = 50 
(solid lines), DPn = 80 (medium dashed lines) DPn = 80 (small dashed lines) 
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Triple detection GPC (THF eluent) was performed (5 mg mL
-1
) on the nine polymers 
synthesised as described above, utilising three PEGx based initiators varying target 
DPn (50, 80, and 120 monomer units). From Figure 5.7, it is clear that linear 
copolymers elute at lower retention volumes as target DPn increases, as expected.  
Conversely, copolymers with the longest target p(HPMA) chains (target DPn = 120 
monomer units) have the highest molecular weight distributions. All linear 
copolymer molecular weight distributions exhibit a lack of symmetry, with shoulders 
extending to higher retention volumes.  This may be due to a small amount of chain 
termination during the reaction. 
 
 
Figure 5.8: GPC chromatograms of PEG17-b-p(HPMA50) (red line), PEG45-b-
p(HPMA50) (green line), PEG113-b-p(HPMA50) (blue line). 
 
The three linear copolymers with a target DPn = 50 monomer units (shown in Figure 
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5.8) also show distinct shoulders at lower retention volumes, potentially due to 
unreacted initiator or due to termination during the early stages of polymerisation. 
By overlaying these chromatograms, shoulders at lower retention volumes in each 
polymer sample can be clearly seen.  Across the linear copolymer series, the most 
symmetrical chromatograms are found when targeting a DPn of 80 monomer units 
irrespective of the macroinitiator used (see Figure 5.8).  The exact reason for this is 
unknown but this trend also appeared during the polymerisation of p(HPMA) 
homopolymers in Chapter 3 (section 3.2), which showed the lowest molecular 
weight distribution when the target DPn = 80 monomer units. A summary of the nine 
linear copolymer characterisation data is shown in Table 5.2. 
 
Sample 
Mn (g mol
-1
) 
(Theory) 
Mn (g mol
-1
) 
(GPC)* 
Mw (g mol
-1
) 
(GPC)* 
Mw/Mn 
(GPC)* 
Conversion 
(%) 
      
PEG17-b-p(HPMA50) 8000 8100 9800 1.21 > 99 
PEG17-b-p(HPMA80) 12300 13100 15100 1.15 > 99 
PEG17-b-p(HPMA120) 18100 19300 23500 1.22 > 99 
      
PEG45-b-p(HPMA50) 9200 10100 12100 1.20 > 99 
PEG45-b-p(HPMA80) 13500 13900 16600 1.19 > 99 
PEG45-b-p(HPMA120) 19300 20100 24900 1.24 > 99 
      
PEG113-b-p(HPMA50) 12200 13300 16800 1.26 > 99 
PEG113-b-p(HPMA80) 16500 17600 21500 1.22 > 99 
PEG113-b-p(HPMA120) 22300 23400 30700 1.31 > 99 
Table 5.2: Summarising data obtained for linear polymers PEGx-b-p(HPMAy) where 
x = 17, 45, 113 and y = 50, 80, 120. * THF eluent. 
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The molecular weight data obtained and shown in Table 5.2 are consistently higher 
than those predicted, yet this was also observed for the homopolymerisations of 
p(HPMAx) in Chapter 3 (section 3.2).  The most accurate molecular weights are 
obtained using the PEG17-Br macroinitiator; whereas increased inaccuracy is seen as 
the molecular weight of the macroinitiator is increased.  For example, PEG17-b-
p(HPMA50) has an Mn of 8100 g mol
-1
, which is extremely close to that predicted 
(8000 g mol
-1
), whereas PEG113-b-p(HPMA50) has an Mn of 23400 g mol
-1
; 
significantly higher than predicted (22300 g mol
-1
).  This discrepancy is most likely 
due to initiator efficiency decreasing as the molecular weight of the initiator 
increases, causing monomer to react with fewer than predicted initiating sites.  There 
could also be complications during GPC analysis as the solubility of the copolymers 
in THF may vary as the relative ratio of PEG to p(HPMA) increases. 
In this section it has been shown that a range of PEG based macroinitiators were able 
to successfully polymerise HPMA to three target primary chain lengths (50, 80 and 
120 monomer units).  All reactions proceeded to > 99% conversion and the 
subsequent polymers gave molecular weights (and therefore DPn) comparable to 
those targeted.  The molecular weight distributions of polymers (1.15 to 1.31) 
suggest controlled polymerisations took place. 
 
5.3.1 Copolymerisation Kinetic Studies of PEG17-b-p(HPMA80), PEG45-
b-p(HPMA80) and PEG113-b-p(HPMA80)  
 
In order to determine if the reactions of the previously synthesised amphiphilic 
copolymers proceeded in a controlled manner to high conversion, kinetic studies 
were performed on a subset of polymers utilising all three previously synthesised 
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initiators whilst maintaining the target DPn.  It should be noted here that due to the 
higher molecular weight of these PEG-Br based macroinitiators in comparison to 
EBiB (used throughout Chapter 3), it was necessary to increase the volume of solvent 
in order for all components to be suitably solubilised, and also to ensure the viscosity 
of the polymerisation mixture at high conversions did not significantly affect the 
diffusion of polymer chains.  The volume of methanol was adjusted, and took into 
account the mass of the initiator as well as HPMA monomer, therefore overall 
reactions were 50 w/v % (monomer,initiator/solvent) (see Chapter 2 section 2.4.2.2)  
Reactions were monitored with regular sampling of the polymerisation mixtures 
which were subsequently analysed by 
1
H NMR spectroscopy in DMSO-d6 and triple 
detection GPC (THF eluent). 
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Figure 5.9: Kinetic studies of p(HPMA80) using PEG-Br based macroinitiators.  A) 
PEG17-b-p(HPMA80). B) PEG45-b-p(HPMA80). C)  PEG113-b-p(HPMA80). 
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Figure 5.9 shows the kinetic data for the copolymerisation of p(HPMAx) using 
various PEG-Br based macroinitiators, maintaining a target DPn of 80 monomer 
units.  Despite varying the molecular weight of the initiator, data suggests reactions 
proceeded via conventional ATRP, as the percentage consumption of monomer is 
high at low conversion and at high conversion, where little un-reacted monomer is 
available, rates of reaction are dramatically reduced.  All of the semi logarithmic 
plots appear to be relatively linear, indicative of the maintenance of radical 
concentration throughout the copolymerisation and as such, these kinetic experiments 
were thought to be successful.  In order to draw solid conclusions of how varying the 
molecular weight of initiator affects reaction kinetics, it was necessary to overlay the 
data, which can be seen in Figure 5.10. 
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Figure 5.10: Kinetic studies of p(HPMA80) polymerisation using PEG-Br based 
macroinitiators.  A)  Conversion vs. time.  PEG17-Br (red), PEG45-Br (green), 
PEG113-Br (blue).  B) Semi-logarithmic plot.  PEG17-Br (red), PEG45-Br (green), 
PEG113-Br (blue). 
 
By grouping the sets of data in this way, it becomes clearer to see the effect of 
varying initiator molecular weight with respect to kinetic data.  From Figure 5.10(A), 
it can be seen that by using PEG17-Br (the lowest molecular weight initiator) high 
conversion is reached in a significantly shorter time (> 99 % in 7 hours), compared to 
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the other initiators where approximately 100 hours reaction time was necessary in 
order to achieve the same conversion.  It is believed the reason for this in mostly due 
to the extremely high viscosity of the solution, even at relatively low conversions in 
comparison to PEG17-Br.  Viscosity undoubtedly affects the diffusion and mobility of 
the active polymer chains and it is unsurprising that these highly viscous solutions 
require much longer reaction times to reach > 99 % conversion.  However, the 
observed conversion vs. time curves using PEG45-Br and PEG113-Br are typical for 
reported ATRP reactions.  It is apparent from Figure 5.10(A) that higher conversions 
are reached in slightly shorter reaction times using PEG113-Br when compared to 
PEG45-Br; this result was not anticipated as it was thought that the molecular weight 
of the initiator had a direct effect on reaction rates and should therefore be the 
“slowest” reaction. The differences are not large and it should be noted that these 
reactions were only conducted once, on different days and at varying ambient 
temperatures which may have affected the reaction rate slightly.  Figure 5.10(B) 
shows the semi logarithmic plots for these three reactions; rather unsurprisingly the 
fastest rate is found by using the PEG17-Br initiator with the lowest molecular weight.  
As noted previously, it was expected that utilising PEG113-Br would have the slowest 
rate, but this was not the case here. The plots are also not perfectly linear, as would 
be expected for first order kinetics, but show a sight curvature for the longest two 
macroinitiators. Again, it is believed this may be due to slight temperature changes 
and also possible termination reactions over the extended reaction times at ambient 
temperature. Despite these possible discrepancies, no conclusive trends can be 
interpreted from this data, as the concentration of these reactions was 50 w/v % 
(initiator, monomer/solvent), causing the concentration of catalyst/ligand and also 
HPMA monomer to be unavoidably changed in all three polymerisations. It is likely 
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this would result in different semi logarithmic plots and therefore, no direct trends 
can be found in this study.  Unfortunately there is no possible way to overcome this 
concentration difference.  If the opposite approach was taken, where the volume of 
methanol was maintained throughout the reactions, the concentration of all other 
components in the polymerisation would vary from reaction to reaction.  This is due 
to the same number of moles of initiator being utilised, undoubtedly affecting the 
actual mass added to the reaction mixture as initiator varies, and therefore the 
catalyst/ligand and HPMA monomer concentration will vary as a result.  As reaction 
kinetics are affected by concentration, and it has been shown that this cannot be 
maintained successfully, it is impossible to quantitatively report how the kinetics of 
the polymerisation of p(HPMAx) are affected by using various PEGx-Br based 
initiators from the reactions carried out. 
 
Figure 5.11: Evolution of molecular weight with conversion.  PEG17-Br (red), 
PEG45-Br (green), PEG113-Br (blue).   
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It is suggested that these polymerisations proceed via conventional ATRP, where 
molecular weight is expected to increase linearly with conversion, suggesting good 
control during the entire polymerisation.  From Figure 5.11 it is shown that when 
employing PEG17-Br (the lowest molecular weight initiator), good linearity between 
Mn and conversion is seen.  For copolymerisations utilising PEG45-Br and PEG113-Br, 
their respective results deviate away from linearity after approximately 70 % 
conversion.   This suggests that after this point, these two polymerisations do not 
show good control and as such, are not proceeding via conventional ATRP.  The 
plots of Mn vs. conversion actually curve upwards at high conversion suggestive of 
termination, and therefore there are more monomer units available to polymerise with 
fewer active chains.  This result coincides with their respective semi logarithmic 
plots, which curve downwards suggesting there are fewer radicals present within the 
respective reactions.   
In summary, it has been shown that utilising the PEG17-Br initiator to copolymerise 
p(HPMAx) to a target DPn of 80 monomer units was well controlled, and proceeded 
via conventional ATRP mechanisms.  As the molecular weight of the initiator 
increased (PEG45-Br and PEG113-Br) control begins to break down after 
approximately 60 % conversion, although copolymers with relatively low 
polydispersities (<1.3) have been successfully polymerised with these initiators.  
Optimisation of these experiments (concentration, temperature etc) could result in 
kinetic results indicative of conventional ATRP. 
5.3.2 Copolymerisation Kinetic Studies of PEG17-b-p(HPMA30), PEG17-
b-p(HPMA50) and PEG17-b-p(HPMA100) 
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In the previous section it was shown that varying the number of ethylene oxide 
repeat units in a PEGx-Br based macroinitiator does have an effect on reaction 
kinetics when the target DPn of the HPMA polymer chains is maintained.  In this 
section, one initiator was selected (PEG17-Br) and used to polymerise HPMA to 
three different target chain lengths (DPn = 30, 50 and 100 monomer units).  These 
experiments aim to highlight the capability of the PEG17-Br initiator to successfully 
initiate and yield copolymers with accurate molecular weights (with respect to the 
target DPn) whilst maintaining low molecular weight distributions under 
conventional ambient ATRP conditions.  Similar experiments were carried out in 
Chapter 3 utilising EBiB as the initiator and comparisons between these two studies 
will be reported here.  In the last section, solid conclusions were not found regarding 
the comparison of reaction kinetics utilising different initiators, due to unavoidably 
inconsistent reaction concentrations.  In this study, the same initiator is employed 
(PEG17-Br), therefore the volume of solvent is only altered due the increasing target 
DPn of the polymer chain to give an overall concentration of 50 w/v % (initiator, 
monomer/ solvent).  Linear p(HPMAx) chains with a target DPn of 30, 50 and 100 
monomer units were chosen, the molar ratio of the initiator was maintained aiming to 
ensure the same number of potential initiating chains was kept constant throughout 
the reaction.  Reactions were conducted in parallel using methanol (50 w/v%; 
initiator+monomer/solvent) at ambient temperature.  Kinetic sampling was employed 
whereby two samples, one for 
1
H NMR spectroscopy and one for GPC analysis were 
taken at regular intervals throughout the reactions.  These experiments were 
conducted to ensure that any further polymers synthesised using PEG based 
macroinitiators proceeded via conventional ATRP.  
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Figure 5.12: Kinetic studies of p(HPMAx) using PEG17-Br initiator.  A) PEG17-b-
p(HPMA30). B) PEG17-b-p(HPMA50). C)  PEG17-b-p(HPMA100). 
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The data in Figure 5.12 suggests that all three polymerisations proceeded via typical 
ATRP mechanisms, identified by the high rate of reaction at low conversion where 
the concentration of monomer high.  Whereas when monomer concentration begins 
to deplete at much higher conversions, a much slower rate of reaction is found.  In 
conjunction to this, all of the semi logarithmic plots in Figure 5.12 are linear with 
respect to reaction time, indicative of a constant concentration of radicals present 
throughout the reactions.  It is therefore assumed monomers are polymerising at a 
steady rate. 
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Figure 5.13: Kinetic studies of p(HPMAx) using PEG17-Br macroinitiator.  A)  
Conversion vs. time.  x = 30 (filled circles), x = 50 (filled triangles), x = 100 (filled 
squares).  B) Semi-logarithmic plot.  x = 30 (open circles), x = 50 (open triangles), x 
= 100 (open squares). 
By grouping the data, the effect of increasing target DPn of p(HPMA) with respect to 
kinetic data can be seen.  Figure 5.13(A) suggests the reaction with the lowest target 
DPn (30 monomer units) is the fastest polymerisation, followed by DPn = 50 
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monomer units and then 100 monomer units.  This is essentially the same trend 
encountered in Chapter 3 (section 3.2.2) where EBiB was utilised as the initiator. The 
data suggests that regardless of the size and chemical composition, the fastest 
reactions for the polymerisation of p(HPMA) is found when targeting shorter primary 
chain lengths.  The semi logarithmic plots are all linear with respect to monomer 
conversion as seen in Figure 5.13(B); these trends are comparable to those found in 
Chapter 3 (section 3.2.2).  Despite varying the primary chain length, no detectable 
termination occurred at any stage of polymerisation and again, the rate of reaction 
lessens with increasing target DPn, (also observed in Chapter 3 (section 3.2.2).  The 
difference in rate directly relates to the change in concentration of the catalyst/ligand 
within the reaction; this change is unavoidable due to the reactions being carried out 
at 50 w/v % (initiator+monomer/solvent).  Therefore, in the copolymerisation of 
PEG17-b-p(HPMA50), the concentration of catalyst/ligand will be less than in the 
polymerisation of PEG17-b-p(HPMA120), as more monomer (and therefore solvent) 
will have to be used in order to maintain 50 w/v %.  Also, the variation in monomer 
concentration is expected to have an effect on the rate of reaction. 
In summary, data suggests that despite varying the primary chain length of 
p(HPMAx) reactions proceed via conventional ATRP mechanisms.  The trends 
appearing in this study are identical to those found during the kinetic analysis of 
p(HPMAx) in Chapter 3 (section 3.2.2). 
 
 
 
 
Chapter 5 
261 
5.4 Synthesis of PEG17-b-p(HPMAx) Block Copolymers (x = 
20, 30, 50, 60, 70, 80, 100, 120)  
A wide range of p(HPMAx) primary chain lengths were targeted using a selected 
initiator (PEG17-Br).  The previous studies have focused heavily on targeting only 
DPn = 50, 80 and 120 monomer units; here, much shorter polymer chains were 
targeted in order to investigate the limits of using PEGx-Br macroinitiators to 
polymerise HPMA using methanolic ATRP.  A wide range of polymers with 
accurate molecular weights and low polydispersities were obtained, where target DPn 
= 20, 30, 50, 60, 70, 80, 100, and 120 monomer units.                      
Copolymers were synthesised as described in Chapter 2 section 2.4.2 with the 
number of moles of initiator remaining constant, therefore the molar ratio of HPMA 
monomer was adjusted in order to achieve the correct target DPn.  Aiming to ensure 
the same number of initiating species is present at the beginning of all reactions, and 
minimising the possibility of experimental error.  For example: PEG17-Br (0.5 g, 
0.547 mmol) was added to HPMA monomer (target DPn = 20 monomer units; 
1.58 g, 11 mmol) or HPMA monomer (target DP = 30 monomer units; 2.37 g, 
16 mmol).  All reactions were left to polymerise until conversion of > 98% was 
reached (as assessed by 
1
H NMR spectroscopy) and terminated via exposure to the 
atmosphere and addition of approximately 200 mL of methanol whilst maintaining 
sufficient stirring.  The copolymer solution was reduced under vacuum and 
precipitated into cold n-hexane. Molecular weight and molecular weight distributions 
were determined by GPC (THF eluent).   
 
Chapter 5 
262 
 
Initiator 
Target 
DPn 
Target Mn 
(g mol
-1
) 
GPC (THF eluent) 
DPn 
Mn 
(g mol
-1
) 
Mw 
(g mol
-1
) 
Mw/Mn 
       
PEG17-Br 
20 3800 25 4600 6300 1.37 
PEG17-Br 
30 5200 30 5200 6800 1.28 
PEG17-Br 
50 8000 43 7100 8300 1.17 
PEG17-Br 
60 9400 50 8100 9100 1.13 
PEG17-Br 
70 10900 57 9100 10600 1.16 
PEG17-Br 
80 12400 60 9500 11000 1.16 
PEG17-Br 
100 15300 74 11500 13400 1.18 
PEG17-Br 
120 18000 97 14800 17300 1.17 
          
Table 5.3:  Summary of data obtained for the copolymerisations of PEG17-b-p-
(HPMAx). 
The data obtained through analysis of the eight copolymers synthesised using the 
PEG17-Br initiator shown in Table 5.3. DPn  was not analysed via 
1
H NMR 
spectroscopic analysis using the methoxy signal at 3.24 ppm due to extreme 
inaccuracy resulting from peak overlap, due to the water signal in the spectra.  
However, GPC analysis generally (apart from the polymer with a target p(HPMA) of  
DPn = 20 monomer units) gives molecular weights which are lower than those 
predicted; this will be explained later in the section.  Overall, the data suggests 
considerable control has been achieved during each polymerisation, as molecular 
weights increase as target DPn increases whilst maintaining relatively narrow 
molecular weight distributions.   
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Figure 5.14: GPC chromatograms (THF eluent) for PEG17-Br initiated p(HPMA) 
copolymers with target DPn ranging from 20 to 120 monomer units. 
Figure 5.14 shows GPC traces for copolymers with target DPn ranging from 20 to 
120 monomer units which are highly symmetrical. It should be noted that a small 
shoulder appears for copolymers with very low molecular weight (namely DPn = 20 
monomer units), which is likely to be due to termination within the reaction at low 
conversion, directly impacting on the molecular weight distribution (Mw/Mn = 1.37).  
By targeting low molecular weight copolymer chains it is unavoidable that their 
molecular weight distributions will be higher with respect to those with longer 
chains; adding just 3 more monomer units onto a chain (for a target DPn of 20 
monomer units) results in a 15 % molecular weight increase, whereas molecular 
weight increases by < 3 % when applied to a target DPn of 120 monomer units. 
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To demonstrate this further, Figure 5.15 shows the measured dispersities vs. target 
DPn across the range of synthesised polymers; a sharp decrease in molecular weight 
distribution is seen as DPn increases.  By targeting higher DPn  values (> 60 
monomer units), other factors may contribute to the increased molecular weight 
distribution, such as chain termination and or chain coupling due to longer reaction 
times needed to reach > 99 % conversion.   
 
Figure 5.15 Dispersity vs. target DPn for PEG17-Br initiated polymers. (Symbol 
colours are indicative of those used for individual GPC chromatograms in Figure 
5.14). 
Figure 5.16 demonstrates the accuracy of the number average molecular weights 
obtained for the polymers with respect to their targeted molecular weight.  Plots of 
theoretical Mn vs. actual Mn acquired from 
1
H NMR spectroscopy and GPC analysis 
are both linear, suggesting good control is achieved consistently across all 
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synthesised polymers.  Apart from DPn = 20 monomer units, all of the molecular 
weights obtained via GPC are lower than those from 
1
H NMR spectroscopic 
analysis; this is believed to be due to 
1
H NMR spectroscopic analysis accounting for 
all of the initiator added to the reaction, including residual initiator which may not 
have initiated efficiently and have not been removed during purification; the actual 
DPn is unsurprisingly close to the theoretical DPn if this is the case.  However, these 
results are reassuring as it indicates consistently high levels of accuracy being 
achieved in terms of experimental protocols.  GPC analysis does not account for low 
molecular weight unreacted initiators as they are generally undetectable due their 
high elution volume.  
 
Figure 5.16: Target vs. Actual Mn for PEG17-Br initiated copolymers with target DPn 
ranging from 20 to 120 monomer units. 
1
H NMR (squares) GPC (triangles). (Symbol 
colours are indicative of those used for individual GPC chromatograms in Figure 
5.14 and Figure 5.15). 
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As the resultant molecular weights of the synthesised polymers correlate well with 
those predicted, it is suggested that accurate control can be achieved upon varying 
the primary chain length of p(HPMAx).  All polymer GPC chromatograms are 
monomodal and highly symmetrical with molecular weight distributions ranging 
from 1.13 to 1.37 which is typical for linear ATRP polymerisations. Further 
experiments to investigate the upper and lower limits in terms of target DPn where 
ATRP mechanisms begin to fail and control begins to break down have not been 
explored here.  
5.5 Chain Extension of PEG17-b-p(HPMAx) Block 
Copolymer (x = 30, 50, 100)  
The previous section showed that utilising the PEG17-Br initiator to polymerise 
p(HPMA) to various chain lengths was highly successful, due consistently accurate 
molecular weights with respect to their target DPn, alongside kinetic investigations 
confirming reactions were highly controlled and indicative of a controlled ATRP 
mechanism. This section focuses on the attempted chain extension of PEG17-Br 
initiated p(HPMA); analogous to the chain extension experiment reported in Chapter 
3 (section 3.2.3) which utilised EBiB as the initiator and was deemed highly 
successful.  By conducting these current experiments, it is aimed to show that chain 
ends remain active at relatively high conversion and are able to polymerise a second 
batch of HPMA monomer.  These experiments are “self-blocking” polymerisations 
as both monomer batches are identical.  HPMA was polymerised using PEG17-Br to 
three different target DPn values (30, 50 and 100 monomer units) after which a 
second batch of HPMA monomer (equivalent to a DPn of 30 monomer units) was 
added when the polymerisations had reached high conversions (88 % to 98%).  The 
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molar ratio of initiator was kept constant through the experiments and the molar ratio 
of HPMA monomer was changed in order to achieve the correct target DPn. The 
reactions were left until > 98% conversion (as judged by 
1
H NMR), terminated, and 
purified via precipitation into cold n-hexane.  A representation of chain extension is 
shown in Scheme 5.2.  
 
Scheme 5.2: Representation of the chain extension process in methanol for linear 
PEG17-b-p(HPMA30)-b-p(HPMA30) employing PEG17-Br as the initiator.  (Initiator: 
monomer feed is not to scale). 
Performing reaction kinetics was necessary in order to determine approximately at 
what time the second batch of monomer should be added.  If high conversion was 
not reached, there would remain much more un-reacted monomer in the vessel 
(remaining monomer from the first block, plus monomer from second block) leading 
to a much higher molecular weight second block, although the overall calculated 
molecular weight and therefore DPn, would be unaffected.  Conversely, if reactions 
were left to reach full conversion before addition of the second batch, i.e. solely 
consisting of radical containing chain ends, the likelihood of two of these coupling 
(and terminating) is much higher, with the remaining chains still able to propagate 
and consume the available monomer.  This lack of uniformity would ultimately lead 
to a much broader molecular weight distribution.  According to previous reports,
10
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approximately 95% conversion is optimal for chain extension to achieve a high 
blocking efficiency.  Prior kinetic experiments allowed for the determination of time 
taken for reactions to achieve approximately 95 % conversion.  Experimentally, two 
samples were removed from the polymerisation pot after high conversion had been 
reached followed by the addition of a second HPMA monomer feed in quick 
succession.  As kinetic analysis for PEG17-b-p(HPMA30), PEG17-b-p(HPMA80) and 
PEG17-b-p(HPMA120) has been discussed in Section 5.1.2.2, the timing of the second 
monomer feed addition could be approximated as the molar ratios of 
initiator:monomer were kept constant for chain extension experiments. 
Having analysed the pre-experiment kinetic results, three chain extension reactions 
were performed.  As previously stated, samples for GPC measurement were taken as 
the second monomer feed was added and quickly terminated in THF before removal 
of catalyst by addition of resin beads and followed by passing over a small basic 
alumina column. This process was repeated on a larger scale once the polymerisation 
had reached > 99 % conversion where a sample was taken for GPC (THF eluent) 
analysis. 
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Figure 5.17: Triple detection GPC chromatograms for the chain extension of 
p(HPMAx) utilising PEG17-Br initiator.  (A) PEG17-b-(p(HPMA30)-b-p(HPMA30)).  
(B) PEG17-b-(p(HPMA50)-b-p(HPMA30)).  PEG17-b-(p(HPMA100)-b-p(HPMA30)). 
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Figure 5.17 shows the GPC chromatograms for the three chain extension 
experiments.  It should be noted here that the colours utilised in Figure 5.17 (apart 
from PEG17-b-(p(HPMA100)-b-p(HPMA30)) correlate to those used in Figure 5.14.  
The first copolymer blocks (ranging from 88 % to 98 % conversion) all elute at a 
lower retention volumes than the final chain extended copolymers.  The remaining 
monomer is also visible at an elution volume of approximately 21-22 mL; after the 
second monomer feed this peak in Figure 5.17(A)&(B) is almost indistinguishable 
from the baseline.  This un-reacted monomer peak is still visible in Figure 5.17(C) 
which may be due to the reaction reaching a slightly lower conversion (98 %), but 
could also be due to less blocking efficiency, as the target DPn of the first block was 
relatively high (100 monomer units). 
Initiator Target 
DPn 
Target 
Mn 
(g mol
-1
) 
1
H NMR GPC 
   Conv 
(%) 
Mn 
(g mol
-1
) 
DPn 
Mn 
(g mol
-1
) 
Mw 
(g mol
-1
) 
Mw/ 
Mn 
PEG17-Br 30 5100 90 4600 27 4600 4900 1.06 
PEG17-Br 30+30 9400 99 9400 57 9000 9900 1.10 
 (60)        
PEG17-Br 50 8000 98 7800 40 6500 7700 1.19 
PEG17-Br 50+30 12300 99 12300 77 11900 13300 1.12 
 (80)        
PEG17-Br 100 15200 88 13400 86 13200 14900 1.13 
PEG17-Br 100+30 19500 98 19500 117 17600 20200 1.15 
 (130)        
 
Table 5.4: Summarising data obtained from PEG17-Br initiated chain extension 
experiments. 
The data shown in Table 5.4 suggests most of the polymer chains are still capped 
with halogen atoms at high conversion and therefore sufficient chain extension 
occurs.  An Mn = 4600 g mol
-1
 and a dispersity of 1.06 was achieved for a target DPn 
of 30 monomer units for the first batch of HPMA monomer and a final Mn = 9000 
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g mol
-1
.  This figure is approximately twice the initial number average molecular 
weight and the dispersity was virtually unchanged at 1.10.  The GPC chromatograms 
for this experiment (Figure 5.17) indicate high self-blocking efficiencies suggesting 
relatively good controlled radical character under these conditions.  Blocking 
efficiency appears to be reduced as the target DPn increases.  This is shown for a 
final target DPn of 130 monomer units, where a final Mn = 17600 g mol
-1
 is found. 
This is much lower than the expected Mn (19500 g mol
-1
) although the dispersity 
remains low at 1.15; this roughly equates to a chain that is 13 monomer units shorter 
than expected on average. 
The final copolymers show predictable molecular weights with dispersities as low as 
1.06 at 90 % conversion for PEG17-b-p(HPMA30), where shoulders at lower retention 
volumes are not observed within the GPC analysis, indicating negligible termination 
of the p(HPMA) chains, even at high conversion. 
Figure 5.18 demonstrates the reproducibility of PEG17-Br initiated copolymerisations 
and also allows for a direct comparison between linear copolymers and linear chain 
extended copolymers.  By overlaying a copolymer counterpart GPC chromatogram; 
that is a copolymer that was synthesised using a single monomer addition and whose 
target DPn is equal (or similar) to that of the combined target DPn of chain extended 
copolymers, it is clear to see the impact of adding a second batch of monomer to an 
already polymerising reaction. 
 
 
Chapter 5 
272 
 
Figure 5.18: GPC chromatograms of PEG17-Br initiated chain extended HPMA 
polymers (dot-dot-dashed lines) and their linear non-extended counterparts (solid 
lines).  (A) Overall DPn = 60 monomer units. (B) Overall DPn = 80 monomer units. 
(C) Chain extended polymer - overall DPn = 130 monomer units and non-extended 
polymer - overall DPn = 120 monomer units. 
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A near-perfect overlay of GPC chromatograms is seen in Figure 5.18(A) as expected 
due to both copolymers containing virtually the same number of monomer units (60).  
The same near-perfect overlay is found in Figure 5.18(B), where both polymers 
contain approximately 80 monomer units.  Figure 5.18(C) does not show complete 
overlay of the chromatograms as these copolymers have different targeted chain 
lengths.  
 In short summary the synthesis and characterisation of a wide range of p(HPMAx) 
copolymers utilising a variety of PEG based macroinitiators has been reported with 
individual kinetics explored.  Linear copolymers are capable of chain extension 
where little to no termination occurred during multiple reactions.  In conjunction to 
the high blocking efficiencies, reproducibility of copolymer synthesis was 
demonstrated. 
5.6 Synthesis of Branched PEGx-b-(p(HPMAy)-co-EGDMA0.95)) 
Block Copolymers ( x = 17, 45, 113, y= 50, 80, 120) 
In the previous sections it has been shown that methanolic ATRP can be used to 
synthesise linear polymers consisting of p(HPMAx) at various chain lengths utilising 
PEGx-Br based macroinitiators (of different molecular weight).  The facile one pot 
methanolic polymerisation of branched p(HPMAx) using these PEG based 
macroinitiators is described here; reactions are based on the previously reported 
branched polymerisations utilising EBiB as the initiator in Chapter 3 section 3.3 with 
0.95 equivalents of EGDMA brancher employed to yield high molecular weight 
materials with complex branched A-B amphiphilic block copolymer architectures.  
These reactions were carried out at ambient temperatures and 50 w/v % 
(initiator+monomer/solvent) and left to polymerise until > 99% conversion (judged 
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by 
1
H NMR spectroscopy) followed by manual termination via exposure to the 
atmosphere and addition of methanol.  
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Figure 5.19: Representation of the targeted branched p(HPMAx) copolymers utilising PEGx-Br based macroinitiators. 
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Figure 5.19 displays representations of branched copolymer structures utilising 
PEGx-Br macroinitiators and demonstrating the architectural effect of varying both 
components of the copolymer.  For example, the overall target molecular weight of 
the linear copolymer in PEG113-b-(p(HPMA120)-co-EGDMA0.95)) (bottom right of 
Figure 5.19) is approximately three times higher than that in PEG17-b-(p(HPMA50)-
co-EGDMA0.95)) (top left of Figure 5.19).  Providing that the branching process is 
unaffected by these various initiators, this indicates that the former branched 
copolymer should generate much higher molecular weight material.  This 
representation aims to highlight the various branched structures synthesised by 
altering two parameters (ethylene oxide repeat units in the initiator, and HPMA 
monomer feed).  Unlike their linear counterparts, a target Mn of the overall polymer 
sample cannot be determined due to the inclusion of a brancher molecule (EGDMA) 
which covalently links otherwise linear chains.  The number of chains involved in 
these branched structures cannot be predicted as EGDMA is incorporated 
statistically, however, the primary chains of the branched architectures will be 
monodisperse and have the target Mn values of the linear materials produced in the 
absence of EGDMA. In Chapter 3 section 3.3, analysis showed that the distribution 
of molecular weight for branched materials is extremely high, suggesting 
copolymers do not consist of solely x number of primary chains.  It should be noted 
that the copolymer representations in Figure 5.19 contain four primary p(HPMAx) 
chains which was simply for demonstrative purposes.  A total of nine branched 
copolymers were synthesised containing PEGx (x = 17, 45, 113) and p(HPMA) 
where target DPn = 50, 80, 120 monomer units.  No visual gelation occurred and as 
such triple detection GPC (THF eluent) was performed.  These chromatograms are 
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shown in Figure 5.20. 
 
Figure 5.20: GPC chromatograms of PEGx-Br initiated branched p(HPMA) 
copolymers.  (A) PEG17-b-(p(HPMAx)-co-EGDMA0.95)) (B) PEG45-b-(p(HPMAx)-
co-EGDMA0.95)) (C) PEG113-b-(p(HPMAx)-co-EGDMA0.95)).  X = 50 (solid lines), X 
= 80 (medium dashed lines) X = 120 (small dashed lines). 
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Figure 5.20 suggests high molecular weight materials have been synthesised, due to 
the detection of  large concentrations of material eluting at low retention volumes.  It 
should be noted that Figures 5.20 (A), (B) and (C) are shown with the same retention 
volume scales, as such, it is apparent that increasing the molecular weight of the 
PEG initiator hinders the production of extremely high molecular weight material.  
For example, PEG17-b-(p(HPMA120)-co-EGDMA0.95)) begins to elute at 
approximately 14 mL whereas PEG113-b-(p(HPMA120)-co-EGDMA0.95)) begins to 
elute at 16.2 mL, indicative of lower molecular weight materials; this will be 
discussed later in the section.  
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Sample 
Mn (g mol
-1
) 
(GPC) 
Mw (g mol
-1
) 
(GPC) 
Mw/Mn 
(GPC) 
Conversion 
(%) 
     
PEG17-b-(p(HPMA50)-co-
EGDMA0.95)) 
57200 150400 2.63 > 99 
PEG17-b-(p(HPMA80)-co-
EGDMA0.95)) 
76500 274600 3.59 > 99 
PEG17-b-(p(HPMA120)-co-
EGDMA0.95)) 
95900 448800 4.68 > 99 
     
PEG45-b-(p(HPMA50)-co-
EGDMA0.95)) 
43300 110400 2.55 > 99 
PEG45-b-(p(HPMA80)-co-
EGDMA0.95)) 
45900 137200 2.99 > 99 
PEG45-b-(p(HPMA120)-co-
EGDMA0.95)) 
52400 163500 3.12 > 99 
      
PEG113-b-(p(HPMA50)-co-
EGDMA0.95)) 
45400 118500 2.61 > 99 
PEG113-b-(p(HPMA80)-co-
EGDMA0.95)) 
47800 119900 2.51 > 99 
PEG113-b-(p(HPMA120)-co-
EGDMA0.95)) 
49600 135900 2.74 > 99 
     
Table 5.5: Summary of the data obtained for the copolymerisations of PEGx-b-
(p(HPMAy)-co-EGDMA0.95)) where x = 17, 45, 113 and y = 50, 80, 120. 
The data presented in Table 5.5 for all nine branched copolymers demonstrates that 
despite each copolymer containing EGDMA, weight average molecular weights vary 
dramatically from 110400 to 163500 g mol
-1
, as well as molecular weight 
distribution (2.5 to 4.7).  On average, the highest molecular weights are obtained 
when utilising the lowest molecular weight initiator (PEG17-Br), which also has the 
broadest molecular weight distributions.  The data suggests that the PEG based 
macroinitiators are in some way directing the branching process.  Intuitively, the 
working hypothesis assumed that, if the branching is independent of initiator 
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structure and/or molecular weight, the highest molecular weight copolymers should 
be PEG113-b-(p(HPMA120)-co-EGDMA0.95)).  As this is not the case here, it is 
assumed that branching is hindered as the molecular weight of the initiator increases.  
This observation will be discussed in more detail later in the section. 
5.7 Reproducibility of Branched Copolymer Synthesis 
It was questioned whether the systematic variation in the shape of the GPC 
chromatograms seen in the previous section were in fact due to the effect of the 
initiator molecular chain length and whether the statistical branching process was 
reproducible.  What can is evident from Figures 5.21, 5.22 and 5.23 are three distinct 
sections within each of the chromatograms, the first section (at high retention 
volumes) is attributed to linear material, following with lightly branched material 
and finally high molecular weight material (at low retention volumes).  As the 
molecular weight of the initiator increases, GPC traces fail to reach extremely low 
retention volumes, indicative of very highly branched polymers.  In order to 
determine whether this is a true trend, each polymerisation was conducted again.  It 
should be noted that these polymerisations were conducted at ambient temperature 
and reproducibility experiments were performed after a considerable time period, 
using different batches of HPMA, EGDMA and catalyst/ligand. The experimental 
protocol was, however, identical. 
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Figure 5.21: Repeat GPC Chromatograms (THF eluent) of PEG17-b-(p(HPMAx-co-
EGDMA0.95).  A) PEG17-b-(p(HPMA50-co-EGDMA0.95). B) PEG17-b-(p(HPMA80-
co-EGDMA0.95). C) PEG17-b-(p(HPMA120-co-EGDMA0.95). 
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Figure 5.22: Repeat GPC Chromatograms (THF eluent) of PEG45-b-(p(HPMAx-co-
EGDMA0.95).  A) PEG45-b-(p(HPMA50-co-EGDMA0.95). B) PEG45-b-(p(HPMA80-
co-EGDMA0.95). C) PEG45-b-(p(HPMA120-co-EGDMA0.95). 
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Figure 5.23: Repeat GPC Chromatograms (THF eluent) of PEG113-b-(p(HPMAx-co-
EGDMA0.95).  A) PEG113-b-(p(HPMA50-co-EGDMA0.95). B) PEG113-b-(p(HPMA80-
co-EGDMA0.95). C) PEG113-b-(p(HPMA120-co-EGDMA0.95). 
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Clearly from all of the above chromatograms the repeat polymerisations give 
extremely similar RI traces in their GPC analysis.  This data suggests that despite 
time/temperature and reagent differences, the branching process is near identical 
when utilising the same PEGx-Br initiator.  The results show that these 
polymerisations are robust and reproducible and no report of similar analysis can be 
found in the literature. 
5.8 Further Analysis of Branched Copolymer Architecture 
As previously noted, distinct peaks exist at high retention volumes which we can 
attributed to linear material being present within these branched copolymer samples.  
This occurs within all nine branched copolymers, however, a linear p(HPMA) and a 
branched copolymer with the same target DPn = 80 monomer units was chosen to 
highlight this in Figure 5.24.  Again, this is analysis correlates well to the branched 
copolymers previously synthesised in Chapter 3 (section 3.3), which utilised EBiB as 
the initiator.  This data is in good agreement with the Monte Carlo modelling of 
monovinyl and divinyl monomers reported by Armes and co-workers
11
 which 
predicts that a multitude of different structures are obtained during the branching 
process; including linear material.  What is also apparent from Figure 5.24 is the 
occurrence of low molecular weight shoulders within the branched copolymer 
chromatograms which appear  to increase in size as the molecular weight of the 
initiator increases, believed to be due to termination during early stages of 
polymerisation (unlike in their linear counterparts).  The exact source of the 
observed peaks is unknown.   
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Figure 5.24: GPC (THF eluent) chromatograms of linear and branched p(HPMA80) 
utilising PEGx based initiators.  A) PEG17-Br B) PEG45-Br C) PEG113-Br. 
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Figure 5.25 shows multiple detector analyses of three branched copolymers with 
p(HPMA) primary chain lengths of 80 monomer units with varied PEGx-Br 
macroinitiators.  Refractive Index response (RI) is essentially concentration based, 
and as such, the fraction of linear material decreases with respect to higher molecular 
weight material as the molecular weight of the initiator increases based on peak 
heights.  By analysing the Right Angle and Low Angle Light Scattering detectors 
(RALS and LALS) (where materials with larger hydrodynamic volumes scatter much 
more light (with a scattering dependence proportional to the particle radius
6
) the 
majority of the copolymer samples have a branched architecture where scattering at 
lower retention volumes within all three copolymer samples is observed.  The 
Intrinsic Viscosity (IV) detectors show the majority of scattering exists at lower 
retention volumes throughout these samples.  This is due to branched materials 
having increased viscosity, in comparison to linear architectures, due to the increased 
molecular weight.  In short summary, by taking into account all of the detector 
responses during triple detection GPC analysis of these branched copolymers, the 
presence of linear material is confirmed yet, significant proportions of the materials 
have high molecular weights and are believed to have branched architectures.      
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Figure 5.25: GPC chromatograms of PEGx-b-(p(HPMA80)-co-EGDMA0.95)).  RALS 
(blue line), LALS (red line) and Intrinsic Viscosity (green line). A) PEG17 RI (dark 
red dashed line). B)  PEG45 RI (dark green dashed line). C) PEG113 RI (dark blue 
dashed line) 
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5.9 Copolymerisation Kinetic Studies for PEGx-b-
(p(HPMA80)-co-EGDMA0.95)) (x = 17, 45, 113 ) 
It has been shown that high molecular weight copolymers consisting of various 
molecular weight PEG based macroinitiators can be synthesised using methanolic 
ATRP by the addition of an EGDMA brancher.  To determine whether these 
polymerisations proceed in a controlled manner, it was necessary to perform reaction 
kinetics.  All three PEGx-Br macroinitiators were used to synthesise p(HPMA) to one 
target DPn (80 monomer units) with the addition of EGDMA (0.95 equivalents).  
These were carried out under identical conditions to those used for their linear 
counterparts.  Regular sampling was performed, where aliquots were analysed by 
1
H 
NMR spectroscopy and triple detection GPC (THF eluent).  Reactions proceeded to 
> 99 % conversion after which they were manually terminated.   
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Figure 5.26: Kinetic studies of branched p(HPMA80) using PEG based 
macroinitiators.  A)  Conversion vs. Time.  PEG17-Br (dark red), PEG45-Br (dark 
green), PEG113-Br (dark blue).  B) Semi-logarithmic plot.  PEG17-Br (dark red), 
PEG45-Br (dark green), PEG113-Br (dark blue). 
 
Figure 5.26(A) shows conversion vs. time plots for each polymerisation conducted. 
All three graphs show the characteristic curvature synonymous with ATRP 
mechanisms, where the majority of the monomer feed is consumed within a short 
period of time due to the high concentration of unreacted monomer, in the early 
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stages of polymerisation.  After approximately 80 % conversion, the rate of monomer 
conversion decreases, due to the depletion of HPMA monomer in conjunction with 
the increased viscosity of solution, until extremely high conversions are reached 
(where it is believed reactions are mainly diffusion controlled).  It should be noted 
that the copolymerisation which utilises PEG17-Br reaches > 99 % conversion in a 
significantly shorter space of time when compared to the other copolymerisations.  
This behaviour is identical to that seen for their linear counterparts, which is 
attributed to differences in viscosity, where the molecular weight of this initiator is 
significantly less than that of the other initiators.  It is thought PEG17-Br has 
increased chain mobility (compared to PEG45-Br and PEG113-Br), and therefore 
chains are able to polymerise at a faster rate.  The semi logarithmic plot for PEG17-b-
(p(HPMA80)-co-EGDMA0.95)), shown in Figure 5.26(B), is linear with respect to 
time although the other plots curve downwards slightly at higher reaction times, 
suggesting some termination is occurring during the later stages of copolymerisation. 
As these reactions take upwards of 80 hours to reach extremely high conversion, and 
coupled with the extremely high viscosity (due to the high molecular weight 
branched structures), the probability of active chain ends coupling with each other is 
higher than the probability of monomer addition.   
Despite these discrepancies, data suggests that branched polymerisations follow a 
conventional ATRP mechanism.  It is believed that this is the first report on the study 
of branched copolymers which utilise PEGx-Br (or indeed any) macroinitiators.  In 
Chapter 3 (section 3.3.1), linear and branched kinetics data was compared (utilising 
EBiB as the initiator), indicating that the branched copolymerisation proceed at 
slightly slower rates compared to linear counterparts. Having now reported both 
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linear and branched analogues for copolymerisations utilising PEG based 
macroinitiators, kinetics data results can be compared (shown in Figure 5.27). 
 
Figure 5.27: Kinetics plots for linear (open symbols) and branched (full symbols) 
copolymerisations of p(HPMA80) using various PEG macroinitiators. A) PEG17-Br, 
B) PEG45-Br, C) PEG113-Br.    
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Figure 5.27 clearly shows near identical kinetics data obtained for linear and 
branched copolymerisations utilising PEG macroinitiators, despite varying the 
molecular weight of the initiator.  This consistent behaviour leads to the conclusion 
that, incorporation of EGDMA has absolutely little to no effect on reaction kinetics 
when compared to linear analogues in systems also containing PEGx-Br initiators.  
This is somewhat surprising, but nevertheless the data highlights the capabilities of 
these macroinitiators.   
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Figure 5.28: Evolution of Mw with conversion.  A) PEGx-b-(p(HPMA80)-co-
EGDMA0.95)) PEG17-Br (dark red), PEG45-Br (dark green), PEG113-Br (dark blue).  
B) PEG17-b-p(HPMA80) (red) and PEG17-b-(p(HPMA80-co-EGDMA0.95) (dark red). 
 
Figure 5.28 (A) shows the high molecular weights achieved during these branched 
copolymerisations utilising PEG macroinitiators.  The molecular weights of each 
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copolymerisation begins to increase dramatically after approximately 85 % 
conversion has been reached; indicative of the covalent linking of polymer chains 
dominating the latter stages of copolymerisation, where monomer feed has become 
almost exhausted.  This is in complete agreement with the results in Chapter 3 
(section 3.3.1).  The comparison between the evolution of molecular weight in linear 
and branched systems which both employ a PEGx-Br macroinitiator is shown in 
Figure 5.28(B).  This highlights the very different development of weight average 
molecular weight when utilising EGDMA in the initial monomer feed.   
 
5.9.1 Comparison of p(HPMA80)-co-EGDMA0.95 and PEG17-b-
(p(HPMA80)-co-EGDMA0.95)) Reaction Kinetics. 
The controlled branched copolymerisations of p(HPMAx) utilising PEG based 
macroinitiators have been discussed where trends in kinetic data are attributed to 
changes in the molecular weight (or number of ethylene oxide repeat units) in the 
PEG based macroinitiators.  Here, the branched reaction kinetics of p(HPMA80) 
utilising EBiB and PEG17-Br as initiators are compared.  Unfortunately, due to their 
significant reaction times, it was not possible to include the reaction kinetics 
employing PEG45-Br and PEG113-Br on the same graph scales.      
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Figure 5.29: Kinetics plots for p(HPMA80)-co-EGDMA0.95 (black symbols) and 
PEG17-b-(p(HPMA80)-co-EGDMA0.95)) (dark red symbols). 
Figure 5.29 shows the marked difference in reaction kinetics between the two 
copolymerisations.  Quite surprisingly, much more monomer is consumed during the 
early stages of polymerisation when the PEG based macroinitiator is employed, 
suggesting this initiator is more efficient than EBiB.  The rate of reaction is much 
faster when utilising PEG17-Br in comparison to EBiB, due to its steeper gradient.  
However, no solid conclusions can be drawn from this set of data due to 
concentration differences with respect to catalyst/ligand within the reactions. This 
concentration difference is unfortunately unavoidable, as the volume of solvent used 
is based on the mass of the initiator (and monomer) and as this has changed, the 
concentration of catalyst/ligand is also changed.   Both reactions were conducted at 
ambient temperature and this also could have affected the rate of polymerisation.  
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. 
Figure 5.30: GPC chromatograms of kinetics studies for branched 
copolymerisations. A) p(HPMA80)-co-EGDMA0.95 B) PEG17-b-(p(HPMA80)-co-
EGDMA0.95)). 
In the previous section it was found that as the molecular weight of the initiator 
increases, the ability to generate extremely high molecular weights decreases.  To 
demonstrate this effect, Figure 5.30 shows GPC traces for kinetic experiments 
performed using EBiB, Figure 5.30(A), and PEG17-Br, Figure 5.30(B), initiators 
where the development of branching within the systems can be seen.  Figure 5.30(A) 
shows that the development of branching is occurring even at extremely high 
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conversions, indicated by the tailing of the RI trace at low retention volumes.  In 
stark contrast to this, when utilising PEG17-Br, Figure 5.30(B), little to no branching 
occurs at these high molecular weights, although the proportion of high molecular 
weight material in comparison to linear is much higher.   
 
Figure 5.31: GPC chromatograms of branched copolymers at different stages of 
polymerisation.  p(HPMA80)-co-EGDMA0.95 (black traces), PEG17-b-(p(HPMA80)-
co-EGDMA0.95)) (red traces).  RI detector responses (A) and (B), RALS detector 
responses (C) and (D). 
Along with their RI detector responses, Figure 5.31 also shows the response from the 
RALS detector at two selected times during branched copolymerisations, where 
different initiators are employed.  When EBiB is employed, significant tailing at high 
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conversion is seen in both detectors, whereas when PEG17-Br is utilised no tailing is 
observed.  It should be noted here that the RALS detector evaluates the amount of 
light scattering and is therefore heavily weighted towards larger (higher molecular 
weight) materials, and as such, little scattering due to low molecular weight material 
is expected, as observed in Figure 5.31(D). After 7 hours, a significant proportion of 
linear and lightly branched material is apparent, in contrast to Figure 5.31(C). This 
suggests that branching is somewhat hindered when utilising PEG based 
macroinitiators under these conditions. 
 
Figure 5.32: Evolution of Mn during p(HPMA80)-co-EGDMA0.95 (black) and PEG17-
b-(p(HPMA80)-co-EGDMA0.95)) copolymerisations. 
Alongside the GPC traces, the lack of tailing at low retention volumes is seen in 
Figure 5.32 suggests that utilising the PEG17-Br initiator (and under near identical 
reaction conditions) extremely high molecular weight is not achieved, when 
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compared to the copolymerisation utilising EBiB.  This suggests PEGx-Br initiators 
in some way direct the branching process within these systems.  In conjunction to 
this, as the molecular weight of the initiator increases, the system becomes 
increasingly unable to achieve highly branched materials.  The exact reason or 
reasons for this are unknown, but it is likely that as the viscosity of the solution 
(increasing as PEG chain length increases), the active chain ends become hidden 
within the branched copolymer structure and are therefore unable to react with 
pendant vinyl groups, or even another active chain end of another branched 
copolymer. It may also be possible that the increasing size of the macroinitiator may 
prevent the physical proximity of chains required to generate intermolecular 
branching. If this is true, some cyclisation or abstraction of protons from the 
surrounding solution may be occurring and preventing copolymers reaching the 
extreme molecular weights seen when using EBiB as the initiator. 
5.10  Summary 
In this chapter it has been shown that a series of linear copolymers with varying 
PEGx-Br initiators as well as varying p(HPMAx) primary chain length, can be 
synthesised using identical conditions to the EBiB initiated homopolymers 
synthesised in Chapter 3 (section 3.2), with individual kinetics data interpreted.  The 
target primary chain length can be adjusted, yielding polymers with narrow 
molecular weight distributions and highly accurate targeted molecular weights.  It 
has been shown that copolymer chains can be extended using a “self-blocking” 
technique, producing polymers with accurate molecular weights.  The branching of 
these polymers has been performed (using EGDMA) with no experimental difficulty, 
supported by kinetic data, where high molecular weights soluble polymers can be 
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prepared.  The difference in the branching process (characterised by GPC analysis) 
has been compared to that observed in Chapter 3 (section 3.3.1).  Based on 
experimental results, there is a direct link between the chain length of the PEG based 
macroinitiator and the resultant molecular weight of the final branched copolymers. 
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6. Synthesis of loaded and un-loaded Polymeric 
Nanoparticles using PEG Copolymers 
6.1 Introduction 
In Chapter 4 section 4.4.12, it was found that extremely stable nanoparticles 
consisting solely of branched p(HPMAx) could be prepared using a rapid 
precipitation approach from acetone (see Chapter 2 section 2.5.1.1).  It is believed 
their stability arises due to charge stabilisation and the branched architecture of the 
polymers. Through the variation of concentration of dissolved polymer in acetone 
and also the final nanoparticle concentration in water, their z-average diameters 
could be controlled.  In this section, nanoprecipitation (from acetone) of branched 
PEGx containing copolymers (see synthesis and characterisation in Chapter 2 section 
2.4.2) is explored in order to determine whether the same degree of control of z-
average diameter is found.  
 It should be noted the reason for the absence of loaded nanoparticles consisting of 
linear copolymers is twofold; 1. All nanoprecipitation of linear copolymers produced 
size distributions with bimodal traces.  2. Similar to results in Chapter 4, these 
nanoparticles were not stable for significant periods of time with precipitation 
evident after 2 days.  As these polymers exert partial aqueous solubility (due to the 
PEGx content in the polymers) it was anticipated that nanoparticles would be more 
stable (with respect to time) in comparison to their non-PEGx containing linear 
counterparts; however, this was not the case and precipitation of polymer (regardless 
of DPn) was observed after just two days.   
Chapter 6 
302 
 
The rationale of branched polymer nanoparticle formation will be discussed and 
compared to non-PEGx containing nanoparticle formation.  Following this 
discussion, investigation into the loading capabilities of the particles will be explored 
with DLS size analysis.  This was achieved through co-dissolving candidate 
materials within the original polymer/acetone solution followed by identical 
nanoprecipitation protocols used for blank particle formation. 
6.2 Rapid nanoprecipitation of PEGx-b-p(HPMAy) where x= 
17, 45, 113 and y = 50, 80, 120 
Nanoparticles containing linear PEGx containing p(HPMAx) copolymers were 
generated using the rapid precipitation method described in the Chapter 2 section 
2.5.1.1 with a starting copolymer concentration of 10 mg mL
-1
 in acetone. Each of 
the nine previously synthesised copolymers were diluted five-fold into warmed 
water, giving a final aqueous concentration of 2 mg mL
-1
.   After acetone removal, 
dynamic light scattering was used to determine z-average diameters of resultant 
nanoparticles.  It should be noted that the recorded sizes are an average of six 
measurements and although precipitation occurred after approximately two days 
these measurements were performed after one day of preparation and as such the 
data met the quality criteria for successful size determination (i.e. aggregation was 
not observed).  
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Figure 6.1: DLS measurements for linear PEGx copolymer nanoparticles using a 
rapid precipitation approach varying p(HPMAx) primary chain length. (10 mg mL
-1
 
starting concentration, 2 mg mL
-1
 final concentration).  A) PEG17 B) PEG45 C) 
PEG113. 
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Copolymer 
Peak 1 
Diameter 
(nm)*
a
  
Peak 2 Diameter 
(nm)*
b 
Polydispersity 
Index*
c 
    
PEG17-b-p(HPMA50) 136 837 0.674 
PEG17-b-p(HPMA80) 168 568 0.269 
PEG17-b-p(HPMA120) 126 461 0.238 
PEG45-b-p(HPMA50) 70 348 0.270 
PEG45-b-p(HPMA80) 104 610 0.429 
PEG45-b-p(HPMA120) 79 765 0.643 
PEG113-b-p(HPMA50) 31 107 0.142 
PEG113-b-p(HPMA80) 56 141 0.167 
PEG113-b-p(HPMA120) 53 134 0.156 
 
Table 6.1: DLS analysis of nanoparticles comprised of PEGx containing linear 
copolymers prepared by rapid precipitation.  10 mg mL
-1
 starting concentration, 2 
mg mL
-1
 final concentration.   *
a
 peak with smallest diameter, *
b
 peak with largest 
diameter, *
c
 of both peaks. 
Figure 6.1 (A-C) clearly shows the lack of monomodality and also of any apparent 
trends due to either variation of PEGx or p(HPMAx) chain length.  This data shows 
that near identical behaviour to the linear p(HPMAx) containing nanoparticles (see 
Chapter 4 section 4.4) is observed here; although these nanoparticles contain PEGx 
stabilising chains this does not appear to aid in producing particles within  a uniform  
size range.  It is noted that there are particles generated which are approximately 100 
nm in size which is consistent with previous nanoparticle sizes (see Chapter 4 
section 4.4) yet much larger particles are also formed (> 100 nm) when utilising 
PEG45 and PEG113 macroinitiators regardless of the primary chain length of 
p(HPMAx) (Figure 6.1 (A) and (B)).  By utilising PEG17 two size distributions are 
found but both have much narrower polydispersities compared to PEG45, where 
traces are not as well-defined. This can only be attributed to the influence of the 
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larger PEGx chains as identical experimental protocols were followed.  Increasing 
PEGx chain length, resultant nanoparticles have much narrower polydispersities 
regardless of DPn, (e.g. 0.142 for PEG113-b-p(HPMA50) compared to 0.27 for PEG45-
b-p(HPMA50) and do not produce larger nanoparticles, as shown in Table 6.1.  This 
behaviour is believed to be due to the high aqueous solubility of these polymers; 
however, the exact reasons are unknown.   
6.3 Nanoprecipitation of PEGx-b-p(HPMA80) using the dialysis 
method  where x= 17, 45, 113 
Dialysis was performed on the linear copolymers PEG17-b-p(HPMA80), PEG45-b-
p(HPMA80) and PEG113-b-p(HPMA80) to determine whether this method would 
produce well-defined and stable nanoparticles, when compared to the rapid 
precipitation approach.  This process allows copolymers to progressively arrange 
themselves into the most energetically stable structure(s) through the loss of 
solubility and can be thought of as a thermodynamic process; in contrast, the rapid 
precipitation approach subjects the copolymers to a quick solvent switch and the 
chains must therefore quickly arrange themselves into structures. This may be 
thought of as a kinetic-driven process.  As described in Chapter 2 section 2.5.1.1, 
copolymers were first dissolved in acetone at 10 mg mL
-1
 and slowly dripped into 
warmed stirring water to give a final copolymer concentration of 2 mg mL
-1
 and the 
mixtures were carefully poured into sections of dialysis tubing, placed into large 
water filled beakers for two days and the surrounding sink water was changed 
approximately every eight hours. The use of slow dropping method was due to a 
range of literature reports that also describe this approach for amphiphilic A-B linear 
block copolymers.
1
  Size determination was performed on the nanoparticulate 
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solutions without further purification and/or filtration and measurement data is 
displayed in Figure 6.2 and Table 6.2. 
 
Figure 6.2: DLS size determination of nanoparticles comprising of PEGx containing 
linear copolymers using dialysis.  10 mg mL
-1
 starting concentration, 2 mg mL
-1
 final 
concentration. 
Copolymer 
Peak 1 
Diameter 
(nm)*
a
  
Peak 2 Diameter 
(nm)*
b 
Polydispersity 
Index*
c 
    
PEG17-b-p(HPMA50) 322 1569 0.293 
PEG45-b-p(HPMA80) 
PEG113-b-p(HPMA80) 
168 1040 0.562 
27 1090 1 
Table 6.2: DLS size data of nanoparticles consisting of PEGx containing linear 
copolymers prepared by dialysis. 10 mg mL
-1
 starting concentration, 2 mg mL
-1
 final 
concentration. *
a
 peak with smallest diameter. *
b
 peak with largest diameter, *
c
 of 
both peaks. 
Chapter 6 
307 
 
It is clear from Figure 6.2 and Table 6.2 that this dialysis route was not able to 
achieve monomodal nanoparticle samples, regardless of the PEGx initiator used to 
prepare the A-B block copolymers.  However, only a small peak at 322 nm is found 
using copolymers containing PEG17, and the majority of particles are approximately 
1569 nm in size.  It is noted that for each polymer, Peak 1 not only decreases in size 
but also increases in intensity (relative to the corresponding Peak 2) as the molecular 
weight of PEGx increases.  The exact reason for this is unknown; however, it is likely 
to be due to the inherent solubility of the copolymers (i.e. increasing with increasing 
PEGx molecular weight).  In an effort to optimise the dialysis approach and produce 
single distributions of particles (with varying PEGx content) a lower starting 
concentration of polymer/acetone solution was chosen (5 mg mL
-1
), however, the 
experimental protocol remained whereby the solution was diluted five-fold achieving 
a final concentration of 1 mg mL
-1
.  It was thought by reducing the initial 
polymer/acetone solution the formation of particles would be more controlled as the 
particles form from a more dilute solution.  
By reducing the initial polymer/acetone concentration it is found that generally 
smaller particles form despite experimental protocols remaining the same (Figure 6.3 
and Table 6.3.  The largest nanoparticles are formed utilising PEG45, generating 
nanoparticles which are approximately 590 nm in diameter (compared to 1569 nm, 
using a starting concentration of 10 mg mL
-1
).  Perhaps the most marked difference 
is found between particle diameters comprising of PEG113-b-p(HPMA80) where not 
only monomodality has been achieved but nanoparticle size has been reduced by 
almost 1000 nm by simply altering the polymer/acetone concentration.   
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Figure 6.3: DLS size determination of nanoparticles comprising of PEGx containing 
linear copolymers using dialysis.  5 mg mL
-1
 starting concentration, 1 mg mL
-1
 final 
concentration. 
Copolymer 
Peak 1 
Diameter 
(nm)*
a
  
Peak 2 Diameter 
(nm)*
b 
Polydispersity 
Index*
c 
    
PEG17-b-p(HPMA80) 379 / 0.250 
PEG45-b-p(HPMA80) 
PEG113-b-p(HPMA80) 
99 587 0.465 
98 / 0.261 
Table 6.3: DLS size data of nanoparticles consisting of PEGx containing linear 
copolymers prepared by dialysis. 5 mg mL
-1
 starting concentration, 1 mg mL
-1
 final 
concentration. *
a
 peak with smallest diameter. *
b
 peak with largest diameter, *
c
 of 
both peaks. 
The concentration of the initial polymer/acetone solution clearly has a direct impact 
on resultant nanoparticle diameters (regardless of PEG chain length). As previously 
noted, the exact mechanism of particle formation is unknown, yet it is speculated 
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that the materials generated by the linear polymers are uncontrolled in their 
formation and can generate mixed populations. The previous dialysis techniques 
involved the slow addition of polymer/acetone solutions (at either 10 mg ml
-1
 or 5 
mg mL
-1
) into warmed stirring water achieving a five-fold dilution (2 mg mL
-1
 or 1 
mg mL
-1
); experimentally this is time consuming and syringe pumps were utilised.  
It was questioned whether similar size distributions of resultant nanoparticles would 
be found if rapid precipitation approach of polymer/acetone was employed into 
water, followed by dialysis.  A starting concentration of 5 mg mL
-1
 was chosen as 
this produced the smallest nanoparticles (regardless of PEGx) and DLS size data is 
shown in Figure 6.4 and Table 6.4. 
 
Figure 6.4:  DLS size determination of nanoparticles comprising of PEGx containing 
linear copolymers using a modified dialysis approach .  5 mg mL
-1
 starting 
concentration, 1 mg mL 
-1
 final concentration. 
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Copolymer 
Peak 1 
Diameter 
(nm)*
a
  
Peak 2 Diameter 
(nm)*
b 
Polydispersity 
Index*
c 
    
PEG17-b-p(HPMA80) 87 477 0.261 
PEG45-b-p(HPMA80) 
PEG113-b-p(HPMA80) 
65 441 0.361 
56 / 0.162 
Table 6.4: DLS size data of nanoparticles consisting of PEGx containing linear 
copolymers prepared by a modified dialysis approach.  5 mg mL
-1
 starting 
concentration, 1 mg mL
-1
 final concentration. *
a
 peak with smallest diameter. *
b
 peak 
with largest diameter, *
c
 of both peaks. 
This experiment has shown that there is little difference in the shapes of size 
distributions by employing a rapid precipitation (followed by dialysis), rather than a 
slow dripping method (followed by dialysis).  For example, both PEG17 and PEG45 
contain material < 100 nm with intensity increasing with PEGx molecular weight.  A 
difference of only 42 nm is found for PEG113-b-p(HPMA80), and in both experiments 
their traces are monomodal.  These findings may be important in nanoparticle 
formation containing polymers which cannot be formed by rapid nanoprecipitation 
alone i.e. using dialysis. 
Despite these experiments, all of the nanoparticle suspensions began to precipitate 
after approximately two days, due to polymer aggregation (as seen for non-PEGx 
containing p(HPMAx) nanoparticles in Chapter 4 section 4.3.  It is believed that the 
hydrophobic linear chains do not pack efficiently within the nanoparticle core and 
stability is not provided in spite of the stabilising ethylene glycol repeat units 
present; therefore these groups do not provide sufficient steric stability to the final 
nanoparticles. 
Chapter 6 
311 
 
Stable and near monodisperse amphiphilic block copolymer micelles have been 
reported, which were prepared by dialysis using a polymer concentration of 10 mg 
mL
-1
 (in various organic solvents).
2
  However, after nanoparticle preparation, 
solutions were subjected to sonication and centrifugation prior to resuspension.  The 
authors report that these micelles are stable with respect to time, but fail to note the 
aqueous concentration of micelles in their studies.  Therefore, it is believed further 
purification of PEGx-b-p(HPMAy) nanoparticles (prepared by dialysis)  may result in 
more monodisperse and stable suspensions.  As this is extremely time consuming, no 
further modification was investigated.  
6.4 Nanoprecipitation of PEGx-b-(p(HPMA80)-co-EGDMA0.95)) 
using the dialysis method where x= 17, 45, 113   
In the previous section it was found that unstable nanoparticles with mostly bimodal 
size distributions resulted when utilising linear copolymers containing various PEGx 
molecular weights and PEG/p(HPMA) ratios. In this section, the primary chain 
length of the p(HPMA80) block remains constant yet the molecular weight of PEGx is 
varied within the branched A-B block copolymer samples.  It was thought that the 
branched architecture of p(HPMA80) copolymers combined with the water soluble 
PEGx segments (of various molecular weight), would produce stable uniform 
nanoparticles through a dialysis approach.   
A starting concentration of 10 mg mL
-1
 was chosen; although this concentration did 
not aid in producing stable nanoparticles from the linear examples, the architecture 
of these polymers (and the overall molecular weights) is dramatically different and it 
would have been presumptuous to assume these materials behave in the same 
manner.  It was thought that the branched cores would provide sufficient stability in 
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subsequent nanoparticles, and would perhaps be less affected by this relatively high 
starting polymer/acetone concentration, in comparison to linear polymer 
counterparts.  Identical protocols were followed, whereby polymer/acetone solutions 
were slowly dripped into warmed stirring water followed by addition into dialysis 
membrane tubes followed by water exchange for two days.   Nanoparticle 
suspensions were analysed using DLS and the data obtained is shown in Figure 6.5 
and Table 6.5. 
 
Figure 6.5:  DLS size determination of nanoparticles comprising of PEGx containing 
branched copolymers using dialysis.  10 mg mL
-1
 starting concentration, 2 mg mL
-1
 
final concentration. 
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Copolymer 
Peak 1 
Diameter 
(nm)*
a
  
Peak 2 
Diameter 
(nm)*
b 
Peak 3 
Diameter 
(nm)*
b
 
Polydispersity 
Index*
c 
     
PEG17-b-(p(HPMA80)-co-
EGDMA0.95)) 
392 
/ / 0.282 
PEG45-b-(p(HPMA80)-co-
EGDMA0.95)) 
PEG113-b-(p(HPMA80)-co-
EGDMA0.95)) 
79 519 3043 0.588 
35 250 792 0.809 
 
Table 6.5: DLS size data of nanoparticles consisting of PEGx containing branched 
copolymers prepared by dialysis (10 mg mL
-1
 starting concentration, 2 mg mL
-1
 final 
concentration). *
a
 peak with smallest diameter. *
b
 peak with largest diameter, *
c
 of 
both peaks. 
By utilising PEG17, monomodality is found and nanoparticles are approximately 392 
nm in diameter, although this diameter is markedly different than found for its linear 
counterpart (Peak 1, 322 nm; Peak 2, 1564 nm).  The polydispersity of nanoparticles 
increases as the molecular weight of PEGx increases, where particle diameters of > 
1000 nm are found for PEG113-b-(p(HPMA80)-co-EGDMA0.95)) (Figure 6.5), 
suggesting that by increasing PEGx, control of producing particles within a uniform 
distribution is lost.  Indeed, for PEG113-b-(p(HPMA80)-co-EGDMA0.95)) 
nanoparticles of 35 nm in diameter are found; however, it is likely that these are 
desolvated single branched polymer chains.  For PEG45-b-(p(HPMA80)-co-
EGDMA0.95)) nanoparticles of 79 nm are found, and similarly these may be either 
single branched polymers or aggregates of < five branched polymers (this is an 
approximation and is based on data not yet reported) (see section 6.9).   
As for the linear counterparts, it was thought that decreasing the initial 
polymer/acetone concentration to 5 mg mL
-1
 may increase the likelihood of 
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producing more well-defined nanoparticles.  By diluting the initial solution, the 
solvated copolymers are physically more dispersed within the solution and 
subsequent aggregation is likely to be better controlled. 
 
Figure 6.6: DLS size determination of nanoparticles comprising of PEGx containing 
branched copolymers using dialysis.  5 mg mL
-1
 starting concentration, 1 mg mL 
-1
 
final concentration. 
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Copolymer 
Peak 1 
Diameter 
(nm)*
a
  
Peak 2 
Diameter 
(nm)*
b 
Polydispersity 
Index*
c 
    
PEG17-b-(p(HPMA80)-co-
EGDMA0.95)) 
109 
/ 0.077 
PEG45-b-(p(HPMA80)-co-
EGDMA0.95)) 
PEG113-b-(p(HPMA80)-co-
EGDMA0.95)) 
99 / 0.111 
110 / 0.255 
 
Table 6.6: DLS size data of nanoparticles consisting of PEGx containing branched 
copolymers prepared by dialysis (5 mg mL
-1
 starting concentration, 1 mg mL
-1
 final 
concentration). *
a
 peak with smallest diameter. *
b
 peak with largest diameter, *
c
 of 
both peaks. 
By halving the initial polymer/acetone solution (from 10 mg mL
-1
 to 5 mg mL
-1
) and 
subsequently diluting five-fold to give a final concentration of 1 mg mL
-1
, it is found 
that extremely narrow size distributions can be achieved from the branched 
copolymers (Figure 6.6 and Table 6.6).  It should be noted that the polydispersity of 
nanoparticles increases as the molecular weight of PEGx also increases; the exact 
reason for this is unknown, however, is likely to be due to the increased solubility of 
branched copolymers or the reduced content of the hydrophobic component within 
the polymer; each copolymer is processed from the same wt/vol concentration and 
the inclusion of larger block segments of PEGx leads to a reduction in the p(HPMA) 
block content at any given concentration.  It is also found that the DLS trace for 
PEG113-b-(p(HPMA80)-co-EGDMA0.95)) is not symmetrical and contains material 
approximately 30 nm in diameter, consistent with single desolvated branched 
copolymers (see section 6.9.2 later in the chapter).  The diameters of these 
nanoparticles do not appear to depend on the molecular weight of PEGx as they are 
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all approximately 100 nm.  This suggests the mechanism of nanoparticle formation is 
near identical in all three experiments.   
In the previous section it was found that altering the method (i.e. speed) of 
polymer/acetone solution addition had little effect on resulting nanoparticle size and 
distribution (regardless of PEG chain length).  It was considered important to 
investigate whether this result would also be relevant for the branched A-B block 
copolymers.  A 5 mg mL
-1
 polymer/acetone solution was rapidly added to warmed 
stirring water (rather than slowly dripped), and diluted five-fold to achieve a final 
concentration of 1 mg mL
-1
.  This solution was quickly added to a dialysis 
membrane tube and dialysed against water for two days.  The resulting nanoparticle 
solutions were then characterised by DLS.     
 
Figure 6.7: DLS size determination of nanoparticles comprising of PEGx containing 
branched copolymers using a modified dialysis approach .  5 mg mL
-1
 starting 
concentration, 1 mg mL 
-1
 final concentration. 
Chapter 6 
317 
 
Copolymer 
Peak 1 
Diameter 
(nm)*
a
  
Peak 2 
Diameter 
(nm)*
b 
Polydispersity 
Index*
c 
    
PEG17-b-(p(HPMA80)-co-
EGDMA0.95)) 
99 
/ 0.051 
PEG45-b-(p(HPMA80)-co-
EGDMA0.95)) 
PEG113-b-(p(HPMA80)-co-
EGDMA0.95)) 
120 / 0.100 
155 3810 0.470 
 
Table 6.7: DLS size data of nanoparticles consisting of PEGx containing branched 
copolymers prepared by a modified dialysis approach (5 mg mL
-1
 starting 
concentration, 1 mg mL
-1
 final concentration). *
a
 peak with smallest diameter. *
b
 
peak with largest diameter, *
c
 of both peaks. 
Figure 6.7 and Table 6.7 show that near identical nanoparticle diameters and 
polydispersities are found for PEG17-b-(p(HPMA80)-co-EGDMA0.95)) (109 nm, 
polydispersity 0.077, slow dripping followed by dialysis; 99 nm, polydispersity 
0.051, rapid addition followed by dialysis).  Nanoparticles comprising of PEG45-b-
(p(HPMA80)-co-EGDMA0.95 are also comparable in size and polydispersity  (99 nm, 
polydispersity  0.111, slow dripping followed by dialysis; 120 nm, polydispersity 
0.100,  rapid addition followed by dialysis).  However, nanoparticles comprising  
PEG113-b-(p(HPMA80)-co-EGDMA0.95)) are not unimodal and are not symmetrical; 
the exact reason for this is unknown but is likely to be due to the inherent solubility 
of this branched copolymer.  It should be noted here that the nanoparticles 
comprising branched copolymers exerted higher stability compared to their linear 
counterparts however precipitation occurred after approximately three weeks.  This 
suggests the steric or charged character of the nanoparticles is not strong enough to 
suppress aggregation; therefore subsequent precipitation of copolymer occurs.    
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 Having considered these results, and taking into account the period of time which is 
needed to produce materials using a dialysis method, it was decided no further 
investigations of this nature were to be performed.  It should be noted here that these 
materials could be filtered to remove either the high or low molecular weight 
material, which would isolate nanoparticles in the 100 nm region which has been 
previously reported.
3
  Further modification of these experiments may aid the 
recovery of nanoparticles with low polydispersities, which may include alteration of 
initial polymer/acetone concentration and also choice of solvent.   
6.5 Rapid precipitation of PEGx-b-(p(HPMAy)-co-
EGDMA0.95)) where x = 17, 45, 113 and y = 50, 80, 120 
In Chapter 4, section 4.4.3 it was found that through systematic variation of starting 
and final concentrations of polymer/acetone solutions nanoparticle sizes could be 
easily tuned for a series of hydrophobic branched p((HPMAx)-co-EGDMA0.95) 
copolymers when using a rapid nanoprecipitation approach.  This is believed to be 
due to their hydrophobicity and electrostatic stability (from the negatively charged 
p(HPMA)) and here it is investigated whether this same technique can be applied to 
their PEGx containing branched A-B block copolymer counterparts.  This process 
was expected to be more complex as the structure and chemistry of these polymers 
are different, despite both having branched hydrophobic architectures.   
In this section, PEG17-b-(p(HPMAx)-co-EGDMA0.95)), PEG17-b-(p(HPMAx)-co-
EGDMA0.95)) and PEG17-b-(p(HPMAx)-co-EGDMA0.95)) where x = 50, 80 and 120 
were rapidly precipitated into water using the identical protocol described in Chapter 
4 section 4.4.3, to produce nanoparticles.  Starting concentrations of 10 mg mL
-1
, 5 
mg mL
-1
 and 1 mg mL
-1
 were again chosen and precipitated into a range of water 
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volumes (dilution ratios = 1, 0.8, 0.4, 0.2, 0.05 and 0.01).  It should be noted that all 
of the data points displayed are an average of six DLS measurements and were 
recorded one day after their synthesis. 
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Initial 
concentration 
(mg mL
-1
) 
Final 
concentration 
(mg mL
-1
) 
Dilution 
ratio 
Primary chain length of branched copolymer PEG17-b-(p(HPMAx)-co-EGDMA0.95) 
HPMA DPn = 50 HPMA DPn = 80 HPMA DPn = 120 
Diameter 
(nm) 
Polydispersity 
Diameter 
(nm) 
Polydispersity 
Diameter 
(nm) 
Polydispersity 
10 10 1 328 0.249 175 0.0670 423 0.166 
 8 0.8 217 0.195 156 0.0913 313 0.163 
 4 0.4 189 0.155 111 0.1335 143 0.138 
 2 0.2 109 0.114 84 0.1312 120 0.185 
 0.5 0.05 115 0.110 85 0.1428 121 0.181 
 0.1 0.01 117 0.168 83 0.1615 121 0.193 
5 5 1 / / 179 0.0942 / / 
 4 0.8 / / 176 0.0855 / / 
 2 0.4 228 0.095 129 0.1205 156 0.063 
 1 0.2 101 0.088 111 0.1233 127 0.137 
 0.25 0.05 112 0.097 133 0.1217 128 0.159 
 0.05 0.01 133 0.139 115 0.1367 123 0.177 
1 1 1 120 0.076 130 0.071 168 0.072 
 0.8 0.8 101 0.064 112 0.064 156 0.089 
 0.4 0.4 87 0.070 96 0.069 112 0.148 
 0.2 0.2 73 0.089 74 0.080 107 0.163 
 0.05 0.05 87 0.081 88 0.054 110 0.154 
 0.01 0.01 117 0.099 102 0.076 106 0.199 
 
Table 6.8: Formation of branched PEG17 copolymer nanoparticles generated using rapid nanoprecipitation from acetone. 
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Initial 
concentration 
(mg mL
-1
) 
Final 
concentration 
(mg mL
-1
) 
Dilution 
ratio 
Primary chain length of branched copolymer PEG45-b-(p(HPMAx)-co-EGDMA0.95) 
HPMA DPn = 50 HPMA DPn = 80 HPMA DPn = 120 
Diameter 
(nm) 
Polydispersity 
Diameter 
(nm) 
Polydispersity 
Diameter 
(nm) 
Polydispersity 
10 10 1 133 0.107 190 0.153 235 0.199 
 8 0.8 104 0.187 150 0.239 158 0.235 
 4 0.4 81 0.209 115 0.205 143 0.128 
 2 0.2 92 0.229 77 0.169 105 0.116 
 0.5 0.05 145 0.186 93 0.129 110 0.074 
 0.1 0.01 109 0.156 106 0.198 101 0.152 
5 5 1 133 0.158 163 0.095 153 0.154 
 4 0.8 119 0.133 148 0.152 149 0.084 
 2 0.4 105 0.136 129 0.158 141 0.086 
 1 0.2 85 0.144 79 0.154 126 0.119 
 0.25 0.05 126 0.138 138 0.141 93 0.121 
 0.05 0.01 117 0.116 107 0.124 108 0.143 
1 1 1 239 0.193 108 0.156 121 0.082 
 0.8 0.8 126 0.039 106 0.067 127 0.086 
 0.4 0.4 92 0.064 80 0.087 110 0.097 
 0.2 0.2 66 0.098 84 0.075 99 0.097 
 0.05 0.05 86 0.127 95 0.062 122 0.087 
 0.01 0.01 105 0.131 103 0.075 104 0.111 
 
Table 6.9: Formation of branched PEG45 copolymer nanoparticles generated using rapid nanoprecipitation from acetone. 
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Initial 
concentration 
(mg mL
-1
) 
Final 
concentration 
(mg mL
-1
) 
Dilution 
ratio 
Primary chain length of branched copolymer 
PEG113-b-(p(HPMAx)-co-EGDMA0.95) 
HPMA DPn = 80 HPMA DPn = 120 
Diameter (nm) Polydispersity Diameter (nm) Polydispersity 
10 10 1 173 0.212 145 0.111 
 8 0.8 154 0.222 102 0.168 
 4 0.4 116 0.202 73 0.186 
 2 0.2 99 0.211 77 0.190 
 0.5 0.05 131 0.161 81 0.187 
 0.1 0.01 129 0.164 94 0.150 
5 5 1 165 0.184 144 0.075 
 4 0.8 145 0.166 126 0.058 
 2 0.4 109 0.162 92 0.150 
 1 0.2 97 0.169 79 0.151 
 0.25 0.05 117 0.138 107 0.133 
 0.05 0.01 137 0.212 104 0.125 
1 1 1 131 0.147 133 0.158 
 0.8 0.8 113 0.126 136 0.045 
 0.4 0.4 100 0.126 103 0.059 
 0.2 0.2 104 0.101 104 0.094 
 0.05 0.05 97 0.118 112 0.110 
 0.01 0.01 99 0.114 / / 
 
Table 6.10: Formation of branched PEG113 copolymer nanoparticles generated using rapid nanoprecipitation from acetone
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Figure  6.8: DLS analysis of nanoparticles comprised of PEG17-b-p((HPMA50)-co-
EGDMA0.95) prepared by rapid precipitation at various starting/final concentrations. 
(A) 10 mg mL
-1
 starting concentration. (B) 5 mg mL
-1
 starting concentration. (C) 1 
mg mL
-1
 starting concentration. 
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Figure 6.8 shows the DLS analysis of nanoparticles comprised of PEG17-b-
p((HPMA50)-co-EGDMA0.95).  All data is presented in Tables 6.8, 6.9 and 6.10 with 
further size analysis found in Appendix 6.1.  
Figure 6.9 shows that the nanoparticles can be formed using this technique with 
polymers containing the PEG17 initiator. The systematic variation of dilution ratio 
and primary p(HPMA) chain length within the branched amphiphilic A-B block 
copolymers is shown. In Chapter 4 section 4.4.3, the largest nanoparticles were 
produced across all dilution ratios when using a starting concentration of 10 mg mL
-
1
, however, by introducing PEG units to the polymers; this trend is not generally 
seen.  The smallest nanoparticles are consistently generated when using a starting 
concentration of 1 mg mL
-1
, comparable to previous nanoparticle synthesis.  The 
change in particle diameter across the range of dilution ratios (starting at 1 mg mL
-1
) 
is extremely low for PEG17-b-(p(HPMA50)-co-EGDMA0.95) ( 46 nm), PEG17-b-
(p(HPMA80)-co-EGDMA0.95)) (47 nm) and PEG17-b-(p(HPMA120)-co-EGDMA0.95))  
(51 nm).  This suggests that at this low starting concentration (1 mg mL
-1
), resultant 
nanoparticle size is relatively unaffected by changes in dilution ratio.  A number of 
data points in Table 6.8 and Table 6.10 have been removed as these were > 1000 nm.  
((PEG17-b-(p(HPMAx)-co-EGDMA0.95) (x = 50 and 120 monomer units)  dilution 
ratio = 1 and 0.8) the reason for these unexpectedly high results is unknown but is 
likely due to human error during nanoparticle preparation.   
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Figure 6.9: Z-average diameters of nanoparticles comprised of PEG17-b-(p(HPMAx)-
co-EGDMA0.95)) produced via rapid precipitation with varied dilution ratios.  
Starting concentrations; 10 mg mL
-1
 (circles), 5 mg mL
-1
 (triangles) and 1 mg mL
-1
 
(squares). A) x = 50 B) x = 80 C) x = 120. 
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Despite varying the primary chain length of p(HPMAx), there appears to be a general 
trend, whereby the sizes of nanoparticles (regardless of starting concentration) 
decrease until a dilution ratio of 0.2 is reached, after which the sizes of nanoparticles 
increase slightly.  In Chapter 4 section 4.4.3, there was insignificant change in z-
average diameters beyond a dilution ratio of 0.05, yet no increase was observed as is 
the case here.  The exact reason for this is unknown, but suggests polymers 
aggregate consistently differently when in extremely dilute preparation regimes.  
Further dilutions were not attempted here as the scattering of nanoparticles is 
extremely low, and DLS detectors struggle to obtain data beyond these low dilutions, 
often leading to inaccurate measurements.   
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Figure 6.10: Z-average diameters of nanoparticles comprised of PEG45-b-
(p(HPMAx)-co-EGDMA0.95)) produced via rapid precipitation with varied dilution 
ratios.  Starting concentrations; 10 mg mL
-1
 (circles), 5 mg mL
-1
 (triangles) and 1 mg 
mL
-1
 (squares). A) x = 50 B) x = 80 C) x = 120. 
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Figure 6.11: Z-average diameters of nanoparticles comprised of PEG113-b-
(p(HPMAx)-co-EGDMA0.95)) produced via rapid precipitation with varied dilution 
ratios.  Starting concentrations; 10 mg mL
-1
 (circles), 5 mg mL
-1
 (triangles) and 1 mg 
mL
-1
 (squares). A) x = 80 B) x = 120. 
Nanoprecipitation data using PEG113-b-(p(HPMA50)-co-EGDMA0.95)) was not 
obtained due to experimental errors during preparation, other attempts could not be 
performed due to time restraints.  The same trends that were observed when utilising 
PEG17 are also seen when PEG45 and PEG113 are employed for nanoparticle synthesis 
(Figure 6.10 and Figure 6.11).  Z-average diameters generally decrease with 
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decreasing dilution ratio, with consistently higher z-average diameters beyond 0.2, 
despite varying PEGx chain length.  There does not appear to be any consistent effect 
on nanoparticle size with respect to primary p(HPMAx) chain length across the 
dilution ranges (as noted previously), however, the at high dilution factors the order 
of nanoparticle sizes does seem to loosely correlate to starting polymer solution 
concentration.  The lack of clear trends does imply that the PEGx units are directing 
the nanoparticle formation to a higher degree than p(HPMA), and nanoparticle 
formation is more complex and perhaps less controlled than observed in Chapter 4 
section 4.4.3.  The experiments in this chapter aimed to demonstrate the comparisons 
of z-average diameters of particles containing the same PEGx chain length; the aim 
was to show more clearly how nanoparticle size is affected by not only the length of 
the PEGx units (whilst maintaining a primary chain length (p(HPMAx) of 80 
monomer units), but the starting concentration of polymer/acetone solutions. 
6.6 PEGx-b-(p(HPMA80)-co-EGDMA0.95)) Nanoparticles- 
comparison of p(HPMA) primary chain length. (x = 50, 80, 
120) 
A lack of clear trends are seen when presenting an overview of the nanoprecipitation 
of all branched amphiphilic polymer samples, therefore an analysis of the effect of 
PEGx chain length on the a series of polymers with consistent p(HPMA) primary 
chain length (DPn = 80 monomer units) was generated, across the dilution factors 
and starting polymer concentrations.  
Using a starting concentration of 10 mg mL
-1
 (Figure 6.12 (A)) appears to generate 
nanoparticles with very similar z-average diameters irrespective of PEGx chain 
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length, until a dilution ratio of 0.2 is reached.  However, by reducing the starting 
concentrations of polymer/acetone (Figure 6.12 (B) and C)), this trend begins to 
deviate.  As previously stated, increased z-average diameters are found at higher 
dilution ratios than 0.2, however, for a 1 mg mL
-1
 starting concentration, the range of 
achievable z-average diameters (regardless of PEGx chain length) over the range of 
dilution ratios is much lower than at 10 mg mL
-1
 and 5 mg mL
-1
 with these polymers. 
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Figure 6.12: Z-average diameters of nanoparticles comprised of PEGx-b-
(p(HPMA80)-co-EGDMA0.95)) produced via rapid precipitation with varied dilution 
ratios.  A) Starting concentration = 10 mg mL
-1
 B) Starting concentration = 5 mg 
mL
-1 
C) Starting concentration = 1 mg mL
-1
. 
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It should be noted that all of the nanoparticles generated in this section were 
monomodal, however, their polydispersities vary and this data is displayed in Figure 
6.13.  These are generally lowest when nanoparticles are formed from a starting 
concentration of 1 mg mL
-1
, where polydispersity varies from 0.054 to 0.156 
(regardless of PEGx chain length).  Whereas the range of polydispersities is much 
larger when using a starting concentration of 10 mg mL
-1
 (0.067 to 0.239), producing 
nanoparticles with generally larger polydispersities.  From these results, it is 
speculated that increasing the initial polymer/acetone concentration, nanoparticle 
generation is less controlled, as these branched polymers are in closer proximity, and 
therefore produce less monodisperse particles.   
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Figure 6.13: Polydispersity of nanoparticles comprised of PEGx-b-(p(HPMA80)-co-
EGDMA0.95)) produced via rapid precipitation with varied dilution ratios.  A) 
Starting concentration = 10 mg mL
-1
 B) Starting concentration = 5 mg mL
-1 
C) 
Starting concentration = 1 mg mL
-1
. 
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Unfortunately this section has failed to produce a series of nanoparticles whose 
properties can be tuned by adjustment of initial/final polymer/acetone 
concentrations. These polymers are identical to those in utilised in Chapter 4, with 
the exception of their PEGx units, suggesting the ethylene glycol repeat units have a 
huge impact on nanoparticle formation, possibly due to the considerable solubility of 
PEGx. A series of very monodisperse nanoparticle samples have, however, been 
reproducibly generated from a simple polymerisation procedure, coupled to a rapid 
nanoprecipitation, that have the potential for steric stabilisation and the amphiphilic 
character of many postulated literature drug delivery systems.   
6.7 Aqueous serial dilution of nanoparticles comprised of 
PEG17-b-(p(HPMA80)-co-EGDMA0.95)) 
In Chapter 4 section 4.4.5, it was found that nanoparticles comprising of solely 
p(HPMA80)-co-EGDMA0.95) (5 mg mL
-1
 starting concentration; 1 mg mL
-1
 final 
concentration) were highly stable with respect to aqueous dilution.  It is believed that 
this resulted from strong hydrophobic interactions within the dense cores of the 
nanoparticles, combined with electrostatic repulsion between nanoparticles.  Here it 
is investigated whether nanoparticles comprised of branched A-B block copolymers 
containing PEG17 segments exert similar stability with respect to aqueous dilution.   
PEG17-b-(p(HPMA80)-co-EGDMA0.95)) was dissolved in acetone at 5 mg mL
-1
; this 
solution was added rapidly to warm stirred water and subsequently formed a 1 mg 
mL
-1
 aqueous
 
nanoparticle solution.  DLS measurements were performed and the 
solution was diluted (two-fold) giving an aqueous concentration of 0.5 mg mL
-1
 
which was analysed. This dilution process continued until a final concentration of 
2.44 x 10
-4
 mg mL
-1
 was achieved.  It should be noted here that each data point is an 
Chapter 6 
335 
 
average of six measurements.  By monitoring z-average diameter, polydispersity, 
derived count rate and the attenuator level during dilution (Figure 6.14), it is possible 
to speculate whether these particles are reversibly aggregated in a similar way to 
colloidal particles.  Changes in these parameters such as an increased z-average 
diameter could indicate particle aggregation or dissociation. 
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Figure 6.14: Serial dilution data of nanoparticles comprised of PEG17-b-
(p(HPMA80)-co-EGDMA0.95)) with a starting and finishing concentration of 5 mg 
mL
-1
 and 1 mg mL
-1
 respectively.  A) Nanoparticle diameter and polydispersity vs. 
concentration of suspension.  B)  Derived count rate and Attenuator vs. concentration 
of suspension. 
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Figure 6.14 (A) indicates these particles are extremely stable with respect to dilution 
as there is little change in z-average diameter and polydispersity until a concentration 
of 0.002 mg mL
-1
 is reached which is a five hundred-fold dilution.  Figure 6.14 (B) 
shows the derived count rate measurements during the experiment; this figure is 
indicative of the number of particles present in solution (this is directly related if the 
attenuator is set at a single value).  During dilution, this figure decreases almost 
linearly suggesting these particles are not dissociating.  An increase in derived count 
rate would be expected if dissociation was occurring.  To support this observation, it 
is noted that the attenuator increases during dilution (this is automatically set by the 
instrument).  The attenuator setting increases allowing wider areas of the sample to 
be analysed due to low material concentration.  Once the attenuator has reached 
values > 9, measurements become unreliable as the instrument is unable to analyse 
the extremely dilute samples.  Analysis of the sample beyond an attenuator setting of 
> 9 is shown in Figure 6.14 (B) to highlight this point; the z-average diameters and 
polydispersities (Figure 6.14 (B)) at these low concentration are extremely high and 
do not correlate well with previous measurements.  These results may be due to a 
combination of instrument unreliability and also possibly aggregation of particles (as 
both z-average diameter and polydispersity increase), however, the continually 
decreasing derived count rate is indicative of a steadily decreasing number of 
particles in the sample after dilution.  Further dilutions were abandoned due to the 
inability to record reliable measurements.  This experiment shows that nanoparticles 
comprised of PEG17-b-(p(HPMA80)-co-EGDMA0.95)) are extremely stable to 
aqueous dilution, as z-average diameter and polydispersity were little affected during 
dilution. 
 
Chapter 6 
338 
 
6.8 Zeta-potential Studies 
In Chapter 4 section 4.4.10, it was shown that the zeta potential of nanoparticles 
comprised of p((HPMA50)-co-EGDMA0.95), p((HPMA80)-co-EGDMA0.95) and 
p((HPMA120)-co-EGDMA0.95) were -34.1 mV, -41.0 mV and -44.5 mV, respectively.  
It is believed this arises from the pedant hydroxyl groups of p(HPMA), however, the 
exact reason for the negative charge is unknown.  In this section, the zeta potential of 
nanoparticles comprised of PEG containing linear and branched copolymers was 
recorded, using the protocol found in Chapter 2 section 2.2.3.1.  It is noted that 
nanoparticles comprised of linear copolymers were used before the onset of 
aggregation. 
 
Figure 6.15: Zeta potential measurements of nanoparticles comprised of PEGx-b-
p(HPMA80) and PEGx-b-(p(HPMA80)-co-EGDMA0.95)), produced by rapid 
precipitation.  5 mg mL
-1
 starting concentration; 1 mg mL
-1
 final concentration. (x = 
17, 45, 113). Linear Polymers (black), Branched Polymers (grey).           
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Copolymer Zeta Potential (mV)  
  
PEG17-b-p(HPMA80) -41.1 
PEG45-b-p(HPMA80) -14.9 
PEG113-b-p(HPMA80) -14.1 
PEG17-b-(p(HPMA80)-co-(EGDMA0.95)) -22.00 
PEG45-b-(p(HPMA80)-co-(EGDMA0.95)) -9.76 
PEG113-b-(p(HPMA80)-co-(EGDMA0.95)) -9.23 
 
Table 6.11: Summary of Zeta potential data of nanoparticles comprised of PEGx-b-
p(HPMA80) and PEGx-b-(p(HPMA80)-co-EGDMA0.95) (x = 17, 45, 113). 
Figure 6.15 and Table 6.11 show the comparative zeta potentials of nanoparticles 
comprised of linear (grey) and branched (black)  copolymers with varying PEG 
content, maintaining p(HPMA) chain length (DPn = 80 monomer units).  All 
nanoparticles are negatively charged, however, there is a clear trend seen when 
comparing linear and branched copolymer architectures.  Nanoparticles comprised of 
linear copolymers are more negatively charged compared to branched counterparts, 
and nanoparticles generated from both architectures become less negative as PEG 
chain length increases.   
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Figure 6.16: Zeta potential measurements of nanoparticles comprised of PEG113-b-
p(HPMAx) and PEG113-b-(p(HPMAx)-co-EGDMA0.95)), produced by rapid 
precipitation.  5 mg mL
-1
 starting concentration; 1 mg mL
-1
 final concentration. (x = 
50, 80, 120). Linear Polymers (black), Branched Polymers (grey). 
 
 
Copolymer 
Zeta Potential (mV)  
  
PEG113-b-p(HPMA50) -14.70 
PEG113-b-p(HPMA80) -14.10 
PEG113-b-p(HPMA120) -9.55 
PEG113-b-(p(HPMA50)-co-(EGDMA0.95)) -10.70 
PEG113-b-(p(HPMA80)-co-(EGDMA0.95)) -9.23 
PEG113-b-(p(HPMA120)-co-(EGDMA0.95)) -10.30 
 
Table 6.12: Summary of Zeta potential data of nanoparticles comprised of PEG113-b-
p(HPMAx) and PEG113-b-(p(HPMAx)-co-EGDMA0.95) (x = 50, 80, 120). 
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Nanoparticles were also prepared by rapid nanoprecipitation (5 mg mL
-1
 starting 
concentration; 1 mg mL
-1
 final concentration) from linear and branched architectures 
comprised of PEG113 with varying chain lengths of p(HPMA) (target DPn = 50, 80, 
120) and their zeta potentials were recorded.    This experiment aimed to assess the 
impact of p(HPMA) primary chain length (using PEG113) on the charge character of 
the final nanoprecipitates.  Figure 6.16 and Table 6.12  show that as the primary 
chain length of p(HPMA) increases, subsequent nanoparticles become less 
negatively charged (approaching neutrality) irrespective of polymer architecture, 
however, for p(HPMA) (with target DPn values of  50 and 80 monomer units), 
nanoparticles comprised of linear copolymer are more negative compared to their 
branched counterparts.  For p(HPMA) target DPn = 120 monomer units, 
nanoparticles comprised of either linear or branched material have identical zeta 
potentials (within experimental error).  Clearly both p(HPMA) primary chain length 
and polymer architecture influence the zeta potential of nanoparticles, however, the 
reasons for this are unclear. 
 
6.9 Solution Behaviour of Linear and Branched PEG 
Copolymers  
6.9.1 Aqueous Behaviour of PEG45-b-p(HPMA50), PEG45-b-
(p(HPMA50)-co-EGDMA0.95)), PEG113-b-p(HPMA50) and PEG113-b-
p(HPMAx)-co-EGDMA0.95) where x = 50, 80, 120 
A small selection of the linear and branched amphiphilic A-B block copolymers that 
have been synthesised appeared to have an appreciable solubility in water.  This was 
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probably due to the balance of PEG and p(HPMA) content within the copolymer 
structures and therefore the assembly of these materials was studied in water, 
without the application of any of the reported precipitation methods already 
discussed within this thesis. 
The polymers were treated as follows; linear polymers (PEGx-b-p(HPMAy)) and 
branched copolymers p(PEGx-b-(p(HPMAy)-co-EGDMA0.95)) (x = 17, 45, 113) (y = 
50, 80, 120) (50 mg) were added to distilled water (5 mL) and placed on a rolling 
machine overnight to dissolve.  Only PEG45-b-p(HPMA50), PEG45-b-(p(HPMA50)-
co-EGDMA0.95)), PEG113-b-p(HPMA50) and PEG113-b-p(HPMAx) (x = 50, 80, 120) 
appeared to have dissolved (where polymer was not visible to the naked eye).  These 
10 mg mL
-1
 solutions were then analysed directly using DLS, shown in Figure 6.17. 
Chapter 6 
343 
 
 
Figure 6.17: DLS size determination of (A) linear and (B) branched copolymers in 
water at 10 mg mL
-1
.  PEG45-b-p(HPMA50) and PEG45-b-(p(HPMA50)-co-
EGDMA0.95)) (blue).  PEG113-b-p(HPMAx) (x = 50, 80, 120) and PEG45-b-
(p(HPMA50)-co-EGDMA0.95)) (x = 50, 80, 120) (green) 
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Copolymer 
Peak 1 Diameter 
(nm)*
a
 
Peak 2 Diameter 
(nm)*
b
 
Polydispersity 
Index*
c
 
    
PEG45-b-p(HPMA50) 36 582 0.35 
PEG113-b-p(HPMA50) 58 / 0.20 
PEG113-b-p(HPMA80) 30 160 0.22 
PEG113-b-p(HPMA120) 117 / 0.32 
PEG45-b-(p(HPMA50)-co-
(EGDMA0.95)) 
28 347 0.40 
PEG113-b-(p(HPMA50)-co-
(EGDMA0.95)) 
35 235 0.37 
PEG113-b-(p(HPMA80)-co-
(EGDMA0.95)) 
70 455 0.69 
PEG113-b-(p(HPMA120)-co-
(EGDMA0.95)) 
23 166 0.32 
 
Table 6.13: DLS size data of PEGx containing linear and branched copolymers in 
water (10 mg mL
-1
) *
a
 peak with smallest diameter. *
b
 peak with largest diameter, *
c
 
average across full sample. 
Figure 6.17(A) and Table 6.13 show DLS data for linear copolymers dissolved in 
water (10 mg mL
-1
) where PEG113-b-p(HPMA50) gives a monomodal distribution (58 
nm, 0.20 polydispersity), PEG113-b-p(HPMA80) is bimodal, however, there is 
significant overlap with the monomodal distribution of PEG113-b-p(HPMA50.  
PEG113-b-p(HPMA120) also appears to form structures within the aqueous solution  
with diameter of 117 nm and a higher polydispersity of 0.32.  Figure 6.17 (B) shows 
branched copolymer structures in water where all chromatograms are bimodal with 
some materials > 100 nm in diameter.  PEG45-b-p(HPMA50) and PEG45-b-
(p(HPMA50)-co-EGDMA0.95)) appear to form structures which are extremely similar; 
both distributions are bimodal and their architectural differences do not seem to have 
an effect on the aqueous behaviour of these materials. Clear differences are evident 
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between the linear and branched polymers initiated with PEG113-Br and this may, 
again, be a strong indication of the modification of behaviour of linear polymers that 
can be achieved through the introduction of intermolecular branches as their nominal 
compositions (PEG/p(HPMA) are identical within each series. 
It is unclear if any of the structures that are observed are due to the collapse of single 
branched A-B block copolymers; the smallest peak diameter was found to be 23 nm 
when subjecting PEG113-b-(p(HPMA120)-co-(EGDMA0.95)) to this procedure, 
however, linear polymers also form structures with similar sizes.   
 
6.9.2 Behaviour of PEGx-b-p(HPMAy) and PEGx-b-(p(HPMAy)-co-
EGDMA0.95)) in Acetone where x = 17, 45, 113, y = 50, 80, 120  
It has been assumed that prior to nanoprecipitation, that copolymers are suitably 
solvated in acetone. The observation of particulate structures in water suggested an 
examination of acetone solutions of the linear and branched polymers and a suitable 
RI difference between solvent and polymer was expected if dense, self-assembled 
particles were being formed. PEGx containing copolymers (with linear and branched 
architectures) were therefore dissolved in acetone at 10 mg mL
-1
 overnight and 
subsequently analysed directly by DLS.   
It can be seen from Figure 6.18 (A) that a measureable DLS signal was observed for 
several acetone solutions; the data is shown in Table 6.13. PEG17-b-p(HPMA80) is 
monomodal with a peak diameter of 7 nm; as the chain length of PEGx increases (to 
PEG45), the linear copolymers exist in two distinctly separate size ranges; the 
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polydispersity of the individual  peaks are  narrow but clearly the dissolved chains do 
have a tendency to assemble with increasing PEG content.   
 
Figure 6.18: DLS size determination of linear (A) and branched (B) copolymers in 
acetone at 10 mg mL
-1
. 
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Copolymer 
Peak 1 
Diameter 
(nm)*
a
 
Peak 2 
Diameter 
(nm)*
a
 
Peak 3 
Diameter 
(nm)*
a
 
Polydispersity 
Index*
b
 
     
PEG17-b-p(HPMA80) 7 / / 0.18 
PEG45-b-p(HPMA80) 7 217 / 0.54 
PEG113-b-p(HPMA120) 6 237 / 0.83 
PEG17-b-(p(HPMA80)-
co-(EGDMA0.95)) 
117 / / 0.45 
PEG45-b-(p(HPMA80)-
co-(EGDMA0.95)) 
9 37 264 0.38 
PEG113-b-(p(HPMA80)-
co-(EGDMA0.95)) 
18 58 342 0.76 
 
Table 6.13: DLS size data of PEGx containing linear and branched copolymers in 
acetone (10 mg mL
-1
) *
a
 peak mean intensity from small to large diameter. *
b
 peak 
with largest diameter, *
b
 of both peaks. 
Linear PEG113-derived copolymers also exist in two well defined regions, however, 
the polydispersity of the individual peaks are broader than those displayed for 
materials containing the shorter PEG chains.  As mentioned previously, the intensity 
of scattering scales as the sixth power of the particle radius. Although the peaks 
within the intensity distribution appear to be of similar heights within Figure 6.18 
(A), the relative concentrations are highly biased towards the smaller sized materials 
and therefore the larger aggregates are only present at very low concentrations and 
may signify slowly dissolving chains rather than aggregated structures.  This is 
confirmed by measuring size distribution by the number of particles present in the 
sample, where no material > 10 nm is measured; DLS measurement is found in 
Appendix 6.2. 
It is possible to potentially observe the linear fraction of the branched polymer 
distributions as the small shoulders that appear from 7 nm to 12 nm (Figure 6.18 
Chapter 6 
348 
 
(B)).  It should also be noted that the automatic attenuator DLS setting during this 
series of studies varied from 7-10, due to the minimal difference in refractive index 
between copolymer and acetone.  
6.10 Loading capacity evaluation of PEGx-b-(p(HPMA80)-co-
(EGDMA0.95)) Nanoparticles with hydrophobic guest-
molecules. (x = 17, 45, 113) 
In order to determine whether the polymeric nanoparticles generated via rapid 
nanoprecipitation could efficiently encapsulate guest-molecules, co-
nanoprecipitation of branched A-B block copolymers and hydrophobic guest-
molecules was evaluated.  It is proposed that during nanoparticle formation, 
hydrophobic guest-molecules co-precipitate within the hydrophobic segments of the 
copolymers resulting in p(HPMA)-material cores, with PEG coronas. Linear A-B 
block copolymers were not utilised here due to rapid de-stabilisation of 
nanoparticles.  Branched A-B block copolymers with a target DPn of 80 monomer 
units within the p(HPMA) primary chain length and varying PEG block chain 
lengths were chosen as a model to evaluate loading. It should be noted here that 
preliminary experiments showed that the loading capacity of the EBiB-initiated 
p((HPMAx)-co-EGDMA0.95) branched polymers was extremely limited with 
nanoparticle aggregation apparent after only several hours.  
A variety of readily available hydrophobic guest-molecules were utilised in order to 
evaluate stability/size data prior to investigations using the HIV/AIDS antiretroviral 
drug Lopinavir (LPV).  This is due to the limited availability and cost of LPV, where 
preliminary experiments could potentially eliminate drug wastage.  Oil red O, Pyrene 
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and Ibuprofen were chosen as hydrophobic guest-molecules for these initial scoping 
investigations.  The various branched copolymers were co-dissolved in acetone (5 
mg mL
-1
) with a guest-molecule (at varied concentrations) before nanoprecipitation 
into water using a rapid approach and achieving a final copolymer concentration of 1 
mg mL
-1 
and a five-fold decrease in guest-molecule concentration.  This method is 
outlined in Chapter 2 section 2.5.1.4 and is similar to other reported methods of drug 
encapsulation using nanoprecipitation.
4,5,6,7,8
  The resulting nanoparticles were 
analysed by DLS where comparisons between loaded and un-loaded particles can be 
seen.   
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Figure 6.19: Loaded nanoparticle analysis using PEG17-b-(p(HPMA80)-co-
EGDMA0.95)) using rapid nanoprecipitation (5 mg mL
-1
 starting concentration; 1 mg 
mL
-1
 final concentration), with varied loading material concentration, A) Z-average 
particle diameter vs. loading. B) Polydispersity vs. loading. Blank nanoparticle 
(black), Oil Red O (red), Pyrene (green), Ibuprofen (blue). 
It is seen that PEG17-b-(p(HPMA80)-co-EGDMA0.95)) nanoparticles can successfully 
encapsulate guest molecules with concentrations of up to 0.5 mg mL
-1
 (Figure 6.19).  
Higher loading concentrations were unsuccessful where nanoparticles precipitated 
after several hours.  Figure 6.19 (B) indicates that nanoparticles which contain 
Pyrene have significantly higher polydispersities in comparison to Oil red O and 
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Ibuprofen. The exact reason for this is unknown but may be due to the rigid structure 
of Pyrene (planar and aromatic), where packing efficiency may be less than the other 
materials (see Figure 6.25). Individual DLS measurements are shown in Figure 6.20 
where direct comparison between z-average diameter and guest-molecule 
concentration can be clearly seen. 
Figure 6.20 shows the comparison between loaded and-unloaded PEG17-b-
(p(HPMA80)-co-EGDMA0.95)) nanoparticles, where z-average diameter increases as 
loading also increases.  This may suggest a similar number of nanoparticles are 
forming during nanoprecipitation under different conditions, whereby the 
incorporation of hydrophobic material ultimately leads to larger particles; however, 
this is only speculative. It should be noted that polydispersity of nanoparticles 
remains relatively low (apart from Pyrene loading), despite guest-molecule 
concentration increasing, suggesting nanoprecipitation mechanisms are well 
controlled.   
An identical experimental protocol was followed using PEG45-b-(p(HPMA80)-co-
EGDMA0.95)) where guest-molecule loading of up to 1 mg mL
-1 
is found.  It should 
be noted that higher loading was attempted, however, nanoparticles precipitated after 
less than one day and were therefore not analysed.  An overview of the loading 
capacity of PEG45-b-(p(HPMA80)-co-EGDMA0.95)) nanoparticles is shown in Figure 
6.21and Figure 6.22. 
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Figure 6.20: Loaded nanoparticle analysis of PEG17-b-(p(HPMA80)-co-EGDMA0.95)) 
using rapid nanoprecipitation (5 mg mL
-1
 starting concentration; 1 mg mL
-1
 final 
concentration), with varied loading material concentration, A) Oil Red. B) Pyrene. 
C) Ibuprofen. 
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Figure 6.21: Loaded nanoparticle analysis using PEG45-b-(p(HPMA80)-co-
EGDMA0.95)) using rapid nanoprecipitation (5 mg mL
-1
 starting concentration; 1 mg 
mL
-1
 final concentration), with varied loading material concentration, A) Z-average 
particle diameter vs. loading. B) Polydispersity vs. loading. Blank nanoparticle 
(black), Oil Red (red), Pyrene (green), Ibuprofen (blue). 
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Figure 6.22: Loaded nanoparticle analysis of PEG45-b-(p(HPMA80)-co-EGDMA0.95)) 
using rapid nanoprecipitation (5 mg mL
-1
 starting concentration; 1 mg mL
-1
 final 
concentration), with varied loading material concentration, A) Oil Red. B) Pyrene. 
C) Ibuprofen. 
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Similarly to PEG17-b-(p(HPMA80)-co-EGDMA0.95)) nanoparticles, as Oil Red O 
concentration increases, z-average diameter increases whilst polydispersity remains 
relatively narrow (Figure 6.21).   Nanoparticles with diameters of 272 nm formed 
with 1 mg mL
-1
 of Oil Red O, compared to 83 nm for blank nanoparticles; the 
nanoparticle diameter has more than doubled in this case.  A Pyrene loading of only 
0.5 mg mL
-1
 could be achieved using PEG45-b-(p(HPMA80)-co-EGDMA0.95)), where 
rapid precipitation occurred for higher concentrations.  PEG45-b-(p(HPMA80)-co-
EGDMA0.95)) nanoparticles could successfully load Ibuprofen up to 0.5 mg mL
-1
 
whilst maintaining  monomodal size distributions; however, when 1 mg mL
-1
 of 
Ibuprofen is co-precipitated, two discrete size distributions appear (Figure 6.22 (C))  
The small peak (approximately 80 nm) shows significant overlap with un-loaded 
nanoparticles suggesting ibuprofen loading varies between individual nanoparticles.   
In comparison to Figure 6.19, increasing PEGx chain length (from PEG17 to PEG45) 
has a direct impact on nanoparticle loading capacity. This can be observed directly, 
as a higher concentration of oil red, and ibuprofen (double the mass of encapsulated 
material with respect to total polymer concentration) could be successfully 
encapsulated (1 mg mL
-1
, compared to 0.5 mg mL
-1
) into nanoparticles, whilst 
maintaining copolymer concentration (1 mg mL
-1
).  Hypothetically, when increasing 
PEGx chain length, PEG113-b-(p(HPMA80)-co-EGDMA0.95)) nanoparticles should 
successfully load materials with higher concentrations than 1 mg mL
-1
, whilst 
keeping copolymer concentration constant (1 mg mL
-1
).  Analysis of loaded PEG113-
b-(p(HPMA80)-co-EGDMA0.95)) nanoparticles is shown in Figure 6.23 and Figure 
6.24. 
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Figure 6.23: Loaded nanoparticle analysis using PEG113-b-(p(HPMA80)-co-
EGDMA0.95)) using rapid nanoprecipitation (5 mg mL
-1
 starting concentration; 1 mg 
mL
-1
 final concentration), with varied loading material concentration, A) Z-average 
particle diameter vs. loading. B) Polydispersity vs. loading. Blank nanoparticle 
(black), Oil Red (red), Pyrene (green), Ibuprofen (blue). 
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Figure 6.24: Loaded nanoparticle analysis of PEG113-b-(p(HPMA80)-co-
EGDMA0.95)) using rapid nanoprecipitation (5 mg mL
-1
 starting concentration; 1 mg 
mL
-1
 final concentration), with varied loading material concentration, A) Oil Red. B) 
Pyrene. C) Ibuprofen. 
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Loading of Oil Red into PEG113-b-(p(HPMA80)-co-EGDMA0.95)) nanoparticles did 
not successfully encapsulate  at concentrations > 1 mg mL
-1
; clear monomodal traces 
were not found and significant overlap of unloaded material is seen in Figure 6.24 
(A), however, the exact reason for this is unknown. A similar trend is found for 
Pyrene loading, however, a monomodal trace is reported for loading of 1 mg mL
-1
 
Pyrene where z-average diameter increases from 111 nm (un-loaded) to 694 nm (1 
mg mL
-1
 Pyrene).  An attempt was made to load 2 mg mL
-1 
of Pyrene into 
nanoparticles; however, precipitation occurred several hours after preparation.  
Loading PEG113-b-(p(HPMA80)-co-EGDMA0.95)) nanoparticles with a small amount 
of Ibuprofen (0.02 mg mL
-1
) does not produce particles with a larger z-average, 
however, Figure 6.24 (C) demonstrates that the nanoparticles’ polydispersity 
increases on loading with a guest molecule; possible indicating irregular distribution 
of Ibuprofen within nanoparticle cores.  Loading of 1 mg mL
-1
 Ibuprofen resulted in 
an unsymmetrical DLS trace, with a broad polydispersity (0.45), suggesting 
nanoparticle formation is irregular.  It should be noted that these dispersions 
remained stable for > two weeks before the onset of precipitation.   
It is also worth noting that the branched copolymers containing PEG113 as the 
hydrophilic block segment have an appreciable solubility in water and it is possible 
that the high ratio of PEG within these A-B amphiphilic block copolymers hinders 
the formation of encapsulated material during co-nanoprecipitaion. 
The data reported in these experiments suggests that loaded nanoparticle formation is 
highly complex; affected by factors such as guest-molecule structure and their 
miscibility in p(HPMA).  The data also suggests that copolymers with longer PEGx 
chains can load a higher concentration of guest-molecules resulting in stable 
nanoparticles; however, long PEG chains that also impart some enhanced 
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hydrophilicity may hamper guest encapsulation.  In order to consistently generate 
monomodal nanoparticle distributions, further optimisation experiments are 
necessary. 
6.10.1 LPV Loading capacity evaluation of PEGx-b-(p(HPMA80)-co-
(EGDMA0.95)) Nanoparticles (x = 17, 45, 113) 
This aim of this section was to produce aqueous suspensions of stable LPV loaded 
nanoparticles, where variation of concentration parameters was investigated in order 
to optimise conditions.  Ultimately, a concentrated stable nanosuspension of LPV 
would provide a potential oral route of drug administration for HIV/AIDS patients.  
Encapsulating the drug into PEGx-b-(p(HPMAy)-co-EGDMA0.95)) nanoparticles may 
improve bioavailability of the drug through prolonged circulation time and 
minimising first pass metabolism.  If loaded nanoparticles are highly stable, they 
may successfully permeate cell membranes to reach the blood stream followed by 
macrophage uptake.  Macrophages have been highlighted as HIV reservoir sites and 
it is postulated that enzymatic degradation of nanoparticles will release the drug at 
the site of replication.  However, the aim of this chapter was to assess solely the LPV 
loading capacity of branched copolymer nanoparticles, which would lead to 
optimisation of synthetic protocol.   
Section 6.10 failed to draw solid conclusions between nanoparticle loading capacity 
and PEGx chain length.  In the experiments, 5 mg mL
-1
 copolymer solutions were 
precipitated to give a final concentration of 1 mg mL
-1
; however, this does not take 
into account the relative molar ratios of PEGx and HPMA monomer units.  For 
example, a 5 mg mL
-1
 sample of p(HPMA80)-co-EGDMA0.95) contains only HPMA 
monomer repeat units in the copolymer primary chain (EGDMA repeat units were 
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not taken into account), a 5 mg mL
-1
 sample of PEG17-b-(p(HPMA80)-co-
EGDMA0.95)) contains PEG and less HPMA monomer units, (6.1 % PEG, 93.9 % 
p(HPMA).  To maintain the same mass of HPMA in both copolymer acetone 
solutions, simply dividing this HPMA % by 5 achieves the corrected mass for 
preparing samples.  (e.g. 5/0.939 = 5.32 mg mL
-1
).   
Before studying the encapsulation of LPV, the four molecules that have been studied 
as guest molecules need to be considered in detail.  Figure 6.25 shows the relative 
chemical structures of each guest molecule studied. 
 
Figure 6.25: Chemical structures of hydrophobic guest-molecules. A) Oil Red O. B) 
Ibuprofen. C) Pyrene. D) Lopinavir. 
LPV is a complex chiral compound with a high molecular mass; greater than 1.5 
times the mass of Oil Red.  Comparatively, Oil Red has a molecular mass of 408.5 g 
mol
-1
; Pyrene has a molecular mass of 202.3 g mol
-1
; Ibuprofen has a molecular mass 
of 209.3 g mol
-1
; and LPV has a molecular mass of 628.8 g mol
-1
. By preparing 
adjusted copolymer concentrations, a direct comparison between nanoparticle 
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loading capacities, with respect to PEG content was investigated for LPV-containing 
nanoparticles. 
A series of copolymers were nanoprecipitated with a five-fold dilution and using 
adjusted concentrations to provide the same HPMA mass content in the final 
dispersion these were approximately 5 mg mL
-1
 with respect to p(HPMA). Table 
6.14 indicates starting and final concentrations of the polymers used alongside the 
DLS nanoparticle analysis.   
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Copolymer 
HPMA 
monomer 
content 
(%) 
Starting 
Concentration 
(mg mL
-1
) 
Final 
Concentration 
(mg mL
-1
)
 
Z-Average 
Diameter 
(nm)
 
Polydispersity 
      
PEG17-b-
p((HPMA50)-co-
EGDMA0.95) 
90.56 5.52 1.1 
70 0.0950 
PEG17-b-p(HPMA80) 
-co-EGDMA0.95) 
93.90 5.32 1.06 70 0.1850 
PEG17-b-p(HPMA120-
co-EGDMA0.95)) 
95.83 5.21 1.04 108 0.2400 
PEG45-b-p(HPMA50) 
-co-EGDMA0.95) 
78.6 6.39 1.28 29 0.1610 
PEG45-b-p(HPMA80) 
-co-EGDMA0.95) 
85.18 5.87 1.17 35 0.1370 
PEG45-b-p(HPMA120) 
-co-EGDMA0.95) 
89.64 5.58 1.12 89 0.0280 
PEG113-b-p(HPMA50) 
-co-EGDMA0.95) 
59 8.47 1.69 32 0.3120 
PEG113-b-p(HPMA80) 
-co-EGDMA0.95) 
69.97 7.18 1.44 35 0.0580 
PEG113-b-
p(HPMA120-co-
EGDMA0.95)) 
77.58 6.45 1.29 
66 0.3830 
 
Table 6.14: Nanoparticle analysis of PEGx-b-(p(HPMA)-co-EGDMA0.95)) using 
rapid nanoprecipitation (five-fold dilution). Concentrations adjusted for p(HPMA) 
content. 
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Figure 6.26: Nanoparticle analysis of PEGx-b-(p(HPMA)-co-EGDMA0.95)) using 
rapid nanoprecipitation (five-fold dilution). Concentrations adjusted for p(HPMA) 
content (see Table 6.14). (Approximately 5 mg mL
-1
 starting concentration, 1 mg 
mL
-1
 final concentration). (A) PEG17, (B) PEG45, (C) PEG113. 
Chapter 6 
364 
 
Figure 6.26 and Table 6.14 demonstrate that the smallest nanoparticles are generally 
formed utilising a target DPn = 50 monomer units, where z-average diameter 
increases as p(HPMA) primary chain length increases, irrespective of PEGx chain 
length.  Little difference is noted between nanoparticle samples in Figure 6.26 (A) 
however for a target DPn of 120 monomer units, z-average diameter increases to 108 
nm (compared to 70 for target DPn = 50, 80 monomer units).  Figure 6.26 (B) and 
Table 6.14 clearly shows PEG-b-p((HPMAx)-co-EGDMA0.95)) nanoparticle z-
average diameter increasing as target DPn  increases, with narrow polydispersities 
consistently found.  Unfortunately the same clear trend could not be found for 
PEG113-b-p((HPMAx)-co-EGDMA0.95) (Figure 6.26 (C)) where nanoparticles formed 
using a target DPn = 50 monomer units formed in two discrete size ranges, and 
particles whose copolymer had a target DPn = 50 monomer units formed a bimodal 
polydisperse sample.  This data suggests that the size of PEG containing 
nanoparticles cannot be systematically varied through changes in concentration 
parameters, despite maintaining a constant mass of p(HPMA) within samples.   
Nevertheless, aiming to maintain the same concentration of p(HPMA) within 
nanoparticle samples is thought to aid in the optimisation of LPV  loading studies.  It 
is presumed that LPV and p(HPMA) are miscible (and hydrophobic), and will 
therefore co-exist surrounded by a hydrophilic PEG shell. If copolymer 
concentrations are not adjusted to account for PEG content (i.e. maintaining a 5 mg 
mL
-1
 starting concentration), the ratio of LPV/p(HPMA) decreases as PEG chain 
length increases.   
It was not assumed that LPV would be successfully encapsulated within stable 
nanoparticle cores, as loading capacity will be affected by the structure/chemistry of 
LPV, however, using section 6.10 as a guide, and utilising the same encapsulation 
Chapter 6 
365 
 
protocol, a series of experiments were attempted to identify issues with LPV as a 
guest within these branched copolymer nanoparticle systems. 
Polymer 
p(HPMA) 
Mn 
(g mol
-1
) 
p(HPMA) 
Wt% 
 
Initial 
polymer 
concentra-
tion 
(mg mL
-1
) 
Final 
polymer 
concentra-
tion 
(mg mL
-1
) 
Initial LPV 
concentra-
tion 
(mg mL
-1
) 
Final LPV 
concentra-
tion 
(mg mL
-1
) 
Stable 
for 1 
day 
(mg 
mL
-1
) 
Stable for 
5 days 
(mg mL
-1
) 
PEG17-b-
p((HPMA50)-
co-
EGDMA0.95 
7950 90.56 
5.52 1.1 5 1 Y N 
5.52 1.1 10 2 N N 
2.76 0.55 2.5 0.5 Y N 
PEG17-b-
p((HPMA80)-
co-
EGDMA0.95 
12300 93.90 
10.65 2.13 5 1 Y N 
5.32 1.06 5 1 Y N 
5.32 1.06 10 2 N N 
5.32 0.53 5 1 Y N 
2.66 0.53 2.5 0.5 Y N 
PEG17-b-
p((HPMA120)-
co-
EGDMA0.95) 
18000 95.83 
5.21 1.04 5 1 Y N 
5.21 1.04 10 2 N N 
2.61 0.52 2.5 0.5 Y N 
PEG45-b-
p((HPMA50)-
co-
EGDMA0.95) 
9200 78.6 
6.389 1.28 5 1 Y Y 
6.389 1.28 10 2 Y N 
6.389 0.64 5 1 Y N 
3.19 0.64 2.5 0.5 Y N 
PEG45-b-
p((HPMA80)-
co-
EGDMA0.95) 
 
13500 85.18 
11.74 2.35 5 1 Y N 
5.87 1.17 5 1 Y Y 
5.87 1.17 10 2 Y N 
5.87 0.59 5 1 Y Y 
2.93 0.59 2.5 0.5 Y Y 
PEG45-b-
p((HPMA120)-
co-
EGDMA0.95) 
19300 89.64 
5.58 1.12 5 1 Y N 
5.58 1.12 10 2 Y Y 
5.58 0.58 5 1 Y N 
2.79 0.56 2.5 0.5 Y N 
PEG113-b-
p((HPMA50)-
co-
EGDMA0.95) 
12200 59 
8.47 1.69 5 1 Y Y 
8.47 1.69 10 2 Y N 
4.24 0.58 2.5 0.5 Y Y 
PEG113-b-
p((HPMA80)-
co-
EGDMA0.95) 
16500 69.97 
14.34 2.87 5 1 Y N 
7.18 1.44 5 1 Y N 
7.18 1.44 10 2 Y N 
7.18 0.72 5 1 Y N 
3.59 0.72 2.5 0.5 Y Y 
PEG113-b-
p((HPMA120)-
co-
EGDMA0.95) 
22300 77.58 
6.45 1.29 5 1 Y N 
6.45 1.29 10 2 Y N 
3.22 0.64 2.5 0.5 Y Y 
 
Table 6.15: Overview of other LPV loading studies using amphiphilic branched 
copolymer nanoparticles prepared via rapid nanoprecipitation from acetone.   
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Table 6.15 shows that loaded LPV nanoparticles can be generated consistently using 
a variety of branched copolymers. As the PEG increases in length, the ability to form 
loaded nanoparticles that remain stable for 1 day increases.  Branched A-B block 
copolymers containing short PEG chains are incapable of producing loaded 
nanoprecipitates with LPV that remain stable for over 5 days, however, the longer 
chain PEG containing branched polymers do have an ability to do so under varying 
conditions. 
Table 6.16 indicates the z-average diameters of a series of loaded nanoprecipitates, 
ranging from 220 nm (PEG45-b-p(HPMA80)-co-EGDMA0.95)) to 456 nm (PEG113-b-
p(HPMA50)-co-EGDMA0.95)), it should be noted that these systems all remained 
stable for > three days before subsequent precipitation.  
A higher starting LPV concentration in acetone (10 mg mL
-1
), was also investigated, 
where copolymer concentration in acetone was kept at approximately 5 mg mL
-1
 
(concentration adjusted for HPMA content). Therefore, the final nanoparticle 
suspensions concentrations were 1 mg mL
-1 
(LPV) and approximately 1 mg ml
-1
 
(copolymer).  A target DPn of 80 monomer units for the primary chain length was 
chosen for this more detailed study as LPV availability was limited and other 
p(HPMA) primary chain lengths had been excluded by earlier testing.  Unfortunately 
PEG17-b-p(HPMA80)-co-EGDMA0.95) nanoparticles rapidly precipitated after 
synthesis of nanoparticles and therefore could not be analysed, PEG45-b-p(HPMA80) 
-co-EGDMA0.95) and PEG113-b-p(HPMA80)-co-EGDMA0.95) nanoparticles, however, 
remained stable for > 5 days.  All z-average diameters of loaded nanoparticles were 
higher than blank nanoparticles, indicative of LPV encapsulation.  This is shown for 
sample copolymer-LPV systems in Figure 6.27, where target DPn = 80 monomer 
units.   
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Copolymer 
Starting 
Concentration 
(mg mL
-1
) 
Final 
Concentration 
(mg mL
-1
)
 
Z-Average 
Diameter 
(nm)
 
Polydispersity 
     
PEG17-b-p((HPMA50)-
co-EGDMA0.95) 
5.52 1.1 234 0.4290 
PEG17-b-p(HPMA80) -
co-EGDMA0.95) 
5.32 1.06 284 0.4620 
PEG17-b-p(HPMA120-
co-EGDMA0.95)) 
5.21 1.04 276 0.4850 
PEG45-b-p(HPMA50) -
co-EGDMA0.95) 
6.39 1.28 313 0.2030 
PEG45-b-p(HPMA80) -
co-EGDMA0.95) 
5.87 1.17 220 0.1760 
PEG45-b-p(HPMA120) -
co-EGDMA0.95) 
5.58 1.12 255 0.3710 
PEG113-b-p(HPMA50) -
co-EGDMA0.95) 
8.47 1.69 456 0.1370 
PEG113-b-p(HPMA80) -
co-EGDMA0.95) 
7.18 1.44 335 0.2920 
PEG113-b-p(HPMA120-
co-EGDMA0.95)) 
6.45 1.29 234 0.3360 
 
Table 6.16: Analysis of PEGx-b-(p(HPMA)-co-EGDMA0.95)) /LPV loaded 
nanoparticles using rapid nanoprecipitation (five-fold dilution). Concentrations 
adjusted for p(HPMA) content. LPV starting concentration 5 mg mL
-1
, final 
concentration 1 mg mL
-1
. 
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Figure 6.27: Analysis of LPV loaded PEGx-b-(p(HPMA)-co-EGDMA0.95)) and blank 
nanoparticles prepared using rapid nanoprecipitation (five-fold dilution). Copolymer 
concentrations adjusted for p(HPMA) content (see Table 6.16). (Approximately 5 
mg mL
-1
 starting concentration, 1 mg mL
-1
 final concentration). (A) PEG17, (B) 
PEG45, (C) PEG113. 
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Figure 6.27 suggests nanoparticles could successfully encapsulate LPV, 
characterised by an increase in z-average diameter as LPV concentration increases 
(for PEG45-b-p(HPMA80)-co-EGDMA0.95) and PEG113-b-p(HPMA120-co-
EGDMA0.95)).  Figure 6.27 (A) shows peak overlay between loaded and unloaded 
nanoparticles, this may suggest a proportion of nanoparticles contain no, or very 
little, encapsulated LPV.  It is shown in Figure 6.27 (B) that z-average diameter 
increases as LPV concentration increases; this may indicate that similar numbers of 
nanoparticles are formed during nanoprecipitation which have significantly more 
dense hydrophobic cores.  Figure 6.27 (C) shows the same trend of z-average 
diameter increase with increasing LPV, however in this case z-average diameter does 
not increase in regular intervals (seen in Figure 6.27 (B)), the reason for this is 
unknown.   
6.11 Summary  
This chapter has reported the facile nanoprecipitation of amphiphilic linear and 
branched block copolymers, where various preparation methods have been 
evaluated.  Data consistently show that linear copolymers do not form stable 
nanostructures in water, whereas amphiphilic A-B block copolymers with branched 
p(HPMA) structures do form stable nanoparticles when produced by rapid 
nanoprecipitation. Trends in nanoparticle size/polydispersity were investigated by 
producing a large screen where copolymers (of varying amphiphilicity) were 
nanoprecipitated to various dilutions, however, clear and trends could not be found.  
The stability of nanoparticles has been evaluated by conducting a serial aqueous 
dilution experiment showing little change in z-average diameter during dilution.  The 
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surface charge of PEG containing copolymer nanoparticles was also investigated 
where particles become more positive as copolymer PEG content increases. The 
loading capacity of a variety of copolymer nanoparticles with guest-molecules has 
also been evaluated with data suggesting stability/loading is proportional to PEG 
chain length. A series of LPV-loaded nanoparticles that exhibit stability for greater 
than 5 days have been produced and further research is required to evaluate these in 
relevant cell and in vivo models. 
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7. Conclusions and Further Work 
 
7.1 Overview of Chapter 3 
Methanolic ATRP was used to synthesise linear p(HPMAx) using a facile one-pot 
methodology.  By varying the ratio of initiator:monomer feed, homopolymers with 
varying chain lengths (50, 80, 120 monomer units) could be generated.  
1
H NMR 
spectroscopic analysis confirmed all reactions proceeded to > 99 % conversion, 
judged by the disappearance of monomer vinyl proton resonances.  Through GPC 
analysis, actual Mn   was found to be extremely close to predicted Mn for all polymer 
samples, where Mw/Mn remained low.  Detailed kinetic analysis showed that all 
polymerisations proceeded in a controlled manner with excellent correlation to 
expected ATRP behaviour.  A self-blocking experiment also confirmed that chain 
end functionality was maintained at relatively high conversion, generating block 
copolymers with a narrow molecular weight distribution and accurate molecular 
weight.  Branched p(HPMA) copolymers were prepared using the same one-pot 
methodology where (ratio of initiator:EGDMA was kept constant at 1:0.95) 
producing soluble high molecular weight material analysed by triple detection GPC. 
It has been shown that a variety of p(HPMA) primary chain lengths could be targeted 
(DPn = 50, 80, 120 monomer units), where detailed kinetic analysis showed little 
differences between linear and branched reactions.  The evolution of branching 
during copolymerisation was characterised by triple detection GPC analysis, 
performed at regular intervals, showing a dramatic increase in molecular weight at 
high conversion, consistent with reported Monte Carlo modelling predictions for 
branched vinyl polymerisation using controlled radical techniques.  GPC analysis of 
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repeat polymerisations confirmed near identical molecular weights could be attained 
for both linear and branched materials, which has not been reported in the literature. 
It is believed EGDMA has been successfully incorporated into p(HPMA) chains, 
however, GPC analysis showed that a branching density was varied in all samples; in 
order to determine the fraction of linear material, a UV active brancher analogue 
could be employed.  Provided the analogue behaves similarly to EGDMA, GPC 
analysis using a UV detector could potentially determine the fraction of linear 
material present.  In order to obtain solely branched copolymers, fractionation 
techniques could be employed.  
7.2 Overview of Chapter 4  
It has been shown that nanoparticles comprised of p(HPMA) polymers (with linear 
and branched architectures) can be prepared by a variety of methods using a solvent 
switch from acetone to water.  The different methods were evaluated and it is 
proposed that using a rapid nanoprecipitation technique is an extremely reliable and 
reproducible method.  The stability of linear polymer nanoparticles has been shown 
to be extremely limited; however, when polymers with a branched architecture are 
used, nanoparticles were shown to be highly stable with respect to time, dilution and 
sonication, where little changes in z-average diameter and dispersity were found. 
Reports in the literature of the preparation of nanoparticles comprised of branched 
vinyl copolymers have not been found and this research opens new avenues of 
investigation.  Aqueous nanoparticle dispersions were analysed using DLS and 
variation of size from < 100 nm in diameter to over 700 nm was obtainable. The 
range of z-average diameters were correlated to a series of simple systematic 
variation of polymer and processing parameters.  A large nanoparticle screen was 
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produced using three branched p(HPMA) copolymers where comparisons between 
primary chain length and nanoparticle z-average diameter were investigated; a link 
between dilution ratio and polydispersity of nanoparticles was found which has not 
been reported in the literature.  Nanoparticle formation has been shown to be highly 
reproducible and a nucleation-growth mechanism has been proposed.  It is 
speculated that nanoparticle stability arises from electrostatic repulsion whereby 
nanoparticles de-stabilise during the addition of a salt solution.  Data has suggested 
that small oligomeric units of p(HPMA) present within branched copolymer samples 
exert some aqueous stability and branched-block copolymers were synthesised to  
remove these chains and test the hypothesis.  Subsequent nanoparticles showed 
limited stability, characterised by precipitation after approximately seven days 
supporting this theory, however, repeat analysis would be necessary to support this 
theory.  Similarly, the introduction of other monomers (hydrophilic or hydrophobic), 
to form branched statistical copolymers, would reveal interesting insight into the role 
of the chemistry of the primary polymer chains with respect to nanoparticle 
formation, size control and stability. 
7.3 Overview of Chapter 5 
A macroinitiator approach was used to synthesise linear and branched amphiphilic 
A-B block copolymers.  Through simple esterification reactions, a variety of PEG-
based macroinitiators were generated with varying chain length (750 g mol
-1
, 2000 g 
mol
-1
 and 5000 g mol
-1
).  These were used to synthesise linear and branched 
p(HPMA) to varying target DPn using an identical experimental protocol for ATRP 
homopolymerisations and copolymerisations with EGDMA.  Kinetic analysis 
suggested all polymerisations proceeded by conventional ATRP mechanisms and 
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were shown to be reproducible. Polymer molecular weight distributions were narrow 
for linear architectures and extremely broad for branched polymerisations.  It has 
been shown that amphiphilic copolymer chains can be extended using a “self-
blocking” technique, producing polymers with accurate molecular weights.  It is 
believed that this is the first report of amphiphilic branched A-B block copolymer 
synthesis using a macroinitiator strategy thus leading to systematic variation of 
branched copolymer chemistry. 
7.4 Overview of Chapter 6 
Amphiphilic linear and branched block copolymers were used to synthesise 
nanoparticles using various precipitation methodologies, similar to homopolymer 
nanoprecipitation studies.  It was shown that linear copolymers do not form stable 
structures when processed in this way in water, similar to the linear homopolymers 
studied in Chapter 4.  Amphiphilic branched A-B block copolymers have been 
shown to form stable nanoparticles using a rapid nanoprecipitation approach.  Trends 
in nanoparticle size/polydispersity were investigated by producing a large screen 
where copolymers (of varying amphiphilicity) were nanoprecipitated using various 
dilutions.  The stability of nanoparticles has been evaluated by conducting a serial 
aqueous dilution experiment showing little change in z-average diameter during 
dilution.  The surface charge of PEG containing copolymer nanoparticles was also 
investigated where particles become less negative as copolymer PEG content 
increases.  It has also been shown that linear and branched amphiphilic copolymers, 
with significant PEG content, appear to dissolve in water and acetone but close 
observation suggests that association does occur; the impact (positive or negative) on 
the nucleation and growth of nanoparticles during nanoprecipitation is unknown.  
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The loading capacity of a variety of copolymer nanoparticles was investigated using 
Oil red O, Pyrene, and Ibuprofen.  Data suggested that stability/loading is 
proportional to PEG chain length.  Fluorescence studies using Pyrene loaded 
nanoparticles are required to accurately determine loading capacity and confirm the 
presence of pyrene within the hydrophobic environment (i.e. nanoparticle cores). 
The hydrophobic antiretroviral drug Lopinavir (LPV) has been used as a model for 
preliminary encapsulation experiments.  Data has shown that the drug co-exists 
within a series of branched copolymer nanoparticles characterised by no visual LPV 
precipitation or crystallisation for up to five days in an aqueous environment.  In 
many cases, instability and a lack of successful loading was observed.  Further 
optimisation of experimental protocol is necessary to produce near monodisperse 
nanoparticle suspensions.  This may be achieved through variation of concentration 
parameters of both polymer and LPV, perhaps using more dilute solutions to 
generate stable dispersions.  Loading of LPV also could be analysed through 
14
C-
radiolabelling of the drug.  Rigorous toxicity screening is essential to ensure that 
excipients in any proposed drug formulation are safe.  Therefore, performing a 
cytotoxicity evaluation of the following materials would be necessary. 
1. Individual monomers 
2. Copolymers 
3. Unloaded nanoparticles 
4. Loaded nanoparticles 
An initial cytotoxicity screen of various candidate methacrylate monomers was 
performed in collaboration with the Department of Molecular and Clinical 
Pharmacology, University of Liverpool.  In this study, the individual methacrylate 
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monomers (dissolved in phosphate buffered saline), were studied against Caco-2 
cells, a model of the human gut epithelium and the observed luminescence is 
proportional to cell count, which was measured as the concentration of monomer 
increased from 0.01 to 5 w/v %.  Figure 7.1 suggests PEGMA is not toxic to Caco-2 
cell lines, as the amount of luminescence is relatively unchanged throughout the 
experiment.   
 
Figure 7.1: Cytotoxic assay of methacrylate monomers using a Caco-2 cell line. 
All other monomers were shown to be toxic to this cell line at varying degrees, 
where cell death became significant at approximately 0.1 w/v % for EGDMA, for 
example.  This experiment suggests that polymers which are used in drug delivery 
systems must be extensively purified in order to completely remove un-reacted 
monomer. Interestingly, OEGMA (a short PEG chain equivalent of PEGMA) 
showed significant toxicity, suggesting a correlation with PEG chain length that, to 
the best of our knowledge, is not reported in the literature.  If polymerisations can be 
forced to achieve > 99 % conversion (as was the case in this thesis) the issue of 
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residual monomer toxicity becomes less significant and polymer toxicity must be 
established.  
The amphiphilic branched copolymers synthesised in this thesis have the potential to 
form reproducible aqueous nanodispersions using an extremely facile methodology, 
which load LPV as a model HIV/AIDS drug. With further optimisation of synthetic 
conditions, it is thought z-average diameter may be controlled by the simple 
adjustment of concentration parameters, which may be useful for cell uptake studies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 7 
378 
 
 
Chapter 8 
379 
 
8. Appendices 
 
 
 
Appendix 1.1 
 
ARV Type 
FDA 
Approval 
Brand name Generic name Manufacturer 
Fusion 
inhibitors 
2003 Fuzeon Enfuvirtide (T-20) 
Roche Pharmaceuticals & 
Trimeris 
2007 
Selzentry 
(US) 
Celsentri 
(Europe) 
Maraviroc 
 
 
Viiv healthcare co 
 
Nucleoside 
reverse 
transcriptase 
inhibitors 
1987 Retrovir Zidovudine (AZT) GlaxoSmithKline 
1991 Videx Didanosine (ddl) Bristol-Myers Squibb 
1992 Hivid Zalcitabine (ddC) Roche Pharmaceuticals 
1994 Zerit Stavudine (d4T) Bristol-Myers Squibb 
1995 Epivir Lamivudine (3TC) GlaxoSmithKline 
1998 Ziagen Abacavir (ABC) GlaxoSmithKline 
2001 Viread 
Tenofovir disoproxil 
(TVD) 
Gilead Sciences 
2003 Emtriva Emtricitabine (FTC) Gilead Sciences 
Non-
nucleoside 
reverse 
transcriptase 
inhibitors 
1996 Viramune Nevirapine (NVP) Boehringer lngelheim 
1997 Rescriptor Delavirdine (DLV) Pfizer 
1998 Sustiva Efavirenz (EFV) Bristol-Myers Squibb 
2008 Tntelence Etravirine (ETR) Tibotec Therapeutics 
Protease 
inhibitors 
1995 Invirase Saquinavir (SQV) Roche Pharmaceuticals 
1996 Norvir Ritonavir (RTV) Abbott Laboratories 
1996 Crixivan Indinavir (IDV Merck 
1997 Viracept Nelflnavir (NFV) Pfizer 
1999 Agenerase Amprenavir (APV) GlaxoSmithKline 
2000 Kaletra 
Lopinavir + Ritonavir 
(LPV/r) 
Abbott Laboratories 
2003 Reyataz Atazanavir (ATV) Bristol-Myers Squibb 
2003 Lexiva Fosamprenavir (FPV) GlaxoSmithKline 
2005 Aptivus Tipranavir (TPV) Boehringer lngelheim 
2006 Prezista Darunavir (DRV) Tibotec Therapeutics 
Integrase 
inhibitors 
 
2007 Isentress Raltegravir Merck 
 
FDA approved antiretroviral drugs  
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Appendix 3.1 
 
 GPC (THF eluent) chromatograms for the kinetics study of the copolymerisation of 
HPMA and EGDMA by methanolic ambient ATRP to form p((HPMA80)-co-
EGDMA0.95). 
Appendix 3.2  
 
GPC (THF eluent) chromatograms for the kinetics study of the copolymerisation of 
HPMA and EGDMA by methanolic ambient ATRP to form p((HPMA120)-co-
EGDMA0.95). 
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Appendix 3.3 
 
Overlaid GPC chromatograms of p(HPMA80) (solid line) and p((HPMA80)-co-
EGDMA0.95) (dashed line). 
 
Appendix 3.4 
 
Overlaid GPC chromatograms of p(HPMA120) (solid line) and p((HPMA120)-co-
EGDMA0.95) (dashed line) 
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Appendix 3.5 
 
Weight average molecular weight and dispersity vs. conversion (%) plots determined 
during the kinetics study of the copolymerisation of HPMA and EGDMA by 
methanolic ambient ATRP to form p((HPMA80)-co-EGDMA0.95). 
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Appendix 3.6 
 
Weight average molecular weight and dispersity vs. conversion (%) plots determined 
during the kinetics study of the copolymerisation of HPMA and EGDMA by 
methanolic ambient ATRP to form p((HPMA120)-co-EGDMA0.95). 
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Appendix 4.1 
 
 
 
1
 H NMR of Acetone (A) and a nanosuspension comprised of p(HPMA80-co-
EGDMA0.95)  (B) showing no residual acetone.  Both recorded in D2O. 
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Appendix 4.2 
 
 
 
Control of particle z-average diameter by varying initial copolymer concentration in 
acetone for p((HPMA80)-co-EGDMA0.95). 
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Appendix 4.3 
 
Control of particle z-average diameter by varying initial copolymer concentration in 
acetone for p((HPMA120)-co-EGDMA0.95). 
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Appendix 4.4 
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PEGx-b-(p(HPMAy)-co-EGDMA0.95) nanoparticle size analysis using rapid 
precipitation with varied dilution ratios. 
 
Appendix 6.2 
 
DLS characterisation of branched copolymers dissolved in acetone at 10 mg ml
-1
 
measuring size distribution by number. 
 
